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ABSTRACT 

Background 
The Achilles tendon connects the calf muscles (gastrocnemius-soleus muscles) to the 
heel bone (calcaneus) and despite being the strongest and thickest tendon in the 
human body it is commonly injured in both recreational and professional sports. 
Although the mechanisms causing Achilles tendon injuries are poorly understood, 
both extrinsic and intrinsic risks factors have been implicated in the development of 
signs and symptoms of Achilles tendon ruptures (acute injuries) or Achilles 
tendinopathies (chronic overuse injuries). Although inconclusive, some 
investigators have shown that the ABO blood group system is associated with 
Achilles tendon ruptures and Achilles tendinopathies. This suggested that either the 
ABO gene or another closely linked gene(s) on the tip of the long arm of 
chromosome 9 (9q32-q34.3) could be associated with tendon injuries. Although a 
direct link between the ABO gene and tendon injury can not be excluded, it is more 
likely that another gene or several genes linked to the ABa gene on the 9q32-q34.3 
locus, which encode for structural or functional components of tendons, would be 
directly linked to tendon pathology. It is possible that any protein found in the 
extracellular matrix (ECM) of a tendon regardless of its gene's chromosomal location 
is an ideal candidate for tendon pathology. However, in this thesis only genes 
located in the 9q32-q34.3 locus were investigated. 
Aims and Objectives 
This main purpose of this thesis was therefore to investigate whether any specific 
genes on the tip of the long arm of chromosome 9 were associated with Achilles 
tendon injuries, using a case-control study design. The specific objectives were: (i) to 
identify all genes located in the 9q32-q34.310cus in close proximity to the ABO gene, 
that could be involved in tendon injuries (Chapter 2) and (ii) to investigate the 
xii 
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possible association of the identified candidate genes (COLSAl and TNq with both 
Achilles tendon rupture and chronic Achilles tendinopathy (Chapter 3 and 4) and 
(iii) finally to investigate the possible interaction of these two genes with tendon 
function, namely the muscle-tendon unit flexibility (chapter 5) and structure, namely 
the morphological changes of the Achilles tendon (Chapter 6). 
Methods 
One-hundred and twenty-two physically active Caucasian patients with a current or 
.past clinical history of Achilles tendon injury (ATI), including 79 with chronic 
tendinopathies (TEN) and 43 with tendon ruptures (RUP), were included in the 
thesis. Another group of 131 physically active Caucasian control (CON) subjects 
without any history of Achilles tendon injury symptoms were also included. The 
subjects were matched for age of onset of injury and gender. To avoid any possible 
effects of population stratification, the ATI and CON groups were also matched for 
their country of birth. Because of missing information on some of the measurement 
outcomes, the number of subjects reported in each section of the thesis differ slightly 
(Chapters 2, 3 and 4). In chapter 5, a sub-set of 71 male and female ATI subjects 
(designated ATI-F, F for flexibility) and a sub-set of 37 male and female CON 
subjects (designated CON-F) included in the CON were invited to participate in a 
sub-study to explore the COL5Al and TNC genotype effect on muscle tendon unit 
flexibility using the clinical measurement of range of motion (ROM). The ATI-F 
group consisted of 38 subjects diagnosed with chronic Achilles tendinopathy (TEN­
F) and 33 with Achilles tendon rupture (RUP-F). In chapter 6, a sub-set of 36 male 
subjects diagnosed with chronic Achilles tendinopathy (designated TEN-M, M for 
morphology) and a sub-set of 22 male CON subjects (designated CON-M) were 
selected and also invited to participate in a sub-study to investigate the COLSAl and 
TNC genotype effect on Achilles tendon morphology using grey scale and colour 
Doppler ultrasonography. 
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An experienced clinician made the diagnosis of chronic Achilles tendinopathy in the 
TEN sub-group using clinical criteria. The diagnostic criteria for every subject were 
reviewed by a sports physician using validated clinical criteria. In addition to these 
clinical diagnostic criteria, soft tissue ultrasound examination was performed in a 
sub-group of subjects in both the CON and ATI groups (Chapter 6). The diagnosis 
of Achilles tendon rupture was made clinically using standard validated criteria and 
confirmed in all cases by examination at the time of surgery and/or an imaging 
technique. Subjects who had a history of current or past fluoroquinolone antibiotic 
use or previous local corticosteroids injection in the Achilles tendon or the area 
surrounding the Achilles tendon were excluded from the study. Furthermore, 
subjects who had been diagnosed with any connective tissue disorders or any other 
systemic diseases believed to be associated with Achilles tendon pathology were 
also excluded from the study. 
Approximately 4.5 ml of venous blood was collected from subjects and DNA was 
extracted and genotyped for polymorphisms within both COLSAl and TNC genes 
(Chapter 3 and 4) and ABO blood group determined (Chapter 2). 
Genes that flank the ABO gene were identified by searching the OMIMTM (Online 
Mendelian Inheritance In Man), NCBI Map Viewer and Entrez Gene internet-based 
databases. Since the ABO gene has been mapped to the human chromosome 9q34, 
all genes mapped from 9q32 to the end of the chromosome 9 (q34.3) were initially 
identified. Genes were included as possible candidate genes for tendon pathology if 
they encoded for proteins that formed an integral structural component of the 
extracellular matrix (ECM). Since tenocytes have been shown to play an important 
role in tendon pathology, genes encoding for proteins involved in cell proliferation, 
cell death (specifically apoptosis) and other miscellaneous processes were also 
identified. The biological function of the proteins encoded for by the genes on the 
xiv 
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telemetric end of the long arm of chromosome 9 were identified from their 
functional descriptions in the databases. 
Results 
Using internet-based genetic databases, a total of 404 genes located on the tip of the 
long arm of chromosome 9 (9q32-q34.3 locus) closely linked to the ABO gene were 
identified (chapter 2). After retrieving and interpreting all the summary information 
provided on the databases for each gene, 21 possible candidate genes were 
identified, which could theoretically be associated with Achilles tendon injuries. 
However, because the information for most genes was scanty it is very likely that 
more candidate genes in the 9q32-q34.2 locus could be identified in the future as the 
information and knowledge on these genes. become available. Of the 21 genes, 2 
coded for structural proteins found in tendons, namely the COL5Al and TNC genes. 
Therefore, in this thesis polymorphisms within these two genes were further 
investigated (chapters 3 and 4). 
An additional objective of this thesis was to determine if the ABO blood group 
distribution was associated with Achilles tendon injuries in a South African 
Caucasian population. The percentage of individuals with blood group a and the 
A/a ratio were similarly distributed between the CON and ATI groups, as well as 
TEN and RUP sub-groups. 
In chapter 3, 116 A TI and 129 CON subjects were genotyped for the BstUI and DpnII 
restriction fragment length polymorphisms (RLFPs) within the COLSAl gene, which 
encode for a component of type V collagen. There was a significant difference in the 
allele frequencies of the COL5Al BstUI RLFP between the ATI and CON subjects 
(p=0.006). The frequency of the A2 allele was significantly higher in the CON group 
(29.8%) than in the ATI group (18.0%) (odds ratio of 1.9; 95% CI 1.3-3.0; p=0.004). 
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The A2 allele was strongly over-represented in the CON group when only the 76 
patients diagnosed with chronic Achilles tendinopathy were analyzed (odds ratio of 
2.6; 95% CI 1.5-4.5). 
In Chapter 4, 114 A TI and 127 CON subjects were genotyped for a GT dinucleotide 
repeat polymorphism within the TNC gene. The TNC gene encodes for a protein, 
tenascin-C, which is also a component of tendons. A significant difference in the 
allele frequencies of the GT dinucleotide repeat polymorphism was found between 
the CON and ATI groups (Chi square=51.0, p=O.OOl). The frequencies of the alleles 
containing 12 repeats (ATI, 18.9% vs CON, 10.2%) and 14 repeats (ATI, 9.2% vs 
CON, 0.8%) were significantly higher (over-represented, 0) in the ATI group, while 
the frequencies of the alleles containing 13 repeats (ATI, 8.8 % vs CON, 24.0%) and 17 
repeats (ATI, 7.5% vs CON, 20.1 %) were significantly lower (under-represented, u) 
in the ATI group. Subjects who were homozygous or heterozygous for the under­
represented alleles (13 and 17 repeats), but who did not possess an over-represented 
allele (12 and 14 repeats) were theref re at a lower risk of developing Achilles 
tendon injuries (odds ratio, 6.2; 95% CI, 3.5-11.0; p<O.OOl). 
The matching of subjects in chapters 3 and 4 was based on age-at-onset for Achilles 
tendon injury and therefore it was difficult to match for important variable such age, 
in the measurement of flexibility (Chapter 5) and morphological changes in the 
tendon (Chapter 6). To overcome this problem, both asymptomatic and 
symptomatic subjects were divided into the respective allele groups (over­
represented and under-represented) for both COL5Al (A2 and AllA3 alleles) and 
TNC genes (0 and U alleles). 
The range of motion (ROM) measurements of the upper and lower limb extremities 
as measured by a modified standard goniometer and the sit and reach test were 
used as proxy for muscle tendon unit flexibility for a particular joint motion. Except 
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for the non-dominant ankle dorsiflexion ROM in the ATI-F sub-group, there were no 
differences found in the lower limb flexibility measurements between the A2 and 
AllA3 COL5Al genotype groups of the CON-F as wells as the ATI-F subjects. The 
non-dominant ankle dorsiflexion (ND-ADF) was significantly greater in the A TI-F 
subjects with the AllA3 allele (61 ± gO) when compared to the ATI-F subjects with 
the A2 allele. (55 ± gO) (p=O.046). Except for the dominant ankle dorsiflexion ROM in 
the ATI-F group, there were no significant differences in the lower limb flexibility 
measurements between the control (CON-F) subjects with under-represented, even 
and over-represented alleles. The dominant ankle dorsiflexion was significantly 
greater in the A TI-F subjects wit the under-represented alleles (61 ± 8°) when 
compared to ATI-F subjects with the over-represented allele (54 ± 11°) (p=O.047), but 
not different to the ATI subjects with evenly distributed alleles. 
The mean age, weight and BMI were consistently higher in the Achilles 
tendinopathy group compared to the control group. Therefore, for the subsequent 
analysis of the COL5Al and TNC genotype effects on Achilles tendon morphology, 
both the CON-M and TEN-M groups were analysed separately to eliminate any 
possible effect these factors might have on flexibility. The mean pathology scores 
between the individuals without the A2 allele of the COL5Al gene were not 
significantly different from the mean pathology score for individuals containing the 
under-represented alleles (A2) in both the CON-M and TEN-M groups. However, it 
was interesting to note that in the whole CON-M group only individuals without the 
A2 alleles displayed some tendon pathology, while none of the 7 individuals with 
the A2 allele had an abnormal tendon morphological changes when examined using 
ultrasonography. This observation warrants further investigation. There were no 
significant differences in the mean pathology scores of the control subjects with 
over-represented (CON-M-O) and those under-represented (CON-M-U) as well as 
between the Achilles tendinopathy subjects with the overrepresented (TEN-M-O) 
and those with underrepresented (TEN-M-U) allele. 
xvii 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Conclusions 
It has so far been suggested that several extrinsic and intrinsic risk factors, might 
playa role in tendon injuries. However to date no specific genetic factor(s) has been 
identified. Twenty-one genes closely linked to the ABO gene, located on the long 
arm of chromosome 9 (9q32-q34.2), which could theoretically be involved in tendon 
structure and/or function and possibly tendon pathology were identified in this 
thesis. Of the 21 genes, 2 genes that code for tendon structural proteins, namely the 
COLSA1 and TNC genes were selected. The BstUI RFLP within the COL5A1 gene 
was associated with Achilles tendon injuries and more specifically, chronic Achilles 
tendinopathy. Individuals with an A2 allele of this gene were under-represented in 
the subjects with symptoms of chronic Achilles tendinopathy, while the AI/A3 
alleles were over-represented in the control subjects. The GT dinucleotide repeat 
polymorphism within intron 17 of the TNC gene is associated with the symptoms of 
Achilles tendon injury. Alleles containing 12 and 14 GT repeats were over­
represented in the subjects with Achilles tendon injuries, while the alleles containing 
13 and 17 repeats were under-represented. The thesis found that the different 
polymorphisms of both COLSA1 and TNC genes were not associated with 
measurements of range of motion in the lower limb joints tested. The results, 
therefore suggest that both the COLSA1 and TNC genes do not influence the ROM 
measured. Although it was a pilot study, the use of grey scale and Doppler 
ultrasonography to detect tendon morphological changes appear to be highly 
correlated with tendon morpholOgical changes, at least in the Achilles tendon. This 
study did not show that specific polymorphisms with the COL5A1 and TNC genes 
were associated with Achilles tendon morphological changes. However, the fact that 
none of the CON-M subjects with the A2 allele of the COLSA1 gene had pathological 
morphology while examined using ultrasonography warrants further investigation. 
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In conclusion, although it has been suggested for several years that there is a genetic 
risk factor (s) that may be related to Achilles tendon injuries, this is the first study to 
identify specific genetic elements, namely the COL5Al and TNC genes, to be 
associated with Achilles tendon injuries. 
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CHAPTER ONE LITERA TURE REVIEW 

1.1 INTRODUCTION AND THE SCOPE OF THE THESIS 
The Achilles tendon (AT) is the largest and strongest tendon in the human body 
(O'Brien, 1992) but is commonly injured in sports and physical activity related 
events (Kannus and Natri, 1997). Although details of the classification of AT injury 
will be discussed later in this thesis (section 1.2), broadly speaking, AT injury can 
present clinically as a gradual onset injury (chronic tendinopathy) or an acute onset 
injury (partial or complete AT rupture). Although many aspects of these injuries to 
the AT have been documented, the exact aetiology and pathogenesis leading to an 
AT injury is not fully understood (Kannus et al., 2004; Jarvinen et al., 2005; Riley, 
2004). To date, research on AT ruptures has focused primarily on its management 
(surgical versus non-surgical) rather than on its aetiology. With regard to chronic 
Achilles tendinopathy, the debate is about the use of corticosteroids and non­
steroidal anti-inflammatory drugs (NSAIDS) in a condition that appears to be 
mainly degenerative in nature rather than inflammatory as initially thought, at least 
in its chronic stage (Khan et al., 2002; Kannus et al., 2004). Until recently, the role of 
other treatment modalities such as rest, physical modalities (ice, ultrasound, laser, 
electrical stimulation), stretching and eccentric strengthening exercises in chronic 
Achilles tendinopathy has not generated as much interest as the use of medication 
(corticosteroids and NSAIDS). 
However, common to all researchers dealing with AT rupture and chronic Achilles 
tendinopathy is the fact that the number of patients seeking medical treatment as a 
result of Achilles tendon injuries appear to have increased since the early 1950s, 
more especially in the Western countries (Barfred, 1973; Jozsa et al., 1989; Sandelin et 
al., 1988). This is believed to be as a result of an increased availability of leisure 
time, increase in participation in recreational sport and physical activity, and an 
increase in the absolute time spent in training and intensity of training in the case of 
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professional athletes (Jarvinen, 1992). This increased participation in physical 
activity has been attributed partly to the jogging boom in the early 1970s and 1980s, 
resulting in even older individuals participating in recreational sports for many 
years (Smart et al., 1980). A higher number of older individuals generally lead 
sedentary lifestyles and tend to participate intermittently, but not regularly in 
recreational sports. This could also increase the risk for injuries, including AT 
injuries (Kvist, 1994). Furthermore, the increase commercialization of professional 
sport, places greater demands on the professional athlete's training habits. 
However, the increased number of Achilles tendon injuries could also be attributed 
to the absolute increase in population served by medical centers (Leppilahti and 
Orava, 1998). On the other hand, the increased number of these injuries could be as 
a consequence of increased research and publication on the subject. For example, 
J ozsa et al. (1991) reported that before 1929 there had only been 66 Achilles tendon 
ruptures reported in the medical1iterature. 
Therefore, many reasons have been proposed for the perceived increase in the 
number of Achilles tendon injuries, particularly in Western countries. However, 
there is no doubt that the absolute number of these injuries is of concern to the 
medical profession. Because of (i) the accepted benefits of exercise towards health 
(Jarvinen, 1992; Jarvinen, 2000) and (ii) the increased economic benefits of sport, it is 
highly unlikely that there will be a decrease in participation in both recreational 
physical activity and professional sport. This will in tq.rn result in more sports and 
physical activity related injuries, including Achilles tendon injuries. 
There is therefore a need to define the risk factors associated with AT injuries so that 
preventive measures can be insti.tuted and evidence-based advice may be offered to 
individuals wishing to participate in physical activity. The understanding of these 
risk factors will assist with the understanding of the aetiology and pathogenesis as 
well as possible treatment for AT injuries (Barfred, 1973). 
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Both extrinsic and intrinsic risk factors associated with either AT rupture or chronic 
Achilles tendinopathy have been widely reviewed (Kvist, 1994; Kainberger, 1997; 
Jarvinen, 1992; Jarvinen et al., 2001; Jarvinen et al., 2005; Maffulli et al., 2002; 
Paavola, 2000; Renstrom and Johnson, 1981; Riley, 2004). Extrinsic risk factors 
believed to be associated with AT injuries include occupation, physical activity, 
training errors, cold weather, running surface, shoes and other equipment. Intrinsic 
factors include previous injury, poor blood supply and nutrition, lower limb 
malalignment, reduced flexibility, male gender, systemic diseases, corticosteroids, 
quinolone antibiotics and genetic factors. Although both extrinsic and intrinsic risk 
factors will be discussed later (section 1.6), the broad focus of this thesis will be on 
the intrinsic factors that are believed to be associated with Achilles tendon injuries. 
The specific focus of this thesis will be to investigate the possible relationship 
between genetic factors and AT injuries. Genetic factors have been identified as one 
of the intrinsic risk factors for Achilles tendon injuries. However, to date no specific 
genes have been shown to be associated with these conditions. The main question 
that this thesis would like to answer is whether there are specific genetic elements 
associated with the development of AT injuries. 
In this thesis, the reader is made aware of the following: 
• 	 It is believed that in many cases, AT rupture is the end stage of a 
degenerating tendon (Arner et aI., 1959; Gibson, 2001; Kannus and Jozsa., 
1991; Kainberger et al., 1997; Tallon et al., 2001), which has been exposed to 
mechanical loading but failed to adapt adequately, resulting in inadequate 
regeneration and repair. Tallon et aL, 2001 have shown that ruptured 
tendons are more degenerated than tendinopathic tendons supporting the 
notion that tendinopathy precedes a tendon rupture. However, this is not the 
case for all tendon ruptures (see section 1.3). In a comprehensive study of 891 
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patients who had experienced various spontaneous" tendon ruptures,H 
including 397 Achilles tendon ruptures, the histopathology in the majority of 
the patient's tendon was commonly a degeneration of the tendon (Kannus 
and Jozsa, 1991). 
• 	 Therefore, in the tendon degeneration (due to mechanical load) model (see 
section 1.3), it is reasonable to assume that most risk factors associated with 
the development of AT rupture are also valid risk factors for Achilles 
tendinopathy. 
• 	 In this thesis, AT rupture and Achilles tendinopathy will be treated as two 
separate clinical entities, based mainly on the clinical diagnosis and 
supported by surgery and!or imaging results. Therefore, in this thesis, the 
term "Achilles tendon injuries" will include acute Achilles tendon ruptures 
and chronic Achilles tendinopathies (see section 1.2 for definitions). 
• 	 The main emphasis of the thesis is to identify the genetic factors associated 
with AT injury. 
It is acknowledged that there are many aspects of Achilles tendon injury that the 
review can not cover as the subject is broad as evidenced by the number of recent 
reviews on the subject (Bramono et al., 2004; Jarvinen et al., 2005; Kjaer, 2004; 
Maganaris et al., 2004; Midwood et aI., 2004; Riley, 2004; Riley, 2005a; Riley, 2005b). 
However, the review section of this thesis will focus the reader on three main areas 
that are important for the understanding of data and discussions in the subsequent 
chapters. Part one will include the classification of AT injuries (section 1.2), different 
hypotheses for the development of AT injury (section 1.3) and epidemiology of AT 
injuries (section 1.4). Part two will review the normal and pathological tendon 
structure and function, highlighting the specific features of the Achilles tendon 
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(section 1.5). 'The third part of the review will discuss the extrinsic (section 1.6.1) but 
mostly intrinsic (section 1.6.2) risk factors associated with Achilles tendon injuries. 
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1.2 CLASSIFICATION OF ACHILLES TENDON INJURIES 
The literature concerning the classification or nomenclature of Achilles tendon 
pathology is not consistent (Lesic and Bumbasirevic, 2004; Paavola et al., 2002; 
Schepsis et al., 2002). However, it appears that most researchers in the field of 
tendon pathology seem to have adopted the classification by Puddu et al. (1976) 
with some modifications. With regard to the Achilles tendon injury classifications, 
the following terms and descriptions are currently generally accepted: 
• 	 Injury can be defined as "mechanical disruption of tissues resulting in pain" 
(Kumar, 2001) 
• 	 Tendinitis can be defined as an inflammation of a tendon. However, recent 
histopathological, biochemical and molecular studies show that true 
"tendinitis" is rare and the condition is perhaps more accurately described as 
a tendinosis (degeneration disorder) (Ashe et al., 2001; Astrom & Rausing, 
1995; Khan et al., 2002; Movin et al., 1997; Paavola et al., 2002b), particularly if 
the condition is chronic (Alfredson et al., 2003). For acute tendinitis it is 
plausible that there is some transient inflammation, but that is yet to be 
shown (Kannus et al., 2004; Khan et al., 1999; Paavola et al., 2002). 
Investigations have failed to show an increased concentration of 
prostaglandin E2 (a biochemical mediator of inflammation) in patients with 
chronic Achilles tendon pain compared to normal healthy controls (Alfredson 
et al., 1999). Furthermore, there is no agreed specific time criteria to classify 
the chronicity of tendinitis (Paavola et al., 2002), although it has been 
suggested that two weeks represents acute tendinitis, 2 to 6 weeks represents 
sub-acute tendinitis, while any duration greater than 6 weeks represents 
chronic tendinitis (EI Hawary et al., 1997). 
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• 	 Tendinosis can be defined as a degeneration of a tendon substance. 
Histologically, this degeneration can be classified as hypoxic, mucoid or 
myxoid, hyaline, lipoid, fibrinoid, calcific, and a combination of the two or 
more of the above may be found in a degenerate tendon (Jozsa and Kannus, 
1997). Histopathological studies (Astrom and Rausing, 1995; Jozsa and 
Kannus, 1997) strongly suggest that the chronic tendon pain condition that 
was traditionally classified as tendinitis, is more accurately defined as 
tendinosis. However, this does not imply that the entity, tendinitis does not 
exist, at least in the acute stage of tendon adaptation to micro-injury or 
overloading (Kannus et. al., 2004). Clinically, tendinosis may be, and 
frequently is, asymptomatic (Maffuli et al., 1998). Furthermore, it is not clear 
that the disorder is purely degenerative in nature, and therefore some authors 
prefer the use of the term "tendinopathy" (Almekinders and Temple, 1998). 
• 	 Tendinopathy is a non-specific encompassing term that implies that there is 
an underlying pathology in and around the tendon (Ashe et al., 2001). It is 
often due to tendinosis but can include paratenonitis. This is because it is 
often difficult to differentiate between tendinosis and paratenonitis on a 
clinical basis (Paavola et al., 2002). Furthermore, several pathologic 
conditions of the Achilles tendons may co-exist (Schepsis et al., 2002), the 
most common of which are paratenonitis and tendinosis. The cardinal 
feature in tendinopathy is chronic pain, which has been referred to as 
"Achillodynia" (Movin et al., 1997; reviewed in Paavola et al., 2002). 
However, some authors include tendon rupture within the overall diagnosis 
of tendinopathy (Koike et al., 2004; Riley, 2004). However, in this thesis 
Achilles tendon rupture and tendinopathy are treated as two separate 
conditions. 
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The chronicity of Achilles tendinopathy is also a subject of debate and 
uncertainity, with the duration of symptoms of more than 6 weeks (Kader et 
al., 2002i Schepsis et al., 2002) or more than 2 months (Blankestein et aI, 2001) 
being regarded as chronic. However, it is generally accepted that it takes a 
long time (certainly longer than 6 weeks in the majority of cases) to treat 
chronic Achilles tendinopathy and many cases of painful tendinopathy 
persist for months, sometimes even for years (Cook et al., 2003; Riley, 2005; 
Schepsis et al., 2002). For the purposes of this thesis, the duration of chronic 
Achilles tendinopathy has been defined as symptoms lasting at least 6 
months. It is important to note that tendinopathy is a clinical diagnosis which 
can be confirmed using imaging. 
• 	 Tendon rupture can be defined as a tear of a tendon, either partially or 
completely. However, Smart et al. (1980) suggested that partial ruptures do 
not exist. These authors and others are of the opinion that what most 
clinicians refer to as 1/partial ruptures" are actually areas of focal degeneration 
(Gibbon et al., 1999; Smart et al., 1980). However, it is possible that cross­
sectional incomplete ruptures are true ruptures while longitudinal focal tears 
are not. However, clinically, a history of sudden onset of severe pain is 
indicative of an acute tendon rupture (partial or complete), while gradual 
onset of pain and discomfort is the most common clinical presentation of a 
tendinopathy (Leppilahti and Orava, 1998; Maffulli et aL, 2003; Schepsis et al., 
2002). 
• 	 Paratenonitis can be defined as an inflammation of the connective sheath 
surrounding the Achilles tendon, the paratenon, which may be accompanied 
by infiltration of inflammatory cells and blood vessels (neovascularization). 
Clinically, it presents as a gradual onset of pain and swelling (Lesic and 
Bumbasirec, 2004). It has been suggested that the pathogenesis of 
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paratenonitis includes 3 stages: acute (2 weeks), sub-acute (2-6 weeks) and 
chronic (more than 6 weeks) (Clancy et al., 1976). 
• 	 Bursitis refers to an inflammation in a bursa. In the case of the Achilles 
tendon this refers to inflammation of either the retrocalcaneal or the 
subcutaneous calcaneal bursae or both (Schepsis et al., 2002). 
The focus of this thesis was patients diagnosed with an Achilles tendon 
rupture and chronic tendinopathy. Therefore, any patient diagnosed with 
either paratenonitis or bursitis was excluded from this study. 
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1.3 	 HYPOTHESES FOR THE DEVELOPMENT OF ACHILLES TENDON 
INJURIES 
Although the exact mechanisms for Achilles tendon injuries are poorly understood, 
three main hypotheses for the development of Achilles tendon injuries have been 
proposed (Fig 1.1). These include the degeneration, pathological and failure of the 
neuro-inhibitory mechanism hypotheses. 
1.3.1 	 Degeneration hypothesis 
In the degeneration hypothesis, the tendon is believed to be exposed to repetitive 
mechanical loads, which result in microscopic damage. However, the tendon is 
unable to repair fully, leading to chronic tendinitis (an inflammatory process) or 
tendinosis (tendon degeneration). This results in a weak, inflexible and abnormal 
tendon, which can be painful and impair sports performance (Paavola et al, 2002). 
When this weak tendon is exposed to further repetitive mechanical load it fails to 
adapt and eventually ruptures. Thus, according to this hypothesis, the rupture is 
preceded by a structural weakening of the tendon. These ruptures are believed to 
contribute the majority of Achilles tendon injuries (Kannus and Jozsa, 1991). There 
is strong convincing evidence that the majority of Achilles tendon ruptures occur via 
this mechanism (Arner et al., 1959; Gibson, 2001; Kannus and Jozsa., 1991; 
Kainberger et al., 1997; Tallon et aI., 2001). Tallon et al., 2001 have shown that 
ruptured tendons are more degenerated than tendinopathic tendons, supporting the 
notion that tendinopathy precedes a tendon rupture, although this is not the case for 
all tendon ruptures. Furthermore, it has been documented that energy-storing 
tendons such as the Achilles and patella tendons are more frequently injured than 
positional tendons such as tibialis anterior tendon (Smith et al., 2002). However, 
there have been some views not supporting this hypothesis. It has been 
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documented that most of the Achilles tendon ruptures and chronic tendon injuries 
are unilateral (Inglis et al., 1976; Williams, 1986). Also, it is not clear as to the reason 
why the majority of patients who had experienced an acute Achilles tendon rupture 
have had no previous signs and symptoms of Achilles tendon pathology (Inglis et 
at, 1976). It has been documented that the majority of individuals with AT rupture 
do not experience warning symptoms prior to the injury (Kannus and Jozsa, 1991). 
It must be noted that most tendinopathies are probably a result of many factors, and 
the degenerative process that in most cases precedes tendon rupture may be a result 
of a variety of pathways and aetiological factors (Riley, 2004). Such pathways may 
include increased apoptosis (Murrell, 2002), tissue hypoxia (Arner et aI., 1959), 
persistent release of various biochemical factors such as cytokines, growth factors, 
matrix degrading enzymes and their inhibitors, pain-inducing modulators (Riley, 
2004). It has also been suggested that primary inflammatory insults may be present 
at the early phases of tendinopathy and may instigate a cascade of events leading to 
a degenerate tendon (Barr and Barbe, 2004; Kannus et al., 2004). 
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Strong "normal" Tendon 
I 
Sudden excessive 
mechanical load 
Repetitive 
mechanical load 
Systemic disease 
Failure of neuro­
inhibitory mechanism 
Chronic tendonitis 
or tendinosis 
Weak, inflexible, 
abnormal tendon 
Repetitive 
mechanical load 
Weak, inflexible, 
abnormal tendon 
Repetitive 
physiological load 
1/ 

I. Tendon rupture 1 
Fig. 1.1 Schematic diagram showing the three traditional hypotheses from left to 
right, (i) failure of the neuro-inhibitory mechanism, (ii) degeneration and (iii) 
pathological hypotheses, for the development of Achilles tendon injury 
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1.3.2 Pathological hypothesis 
In the second hypothesis, systemic disease(s) through yet largely unknown 
pathological mechanism(s), weaken the tendon. When the tendon is then exposed to 
repetitive physiological mechanical load it can cause injury including rupture. A 
detailed list of systemic diseases that have been associated with the development of 
AT injuries have been extensively described (Josza and Kannus, 1997; Riley, 2004). 
These systemic diseases associated with the development of AT injuries can be 
broadly classified into inherited, endocrine, metabolic and rheumatoid diseases. 
Some of the most common inherited systemic diseases that may be associated with 
AT injuries include Marfan's syndrome, Ehler's Danlos syndrome, Osteogenesis 
imperfecta, and lipid storage diseases. Endocrine and metabolic diseases that may 
be associated with AT injuries include diabetes mellitus and renal diseases, while 
rheumatoid diseases include rheumatoid arthritis and gout (Jozsa and Kannus, 
1997). The ruptures associated with systemic diseases are known as pathological 
ruptures. Pathological ruptures have been reported to account for only a small 
proportion of all Achilles tendon ruptures (Jozsa and Kannus, 1997; Kannus and 
Jozsa, 1991). In a comprehensive study of tendon ruptures, which included 292 
individuals who had sustained Achilles tendon ruptures, only 23 (7.8%) had a 
previous history of systemic disease (Jozsa et al., 1989). 
1.3.3 Failure of the Neuro-inhibitory mechanism hypothesis 
In the third hypothesis, it is suggested that a normal tendon ruptures when it is 
exposed to a sudden excessive load that it cannot withstand (William, 1986). These 
are referred to as acute traumatic ruptures. In this case, prior weakening of the 
tendon due to degeneration is not a requirement. In addition, the inhibitory 
neuroprotective (golgi tendon organs) mechanisms are overcome by the higher than 
normal sudden and excessive loading on the tendon. 
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From the above hypotheses, it is generally assumed that the tendon is "normal" 
(starting point, see Fig. 1.1). However, in this thesis, the possibility that due to the 
genetic background, some individuals may have tendon structure and function that 
is not able to withstand repetitive or acute mechanical loads as a result of their 
genotype will be explored. This suggests that genetic factors may, at least in part, 
determine the adaptation to the different mechanical and other stimuli, making the 
susceptibility to tendon injury variable amongst individuals. This hypothesis will be 
further explored in this review of the literature and in this thesis. 
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1.4 	 BRIEF OVERVIEW OF THE EPIDEMIOLOGY OF ACHILLES TENDON 
INJURIES 
It has been stated that between 30 to 50% of all sports injuries are overuse injuries 
(reviewed in Jarvinen, 1992), of which between 6 to 18% are overuse Achilles tendon 
injuries (Mazzone and McCue, 2002). Both acute and overuse tendon injuries are 
common in competitive and recreational sports (Jozsa et al., 1989). Amongst all 
tendon injuries, AT injuries are the most commonly associated with sports or 
physical activity (Jozsa et al., 1989). Individual national sports cultures and 
traditions can influence the nature and patterns of sports injuries in each country. 
For instance, in Canada and many European nations, soccer, badminton and skiing 
are responsible for the majority of all AT injuries (Cetti and Christensen, 1981; 
reviewed in Jarvinen, 1992; Jozsa et al., 1989; Kellam et al., 1985; Nillius et al., 1976;), 
while in the United States of America, basketball is associated with Achilles tendon 
ruptures (Inglis and Scuko, 1981). In South Africa, Pinshaw et al. (1984) showed in a 
case series study of 196 running injuries, that tendinopathy was the fifth most 
common injury among runners. Within the tendinopathy group, injury to the 
Achilles tendon was reported to be the most common (Pinshaw et al., 1984). The 
precise quantification of the occurrence of AT injuries has however not been well 
established. This is because the terms incidence (a descriptive measure of new 
occurrences during a specified period) and prevalence (a measure of the presence of 
disease or condition at a specified period or point) have frequently been used 
interchangeably. 
The majority of the data on the epidemiology of Achilles tendon injury has been 
published specifically on Achilles tendon rupture. This is possibly because it was 
easier to document an acute rupture that in most cases mandated hospitalization as 
opposed to an Achilles tendinopathy. Therefore, the following sections will focus on 
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Achilles tendon rupture to demonstrate the epidemiology of Achilles tendon injury. 
There are similarities and differences in the nature of these tvvo separate injuries that 
are highlighted on Table 1.1. Briefly, an Achilles tendon rupture has an acute onset, 
while an Achilles tendinopathy has a gradual onset (Schepsis et aL, 2002). It has 
been suggested that a rupture is associated with ball games, while an Achilles 
tendinopathy is associated with running. Also, it has been suggested that Achilles 
tendon ruptures are mostly associated with extrinsic factors, while Achilles 
tendinopathy often involves the interaction of both intrinsic and extrinsic fators 
Oarvinen et aL, 2005). 
It appears that there might be a stronger indication for involvement of genetic 
factors in Achilles tendinopathy than in ruptures. In a 8-year follow-up study of 
patients who had sustained an Achilles tendinopathy and operated on, it was found 
that unilateral injury strongly predicted future contralateral leg injury (Paavola et 
aL, 2002). However, it was also found that previous unilateral rupture also 
predicted future rupture in the other leg (Aroen et aI., 2004), but the proportion of 
individuals sustaining a bilateral Achilles tendinopathy is far larger than those 
sustaining Achiles tendon rupture. The majority of individuals sustaining an 
Achilles tendon injury are males. 
16 Department of Human Biology 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER ONE LITERATURE REVIEW 
Table 1.1 Comparison of the epidemiology of Achilles tendinopathy and Achilles 
tendon rupture 
Factor Achilles tendinopathy Achilles tendon rupture 
Onset 
Activity 
Sports 
Prevalence 
Gender 
Age 
Genetic 
predisposition 
Genetic 
Predisposition 
Gradual 
Extrinsic and intrinsic factors 
interact 
Predominantly running 
55-65% of AT injury 
Males predominate 
Peak 4th decade 
Bilateral injury common 
Unilateral injury may predict 
future injury in the 
contralaterallega 
Sudden 
Extrinsic factors predominate 
Predominantly ball games 
3% of AT injury 
Males predominate 
Peak 4th decade 
Bilateral injury rare 
Unilateral rupture may predict 
higher risk for future rupture in 
the contralaterallegb 
apaavola et aI., 2002a; bAroen et aI., 2004 
1.4.1 What is the incidence, prevalence and the trend ofAchilles tendon injury? 
It appears that the incidence of AT injuries has increased in European industrialised 
countries since the late 1950s. There is some evidence that the number and rate of 
Achilles tendon injuries has increased in the last few decades (Barfred, 1973; 
Jarvinen, 1992, Jozsa and Kannus, 1997; Leppilahti et. aI., 1996; Maffulli et. aI., 1999). 
In Hungary, the number of patients who sustained Achilles tendon ruptures 
increased 285% in males and 500% in women between two successive 7-year periods 
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Gozsa and Kannus, 1997), while in Finland the incidence increased from 2 per 
100,000 in 1986 to 12 per 100,000 on 1994 (Leppilahti et aL, 1996). In Scotland, the 
overall incidence of AT rupture increased from 4.7 per 100,000 in 1981 to 6 per 
100,000 in 1994 (Maffulli et al., 1999). 
1.4.2 When does Achilles tendon rupture occur in life? 
In the majority of studies, the peak incidence of Achilles tendon rupture occurs 
during the fourth decade of life (Table 1.1). However, two studies have reported 
another peak during the eighth decade (Maffulli et al., 1999; Moller et aL, 1996). 
Therefore, this suggested that the peak incidence of Achilles tendon rupture is 
bimodal, with the first peak associated with overuse injuries while the latter peak is 
associated with ageing-induced degeneration (Maffulli et al., 1999; Moller et aL, 
1996). 
1.4.3 Who is most affected by Achilles tendon ruptures? 
Achilles tendon rupture affects predominantly middle aged people 30-50 years old 
(Mazzone and McCue, 2002; Nillius et al., 1976; Noble, 1991), mostly with white 
collar or sedentary occupations. Athletes in running sports predominantly 
experience overuse injuries (Mazzone and McCue, 2002), whereas sports or actions 
that includes abrupt repetitive jumping and sprinting, short runs and stops, pushing 
off and quick turns such as ball games, may result in acute injury such as Achilles 
tendon rupture Gozsa et aL, 1989; Leppilahti and Orava, 1998). Between 60 to 75% of 
all AT ruptures were related to sports in contrast to other tendon ruptures, which 
recorded only a 2% association (Kannus and Natri, 1997; Josza et aL, 1989). The 
majority of AT injuries in sport were found to occur in males, presumably because 
higher numbers of males participate in sport compared to females (Kvist, 1994). 
However, it is possible that a gender difference plays a role in Achilles tendon 
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ruptures (Kvist, 1994). In the injury studies reviewed, the ratio of males to women 
has ranged from 2:1 to 18:1 (Table 1.1) 
1.4.4 How does Achilles tendon injury occur? 
Majority of Achilles tendon ruptures occur spontaneously during a sporting activity 
or through falling, tripping and push-off, with only very few resulting from trauma 
or violent forces (Jozsa et al., 1989). Many of these sports involve abrupt repetitive 
jumping and sprinting movements, such as downhill skiing, soccer, basketball, 
tennis, squash, badminton and tennis. In one study, the majority (88%) of acute AT 
ruptures had occurred in ball games (Leppilahti et al., 1996). In addition, the 
majority (70%) of athletes were recreational. (Leppilahti et al., 1996). However, it 
must be noted that professional or competitive athletes constitutes a small number 
of participants in any sport. A large proportion (80-90%) of the affected individuals 
with Achilles tendon ruptures report no previous warning symptoms before the 
rupture (Jozsa et al., 1989; Beskin et al., 1987). About 83% of the Achilles tendon 
rupture occurs 2 to 6 cm above calcaneal insertion (Jozsa et al., 1989). The onset of 
an AT rupture is sudden, while in Achilles tendinopathy, the onset is gradual (Jozsa 
and Kannus, 1997). 
1.4.5 Why does Achilles tendon injury occur? 
The increase in AT ruptures has been attributed to (i) the increased popularity of 
recreational sports (Leppilahti and Orava, 1998) (ii) to the increase in sedentary 
lifestyle in these countries which is associated with irregular participation in 
physical activity or sport (Jozsa et aI., 1989) and (iii) to the availability and the 
general awareness of health care in these countries, which in turn result in increase 
chance of case reporting (Beskin et al., 1987; Jarvinen, 2000; Leppilahti and Orava, 
1998). Both extrinsic and intrinsic risk factors have been implicated in the aetiology 
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of AT rupture and chronic Achilles tendon injuries (Jarvinen et al., 2005; Riley, 
2005b). However, the precise aetiogy and pathogenesis of AT rupture is still not 
well documented (Jarvinen et al., 2005; Riley, 2005b). 
In summary and as shown in Table 1.1: 
• 	 The percentage of running-associated AT ruptures is only less than 8% 
• 	 The dominant peak incidence of AT ruptures occurs during the 4th decade of 
life 
• 	 Most AT ruptures are sustained by men 
• 	 Majority of AT ruptures are associated with sports 
• 	 The sporting culture of different nations influences the distribution of AT 
ruptures association with specific sports. 
20 	 Department of Human Biology 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
---- -------- ----- ----
CHAPTER ONE LITERATURE REVIEW 
Table 1.2 Investigative studies on the epidemiology of Achilles tendon rupturea 
Author Male:Female Peak Incidence City, Country Major Sport(s) %Sport %Running 
ratio (n) Incidenceb (per lOS) 

Yearo - Yearf (mean age) 

Houshian 3:1 (718) 4th (42.1) 37 Ribe County, Badminton (46.3 % ) 74.2% 0.9% 
et al., 1998 1984-1996 Denmark 
Levi et al., 2.9:1 (209) 4th (41) 33 Copenhagen, Badminton (49.7%) N/A 2.1% 
1997 1978-1995 Denmark 
Maffulli et 1.7:1 (4201) 4th, 8th (30) 8 Scotland N/A N/A N/A 
al.,1999 1980-1995 
Moller et 6:1 (153) 4th, 8th (37) 30 Malmo, Badminton (50%), 64% <4% 
al.,1996 1987-1991 Sweden Soccer (24%) 
Leppilahti 5.5:1 (110) 4th 18 Oulu, Volleyball (24%) 81% 6% 
et al., 1996 1979-1994 Finland Badminton (22%) 
Soccer (17%) 
Jozsa et al., 4:1 (292) 4th (35.2) N/A Budapest, Soccer (33.5%) 59.2% 8.1% 
1989 1972-1985 Hungary Basketball (33 % ) 
Nillius et 7:1 (229) 5th 10 Malmo, Badminton (28%), 59% 4.4% 
al.,1976 1950-1973 Sweden Soccer (26%) 
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Table 1.2 (continued). Investigative studies on the epidemiology of Achilles tendon rupturea 
Author 	 Male:Female Peak Incidence City, Country Major Sport(s) %Sport %Running 
ratio (n) Incidenceb (per lOS) 

Yearo - Yearr (mean age) 

Arner & 6.1:1 (92) 4th N/A Stockholm, Running (N/A) N/A N/A 
Lindholm, 
1959 1940-1957 Sweden Soccer (N / A) 
Handball (N/A) 
Rantanen 3.9:1 (39) . 5th (46) 2 Salo, Volleyball (33% ) 64% N/A 
et al., 1993 1980-1991 Finland 
Cretnik 18,:1 (116) 4th (37) 7 Maribor, Soccer (31 %) 65% N/A 
and Frank, 
2004 1991-1996 Slovenia Basketball (11%) 
Tennis (9%) 
Suchaket 4th (41.4) 8 Edmonton, Soccer (12%) 78.6% N/A 
al.,2005 Canada Volleyball (10%) 
aAll the studies investigated Achilles tendon rupture only. 
bPeak incidence is recorded in decades 
NjA, data not available 
Yearo- Yearr, the duration of data collection from year 0 to the final year of study 
%Sport, The percentage of subjects sustaining injury during sporting activity 
%Running, The percentage of sports-related ruptures that occured during running. 
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1.5 	 BRIEF OVERVIEW OF HUMAN TENDON STRUCTURE AND 
FUNCTION 
The following section will review the macroscopic, microscopic, and biochemical 
structure and function of healthy and injured tendons. The specific features of 
the Achilles tendon such as blood supply and innervation will also be reviewed. 
1.5.1 	 Macroscopic anatomy of normal human tendons 
Tendons are anatomic structures joining muscles to bones and function as force 
transducers allowing joint movement (Benjamin and Ralphs, 1996). They are able 
to withstand large mechanical loads, in the form of tensile, compressive and 
shear stress (Kannus, 2000). The main body of the tendon is usually exposed to 
tension, while the sites where tendon pulleys or bony prominences are located 
also experience compression and shear forces. Therefore, the structural 
composition of a tendon at these sites differs slightly. In general the area 
experiencing tensile stress being more fibro-elastic (Kannus, 2000), while the area 
experiencing compression or shear stress being fibrocartilaginous (Smith et al., 
2002). Because the focus of this thesis is to identify genetic factors which encode 
for proteins in the predominant fibro-elastic portion of the tendon, the structure 
and function of this portion will be emphaSized in the review. 
It should be noted that tendons are part of the complex muscle-tendon unit 
(MTU) and therefore their function are interlinked to the muscle function 
(Benjamin and Ralphs, 1996). Tendons are relatively non-elastic, but provide 
substantial contribution to the storage and release of passive elastic energy of the 
MTU (Fukunaga et al., 2002). Also, it should be borne in mind that although 
tendons are largely inextensible, they are able to stretch (Benjamin and Ralphs, 
1996). At rest the tendon fibers exhibit a wavy configuration or crimp, but 
straighten under mechanical loading Gozsa and Kannus, 1997). 
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The area where the muscle and tendon join is called the myotendinous junction 
" 
(MT]), while the area where the tendon joins the bone is called the 
osteotendinous junction (aT]) (Jozsa and Kannus, 1997). The detailed structure 
of the MTJ and OTJ are specialized and beyond the scope of this review. 
However, the structure of MTJ and OTJ has been extensively reviewed (Jozsa and 
Kannus, 1997). Macroscopically, healthy tendons appear "brilliant white" in 
colour and are fibro-elastic in texture (Jozsa and Kannus, 1997; Kannus, 2000). 
They appear in many shapes and differ in the way they attach to bone (Kannus, 
2000). They are covered by many layers, which may be fibrous sheaths or 
retinacula, reflection pulleys, synovial sheaths, paratenon and bursae (Kannus, 
2000). 
Specifically, the Achilles tendon is formed by the conjoined tendon of the 
gastrocnemius and soleus muscles (Maffulli, 1999). Its length of the 
gastrocnemius component of the Achilles tendon ranges from 11 to 26 cm and the 
soleus component ranges from 3 to 11 cm (Jones, 1998; reviewed in Maffulli, 
1999). Unlike most tendons, which are enclosed in a sheaths, the AT is wrapped 
in a paratenon (which is not a true sheath) (Jozsa and Kannus, 1997). A 
retrocalcaneous bursa lies between the Achilles tendon and the calcaneus, while a 
subcutaneous bursa may be found between the tendon and the skin (Jozsa and 
Kannus, 1997). These bursae are useful in reducing the tendon friction as it 
glides during movement. Associated with the Achilles tendon is the plantaris 
tendon that lies between the gastrocnemius and soleous muscles (Invaco et a1., 
1987). 
The blood supply to the Achilles tendon comes mainly from the post~rior tibial 
artery and the vessels enter via three sites. These are the musculotendinous 
(MT]) and oseteotendinous junctions (aT]), and the paratenon (Carr and Norris, 
1989). 
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The nerves to the Achilles tendon are received via fascicles occurring 
subcutaneously, mainly originating from the sural nerve, and via nerves 
supplying the attaching muscles (reviewed in Bjur et aL, 2005). However, the 
exact pattern of distribution of nerve supply within the Achilles tendon is 
currently unknown (Bjur et al., 2005). 
1.5.2 Microscopic anatomy ofnormal tendons 
Tendons consist mainly of dense regular collagenous connective tissue (Jozsa and 
Kannus, 1997; Riley, 2005). Tendon cells, tenocytes and tenoblasts, are embedded 
and anchored in the collagenous tissue. The essential feature of connective tissue 
that distinguishes it from other tissues is that it consists of relatively fewer cells 
that are separated by an abundant extracellular matrix (ECM) (Junqueira et aL, 
1998). In fact, the major constituent of connective tissues is the ECM. The ECM 
consists of fibrous proteins (collagen and elastin), non-fibrous proteins 
(glycoproteins), ground substance and tissue fluid. The major macromolecules of 
the ground substance are proteoglycans and glycosaminoglycans (GAGs). 
Tendons are made predominantly of type I collagen, which is organized in a 
complex hiearchical structure from soluble tropocollagen molecules, which 
aggregate to form insoluble collagen molecules (which are cross-linked 
tropocollagen molecules) (Jozsa and Kannus, 1997). The collagen molecules then 
form collagen fibrils (Figure 1.2). A group of collagen fibrils aggregate to form 
collagen fibers, which in turn are grouped to form primary (subfascicle), 
secondary (fascicle) and tertiary fiber bundles of tendon (Figure 1.2). The 
primary, secondary and tertiary fiber bundles are covered by a layer of 
connective tissue called endotendon, while the whole tendon is covered by 
another layer of connective tissue called epitenon (Jozsa and Kannus, 1997). 
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1.5.2.1 Tendon Cells 
The main resident cell types found in tendons are a special type of fibroblasts 
known as tenoblasts (active) or tenocytes (quiescent) (Junqueira et al., 1998). 
These cells are responsible for the synthesis and degradation of the tendon 
matrix, a process called matrix turnover (Jozsa and Kannus, 1997). This is a 
normal process in response to tendon loading as a result of exercise, mechanical 
strain and injury. The matrix is constantly being remodeled to keep the balance 
between synthesis and degradation at homeostasis, therefore maintaining the 
correct matrix composition, tenocytes numbers and amount of tissue fluid. 
The tenocytes are predominantly flat and elongated in shape and have elongated 
nuclei, just like other fibroblasts (Junqueira et aL, 1998). They are usually found 
sparsely distributed in normal tendons, between the collagen fibrils (Jozsa and 
Kannus, 1997). Although sparsely distributed, they have been reported to 
communicate effectively via gap junctions (Banes et al., 1999; Mc Neilly et. aL, 
1996). These gap junctions are found at the end of the tenocytes cellular 
processes. The tenocytes use the gap jUhctions to communicate both 
longitudinally and laterally. Although relatively fewer (about 10%), other cell 
types such as chrondrocyte-like cells, capillary endothelial cells, smooth muscle 
cells, nerve cells and mesenchymal cells are also found in tendons (Jozsa and 
Kannus, 1997). 
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Figure 1.2 The hierarchical organization of a tendon structure (taken from Jozsa 
and Kannus, 1997). 
1.5.2.2 Tendon Proteins 
For the purpose of this thesis, the proteins found in tendons will be categorized 
into the collagen and non-collagen' proteins. However, functional classifications 
will be highlighted where appropriate. 
1.5.2.2.1 Collagen proteins in normal tendons 
Tendons consist predominantly of the protein, collagen, constituting about 65­
80% of the total dry mass of tendon protein content (Kannus, 2000). It has been 
stated that collagen is the most abundant protein found in most mammalian 
bodies (Fuller and Shields, 1998). Briefly, collagen is made up of three 
polypeptide alpha chains, which could all be identical (forming a homotrimer) or 
might be constituted from two or three different alpha chains (forming a 
heterotrimer). The collagen molecule formed from the 3 alpha chains is a right­
handed triple helix. 
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To date, forty two different vertebrate alpha chains have been identified and it is 
these alpha chains that combine in different ways to produce the 27 different 
collagen molecules that have been identified to date (Riley, 2005b). Each alpha 
chain contains one or more typical repeated amino acid motif Gly-X-Y of variable 
length, where X and Y are usually proline and hydroxyproline. The collagens 
also contain globular, non-collagenous domains located at variable positions, of 
different sizes and numbers (Myllyharju and Kivirikko, 2001). 
In tendons, the major collagen type is type I collagen, which is believed to 
constitute up to 95% of the total collagen in tendon (Riley et aL, 1994; reviewed in 
Riley, 2004). The next most abundant collagen is type III, constituting 
approximately 3%, at least in human supraspinatus and biceps brachii tendons 
(Riley et aLI 1994). Other collagens found in relatively smaller concentrations are 
types IV, V, VI, XII and XIV, but their exact proportions in tendons are not 
known (Riley, 2005b). In addition, collagen type It IX, X and XI are found at the 
fibrocartilagenous tendon insertion and other areas subjected to compression 
forces such as pulleys and osteotendinous region (Waggett et aL, 1998; Fukuta et 
aL,1998). 
Table 1.2 shows the 11 different types of collagens found in tendons to date and 
their various functions. These collagens can be classified and have been grouped 
accordingly, into (i) fibril forming, (ii) fibril-associated collagens with interrupted 
triple helix (FACIT), (iii) meshwork forming and (iv) beaded filament forming 
(Myllyharju and Kivirikko, 2001; Riley, 2005). Types I, II, III, V and XI collagens 
are fibril-forming. The collagens found on the surface of fibrils (FACIT) are type 
XII, XIV. Types IV and X form extensive meshwork of fibers, while type VI forms 
beaded microfilaments (Riley, 2005). However, tendons require at least both 
fibril-forming collagens to maintain its structure and other types of collagens for 
other regulatory processes such as fibrillogenesis, ECM modulation and fibril 
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growth. Precisely which one collagen type dominates in content is. dependent on 
its functional demands. 
In the core of the tendon, which experiences predominantly tensile stress, the 
major fibril forming collagens are type I (about 95% of the total collagen and 60% 
of the dry mass of tendon tissue) and to a lesser extent typesIII (about 3%) and V 
(Riley, 2004). Type III collagen forms thinner fibrils, often associated with repair 
of damaged tendons Oozsa and Kannus, 1997; reviewed in Riley, 2004). Type V 
forms heterotypic fibrils with type I collagen and is believed to regulate the 
diameter and tensile strength of fibrils (Birch et aL, 1990; Birch, 2001), however, 
the detailed role of type V collagen will be discussed in Chapter 3. In the 
predominantly fibrocartilagenous insertion region the fibril forming collagen 
type II is the major collagen molecule, while type XI is a minor structural 
component (Waggett et aL, 1998). 
The collagens of the FACIT group, type IX, XII and XIV are found at the surface 
of the type I collagen fibrils, especially at the fibrocartilaginous insertion region 
(reviewed in Riley, 2005b). They are believed to mediate interactions between 
cells and matrix. Meshwork forming collagens, type IV and X are restricted to 
the basal membranes of the tendon cells, blood vessels and fibrocartilaginous 
portion of tendon (Fukuta et al., 1998; Myllyharju and Kivirikko, 2001). Type VI 
collagen is the only beaded filament forming collagen found in tendons (Riley, 
2005b). It is found at both the core and fibrocartilagenous regions (Waggett et aL, 
1998). However, in the core region of the tendon it is associated with type I 
collagen fibrils, while in the fibrocartilagenous region it is predominantly found 
associated with cells (Waggett et al., 1998). Type VI collagen is believed to playa 
role in binding cells to components of the ECM such as hyalorunan, decorin and 
fibrillar collagens (reviewed in Waggett et al., 1998). 
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Table 1.3 Descriptive summary of the location and function of the 11 different 
collagen types found in a tendon 
Collagen Location Function 
Mid-portion (about 95% 
collagen) 
of total Forms larger and organized fibrils 
within the tensile region 
Insertion Forms fibrils 
compressed region 
within the 
IlIa Mid-portion (about 
collagen) 
3% of total Forms thinner and less organized 
fibrils within the tensile region 
Mid-portion Forms heterotypic fibrils with 
type I collagen, fibrillogenesis and 
modulation of fibril growth 
Xla . Insertion within the core of type II 
fibrils 
Forms heterotypic fibrils with 
type II collagen, fibrillogenesis 
IXb Insertion, associated 
surface of type II fibrils 
with the Mediates cell-matrix interactions 
with type II collagen fibril surface 
XIIb Insertion~ associated 
surface of type I fibrils 
with the Modulation of ECM 
with type I fibrils 
interaction 
XIVb Insertion, associated 
surface of type I fibrils 
with the Modulation of ECM 
with type I fibrils 
interaction 
IVe Basement membrane of blood Forms meshwork 
vessels 
Insertion, associated with the cells Forms meshwork 
Vld Inserti()n, associated with cells as Forms beaded filaments (sheet­
well as the core, associated with like structure) 
the type I fibrils 
aFibril-forming collagens, bFibril-associated collagens with interrupted triple helices 
(FACIT), cHexagonal network (meshwork)-forming, and dBeaded filament-forming 
collagens. ECM, Extracellular matrix (adapted from Riley, 2005b). 
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1.5.2.2.2 	 N on-collagen proteins in normal tendons 
Two major classes of non-collagen proteins are found in tendons. These are 
proteoglycans and glycoproteins. These proteins have greater tum-over rates 
than collagen proteins. 
1.5.2.2.2.1 	 Proteoglycans and their associated glycosaminoglycans in normal 
tendons 
Proteoglycans are composed of a core protein (about 5%) covalently bound to 
linear (unbranched) polysaccharide chains (glycosaminoglycans or GAGs) (95%) 
Gunqueira et aL 1998). The polysaccharides (GAGs) are made up of repeated 
chains of disaccharides, which are highly hydrophilic, enabling the ECM to 
absorb water and swell (Fuller and Shields, 1998). This hydrophilic property 
permits the ECM to withstand large compressive and shear forces (Kannus, 
2000). The GAGs are also important for stabilizing the collagenous tissue and 
help maintain ionic homeostasis and collagen fibrillogenesis (Kannus, 2000). 
The most common GAGs found in tendons include dermatan sulphate, 
chondroitin sulphate, heparan sulphate and hyaluronic acid (Koboyashi et al., 
1999). The presence of keratin sulphate and heparin has not been demonstrated 
in tendon tissue (Kannus, 2000). The most abundant GAG in the fibro-elastic 
region of the tendon is dermatan sulphate (60% of the GAG content), while the 
insertion region is dominated by chondroitin sulphate (Kannus, 2000). 
Compared to other tissues such as cartilage, healthy tendons contain very little 
amount of GAGs (about 0.2% dry mass of tissue versus 3.5 - 5% in cartilage) 
(Kannus, 2000). 
There are two groups of extracellular matrix (ECM) proteoglycans; the small 
leucine-rich repeat proteoglycans (SLRPs) and the large modular proteoglycans 
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(Riley, 2005a). The large modular proteoglycans are sub-divided into the 
hyalectans (as they can bind both hyaluronan and lectin) and those that do not 
bind hyaluronan (Riley, 2005a). In tendons, proteoglycans include hyalectans 
such as aggrecan and versican as well as the SLRPs, which include decorin, 
biglycan, fibromodullin and lumican. The distribution of these proteoglycan in 
tendons varies according to the tendon function and region. The anatomical sites 
experiencing compression contain large proteoglycans such as aggrecan and 
biglycan, which have fibrocartilageneous characteristics (Waggett et al., 1998; 
Thomopoulos et al., 2003). On the other hand, the tensile regions contain small 
proteoglycans, which are leucine-rich such as decorin and fibromodulin as well 
as the large proteoglycan versican (Riley, 2004; Samiric et a1., 2004; Wagett et al., 
1998). Within the proteoglycan family, the turnover rate of hylectans is much 
greater than that of SLRPs (Samiric et al., 2004). 
In human Achilles tendons, both mRNA and protein expression of decorin, 
biglycan, lumican and fibromodulin has been detected in both the mid-substance 
and fibrocartilagenous regions (Waggett et a1., 1998). It has also been observed 
that versican is the major large proteoglycan found in the mid-substance of the 
Achilles tendon, with virtually no aggrecan, while a reciprocal observation has 
been made at the insertion region, which contains abundant aggrecan and very 
little versican (Waggett et al., 1998). Of the SLRPs, decorin is the most abundant 
proteoglycan in the mid-substance of the Achilles tendon (Riley, 2005a). 
Proteoglycans playa role in holding water in tissues, helping tissues resist 
compression, lubricating fiber bundles during movement and in the 
sequesteration of growth factors, mediate cell-matrix interactions and enzymes in 
the ECM (Hardigham and Fosang, 1992; reviewed 'in Riley, 2005a). It has also 
been shown using knockout animal models of these molecules that they may be 
important in fibrollogenesis (Ameye et aL, 2002; Jepsen et al., 2002; Vij et al., 
2004). 
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1.5.2.2.2.2 Glycoproteins in normal tendons 
Glycoproteins are protein molecules to which branched chains of 
monosaccharides are covalently attached (Junqueira et al., 1998). The 
glycoproteins found in tendons include elastin, fibrillin, tenascin-C cartilage 
oligomeric matrix protein (COMP), fibronectin, laminin, thrombospondin, link 
protein (Riley, 2005b) and tenomodulin (Docheva et aL, 2005). 
Table 1.3 summarizes the functions of the different proteoglycans and 
glycoproteins found in tendons. Briefly, elastin is a fibrous glycoprotein found in 
small quantities (1-2% of the dry mass) in tendon and together with fibrillin they 
form intergral part of elastic fibers (Midwood and Schwarzbauer, 2002). They are 
believed to be responsible for providing some elasticity to tendons, therefore 
allowing tendon tissue to stretch and recoil without damage (Midwood and 
Schwarzbauer, 2002). The glycoproteins tenascin-C, COMP, fibronectin and 
thrombospondin function to attach cells to the matrix (reviewed in Riley, 2005b). 
The detailed role of Tenascin-C will be discussed further in Chapter 4. Laminin 
is a modular protein found in the basement membrane of cells and walls of blood 
vessels (Sasaki et al., 2004). Laminin is also found in large amounts at the 
myotendinous junction (Kannus et al., 1998) and helps in anchoring cells to the 
matrix mainly via intergrin connections (Sasaki et aL, 2004). The interaction 
between proteoglycans and hyaluronan is stabilized by link protein (Jozsa and 
Kannus, 1997) . 
. A new transmembrane glycoprotein, tenomodulin has been identified and 
characterized (Brandau et aL, 2001). Tenomodulin was found to modulate 
tenocyte proliferation and collagen fibril maturation (Docheva et al., 2005). 
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Table 1.4 The non-collagen proteins found in a tendon 
Protein Description Function 
Decorin SLRP Binds collagen 
r::: 
ca 
u 
>, 
be 
0 
!! 
0 
cl:: 
Biglycan 
Fibromodullin 
Lumican 
Aggrecan 
SLRP 
SLRP 
SLRP 
Hyalectan 
Binds collagen 
Binds collagen 
Binds collagen 
Resist compression 
Versican Hyalectan Lubricates fibrils 
r:::
...... 
Q)
..... 
0 
I-< 
0.. 
0 
u 
>,
-0 
Elastin 
Fibrillin 
Tenascin-C 
COMP 
Fibronectin 
Laminin 
Thrombospondin 
Link protein 
Tenomodulin 
Branched network 
Linear arrays 
Branched molecule 
Branched molecule 
Modular protein 
Modular protein 
Modular protein 
Globular protein 
Transmembrane 
Protein 
Provides elasticity 
Provides elasticity 
Attach cells to matrix 
Attach cells to matrix 
Attach cells to matrix 
Basement membrane constituent 
Attach cells to matrix 
Stabilizes proteoglycan­
hyaluronan interaction 
Tenocyte proliferation and 
collagen fibril maturation 
Legend: COMP, cartilage oligomeric matrix protein; SLRP, small leucine-rich repeat 
proteoglycan (Adapted from Riley, 2005b). 
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1.5.2.2.3 Tendon matrix regulatory enzymes in normal tendons 
Although cell-mediated synthesis of collagen and non-collagen fibers is crucial 
for the maintenance of tendon proper structure and function, degradation of any 
damaged proteins in tendon tissue is equally important. Although beyond the 
scope of this thesis detailed reviews of regulatory enzyme found in ECM have 
been published (Kaushal and Shah, 2000; Riley, 2005a; Riley, 2005b). The 
degradation of connective tissue proteins is achieved by two families of enzymes, 
also produced by tenocytes, collectively known as (i) matrix metalloproteinases 
(MMPs) and (ii) a disintegrin and metalloproteinase (ADAM)-thrombospondin 
(TS) family (ADAM-TS) (reviewed in Riley, 2005a; Riley, 2005b). 
The MMPs can proteolytically cleave a wide range of substrates, including 
collagens, proteoglycans and glycoproteins (Bramono et al., 2004). They can also 
act on cell surface receptors and growth factors, regulate cell proliferation, cell 
death and cell migration (reviewed in Riley, 2005a). There are currently 23 
classified human MMPs (Riley, 2005a), which can be grouped into (i) 
collagenases (cleave native collagen type I, II and III), (ii) gelatinases (cleave 
denatured collagens and type IV collagen), (iii) steromelysins (cleave 
proteoglycans, type III, IV, and V collagens, fibronectin) and (iv) the membrane 
type MMPs (MT-MMPs) (Bramono et aL, 2004). Their function is influenced by 
growth factor and cytokine activity (Riley, 2005a). They are also tightly regulated 
in vivo at the levels of messenger RNA and protein synthesis, activation and 
inhibition (Riley, 2005a). Generally, the activity and expression of MMPs is low 
in normal tissue and have been detected in ligaments, tendons and cartilage 
(Bramono et aL, 2004). MMP-l is found present in normal patellar tendon (Fu et 
al., 2002), while in normal supraspinatus and biceps brachii tendons MMP-l, 2 
and 3 are expressed (Riley et aL, 2002). However, the expression of all these 
MMPs was higher in supraspinatus tendons compared to biceps brachii tendons, 
emphasizing the different demands of these tendons (Riley et al., 2002). MMP-2, 
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3, 14, 16, 19 have been shown to be expressed in normal Achilles tendons using 
cDNA arrays (Ireland et al., 2001). Surprisingly, MMP-1 expression was not 
detected in normal Achilles tendon tissues using this technique (Ireland et al., 
2001). 
As it can be imagined the continued degradation of the matrix can be detrimental 
to tissues, therefore the MMPs activity has to be regulated. The specific inhibitors 
of MMP activity are enzymes (also produced by resident tendon cells) known as 
tissue inhibitors of metalloproteinases (TIMPs) (Murphy et al., 1995). To date, 
four TIMPs, namely TIMP-1 to TIMP-4 have been identified (Riley, 2005a). The 
expression of three (TIMP-1 to TIMP-3) of the four TIMPs in normal Achilles 
tendon tissue sample has been detected using cDNA arrays (Ireland et al., 2001). 
Another group of enzymes with proteolytic activity predominantly for non­
collagen proteins (proteoglycans and glycoproteins) in connective tissue are 
known as a disintegrin and metalloproteinase (ADAM)-thrombospondin (TS) 
family, of which 19 have been classified (reviewed in Riley, 2005a). The most 
commonly studied members of this group are the aggrecanases, known for 
cleaving the proteoglycan aggrecan (reviewed in Riley, 2005a, Riley, 2005b). 
1.5.2.3 Tendon Tissue Fluid 
Normal tendon contains about 55-70% water (Kjaer, 2004), which is essential in 
the hydration of the ECM and serves as a medium for water-soluble substrates 
providing nutrients to cells. Tissue fluid also contains inorganic compounds 
constituting less than 0.2% of the dry mass of the tendon (Kannus, 2000). The 
most abundant inorganic compound in the tendon is calcium, which is higher at 
the insertion area compared to the tensile region of the tendon. Other inorganic 
components include magnesium, manganese, cadmium, cobalt, copper, zinc, 
nickel, lithium, lead, fluoride, phosphor and silicon (reviewed in Kannus, 2000). 
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These molecules are important in growth, development and normal tendon 
metabolism. For instance, the activity of the MMPs requires the presence of 
bivalent cations (Bramono et al., 2004). Collagen cross-linking requires copper, 
while manganese is required for a variety of enzymatic reactions (reviewed in 
Kannus,2000). However, the detailed function of the inorganic component of the 
tendon matrix is relatively under-investigated (Kannus, 2000). 
1.5.3 Pathology of injured tendons 
1.5.3.1 Macroscopic anatomy of injured tendons 
Through a naked eye observation, a tendinopathic tendon appears grey and 
armophous, having lost their glistening white colour (Kannus and Jozsa, 1991; 
Jozsa and Kannus, 1997). When palpated, the tendon feels tender, appears 
swollen and thicker (Kannus and Jozsa, 1991). A summarized comparative 
description of both a normal and injured tendon is showed in Table 1.5. 
1.5.3.2 Microscopic anatomy of injured tendons 
The characteristic histopathologic features of Achilles tendinopathy are tendon 
degeneration, disordered arrangements of collagen fibers, increased vascularity 
together (Astrom and Rausing, 1995). Further review of Achilles tendon imaging 
will be discussed in chapter 6. The histopathology of Achilles tendon rupture is 
similar to Achilles tendinopathy (Tallon et al., 2001). However a recent study has 
shown that ruptured Achilles tendons exhibit more degenerate features than 
tendinopathic tendons (Tallon et. al., 2001). This suggests that Achilles 
tendinopathy may preceed a rupture. 
Achilles tendon degenerative change exhibits increased signal intensity on 
magnetic resonance imaging (MRI) and hypoechoic areas under soft tissue 
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diagnostic ultrasonography (Astrom et al., 1996). It is believed that these areas of 
abnormal imaging correspond to areas of disorganized collagen fibers and 
increased ground substance (Jozsa and Kannus, 1997). Light microscopy 
confirms that collagen fibers that are thinner than normal (Josza and Kannus, 
1997). There is also visible evidence of longitudinal splitting of collagen fibers 
while some of the fibers show angulation (Kannus and Jozsa, 1991). Intrafibrillar 
mucoid patches and vacuoles are also present (Kannus and Jozsa, 1991). In 
tendinopathy, mitochondria and the nuclei of tenocytes both show altered size 
and shape. The tenocytes and mitochop.dria accumulate calcium deposits 
internally (Kannus and Jozsa, 1991). There is pronounced rough endoplasmic 
reticulum (RER) presence, indicating active protein production/synthesis 
(Kannus and Jozsa, 1991). Markers of an inflammatory process could not be 
found samples obtained from subjects with chronic Achilles tendinopathy 
(Ireland et al., 2001). 
1.5.3.2.1 Tendon cells in injured tendons 
It has been demonstrated that in chronic painful tendinopathy, there is an 
increased number of cells (Jarvinen et al., 1997; Leadbetter, 1992). The majority of 
the cells at the site of tendinopathy are tenoblasts, which have clearly changed 
their morphological appearance from elongated to rounded or ovoid shape (Jozsa 
and Kannus, 1997; Puddu et al., 1976). Many investigators have not been able to 
find inflammatory cells within tissue samples obtained from subjects with 
chronic tendinopathy (Arner et aI., 1959; Astrom and Rausing, 1995; Kannus and 
Jozsa,1991). However, some have observed inflammatory cells in the paratenon 
but not in tendon substance, when tendinopathy was accompanied by 
paratenonitis (Astrom and Rausing, 1995). It has also been shown that 
tendinopathic tendons exhibit increased number of apoptotic tenocytes 
compared to normal tendons in the human rotator cuff tendon and horse 
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superficial digital flexor tendon (Hosaka et aL, 2005; Murrel, 2002; Yuan et al., 
2002; Yuan et aL, 2003). 
Table 1.5 Summary of contrasting characteristics of a normal healthy versus 
a symptomatic tendinopathic tendon (adapted from Khan et al., 1999) 
Technique Normal healthy tendon Symptomatic tendinopathic 
tendons 
Naked eye Appear glistening white Appear grey and armophous 
Colour Doppler 
Ultrasound 
Microscopy 
Microscopy and 
polarized light 
Microscopy and Aldan 
blue staining 
Microscopy/Histology 
Avidin biotin 
Inconspicuous 
vasculature 
Hierarchical arrangement 
of tightly packed, parallel 
bundle of collagen fibers 
Fibers have a 
characteristic reflectivity 
Very little stainable 
ground substance 
e Inconspicuous tenocytes 
eAbsence of 
inflammatory cells 
fibroblasts and 
myofibroblasts absent 
Increased vasculature 
Discontinuous and 
disorganized collagen fibers 
Fibers lack specific reflectivity 
Increased stainable mucoid 
ground substance 
e Increased number of 
tenocytes 
eAbsence of inflammatory 
cells 
Increased presence of 
fibroblasts and 
myofibroblasts 
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1.5.3.2.2 Tendon proteins in injured tendons 
1.5.3.2.2.1 Collagen proteins in injured tendons 
In spontaneously ruptured Achilles tendons the degeneration of collagen fibrils is 
present and has been shown to be more severe than in chronic tendinopathy 
(Tallon et al., 2001). There is also an increased type I and III collagen in 
tendinopathy, although the ratio of type I to III collagen is decreased, indicating 
that although both type I and III collagen content increase, the amount of type III 
increase is much more than type I (Jozsa and Kannus, 1997). This has been 
postulated to indicate a reparative process of the collagen matrix (Riley, 2004). 
Maffulli et al. (2000), has shown that cultured tenocytes from ruptured Achilles 
tendons produce more type III collagen compared to those from normal tendons. 
It has been shown that type III fibrils are thinner than type I fibrils and it has 
been shown that the thickness of collagen fibrils is associated with the tendon 
tensile strength (Jozsa and Kannus, 1997). Also, morphologically larger tendons 
consist of larger collagen fibrils in keeping with their function (Jozsa and Kannus, 
1997). Type V collagen has been shown to be up-regulated in biopsy samples of 
degenerate human posterior degenerate tendons (Goncalves-Neto et al., 2002). 
Type XII collagen is increased, while the expression of type X collagen is 
decreased in rat healing supraspinatus tendons as detected by in situ 
hybridization (Thomopoulos et al., 2002). 
1.5.3.2.2.2 Non-collagen proteins in injured tendons 
1.5.3.2.2.2.1 Proteoglycans in injured tendons . 
The expression of four of the proteoglycans found in tendons has recently been 
examined in fresh human cadaver samples (Corps et aL, 2006). In tendinopathYI 
the level of aggrecan and biglycan mRNA increased 10-fold and 5-fold, 
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respectively, while the level of dec orin and versican did not change. In ruptured 
tendons, the level of dec orin mRNA decreased, while aggrecan, biglycan and 
versican mRNA expression remained unchanged. An increase in GAG 
concentration has been detected in Achilles tendinopathy (Movin et al., 1997), 
ruptured Achilles tendons (Kannus and Jozsa, 1991; Maffulli et al., 2002), and 
patellar tendinopathy (Khan et al., 1996). It has also been shown that there is an 
increased hyalaronan and other GAGs in tendinopathy of other human tendons 
(Riley et al., 1996). Increased expression of versican, biglycan and perlecan, with 
no change in decorin has been shown using cDNA arrays (Ireland et al., 2001). In 
support of the human studies, changes in the expression of proteoglycans and 
their associated GAGs has been detected in injured rat and exercising chicken 
tendons (Thomopoulos et al., 2002; Yoon et al., 2003). 
1.5.3.2.2.2.2 Glycoproteins in injured tendons 
The distribution of elastin and fibrillin in tendon injury has not fully studied, 
however it has been suggested that tendons become less elastic and stiffer with 
aging (reviewed in Riley, 2004). Fibronectin has been found to be up-regulated in 
injured human and horse tendons (Williams et al., 1984; Jozsa et al., 1989; 
Tillander et al., 2002). However, data have showed using cDNA arrays that 
fibronectin messenger RNA was down-regulated in Achilles tendinopathy but 
up-regulated in Achilles tendon rupture (Ireland et al., 2001). In another study 
using cDNA arrays, up-regulation of the mRNA fibronectin subunit B (FNRB) in 
tissues samples obtained from subjects with chronic Achilles tendinopathy was 
detected (Alfredson et al., 2003). A mutation in the COMP gene result in short 
individuals exhibiting lax joints and early-onset osteoarthritis (Briggs et al., 1990). 
Laminin a4 has been shown to be up-regulated in both Achilles tendinopathy 
and rupture samples, while laminin ~1 and laminin 37kDa types are only up­
regulated in Achilles tendon rupture samples (Ireland et al., 2001). 
Thrombospondin 1 was not detected in both normal and abnormal (rupture and 
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tendinopathy) samples, while thrombospondin 2 was found to be up-regulated in 
both Achilles tendinopathy and rupture samples using cDNA arrays (Ireland et 
aI., 2001). iNC has also been shown to be up-regulated in Achilles tendinopathy 
(Jarvinen et aI., 2000) and rotator cuff tendinopathy (Riley et aI., 1996). This up­
regulation of TNC in degenerate tendons has been supported by cDNA arrays 
(Ireland et aL, 2001). The glycoprotein SP ARC was also found to be up-regulated 
in degenerated tendons using cDNA arrays (Ireland et aL, 2001). 
1.5.3.2.3 Tendon tissue fluid in injured tendons 
Because of the increased GAG content associated with tendinopathy and rupture, 
there is an increase in tissue fluid resulting in swelling which is often visible to 
the naked eye. Also, increased calcium deposits have been detected in between 
or on the degenerated collagen fibrils in 3%, 7%, 5% and 4% of subjects with 
ruptured Achilles, biceps brachii, extensor policis longus and quadriceps group 
tendons, respectively, and the process leading to this deposition has been termed 
calcifying tendinopathy (Kannus and Jozsa, 1991). Other components of the. 
inorganic material found in tendons have not been fully investigated. 
1.5.3.3 Tendon enzymes and their inhibitors in injured tendon· 
In patellar tendinosis, increased MMP-1 has been detected (Fu et aI., 2002). 
However, in ruptured tendons increased activity of MMP-1 and decreased 
activities of MMP-2 and -3 have been recorded (Riley et aI., 2002). It was shown 
that MMP-3 expression was decreased in Achilles tendinopathy and almost 
absent in ruptured tendon tissue using cDNA arrays (Ireland et aI., 2001). 
Surprisingly, the cDNA arrays could not detect MMP-1 expression in abnormal 
Achilles tendon tissues. The mRNA expression levels of the three TIMPs 
detected in normal Achilles tendons showed no changes in tissues samples 
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obtained from both Achilles tendinopathy and rupture tissue subjects (Ireland et 
al.,2001). 
In summary, tendons contain many molecules, including collagen and non­
collagen proteins. There proteins serve diverse functions within the tendon. 
Therefore it can be appreciated that a search for candidate genes for a 
disturbance in protein synthesis and degradation could involve any or several of 
these molecules. The expression of these proteins may differ according to the 
tendon function, such as at the insertion and mid-portion of the Achilles tendon. 
The recent molecular studies of tissues obtained normal, degenerated and 
ruptured tendons are continuing to enhance the available knowledge on tendon 
pathology. However, the limitation with samples obtained from ruptured 
tendons is that it is not clear whether the observed changes are the result or the 
cause of a rupture (Riley, 2004). 
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1.6. RISK FACTORS ASSOCIATED WITH ACHILLES TENDON INJURIES 
As previously mentioned, the exact aetiology and pathogenesis of Achilles 
tendon injuries is still not fully understood. The main aetiologic factors (both 
extrinsic and intrinsic) associated with Achilles tendon acute and overuse injuries 
will be briefly reviewed and are summarized in Tables 1.6 and 1.8, respectively 
(as reviewed in Jarvinen, 1992; Jarvinen et al., 2001; Jarvinen et aL, 2005; 
Kainberger et al., 1997; Maffulli et al., 2002; Paavola, 2000; Renstrom and Johnson, 
1981; Riley, 2004). It is important to note that extrinsic and intrinsic factors 
associated with AT injuries have generally not been systematically studied. 
There is a distinct lack of well cond ucted prospective cohort studies or 
randomized controlled trials (RCTs) that confirm risk factors for injuries 
(Jarvinen et al., 2005). 
In the following section, key studies that focused on identifying extrinsic and 
intrinsic risk factors for AT injuries will be discussed. More importantly, the 
level of evidence for the risk factor associated with AT injuries will be explored. 
For the purpose ·of this thesis, three categories will be used broadly to indicate the 
level of evidence for the association between a specific risk factor and AT injury 
(Wright et al., 2003; refer to Appendix 1.1). 
i) Strong evidence will be defined as evidence from well designed RCTs, 
prospective cohort studies with low risk of bias, systematic reviews of RCTs 
and well-conducted meta-analyses of level I studies. These are level I studies. 
ii) Limited evidence will be defined as evidence from retrospective studies, 
cross-sectional studies, well designed RCTs and prospective cohort studies 
but with high probability of bias and confounding (all level II studies), case­
control studies (level III studies) and meta-analyses of level II and III studies. 
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iii) Weak evidence will be defined as evidence from case series, case reports 
(level IV studies) and expert opinion (level V studies). 
The extrinsic and intrinsic risk factors for AT injury will now be reviewed and 
interpreted according to the level of evidence. Evidence for risk factors that are 
documented orily in animal models will be classified as weak. 
1.6.1 Extrinsic Risk Factors for Achilles tendon injuries 
1.6.1.1 Physical activity 
Anecdotal practical examples of the role of physical activity or mechanical 
loading as possibly the single most instigating stimulus for connective tissue 
homeostasis and adaptation throughout life include immobilization on the one 
extreme and chronic repetitive loading of the musculotendinous unit on the other 
(reviewed in Wren et al., 2001). Results from case series have suggested that the 
majority of Achilles tendon injuries (both ruptures and tendinopathies) are 
associated with participation in sporting activities (Arner and Lindhlom, 1959; 
Cretnik and Frank, 2004; Houshian et al., 1998; Jozsa et al., 1989; Kvist, 1994; Levi, 
1997; Moller et al., 1996; Nillius et al., 1976; Rantanen et al., 1993; Suchak et aL, 
2005). The proportion of Achilles tendon injuries associated with sports 
participation ranged from 59 to 81 % (Cretnik and Frank, 2004; Houshian et al., 
1998; Jozsa et al., 1989; Moller et al., 1996; Nillius et al., 1976; Rantanen et al., 
1993; Suchak et al., 2005). 
The type of physical activity could also be related to the type of AT injury. In 
most case series, it has been suggested that Achilles tendon rupture is associated 
with ball and racket games (Leppilahti and Orava, 1998), while Achilles 
tendinopathy is more common in long distance running (Kvist, 1994). In one 
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study, 53% of the subjects with Achilles tendinopathy were runners (Kvist, 1994). 
It has also been suggested from case series that non-sports related Achilles 
tendon ruptures occur at a later age compared to sports-related Achilles tendon 
ruptures (Leppilahti et aL, 1996; Houshian et aLI 1998; Nillius et aLI 1976). This 
example illustrates the possible interaction between increased age (an intrinsic 
factor) and physical activity (an extrinsic factor) in the development of Achilles 
tendon injury. The implication is that the mean age of sedentary people who 
experience Achilles tendon injury is higher compared to the mean age of sports 
people experiencing AT injuries. 
The amount of physical activity is crucial in the inductio  of appropriate 
adaptation that the musculoskeletal tissue can withstand without injury. It has 
been shown that physical activity in the form of strenuous, non-damaging 
exercise results in increased collagen protein synth sis (Miller et al., 2005), while 
an earlier study had showed that physical activity can lead to an increase in 
tendon width in runners (Rosager et aL, 2002). On the other hand, 
immobilization has been shown to result in a reduction in tendon size (Akeson et 
al., 1987). In an in vitro study, using canine patellar tenocytes, sustained cyclic 
mechanical stress induced apoptosis via loading- and calcium-dependent 
mechanism (Arnoczky et aL, 2002). This study showed that the frequency of 
mechanical loading had no effect on apoptosis. Therefore, this in vitro study 
demonstrated that the amount and duration rather than the frequency of 
mechanical load were important in the intracellular activation of stress kinase­
induced apoptosis of tenocytes. More importantly, the study showed that 
physical activity plays a role in cell-mediated tendon degeneration as increased 
apoptosis has been shown in chronic rotator cuff tendinopathy (Yuan et al., 2002). 
In an animal (rat) model that mimics human rotator cuff injury, a strong causal 
relationship between direct exposure to physical activity and rotator cuff injury 
has been demonstrated (Soslowsky et al., 2000). However,. the results obtained 
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from this model can not be directly translated and interpreted to the study of 
human Achilles tendon. 
In one case-control study, it was shown that orienteering athletes were 10 times 
more likely to sustain Achilles tendinopathy than controls, supporting the notion 
that exercise or physical activity contributes to the development of Achilles 
tendon injury (Kujala et al., 1999). However, in a prospective cohort study of 69 
male military recruits (mean age of 20 yrs) undergoing a 6-week basic military 
training, physical activity was not associated with the development of Achilles 
tendon injury (Mahieu et al., 2006). It must be noted that although this is a 
prospective study, the results may only be generalized to military training 
studies as they tend to recruit young and homogenous groups. The mean age of 
onset for chronic Achilles tendinopathy in the general population is about 40 yrs. 
The chronicity of the Achilles tendinopathy is also a debatable issue in the 
military study. 
There is a general lack of RCTs and prospective cohort studies investigating 
increased and decreased physical activity as an independent risk factor for 
Achilles tendon injury in humans. Therefore, the strength of evidence that 
increased or decreased physical activity is an independent risk factor for Achilles 
tendon injury is currently limited. 
1.6.1.2 Training errors 
Training errors can be defined as sudden increases in training load, frequency or 
intensity or excessive hill training (James et al., 1978; Renstrom and Johnson, 
1985; Smart et al., 1980; Kvist, 1994). Other training errors could possibly include 
excessive interval training and resumption of training activity after a long period 
of inactivity. All of these errors imply that excessive mechanical loading or 
improper loading technique may be a major factor in the development of Achilles 
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tendon injury. K vist and K vist (1980) suggested that training errors were the 
most common cause of overuse Achilles tendon injuries. However, it is not clear 
why only one leg usually gets injured (Inglis et al., 1987) and why only certain 
individuals rather than all individuals exposed to similar training loads sustain 
the injuries. Furthermore, the percentage of subjects who suffer from Achilles 
tendon injuries amongst all physically active individuals is relatively low, 
considering that the majority of physically active individuals are recreational 
athletes. It has been reported that the prevalence of major injuries is very low, 
while a large percentage of all sports related injuries are minor injuries 
(Stevenson et al., 2003). 
It has also been shown that novices are more likely to get injured than 
experienced athletes (Stevenson et al., 2003), possibly because there is higher 
probability of training errors amongst novice compared to experienced athletes. 
Alternatively, it could be that muscle-tendon unit adaptation requires time, and 
novices are more likely to load the muscle-tendon unit relatively quicker than 
expected, without the knowledge and experience. Additionally, it is not clear 
why in the majority of patients there are no prodromal symptoms before the 
occurrence of an Achilles tendon rupture (Soldatis et al., 1997). 
Although intuitive, the different training errors as risk factors for Achilles tendon 
injury have not been properly investigated using prospective cohort studies. The 
strength of evidence for training errors as independent risk factors for AT injury 
is largely based on the experience of medical personnel and athletes and is 
therefore weak. 
1.6.1.3 Training surfaces 
It has been suggested that running on very hard, slippery, cambered or sloping 
surfaces is associated with chronic Achilles tendinopathy (Kannus et al, 1989; 
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Schepsis et al., 2002). It has been shown that the soccer players who played more 
frequently on artificial turf experienced more injuries, including Achilles tendon 
injuries, compared to those playing on grass (Ekstrand and Nigg, 1989). 
However, no studies have directly linked the type of running surface to the 
development of Achilles tendon injuries. Although both uphill and downhill 
running have been implicated in the development of Achilles tendon injuries, 
there are no controlled studies that have investigated the association of either 
uphill or downhill running with Achilles tendon injury.. Therefore, the level of 
evidence for training surface as an independent risk factor for Achilles tendon 
injury is weak. 
1.6.1.4 Environmental conditions 
Poor environmental conditions such as darkness, too cold or hot weather, high or 
low humidity, high altitude and strong wind have all been implicated in the 
development of injuries (reviewed in Jozsa and Kannus, 1997). Cold weather 
may be associated with an increase in local tissue viscosity and therefore may 
induce tissue injury, especially when the athletes do not warm up adequately 
before vigorous exercise. Darkness may become important in a sport such as 
orienteering. In his retrospective study, Kvist (1994) attributed only 2% of 
Achilles tendon injuries to poor environmental conditions. However, none of 
these environmental factors have been systematically investigated. Therefore, 
the level of evidence for poor environmental conditions as independent risk 
factors for Achilles tendon injury is also weak. 
1.6.1.5 Footwear 
Shoes are used to reduce impact forces, and in running, could provide 
mediolateral stability preventing excessive subtalar joint pronation and 
supination (reviewed in Jozsa and Kannus, 1997). It has been suggested that an 
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inadequate heel wedge may contribute to compensatory over-pronation, which is 
believed to be associated with Achilles tendon injuries (reviewed in Mc Crory et 
al., 1999). In a review article, Kvist (1994) suggested that worn midsoles, 
insufficient heel height, too rigid soles, shoe's lack of cushioning and inability to 
twist may predispose athletes to Achilles tendon injury. However, there are 
currently no controlled studies investigating the role of footwear on the 
development of Achilles tendon injury. Therefore, the level of evidence for 
footwear as an independent risk factor for this injury is weak. 
1.6.1.6 Smoking 
It has been suggested that smoking might be associated with tendon ruptures. In 
one retrospective study, Safran and Graham (2002) studied medical records 
collected over a 5-year period and found 14 patients (13 men; 1 woman) who had 
sustained a distal biceps tendon rupture. The investigators found that 6 of 14 
(43%) patients were cigarette smokers compared to 9% in the general reference 
population. Although the study sample size was small, the researchers 
concluded that individuals who smoke were at a 7.5 times higher risk of 
developing a distal biceps tendon rupture. In another retrospective study of 23 
patients who had sustained an acute rupture of flexor tendon, there was no 
association between smoking and rupture (Harris et al., 1999). 
In one prospective cohort study it was documented that the risk of lower 
extremity injury, which included Achilles tendinopathy, was increased in 
smokers than non-smokers during a 12-week military training Gones et al., 1993). 
However, the specific relationship between smoking cigarettes as a risk factor for 
Achilles tendon injury has not been investigated. 
Because of the small sample sizes in both retrospective studies and the lack of 
prospective studies specific for Achilles tendon injury, causality between 
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cigarette smoking and Achilles tendon injury could not be established. Therefore 
the level of evidence for cigarette smoking as an independent risk factor for 
Achilles tendon injury is limited. 
1.6.1.7 Medication and drug use 
In recent years, quinolones especially fluoroquinolones antibiotics, which are 
used in the treatment of bacterial infections, have been found to be associated 
with Achilles tendon ruptures (van der Linden et aL, 2003; van der Linden et aL, 
2002; van der Linden et al., 2001; van der Linden et al., 1999). These antibiotics 
are known to be toxic to tenocytes and inhibit matrix formation (Mc Garvey et aLI 
1996; Movin et al., 1997; Movin et aLI 1998) and have been recently shown to 
induce apoptosis in human tendon cells in vitro (Sendzik et al., 2005). A 
population-based case-control study from the United Kingdom showed that 
between 2-6% of Achilles tendon ruptures in individuals older than 60 years were 
associated with quionolones (van der Linden, 2003). Therefore the level of 
evidence for quinolone use as an independent risk factor for Achilles tendon 
injuries is present but limited. 
It has been suggested that the use of corticosteroids for the alleviation of pain in 
Achilles tendinopathy, is associated an increased risk of AT ruptures (Mahler and 
Fritschy, 1992; Speed, 2001; Read and Motto, 1992; Astrom and Rausing, 1995; 
Westlin and Astrom, 1994; Inglis et al., 1976). In animal studies corticosteroids 
have been shown to induce collagen breakdown (Balasubramaniam et al., 1972), 
although the doses used have been high compared to those use in humans 
(Mahler and Fritschy, 1992). Recently, it has been shown that low doses of 
corticosteroids were harmless to human tendon structure using flouriscopically 
guided injection (Gill et al., 2004). Although it has been shown in vitro that 
corticosteroids result in collagen disruption and tendon matrix degeneration, the 
association of corticosteroids with tendon injuries is still highly controversial 
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(Leppilahti et aL, 1998; Kannus and Jozsa, 1997). The continued use of 
corticosteroids may be because of the pain-reducing effect of corticosteroids in 
tendinopathy and other conditions. However, Shier et al., 1996 conducted a 
meta~analysis of studies that investigated the association of corticosteroids and 
Achilles tendon injuries. These investigators concluded that there was 
insufficient evidence with regard to human studies to make definite conclusions. 
Therefore, the strength of evidence for corticosteroids as independent risk factors 
for the development of Achilles tendon injury is present but limited. 
Several case reports have also suggested that anabolic steroids are associated 
with Achilles tendon injuries (reviewed in Battista et a1., 2003). A case report of a 
35-year old male bodybuilder who experienced asynchronous bilateral Achilles 
tendon rupture after 1 month of androstenediol use has been reported (Battista et 
aL, 2003). In a randomized controlled study in rats, Inhofe et al. (1995) showed 
that the quality of tendon that was injected with anabolic steroids was 
compromised after 12 weeks of follow up. Based on the lack of controlled studies 
in humans, the evidence for anabolic steroid use as an independent risk factor for 
the development of an Achilles tendon injury is weak. 
1.6.1.8 Psychological factors 
It has been suggested that the likelihood of Achilles tendon injury in exercising 
subjects may increase during fatigue. This has been attributed to the decreased 
ability for coordination (Gilcreest, 1933). However, this assertion was based on 
the author's opinion and there have been no studies to investigate fatigue as 
specific risk factor for Achilles tendon rupture. Other psychological factors that 
have been associated with musculoskeletal injuries include being less tough­
minded, decreased cognitive abilities, and life stresses (reviewed in Jozsa and 
Kannus, 1997; Kvist, 1994). However, there have been no controlled studies to 
investigate the relationship between psychological factors and tendon injuries 
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(Jozsa and Kannus, 1997). Therefore the level of evidence for psychological 
factors as independent risk factors for Achilles tendon injury is weak. 
1.6.1.9 Nutrition 
Because of the perceived decreased blood flow in the area 2 to 6 em above the 
calcaneal insertion, it was thought that this area will be predisposed to lack of 
nutrients (Schmidt-Rolfing et al., 1992). The other possible alternative is the 
requirements for vitamin C as a cofactor for proline hydroxylase, the enzyme 
required for the hydroxylation of proline, an essential step in the formation of 
collagen cross-links (Junqueira et al., 1998). However, lack of vitamin C causes 
scurvy, which is characterized by ulceration of gums and haemorrhages. There 
has been no study investigating the possible role of nutrition on the development 
of Achilles tendon injury. Therefore, the evidence for nutrition as an 
independent risk factor for Achilles tendon injuries is weak. 
1.6.1.10 Occupation 
In a case series, it has been shown that the majority of patients with Achilles 
tendon injuries have white collar jobs and lead sedentary lifestyles (Jozsa et al., 
1989). Also the majority of Achilles tendon injuries have been associated with 
recreational sports (Jozsa et al., 1989). However, the proportion of white collar, 
manual labourer was not stated so that the true prevalence could be determined. 
Therefore, the strength of evidence for occupation as an independent risk factor 
for Achilles tendon injury is weak. 
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Table 1.6 Extrinsic risk factors associated with acute and overuse Achilles 
tendon injuries 
Extrinsic factors Level of evidence Key references 
1. Physical activity 
2. Training errors 
3. Surfaces 
4. Environmental 
conditions 
5. FootWear 
6. Smoking 
7. Medication use 
8. Psychological 
factors 
9. Nutrition 
10. Occupation 
Limited 
Weak 
, Weak 
Weak 
Weak 

Weak 

Limited (Quinolones) 
Limited (Corticosteroids) 
Weak (Anabolic steroids) 
. Weak 
Weak 
Weak 
Jozsa et al., 1989 

Kvist, 1994 

Ekstrand and Nigg, 1998 

Jozsa and Kannus, 1997 

Jozsa and Kannus, 1997 

Safran and Graham, 2002 

Harris et al., 1999 

van Der Linden et al., 

2003 

Shrier et al., 1996 

Inhofe et al., 1995 

Gilcreest, 1933 

Schmidt-Rolfing et al., 

1992 

Jozsa et al., 1989 
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1.6.2 Intrinsic Risk Factors for Achilles tendon injuries 
1.6.2.1 A~e 
In a number of case series it has been reported that the majority of Achilles 
tendon injuries, in particular ruptures, occur in individuals aged between 30 and 
50 years old, with the mean age around 40 years of age (Leppilahti et aLi 1996; 
Levi, 1997; Arner and Lindholm, 1959; Jozsa et aL, 1989; Houshian et al., 1998; 
Maffulli et al., 1999; Moller et al., 1996; Cretnik and Frank, 2004; Suchak et al., 
2005). As previously mentioned, the mean age at which AT injuries occurs is 
predominantly sports-related (Leppilahti et aL, 1996). In non-sporting 
individuals, the age at which AT injuries occur is higher (Houshian et aL, 1998; 
Moller et al., 1996). Epidemiological data show that both physical activity 
(exercise) and increased age are strongly associated with strain-induced 
tendinopathy (Gibbon et.al., 1999; Houshian et al., 1998; Nillius et al., 1976; 
Moller et al., 1996). Therefore, effects of both aging and exercise may be 
synergistic. 
Also, reduced blood flow has been reported in older healthy individuals 
compared to younger individuals and it has been linked by implication to a 
reduced nutrient supply to tissues including tendons (Schmidit-Rolfing et al., 
1992; Hastad et al., 1958). However, it was shown, in a case-control study that 
during exercise the blood flow to the Achilles tendon was not different between 
young, middle and old age subjects, suggesting that the role of increased age and 
decreased blood flow in tendons may be insignificant in the development of 
Achilles tendon injury (Langberg et aI, 1999). 
Ageing is also associated with many changes in the tendon matrix. These 
changes include decreased water content in the tendon (Hess et al., 1989), 
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increased collagen degeneration, decreased elastin and proteoglycan matrix, 
especially the GAG content (Astrom and Rausing, 1995). In normal tendons it is 
known that tenocyte activity and number as well as collagen turnover decline 
with age (reviewed in Riley, 1994). 
Although a discussion of advanced glycation end-products (AGEs), markers of 
non-enzymatic collagen cross-linking, is beyond the scope of this thesis, it is 
important to note that blood circulating reducing sugars are able to bind to 
collagen molecule, resulting in irreversible cross-links along the length of 
collagen molecule (reviewed in Riley, 2004). As the individual age increases, 
these AGEs have been shown accumulate along the length of the collagen 
molecule (Riley, 2004). In a cross-sectional study of' 28 patients who had 
undergone surgery for Achilles tendon rupture, tendon biopsy samples showed 
that the mean collagen fiber diameter was smaller in patients older than 30 years 
and younger than 20 years compared to the 20-29 year-old group (Sargon et al., 
2005). It was also shown in another cross-sectional study that elderly women had 
an increased (22%) cross-sectional area compared to younger women, although 
the younger women had greater moment of force around the ankle joint 
(Magnusson et al., 2003). 
The above biochemical changes in the tendon structure associated with ageing' 
and maturity could lead to decreased tendon tensile strength, decreased 
flexibility and therefore increased stiffness (Clement et al., 1984; James et al., 
1978). The reduced tensile strength has been linked to an increased type III to 
type I collagen ratio, as type III collagen forms relatively smaller diameter fibrils 
compared to type I fibrils Oozsa and Kannus, 1997). In a case-control study, 
Chard et al. (1994) obtained biopsy samples from cadavers of supraspinatus and 
common extensor tendons and found that there were increased features of 
degenerative changes with age when compared to uninjured common extensor 
tendon samples. In another case-control study, Maffulli et al. (2000) has however 
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shown using light mIcroscopy, that the number of degenerative changes 
associated with increased age in normal cadavers were much lower compared to 
frequency of abnormal degenerative changes found in a biopsies obtained from 
individuals who had sustained an Achilles tendon rupture. 
It has also been noted that unlike adults, young athletes are unlikely to sustain 
Achilles tendon overuse injuries but they are more prone to develop growth plate 
injuries such as calcaneal apophysitis (Sever's disease) (Noble, 1991). It has been 
suggested that energy-storing tendons are able to adapt to tendon loading during 
growth but has little ability to adapt after skeletal maturity, hence the increased 
incidence of tendon injury with aging (Smith et al., 1994). 
Because of the many biochemical changes that have been documented with 
increased age, it is intuitively reasonable that increased age should be associated 
with increased risk for the development of any injury. However, so far there are 
no prospective cohort studies in humans that can document age as an 
independent risk factor for Achilles tendon injury. Because the majority of the 
studies that suggested that age was a risk factor for Achilles tendon injury were 
case series and one case-control study could not establish age as a risk factor, the 
level of evidence for increased age as an independent risk factor for Achilles 
tendon injury is weak 
1.6.2.2 Gender 
As shown in several case series investigations (Table 1.1), the male to female ratio 
of patients who have sustained an Achilles tendon rupture ranged from 2:1 to 
18:1 (Houshian et al., 1998; Levi et al., 1997; Maffulli et al., 1999; Moller et al., 
1996; Leppilahti et al., 1996; Nillius et al., 1976; Kvist, 1994; Arner and Lindlohm, 
1959; Jozsa et.al., 1989; Astrom and Rausing, 1995; Leppilahti et al., 1996; 
Rantanen et al., 1993; Cretnik and Frank, 2004; Fahlstrom et al., 2002). 
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Furthermore, case-control studies have also shown that chronic Achilles 
tendinopathy is more frequent in males compared to females (Kvist, 1994). 
In a retrospective study of subjects who had previously sustained an Achilles 
tendon rupture it was found that the peak incidence of Achilles tendon rupture 
for men was in the 4th decade, while it was in the 5th decade for women (Suchak 
et al., 2005). The difference in the onset of the rupture was statistically 
significant, suggesting that perhaps there was some other factor(s) protecting 
women from earlier Achilles tendon injury. However another retrospective 
study, showed that in 32 badminton players who had sustained an Achilles 
tendon rupture within the past 5 years, 25 (78%) were males (Fahlstrom et al., 
2002). The limitation with the methodology in the latter study is that it does not 
normalize the proportion to actual number of males and females participating in 
badminton. 
It has been suggested that males and females are likely to participate equally in 
conditioning sports, but that males are much more likely to participate in 
vigorous activities (Stephens et al., 1985). This implies that males may have a 
greater chance for exposure to injury. However, most studies do not take into 
account the relative number of males and females participating in both 
recreational and professional sport. It has been shown that a greater number of 
men participate in sport from adolescence (Dovey et al., 1998). In South Africa, 
where distance running is very popular, the majority of participants are males. 
In two of the most popular ultra-marathon race events, namely the 56 km Two 
Oceans and the 90 km Comrades ultra-marathons, the number of finishers in 
2005 were 5474 (78.5%) males/1502 (21.5%) females and 8209 (70%) males/3519 
(30%) females, respectively (Unpublished data, 2005). It is therefore suggested 
that the number of males and females taking part in anyone sport such as 
distance running should be taken into account to determine the true meaning of 
gender as a risk factor for Achilles tendon injuries. 
58 Department of Human Biology 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER ONE LITERATURE REVIEW 
Interestingly, few prospective studies where exposure to the amount of training 
is similar between men and women have documented, an increased risk of injury 
of lower extremities in women compared to men taking part in basic military 
training (Bell et al., 2000; Altarac et al., 2000). However, these military studies 
did not investigate Achilles tendon injuries specifically. There have been two 
prospective cohort studies that investigated patellar and Achilles tendon injuries 
in civilian and military populations, respectively. However these studies did not 
identify gender as a risk factor for tendon injury (Witvrouw et al., 2003; Mahieu 
et al., 2006). The association of male gender as a risk factor for Achilles tendon 
injury is limited as there are limited prospective cohort studies for this condition. 
1.6.2.3 Previous tendon injury 
In a large case series investigating 891 patients who had sustained various tendon 
ruptures, including Achilles tendon ruptures, the number of previous symptoms 
of tendinopathy was 34%, suggesting that Achilles tendon rupture, may in some 
cases be preceded by symptomatic injury (Kannus and Jozsa, 1991). Also, 97% of 
the 891 patients showed a degenerative tendon change compared to 34 % in the 
445 cadaver controls (Kannus and Jozsa, 1991). Other case series have shown 
similar results in the Achilles tendon (Arner et al., 1959) as well as other tendon 
injuries (Bank et al., 1999). 
There is some evidence that both Achilles tendon rupture and tendinopathy are 
associated with abnormal tissue morphology, suggesting that the tendon matrix 
has been degenerated prior to the development of the injury. In a case-control 
study, it has been shown that patients with Achilles tendon injuries have more 
degenerate tendons than asymptomatic subjects (Maffulli et al., 2002). In another 
case-control study, it was also shown that biopsy samples obtained from human 
Achilles tendon tissue from patients who had sustained a rupture showed 
increased pathology score compared to control tendon samples (Tallon et al., 
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2001). Furthermore, it was shown that individuals with Achilles tendinopathy 
had less degenerated tendons than those with ruptured tendons, but both 
ruptured and tendinopathic tissues were more abnormal than tissues obtained 
from control subjects (Tallon et al., 2001). This may indicate that in most cases, 
tendinopathy precedes a rupture. The above case-control studies provided 
limited evidence for previous injury as a risk factor for Achilles tendon injury, 
although it has been reported that many cases of painful tendinopathy usually 
persist for months or even years without rupture (Riley, 2005). 
In a prospective cohort study, Fredberg and Bolvig (2002), studied 54 
asymptomatic soccer players over a period of 1 year soccer season. They 
measured, using utrasonography (US), the morphological characteristics of both 
the Achilles and patellar tendons pre and post the soccer season. The outcome 
measures were a spindle shape thickening (fusiform) greater than 1 mm in the 
Achilles tendon and a hypoechoic area greater' than lmm diameter for the 
patellar tendon. The study result were that soccer players with preseason US 
features of abnormality had increased risk for developing tendinopathy during 
the season. From this prospective cohort study the strength of evidence for 
previous injury as an independent risk factor for Achilles tendon injuries is 
strong. However, it must be borne in mind that there is still a proportion of 
individuals with abnormal features as shown by US who a're asymptomatic and 
do not sustain a tendon injury (Khan et al., 1999). This observation might be 
explained by the multifactorial aetiological nature of tendon injury. 
From the above review it can be concluded that there is strong association 
between previous injury of the Achilles tendon and future Achilles tendon injury. 
This conclusion is largely based on the results of the prospective cohort study, 
but it also supported by the limited evidence from the case-control studies as well 
as some evidence provided from case series. Therefore, the strength of evidence 
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for previous injury as a likely independent risk factor for Achilles tendon injury 
is strong. 
1.6.2.4 ,Body mass and size 
Although increased body weight and size have been cited as predisposing to 
Achilles tendon rupture (Kvist, 1994), no study has been published that 
specifically investigated the role of body weight in tendon ruptures (Kannus and 
Natri, 1997; Leppilahti et al., 1998). In one prospective study, Jones et aL (1993) 
found low and high BMI and high body fat content for men and shorter height 
for women to be risk factors for sustaining lower extremity injuries among 
military recruits. However, the latter study was not specific for Achilles tendon 
injuries. Therefore, the evidence for increased body mass and size as 
independent risk factors for Achilles tendon injury is weak. 
1.6.2.5 Blood supply 
In several case series investigations of cadavers, obtained from healthy 
individuals before death, using different blood flow measurement techniques, it 
was demonstrated that within the length of the Achilles tendon, the area with the 
least amount of blood perfusion is the region that is 2-6 cm proximal to the 
insertion (Lagergren and Lindholm, 1959; Carr and Norris, 1989; Stein et aLI 2000; 
Schmidt-Rolfing et aLI 1992; Zantop et al., 2003). However, in one case series of 
12 cadavers, also obtained from healthy individuals before death, it was shown 
using angiography and histology that the Achilles tendon had poor blood supply 
throughout its entire length and that there was no difference in the number of 
blood vessels per cross-sectional area of the tendon (Ahmed et aL, 1998). 
There were limitations with the cadaver studies as the measurement of blood 
flow was carried on tissue that was not live which may not have reflected live 
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mechanically loaded tendons. It has also been suggested that the use of dye 
techniques may not reliable (Lagergren and Lindholm, 1959; Theobald et al., 
2005). Therefore, there was a need for better designed studies using live tissue in 
control and symptomatic subjects to establish the reduced blood flow and 
investigate the association between blood flow in the mid-portion of the Achilles 
tendon and Achilles tendon injury. 
However, case-control studies of healthy and symptomatic subjects did not 
confirm the reduced blood flow in the mid-portion of the normal Achilles tendon 
using more reliable and advanced blood flow measurement techniques, such as 
laser Doppler flowmetry and 133Xenon technique (Astrom and Westlin, 1994; 
Astrom, 2000; Langberg et al., 2001; Knobloch et al., 2006). 
Most recently, it was shown that there was no difference in tissue oxygen 
saturation in all tendon regions (Knobloch et al., 2006). It was also shown that 
there was no difference in the blood flow during exercise in the Achilles tendons 
of young subjects compared to middle-aged subjects using a radioactively 
labelled Xenon-133 technique (Langberg et al., 2001). Furthermore, degenerate 
tendons have been shown to have increased blood vessels compared to normal 
tendons (Kannus and Jozsa, 1991; Astrom and Rausing, 1995; Knobloch et al., 
2006). Table 1.7 shows studies that investigated the blood flow in the different 
regions of the Achilles tendon. 
In general, in these studies using cadavers and different techniques to yield 
contrasting results but seem to confirm that the Achilles tendon has fewer blood 
vessels as a whole compared to muscle tissue. Studies using human subjects 
found that during exercise the blood flow in the tendon increased sufficiently 
when young and old subjects were compared (Langberg et al., 2001). It appears 
to be true that the region most affected by injury is the mid-portion but a direct 
link between poor blood supply in the area and Achilles tendon injury has not 
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been established. It may well be that other factors such as tensile mechanical 
loading play more important role than blood flow. Therefore, the level of 
evidence for reduced blood flow as an independent risk factor for Achilles 
tendon injury is weak as no case-control study supported the results of case 
series observations. 
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Table 1.7 Studies investigating blood flow in the human Achilles tendon 
Author 
Stein et al., 2000 
Astromand 
Westlin,1994* 
Subjectsa 
10 legs from 
Cadavers 
mean age, 67 
40 healthy 
subjects & 26 
patients 
Methods 
Cadavers, vascular injection 
into Achilles tendon 
Laser Doppler Flowmetry 
(LDF) 
Outcome 
Blood flow was lowest in the middle (3-6cm above 
ca1caneous) part of the tendon 
Blood flow lowest in the area near the calcaneous, 
but evenly distributed in the rest of the tendon 
Ahmed et al., 1998 
Carr and Norris, 
1989 
12 Cadavers 
Mean age, 62 
16 Cadavers 
I.Angiography 
2. Histology 
Angiography· 
(qualitative) 
No difference in the number of vessels per cross-
sectional area of tendon. 
The Achilles tendon has poor blood supply 
throughout its entire length. 
Decreased blood supply in the paratenon in the 
area 4cm above calcaneous 
Langberg et aI, 
2001 
3 small groups; 
young, middle­
and old-aged 
133Xenon technique Blood flow not different between young and 
middle-aged at rest and during exercise, but 
lower in old-aged subjects 
Astrom, 2000 40 healthy 
subjects & 35 
patients 
Laser Doppler Flowmetry 
(LDF) 
*Simillar to the 1994 study. Patient numbers have 
been increased. 
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Table 1.7. Studies investigating blood flow in the human Achilles tendon (continued) 
Author Subjects Methods Outcome 
Schmidt-Rolfing et Cadavers (n=8) Epoxy resin injection Poor blood flow in the mid portion and posterior 
al.,1992 distal part of the tendon 
Largergren and Cadavers Angiography of the Decreased blood flow in the midportion of the 
Lindholm, 1959 paratenon tendon 
(qualitative) 
Zantop et al., 2003 Cadavers, 10 legs, l.Injection technique Decreased number of vessels in the mid portion of 
freshly frozen 2.Immunohistochemistry the tendon 
Mean age, 67 
Knobloch et al., 66 subjects (132 Laser Doppler Flowmetry Increased blood flow in both insertional and mid­
2006 tendons),3 (LDF) combined with portion tendons, but blood flow similar in 
groups (healthy oxygen-to-see (02C) system uninjured legs compared to healthy tendons 
Achilles tendons, (quantitative) Postcapillary venous filling pressure was higher 
Insertional pain, in both insertional and mid-portion tendons 
midportion pain) Tissue oxygen saturation similar in all tendons 
aAllhumans 
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1.6.2.6 Increased tendon temperature 
It has been hypothesized that tendon tissue may be compromised by repeated and 
prolonged loading associated with exercise which theoretically could cause an 
increase in temperature of the cells, therefore affecting tenocyte function (Wilson 
and Goodship, 1994). In equine superficial digital flexor tendon (SDFT), which has 
the same function in horses as the Achilles tendon does in humans, the threshold for 
some type of fibroblasts viability has been reported to be 42.5 DC. In four horses that 
were made to gallop for a total of 7 minutes on a treadmill it was determined that 
the temperature measured in the centre of the SDFT rose to a mean of 43.3 DC (range 
40-45 DC). The normal horse rectal temperature is 37-38 DC. 
In an in vitro study, fibroblasts derived from equine SDFT were shown to be 
resistant to exposure to temperature below 45 DC, with cell viability sharply 
declining at a peak temperature of 46 DC (Birch et al., 1997). It was concluded that it 
was unlikely that temperatures experienced in the central core of SDFT in vivo 
caused cell death, although other cell functions such as synthesis of matrix products, 
might be compromised. Furthermore, it was shown in vitro that SDFT cultured 
tenocytes were more resistant to heat stress compared to equine dermal fibroblasts 
and a commercially available fibroblasts cell line (Birch et al., 1997). 
Although not yet determined, it is likely that during repetitive tendon loading such 
as in running in humans, the temperature of the Achilles tendon may rise to levels 
high enough to affect tenocyte function. However, the evidence directly linking the 
increase in tendon temperature and tenocyte function is lacking in both equine and 
human tendons. Therefore, the evidence for increased tendon temperature as an 
independent risk factor for Achilles tendon injury is weak. 
66 Department of Human Biology 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER ONE LITERATURE REVIEW 
1.6.2.7 Biomechanical and Alignment Factors 
A number of lower limb biomechanical and alignment factors have been associated 
with Achilles tendon injuries. These include muscle-tendon unit range of motion 
(ROM) (or flexibility), muscle-tendon unit stiffness, leg length inequality, muscle 
strength, muscle imbalance and leg dominance, plantaris tendon presence and foot 
morphological characteristics such as cavus foot, flat foot, genu varum (Kvist 1994; 
Schepsis et al., 2002). 
1.6.2.7.1 Musculotendinous Joint Range of Motion and Stiffness 
A decreased or increased ankle dorsiflexion range of motion (ROM) or flexibility has 
been associated with decreased incidence of musculotendinous injuries. It should be 
noted that until a few years ago, studies investigating the specific relationship 
between tendon flexibility and injury occurrence were not available (Almekinders 
and Temple, 1998). However, in one retrospective study it has been reported that 
patients with Achilles tendon injuries frequently presented with laxity of ligaments, 
joint tightness and hyperflexibility (Kvist, 1994). 
In a prospective cohort study, an increased tightness of the gastrocnemius muscle 
was found to be a risk factor for Achilles tendinopathy (Kaufman et al., 1999). In 
contrast, a recent 6-week prospective cohort study of basic military recruits has 
identified an ankle dorsiflexion greater than 9 degrees as a risk factor for the 
development of Achilles tendon overuse injuries (Mahieu et al., 2006). Interestingly, 
this latter study did not identify Achilles tendon stiffness as a risk factor for Achilles 
tendon injury. In another two-year prospective cohort study, but of an athletic 
population, decreased hamstring and quadriceps muscle flexibility were shown to 
be 'significantly associated with the development of patellar tendinopathy 
(Witvrouw et al., 2001). However, it has been reported that both reduced and 
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excessive range of motion around a joint can predispose a joint to injury (Jones et al., 
1993). 
Based o~ the lack of prospective cohort studies in the civilian population and 
conflicting results of the two prospective cohort studies, the level of evidence for 
joint range of motion as an independent risk factor for Achilles tendon injury is at 
best limited. 
1.6.2.7.2 Leg length inequality 
Anatomical or structural leg length inequality can be defined as a bilateral difference 
in the length of the bony components of the lower limb (McCaw, 1992). Two other 
types, functional and environmental leg length inequality can exit. For instance, if 
there is muscular weakness or inflexibility on one side of the body this would create 
a functional leg length inequality, when camber on the road would create an 
environmental leg length inequality (McCaw, 1992). However, in most cases, 
structural leg length inequality is the measured and analyzed parameter. In a 
retrospective study, leg length inequality of greater than 1 cm has been detected in 
15% of patients with Achill s tendon injuries (Kvist, 1994). However the prevalence 
of leg length inequality in the general population was not stated to make a valid 
conclusion regarding'leg length as a risk factor for Achilles tendon injuries. It has 
,been suggested that the size of the population with a characteristic of interest need 
to be known to make valid comparison (Powell et al., 1986). 
In one case-control study of 101 patients who had sustained an Achilles tendon 
rupture and 87 healthy subjects, Leppilahti et al. (1998) suggested that leg length 
inequality was not an important risk factor for Achilles tendon rupture. It was 
, 
interesting to note that only 10% of the patients who had sustained a rupture had no 
leg inequality, with the,remainder displaying either a longer left (59%) or a longer 
68 Department of Human Biology 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER ONE LITERATURE REVIEW 
right (31 %) leg. Therefore, the level of evidence for leg length inequality as an 
independent risk factor for Achilles tendon injury is weak 
1.6.2.7.3 Abnormal foot morphology 
It has been suggested that pes planus (flat foot), pes cavus (high-arched foot), 
increased talocrural or subtalar joint mobility may predispose to Achilles tendon 
injuries (Smart et. aI., 1980). Retrospective studies have reported that individuals 
with pes cavus, pes planus as well as forefoot /I over-pronation" may expose the 
Achilles tendon to an excessive 1/ whipping action", creating shear forces across the 
Achilles tendon, presumably by placing high eccentric stresses on the medial side of 
tendon (Clement et aI., 1981; Kvist, 1994; Leppilahti et aI., 1998). In one retrospective 
study, it was shown that 99 (91%) of the 109 legs of subjects with Achilles 
tendinopathy in the proximal two thirds of the Achilles tendon displayed· abnormal 
sonographic features (hypoechoic) (Gibbon et aI., 2000). This further supported the 
whipping action mechanism of the Achilles tendon as the degeneration was also 
dominant on the medial side of the Achilles tendon. The medial side of the Achilles 
should the mostly highly degenerated if the whipping action hypothesis is true 
(Gibbon et at, 2000). However, the Achilles tendon "whipping action" hypothesis 
needs to be further investigated. 
In a case-control study, a high longitudinal arch was reported in 37% of Achilles 
tendon rupture patients compared to 29% of controls (p<O.OOl) (Leppilahti et a1., 
1998). It was also found that 21 % of the patients had underpronation of the foot 
compared to 5% of the controls (p<O.OO1), while 32% of patients had overpronation 
of foot compared to 45% of the controls. However, only 10% of the patients had 
both high longitudinal arch and an underpronation of the foot compared to 1 % of 
the control subjects (p<O.OOl). 
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In retrospective study, it has been reported that forefoot varus may predispose to 
Achilles tendon overuse injuries (Kvist, 1994). However, there were no statistical 
differences in the amount of forefoot varus and valgus in Leppilahti et al. (1998) 
control and symptomatic subjects. Anomalies to calcaneal bone may also predispose 
to Achilles tendon injuries (Kvist, 1994). Other factors that may be associated with 
Achilles tendon injuries include bowed legs (genu varum or tibia varum) (Schepsis 
et al., 2002). Studies reporting on abnormal foot morphology are based on case 
series, retrospective and case·control studies at best. It is not clear whether the 
observed foot abnormality in cases is a cause or effect of the injury. Therefore, the 
level of evidence for abnormal foot morphology as an independent risk factor for AT 
injury is weak to limited. 
1.6.2.7.4 Leg dominance 
A few case series have reported that a greater number of individuals experience 
Achilles tendon injuries on their left leg more often than in the right leg (Cetti et al., 
1993, Levi, 1997;Jozsa et al., 1989; Cretnik and Frank, 2004; Leppilahti et al., 1996). It 
has been suggested that the reason for this finding is the need to push off with the 
left leg more often as majority of people are right-foot dominant (Maffulli et al., 
1999). It has been reported that the tendon on the left leg was ruptured in 57% of the 
cases, while the tendon on the right leg was ruptured in 43% and this difference was 
statistically significant (Levi, 1997). The same trend has been reported by Jozsa et al. 
(1989) (59% left Achilles tendon ruptures), Cretnik and Frank (2004) (53% left 
Achilles tendon ruptures) and Leppilahti et al. (1996) (56% left Achilles tendon 
ruptures). Although there have been several case series identifying the left leg as the 
most vulnerable to an Achilles tendon injury, the evidence for leg dominance as an 
independent risk factor for Achilles tendon injury remains weak. 
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1.6.2.7.5 Associated Plantaris tendon 
The plantaris muscle and tendon, if present, lies between and runs parallel to the 
gastrocnemius and soleus muscles (Daseler and Anson, 1943; Invaco et al., 1987). It 
is regarded as a vestigial structure (Daseler and Anson, 1943). In one case-control 
study it was found that 16 (40%) of the 40 subjects with Achilles tendon rupture had 
the plantaris tendon compared to 1295 (92.5%) of 1400 cadavers known to have no 
previous AT injury obtained from the general population (Incavo et al., 1987). 
Another relatively small case series, using a qualitative US examination found that 9 
of the 15 subjects (60%) who had experienced a complete Achilles tendon rupture 
had an intact plantaris tendon as shown by ultrasonography (Gibson, 1998). In a 
case series of 750 human Achilles tendon specimens, it was found that only 6-8% of 
the general population has no plantaris tendon (Daseler and Anson, 1943). 
The above studies have been on case series and case-control studies, therefore the 
evidence for the absence of the plantaris tendon as an independent risk factor for 
Achilles tendon injury is weak. 
1.6.2.7.6- Muscle strength 
It well documented that the majority of Achilles tendon injuries occur during the 4th 
decade of life (Jozsa and Kannus, 1997). Furthermore, muscle strength is decreased 
in older individuals. Also, the lower extremity muscle strength is important in 
coordination of movement and posture. It is therefore reasonable to assume that the 
muscle strength will be important during tendon loading. However, until recently, 
the association of muscle strength and tendon injury has not been investigated 
(Almekinders and Temple, 1998). However, in a recent prospective cohort study it 
was shown that lower plantarflexor muscle strength but not explosive strength was 
a significant predictor of an Achilles tendon overuse injury in 18 year old male 
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military recruits (Mahieu at al., 2006). Because so far this is the only prospective 
study that have shown this relationship, the level of evidence for plantar flexor 
~\ 
muscle strength as an independent risk factor for Achilles tendon injury is limited. 
1.6.2.8 Systemic diseases 
It has been suggested that a variety of systemic medical conditions may playa role 
in the pathogenesis of Achilles tendinopathy and rupture (reviewed in Riley, 2004; 
Jozsa and Kannus, 1997; Jozsa et al., 1989). Some of the most common inherited 
systemic diseases that may be ass~ciated with AT injuries include Marfan's 
syndrome, Ehler's Danlos syndrome, Osteogenesis imperfecta, lipid storage diseases 
(Jozsa and Kannus, 1997; reviewed in Riley, 2004). Endocrinologic and metabolic 
diseases include diabetes mellitus, renal diseases and disorders of thyroid, 
parathyroid, adrenocorticcotrophic and adrenocortical hormone systems (Jozsa and 
Kannus, 1997). Rheumatoid diseases such as rheumatoid arthritis, gout and 
ankylosing spondylitis have also been associated with Achilles tendon injuries 
(Jozsa and Kannus, 1997). For instance, in one case series 14.3% of the patients who 
had experienced acute Achilles tendon rupture also had gout (Beskin et al., 1987). 
Furthermore, it has been reported that in Caucasian patients with ankylosing 
spondylitis the occurrence of the human leucocyte antigen type B27 (HLA-B27) is 
found in 89% of the cases as opposed to 9% in controls (Naik, 2003; Klein and Sa to, 
2000). 
The association between high blood cholesterol or lipids and Achilles tendon injury 
has also been reported (Kannus and Jozsa, 1991). However, to date only two studies 
have documented an association between high serum lipid concentration. and 
Achilles tendon injury (Mathiak et al., 1999; Ozgurtas et al, 2003). In a case series 
investigation, Mathiak et al (1999) measured serum cholesterol amongst 41 patients 
with Achilles tendon ruptures and found cholesterol levels to be elevated in 83% of 
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the patients. However, this study did not have an age, gender and physical-activity 
matched control group to make a valid conclusion. In a case-control study of 47 
subjects who had sustained an Achilles tendon rupture and 26 control subjects, the 
mean total cholesterol, low-density lipoprotein cholesterol and triglycerides were 
found to be higher in the symptomatic compared to the control subjects. The mean 
high-density cholesterol was lower in the Achilles tendon rupture group compared 
to the control group (Ozgurtas et aL, 2003). It is also known that lipid deposition on 
the tendon is associated with some reported cases of Achilles tendon ruptures 
(Kannus and Jozsa, 1991) and has been linked with longitudinal collagen fiber 
separation associated with tendinopathy. 
In a large case series of patients with Achilles tendinopathy, it was shown that the 
proportion of subjects with previous systemic disease was quite small (Jozsa et a1., 
1989). Although hyperlipidemia, hypercholesterolemia and other systemic diseases 
may be risk factors for Achilles tendon injuries, the strength of evidence for a 
systemic disease as independent risk factor for Achilles tendon injury is weak. 
1.6.2.9 Genetic factors 
Ethnicity, the human leucocyte antigen (HLA) system and the ABO blood groups' 
have been the most commonly cited genetic risk factors associated with Achilles 
tendon injuries. 
1.6.2.9.1 Ethnic differences 
A 3 year retrospective study of 865 military personnel showed that black Americans 
were at higher risk of sustaining an Achilles tendon rupture than non-blacks 
(relative risk=4.15, 95%CI 3.63-4.74) (Davis et al., 1999). Interestingly, 53% of these 
injuries occurred while playing basketball, however 65% of the injuries were 
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basketball-related in blacks and 34% were in non-blacks. The authors reported that 
among the injured subjects, blacks had a greater risk of injury related to basketball 
than non-blacks (relative risk=1.82, 95% CI1.58-2.10). It is clear from the study that 
basketball is a risk factor for Achilles tendon rupture in both groups. However, the 
relative proportions of blacks and non-blacks who played basketball on a regular 
basis as well as the amount of play or training were not stated. 
Other authors have reported on the lack of data published on Achilles tendon 
injuries from the developing world, except for China and Saudi Arabia, suggesting 
that perhaps these injuries were less common or given less priority in the 
developing world (reviewed in Jozsa and Kannus, 1997). Therefore, the strength of 
evidence for ethnicity as an independent risk factor for Achilles tendon injury is 
weak. 
1.6.2.9.2 Human Leucocyte Antigen (HLA) system 
There have been two case reports of patients with Achilles tendinopathy who tested 
positive for the HLA-B27 (Olivieriet al., 1987; Olivieri et aI., 1992). Therefore, the 
HLA system has been cited as a possible genetic risk factor for Achilles 
tendinopathy. However, Achilles tendon ruptures have not been associated yet with 
polymorphisms in the HLA markers (Kannus and Natri, 1997), however both the A2 
and BW 35 HLA antigens have been associated with tendon pathology (Amor et.a1., 
1977; Gibson et. a1., 1975). Because of the two case reports of Achilles tendinopathy . 
associated with a HLA-B27, the strength of evidence for the HLA system as an 
independent risk factor in the in the development of Achilles tendon injury is weak. 
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1.6.2.9.3 .ABO blood groups 
A possible association between the ABO blood group and AT ruptures or chronic 
Achilles "peritendinitis" has been reported in some retrospective studies (Josza et al. 
1989; Kujala et al., 1992; Kannus and Natri, 1997), but not in all studies (Mahrlein et 
aL 1995; Leppilahti et aLI 1996; Maffulli et al., 2000; Aroen et al., 2004; Suchak et al., 
2006). The first study to report a possible association between the ABO blood group 
and Achilles tendon injury showed that 53% of individuals who had sustained an 
Achilles tendon injury were of ABO blood group 0 which was higher than the 31% 
found in the general Hungarian population (Jozsa et aL, 1989). However, a detailed 
discussion of the ABO blood group and its possible role in Achilles injury will be 
provided in Chapter 2 of this thesis. Nonetheless, the evidence for ABO blood 
group as an independent risk factor for Achilles tendon injury is weak. 
1.6.3 Summary of the extrinsic and intrinsic factors 
Several extrinsic and intrinsic factors for Achilles tendon injuries have been cited, 
but the majority of them were shown to have weak level of evidence. Only previous 
injury was classified as strongly associated with Achilles tendon injuries. None of 
the extrinsic factors were strongly associated with Achilles tendon injuries. Three 
extrinsic risk factors, namely physical activity, use of quinolones and corticosteroids 
showed limited level of evidence. The intrinsic factors gender, flexibility, muscle. 
strength and hyperlipidemia showed limited level of evidence. It is clear that many 
of the risk factors for Achilles tendon injury have not been investigated properly 
using well designed studies. It is important to note that classification of a possible 
risk factor for Achilles tendon injury as weak level of evidence does not mean it is 
not a risk factor. It only means that currently the only evidence available dictates its 
status, according to the level of evidence rating system. 
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Table 1.8 Intrinsic risk factors associated with acute and overuse Achilles tendon 
injuries 
Intrinsic risk factor Level of evidence Key references 
1. Age 
2. Gender 
3. Body mass and size 
4. Previous injury 
5. Tendon blood supply 
6. Tendon temperature 
7. Biomechanical factors: 
• Flexibility 
• Leg length inequality 
• Leg dominance 
• Foot morphology 
• Muscle strength 
• Associated Plantaris 
8. Genetic factors 
• ABO blood group 
.HLA 
• Ethnic group 
9. Systemic diseases 
• Hyperlipidemia 
Weak 
Limited 
Weak 
Strong 
Weak 
Weak 
Limited 
Weak 
Weak 
Weak 
Limited 
Weak 
Weak 
Weak 
Weak 
Weak 
Limited 
Leppilahti et al., 1996 

Jozsa et al., 1989 

Kannus and Natri, 1997 

Fredberg and Bolvig, 2002 

Knobloch et al., 2006 

Wilson and Goodship, 1994 

Mahieu et al., 2006 

Leppilahti et al., 1998 

Levi,1997 

Kvist, 1994; Leppilahti et al., 1998 

Mahieu et al., 2005; Kvist, 1994 

Daseler and Anson, 1943 

Jozsa et al., 1989 

Olivieri et al., 1987 

Davis et al., 1999 

J ozsa et al., 1989 

Ozgurtas et al., 2003 
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1.7. SUMMARY AND CONCLUSIONS OF THE LITERATURE REVIEW 
Although there have been advancement in the study of tendon pathology, it is 
widely accepted that the aetiology and pathogenesis of Achilles tendon injuries and 
other tendon injuries is multifactorial and still poorly understood. Both extrinsic and 
intrinsic risk factors for Achilles, tendon injuries have been implicated in the 
development of these injuries. Amongst the intrinsic factors, genetic factors have 
been implicated, as some but not all studies that have shown an association of the 
ABO blood group with AT injuries, suggesting that genes on the same locus 
(telomeric end of the long arm of Chromosome 9) as the ABO gene might be 
involved in the aetiology of AT injuries. More recently, studies of the rotator cuff 
tendon (Harvie et aI, 2004) and anterior cruciate liga,ment (Flynn et al., 2005) have 
provided further support to the possible involvement of genetic factors in the 
development of connective tissue injury. However, to date no study has identified 
specific gene (s) involved in tendon pathology. 
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1.8. AIMS OF THE THESIS 
The main aim of the thesis was therefore to investigate whether certain individuals 
are more prone to Achilles tendon injuries by posing the following specific aims: 
1. 	 To identify any candidate gene(s) that are located on the tip of the long arm of 
chromosome 9 (more specifically the 9q32-q34 locus) closely linked to the ABO 
gene which could theoretically be associated with Achilles tendon overuse 
injuries. In addition, the association of ABO blood group system with Achilles 
tendon rupture or chronic tendinopathy in a South African Caucasian population 
was investigated (Chapter 2), 
2. 	 To determine whether one of these identified genes, the COLSAl gene (which 
encodes analpha1 chain of type V collagen) is associated with Achilles tendon 
injury (Chapter 3), 
3. 	 To investigate whether a second candidate gene, the TNC gene (which encodes 
an extracellular matrix glycoprotein found in tendons) is associated with Achilles 
tendon injury (Chapter 4), 
4. 	 To investigate whether there was any COLSAl or TNC genotype effect on the 
muscle-tendon unit range of motion (ROM) (Chapter 5), and finally 
5. 	 To investigate whether there was any COLSAl or TNC genotype effect on the 
morphological changes associated with Achilles tendon injury by grey scale and 
colour Doppler ultrasonography (US) (Chapter 6). 
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CI~IAPTER 1WO CHROMOSOME 9q32-q34 AND ACHILLES TENDON INJURY 
2.1 INTRODUCTION 
As previously discussed in the previous chapter, although there is a reported 
increase in the incidence of Achilles tendon overuse injuries (Leppilahti et al., 
1996a), the mechanisms responsible for these pathologies are poorly understood 
(Riley, 2005a). Several extrinsic and intrinsic factors have nevertheless been 
shown to be associated with Achilles tendon pathology (reviewed in Riley, 2004; 
Kvist, 1994). The ABO blood group has been identified as one of the intrinsic 
factors shown to be associated with Achilles tendon ruptures or chronic Achilles 
"peritendinitis" (Josza et al. 1989; Kujala et al., 1992; Kannus and Natri, 1997). 
In a retrospective study, Josza et al. (1989) compared the frequencies of the ABO 
and Rh blood groups of 292 Hungarian patients with primary Achilles tendon 
ruptures or re-ruptures and 540 patients with various other tendon ruptures with 
a control group consisting of 1 200 000 subjects. These researchers showed that 
the frequency of blood group 0 was significantly higher in the patients with 
Achilles tendon ruptures (53.1%) than for the general Hungarian population 
(31.1 %). The 0 blood group was also more frequently observed in all the other 
investigated tendon ruptures, which included rupture of the long head of biceps 
(48.2%), extensor pollicis longus (53.9%) and the quadriceps (49.0%). 
Interestingly, 68.7% of the patients with multiple tendon ruptures (n=48) or re­
ruptures (n=35) were of blood group O. No association was found in this study 
between the Rh group and any of the tendon rupture groups. Blood group 0 
was still significantly higher in the combined tendon rupture group (54%) when 
443 additional subjects were recruited and analyzed (Kannus and Natri, 1997). 
In another study, Kujala et al. (1992) described a group of 917 Finnish patients 
diagnosed with a variety of musculoskeletal soft tissue injuries. This group 
included 86 patients diagnosed with Achilles tendon ruptures and 63 with 
chronic Achilles peritendinitis. The frequency of the blood group 0 among the 
patients diagnosed with Achilles tendon ruptures (31.2%) was not significantly 
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higher than in the control group (31.4%). The frequency of blood group 0 was 
however higher in the patients diagnosed with Achilles peritendinitis (42.9%). 
The AIO ratios, however, for the groups with rupture (1.0) or peritendinitis (0.7) 
of the Achilles tendon were lower than the control population (1.42). The ABO 
blood group was not associated with any of the other soft tissues injuries, 
including rotator cuff impingement (n=142), patellar dislocation (n=92), anterior 
cruciate ligament (ACL) rupture (n=205), spondylolithesis (n=177), and 
intervertebral disc herniation (n=152). 
More recently, Aroen et al. (2004) have suggested that there may be a genetic 
predisposition towards tendon ruptures as they observed that nine of the ten 
subjects who suffered a contralateral Achilles tendon rupture were of blood 
group B. The investigators, however, did not put forward suggestions why 
blood group B instead of blood group 0 was associated with Achilles tendon 
rupture in their study. 
Contrary to these findings, other studies investigating Finish, German and 
Scottish populations (summarized in Table 2.1), did not show an association 
between the ABO blood groups and Achilles tendon ruptures (Leppilahti et al., 
1996b; Mahrlein et al., 1995; Maffulli et al., 2000). The differences in the result of 
the various studies on the association of ABO blood distribution with Achilles 
tendon injuries could be due to variations in the sample sizes and differences in 
the distribution of the ABO blood group in genetically segregated ethnic groups 
(population stratification) (Maffulli et al., 2003). 
The ABO blood group system is one of approximately 400 blood antigens that 
have been described and together with the Rhesus blood group system is the 
most commonly used clinically. Antigenic surface proteins found on red blood 
cells determine the various blood group systems. In the ABO blood group 
system, 99.99% of individuals express the H antigen on their red blood cells 
(reviewed in Harmerning-Pittiglio, 1989; Suzuki, 2005). 
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Table 2.1. Summary of the studies investigating the association between ABO 
blood groups and Achilles tendon pathology. 
PathologyPopulation ControlReference group(s) Outcome group sample size
sample size 
Jozsa et al., 
1989 Hungarian 
ATR=292 
TR=540 
1,200,000 Blood group o associated 
Kujala et 
al.,1992 Finnish 
Achilles 
Peritendinitis 
& ATR= 149 
5,536 
Blood group 
distribution 
different 
Kannusand 
Natri,1997 Hungarian 
ATR&TR 
=1275 1,200,000 
Blood group 
o associated 
Leppilahti et 
al.,1996 Finnish ATR =215 5,536 No association 
Mahrlein et 
al.,1995 German ATR =531 Unknown No association 
Maffulli et al., 
2000 Scottish ATR=78 24,501 No association 
Aroen et al., 
2004 Norwegian ATR=10 None 
9/10 re­
ruptures were 
B 
ATR, Achilles tendon ruptures and TR, various other tendon ruptures (excluding 
Achilles tendon ruptures) 
As shown in Figure 2.1, different glycosyltransferases are able to modify the H 
antigen to produce the 3 major antigens found in the ABO blood group system. 
Two of the enzymes are encoded by a single gene, the ABO gene, which has been 
mapped to human chromosome 9q32-q34 (Bennet et al., 1995). Different alleles of 
this gene have been identified; allele A encodes for an a.1-3­
acetylgalactosaminyltransferase (transferase A), while allele B encodes for a al-3­
galactosyltransferase (transferase B). A third allele (0) encodes for a non­
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functional protein, leaving the H antigen unchanged. Further discussion of the 
ABO antigens is beyond the scope of this introduction, but it is important to note 
that these three products of the ABO gene determine an individual's ABO blood 
group type (Figure 2.1). 
H antigen precursor 
Fucosyl Transferase 
1(H gene, chromosome 19) 
H antigen 
Transferase A 
(ABO gene, chromosome 9) 
A antigen B antigen 
Figure 2.1. The A and B antigens produced by the A and B transferase activities 
respectively on the H antigen. Individuals with an 0 blood group have an 
unmodified H antigen because a non-functional enzyme is produced from the ABO 
gene. The names and chromosomal locations of the genes encoding the enzymes that 
modify the H antigen precursor are shown (adapted and modified from Daniels, 2005). 
RBC, red blood cell; Gal, galactose; Fuc, fucose; Nac Gal, N-acetyl glucosamine. 
ABO antigens are also found on most other body cells, including white blood 
cells, platelets, epithelial and endothelial cells (Harmerning-Pittiglio, 1989). The 
relationship of an individual's ABO genotype and ABO blood group is 
summarized in table 2.2. 
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Table 2.2. The relationship of the ABO genotype with the ABO blood group 
Possible Functional ABO AandB SerumABO 
enzyme phenotype antigens antibodyGenotype 
AAorAO Transferase A A A Anti-B 
BB or BO Transferase B B B Anti-A 
00 None o None Anti-A, 
Anti-B 
AB 
Transferase A, 
AB A&B None 
Transferase B 
Since the ABO gene encodes for transferases, some investigators have suggested 
that the different enzymes produced by the ABO gene, not only determines the 
structure of the glycoprotein antigens on the red blood cells, but also the 
structure of some of the glycoproteins found in the ground substance of tendons 
(Jozsa et al.~ 1989). Others have however suggested that the association of the 
ABO gene with tendon injuries is not directly linked to the ABO blood group 
antigens (Kujala et al., 1992; Kannus and Natri, 1997; Maffulli et al., 2002). These 
investigators have proposed that other genes, closely linked to the ABO gene on 
the tip of the long arm of chromosome 9 (9q34) (Bennet et al., 1995), which 
encode for components of the extracellular matrix are more likely to be associated 
with Achilles tendon pathology (Kujala et aL, 1992; Kannus and Natri, 1997). No 
other candidate genes have to date been identified within this locus. 
The main aim of this chapter of the thesis was to identify any candidate gene(s) 
that are located on the tip of the long arm of chromosome 9 (more specifically the 
9q32-q34 locus) closely linked to the ABO gene which could theoretically be 
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associated with Achilles tendon overuse injuries. In addition, the association of 
ABO blood group system with Achilles tendon rupture or chronic tendinopathy 
in a South African Caucasian population was investigated. 
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2.2 METHODS 
2.2.1 Subjects 
One-hundred and twenty-two physically active Caucasian patients with a current 
or past clinical history of Achilles tendon injury (ATI), including 79 with chronic 
tendinopathies (TEN) and 43 with tendon ruptures (RUP), were recruited from 
the Medical Practice at the Sport Science Institute of South Africa and other 
clinical practices within the greater Cape Town area in South Africa. The clinical 
practices invited their eligible patients to participate in the study (Appendix 2.1). 
Subjects were requested to contact the investigators if they were interested in 
volunteering for the study. 
One-hundred and thirty-one physically active Caucasian control (CON) subjects 
without any history of Achilles tendon pathology were also recruited for this 
study. The subjects were matched for age and gender. To avoid any possible 
effects of population stratification, the ATI and CON groups were also similarly 
matched for their country of birth. An additional 8 non-Caucasian asymptomatic 
control and 21 non-Caucasian ATI subjects were also recruited but were not 
included in this study. 
Approval for this study was obtained from the Research Ethics Committee of the 
Faculty of Health Sciences within the University of Cape Town (Appendix 2.2). 
Once recruited, the subjects were required to complete an informed consent form 
(Appendix 2.3) and personal particulars, physical activity and medical history 
questionnaires prior to participation (Appendix 2.4). 
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2.2.2 Diagnosis ofAchilles tendon injury 
An experienced clinician made the diagnosis of chronic Achilles tendinopathy 
(n=73) using clinical criteria. The diagnostic criteria for every subject were 
reviewed by a sports physician (Associate Professor Martin Schwellnus). The 
clinical diagnostic criteria for chronic Achilles tendinopathy (Appendix 2.5) were 
gradual progressive pain over the posterior lower limb in the Achilles tendon 
area for greater than 6 months, together with at least one out of the following six 
criteria: (1) early morning pain over the Achilles tendon area, (2) early morning 
stiffness over the Achilles tendoncarea, (3) a history of swelling over the Achilles 
tendon area, (4) tenderness to palpation over the Achilles tendon, (5) palpable 
nodular thickening over the affected Achilles, or (6) movement of the painful area 
in the Achilles tendon with plantar-dorsi-flexion (positive 1/ shift" test) (Schepsis 
et aL, 2002; Kader et al., 2002). In addition to these clinical diagnostic criteria, soft 
tissue ultrasound examination was performed in a sub-group (n=36) of subjects 
to confirm the diagnosis of the affected Achilles tendon. 
The diagnosis of Achilles tendon rupture (Appendix 2.6) was made clinically 
using standard validated criteria (Schepsis et al., 2002) and confirmed in all cases 
by examination at the time of surgery (n=35) or by ultrasound imaging (n=5), 
MRI imaging (n=2) or computer tomography (CT) scan (n=1). Subjects who had 
a history of current or past fluoroquinolone antibiotic use or previous local 
corticosteroids injection in the Achilles tendon or the area surrounding the 
Achilles tendon were excluded from the study. This was necessary because of 
the known association between fluoroquinolone antibiotic (van der Linden et aL, 
2001) or possibly corticosteroids use, and an increased risk of Achilles tendon 
rupture (Leppilahti and Orava, 1998). Furthermore, subjects who had been 
diagnosed with any connective tissue disorders or any other systemic diseases 
believed to be associated with Achilles tendon pathology, such as, but not limited 
to, Ehlers-Danlos syndrome, benign hypermobility joint syndrome, rheumatoid 
arthritis, systemic lupus erythematosus, hyperparathyroidism, renal 
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insufficiency, diabetes mellitus and familial hypercholesterolaemia were also 
excluded from the study (Leppilahti and Orava, 1998). A total of 43 subjects (this 
value was not included in the reported value of 122 ATI subjects in section 2.2.1) 
with unconfirmed diagnoses or did not meet all the inclusion criteria were 
excluded from the study. 
2.2.3 Sample collection and ABO blood grouping analysis 
Approximately 4.5 ml of venous blood was collected from each subject into 
EDTA vacutainer tubes by venipuncture of a forearm vein and stored at 4°C until 
DNA extraction (Chapter 3) and ABO blood group determination. A small 
quantity of the blood sample was aliquoted to determine the ABO blood group in 
118 ATI and 131 CON subjects using standard (forward and reverse) 
agglutination techniques (Western Province Blood Transfussion Services, Cape 
Town, South Africa). Since the reverse test confirmed all the forward tests 
(n=22), the subsequent samples were only ABO typed using the forward test. In 
addition the forward test agreed with 94% (120 of 127) of the available self­
reported ABO blood group types. 
For the forward test, 10 fll of total blood was diluted with 190 JlI of physiological 
saline. A single drop of this suspension was added to 3 separate SmL Kimble test 
tubes containing 1 drop of anti-A, anti-B or anti-AB antibody suspension. The 
contents of the tube were mixed and centrifuged at 1200xg for 2 min at room 
temperature. The test tubes were tapped gently at the bottom to resuspend the 
contents to record if any agglutination occurred. 
For the reverse test, about 4.Sml of blood was centrifuged for 10 min at 1650xg, 
then 100 JlI of the subject's serum with unknown antibodies was aliquoted from 
the tube, from which 1 or 2 drops of the serum was added to 3 separate Kimble 
test tubes containing 1 or 2 drops of test cells (Le. known antigens). The contents 
of the tube were then mixed and centrifuged for 15 seconds at 2100xg. Likewise, 
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macroscopic agglutination was recorded after gently resuspending the contents 
of the tube. 
Individual Caucasian ABO blood group types (WC POP, n=62,216) were 
obtained from the Western Province Blood Transfusion Organization (the official 
blood transfusion center for the greater Cape Town area). 
2.2.4 Identification ofcandidate genes 
Genes that flank the ABO gene were identified by searching the OMIMTM (Online 
Mendelian Inheritance In Man) (www.ncbi.nlm.nih.gov 1entrez/) and NCB I Map 
Viewer (www.ncbi.nlm.gov/mapview/) databases. Since the ABO gene has been 
mapped to the human chromosome 9q34, all genes mapped from 9q32 to the end 
of the chromosome q34.3 were initially identified. Additional information on the 
identified genes and the proteins for which they encode was obtained from the 
Entrez Gene (www.ncbi.nlm.nih.gov 1entrez/) and OMIMTM databases. Genes 
were included as possible candidate genes for tendon pathology if they encoded 
for proteins that formed an integral structural component of the extracellular 
matrix (ECM). Since tenocytes have been shown to play an important role in 
tendon pathology (Kannus and Jozsa, 1991; Yuan et al., 2002; Murrelt 2002), 
genes encoding for proteins involved in cell proliferation, cell death (specifically 
apoptosis) and other miscellaneous processes were also identified. The biological 
function of the proteins encoded for by the genes on the telemetric end of the 
long arm of chromosome 9 were identified from their functional descriptions in 
the databases. 
2.2.5 Statistical analyses 
Data were analyzed using the STATISTICA version 7 (StatSoft Inc., Tulsa, OK, 
USA) and GraphPad InStat version 3 (GraphPad Software, San Diego, CA, USA) 
statistical programs. A one-way analysis of variance (ANOVA) was used to 
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determine any significant differences between the characteristics of the A TI and 
CON groups, as well as the TEN and RUP sub-groups. When the overall F value 
was significant, a Tukey's HSD post hoc test was used to identify specific 
differences. Statistical significance was accepted when p<O.05. Data are 
presented as means ± standard deviations (SD) or frequencies with the number of 
subjects in parentheses. Chi-square analysis (Graphpad lnstat version 3) was 
used to analyze differences in the ABO blood group frequencies between the 
CON, ATI, TEN, RUP and WC POP groups as well as to analyze differences in 
the country of birth and gender frequencies between the CON and ATI groups, 
as well as the TEN and RUP subgroups. Chi-square analysis (Graphpad Instat 
version 3) was also used to compare number of people smoking, number of 
injuries experienced, and the limb injured. The Fisher's Exact Test (Graphpad 
Instat version 3) was used to compare the differences in the dominant hand and 
the position of the Achilles tendon injured. 
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2.3 RESULTS 
2.3.1 Subjects Characteristics 
A total of 118 Caucasian subjects with a current or past clinical history of Achilles 
tendon injury (AT!) and 131 apparently healthy asymptomatic Caucasian 
controls (CON) were included in the ABO blood typing study. The ATI group 
consisted of 75 patients diagnosed with Achilles Tendinopathy (TEN) and 43 
with either a complete or partial rupture of the Achilles tendon (RUP). It is 
important to note that these numbers may be slightly lower in the subsequent 
tables since data such as age, height, weight, BMI, gender, country of birth and 
other variables were missing in some subjects. An additional 62,216 individual 
Caucasian ABO blood group types were obtained from the Western Province 
Blood Transfusi~n Organization (the official blood transfusion center for the 
greater Cape Town area). The larger group (WC POP) represented the general 
population in the study area. 
As shown in table 2.3, the CON, ATI, TEN and RUP groups were similarly 
matched for age, height, gender an~ country of birth. The AT I, TEN and ATR 
groups were however significantly heavier, with the corresponding higher BMI, 
than the CON group. The RUP sub-group was also significantly heavier with a 
higher BMI than the TEN sub-group. The ATI subjects were recruited for the 
present study on average 7.4 ± 8.5 years, ranging from 0 to 39 years, after the 
onset of their initial symptoms. Although most of the subjects in each group 
were right handed, significantly more individuals were right handed in the CON 
group (n=114, 91.9 %) than in the AT! (n=88, 82.2 %, p=0.030, odds ratio of 2.5; 
95% confidence interval 1.1 to 5.6) or in the TEN (n=55, 78.6 %, p=0.013, odds 
ratio of 3.1; 95% confidence interval 1.3 to 7.4). There was however no significant 
difference between the CON and RUP (n=33, 89.2 %, p=0.739, odds ratio of 1.4; 
95% confidence interval 0.4 to 4.7) groups (Table 2.3). There were no reported 
ambidextrous individuals in the study. Significantly fewer ATI (n=70, 61.4%, 
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Chi-square=6.2, p=0.046) and RUP (n=21, SO.O %, Chi-square=10.8, p=O.OOS) 
subjects have never smoked when compared to CON subjects (n=9S, 7S.4%). 
There were no differences when the CON and TEN (n=49, 68.1 %) groups were 
compared (Chi-square=l.5, p=0.480) (Table 2.3). 
Table 2.3. Characteristics of the control (CON) and Achilles tendon injury 
(ATI) groups, as well as the Achilles tendinopathy (TEN) and Achilles rupture 
(RUP) sub-groups. 
CON ATI TEN RUP 
(n=131) (n=118) (n=7S) (n=43) 
Age (yrs)1 41.3 ± 10.9 (124) 
40.2 ± 13.6 
(118) 
40.0 ± lS.l 
(7S) 
40.7± 11.1 
(43) 
Height (cm) 174.7 ± 9.3 (123) 
176.0 ± 9.0 
(118) 
176.1 ± 9.3 
(7S) 
17S.8 ± 8.3 
(43) 
Weight (kg) 71.1 ± 12.0 (127)a,b,d 
80.6 ± 14.0 
(118)a 
77.2 ± 14.0 
(7S)b,e 
86.4 ± lS.2 
(43)d,e 
BMI (kg/cm2) 23.2 ± 2.7 (123)a,c,d 
2S.9 ± 3.9 
(118)a 
24.8 ± 3.4 
(7S)c,e 
27.9 ± 4.0 
(43)d,e 
Gender (% males) 62.3 (130) 73.8 (122) 72.2 (79) 76.7 (43) 
Country of Birth 
(% South Africa) 70.6 (126) 76.9 (117) 74.3 (74) 81.4 (43) 
Right Handed (%) 91.9 (124)f,g 82.0 (111)f 78.1 (73)g 91.9 (38) 
Current Smoker (%) 3.2 (126)h,i 7.7 (117)h S.4 (74) 11.6 (43)i 
Ex-smoker (%) 21.4 (126) h,i 29.9 (ll7)h 2S.7 (74) 37.2 (43)i 
Values are expressed as mean ± standard deviation or a frequency (%) where applicable. 
Number of subjects (n) is in parentheses. IThe age of the AT! group as well as the TEN 
and RUP sub-groups are the age of onset of the symptoms of Achilles tendon pathology. 
aCON vs AT! (p<O.OOl), bCON vs TEN (p=O.005), cCON vs TEN (p=O.002), dCON vs RUP 
(p<O.OOl), eTEN vs RUP (p<O.OOl), fCON vs AT! (p=O.030), gCON vs TEN (p=O.008), 
hCON vs AT! for smoking (p=O.063) and iCON vs RUP for smoking (p=O.006). 
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In the TEN group, the additional documented clinical criteria to confirm the 
diagnosis were tenderness to palpation (63 of 75), early morning stiffness (43 of 
75), a history of swelling (26 of 75), early morning pain (19 of 75), palpable 
thickening (17 of 75) and a positive "shift" test (11 of 75). In 36 of the 75 subjects, 
the diagnosis was confirmed by soft tissue ultrasound examination of the -affected 
Achilles tendon. There were 31 of the 75 subjects with confirmed bilateral 
Achilles tendinopathy. 
In the RUP group, 39 of 43 subjects experienced acute severe pain in the posterior 
lower leg as the main presenting symptom. The diagnosis was confirmed in all 
these subjects by either direct examination at the time of surgery (38 of 43) or by 
imaging (8 of 43) (soft tissue ultrasound, Magnetic Resonance Imaging or 
Computerized Tomography). Four of the 43 subjects had confirmed bilateral 
ruptures of the Achilles tendon, and 16 of 43 subjects had a history of 
tendinopathy prior to rupture. 
Table 2.4. The distribution of subjects with Achilles tendon injury (ATI), 
Achilles tendon rupture (RUP) and Achilles tendinopathy (TEN) according to 
the region of the Achilles tendon injured. 
Position ATI (n=101) 
TEN 
(n=62) 
RUP 
(n=39) 
Lower Third 38.6 (39) 27.4 (17) 56.1 (22) 
Middle Third 60.4 (61) 71.0 (44) 43.6 (17) 
Upper Third 1.0 (1) 1.7 (1) 0(0) 
Values are expressed as percentage with the number of subjects (n) in parenthesis. 
TEN vs RUP, Fisher's Exact test, p=O.007. 
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As shown in table 2.4 , 38.6 %, 60.4 % and 1.0 % of the ATI subjects injured the· 
lower, middle and upper third of their Achilles tendon, respectively. 
Significantly more TEN subjects (71.0 %) injured the middle third of the Achilles 
tendon when compared to the RUP subjects (43.6 %, Fisher's exact test, p=O.OO7). 
There ·were no significant differences in the distribution of number of subjects 
with a left or right leg injury within ATI (33.3 vs 35.1 %), TEN (27.9 vs 26.7 %) and 
RUP (41.9 vs 48.8%) groups (Table 2.5). However, a greater number of subjects in 
the TEN group injured both legs (45.6%) compared to the RUP group (9.3%). The 
majority of the subjects in ATI (75.2%), TEN (81.4%) and RUP (65.1 %) groups had 
sustained only 1 injury to the Achilles tendon (Table 2.6). 
Table 2.5. The distribution of subjects with Achilles tendon injury (ATI) 
group, as well as Achilles tendinopathy (TEN) and Achilles tendon rupture 
(RUP) sub-groups according to the injured leg. 
Leg ATI (n=111) 
TEN 
(n=68) 
RUP 
(n=43) 
Right 35.1 (39) 26.7 (18) 48.8 (21) 
Left 33.3 (37) 27.9 (19) 41.9 (18) 
Both 31.5 (35) . 45.6 (31) 9.3 (4) 
Values are expressed as percentage with the number of subjects (n) in parenthesis. 
TEN vs RUP, Chi-square=16.3, p<O.OOl. 
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Table 2.6. The distribution of subjects with Achilles tendon injury (ATI) 
group, as well as Achilles tendinopathy (TEN) and Achilles tendon rupture 
(RUP) sub-groups according to the number of injuries experienced. 
Injuries ATI (n=113) 
TEN 
(n=70) 
RUP 
(n=43) 
3 or more 8.9 (10) 8.6 (6) 9.3 (4) 
2 15.9 (18) 10.0 (7) 25.6 (11) 
1 75.2 (85) 81.4 (57) 65.1 (28) 
Values are expressed as percentage with the number of subjects (n) in parenthesis. 
TEN vs RUP, Chi-sqaure=5.0, p=O.081. 
2.3.2 Mode ofInjury 
The activity resulting in injury in the majority of the ATI subjects was running (50 
of 107, 46.7%) or playing squash (20 of 107, 18.7%), while the remaining injuries 
occurred as a result of participating in a variety of sports and activities (Table 
2.7). When the ATI group was divided into T~N and RUP, the distribution of 
injuries associated with running and squash changes, showing more clearly that 
Achilles tendinopathy was associated more with running (43 of 65,66.2%) while 
Achilles tendon rupture was more associated with squash (17 of 42,40.5%). 
2.3.3 Physical activity history 
As shown in Table 2.8, all the subject groups and sub-groups were matched for 
the number of years participated in running. Seventy-four percent, 56%, 61 %and 
46% of the CON, ATI, TEN and RUP subjects respectively, participated in 
running. Over the last two years, both the ATI and RUP groups, but not the TEN 
group, trained significantly less than the CON group. The three symptomatic 
Achilles pathology groups, however, participated for significantly more years in 
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high impact sports than the CON group. There were no significant differences in 
the hours of training in high impact sports over the last two years between the 
groups. There were also no significant differences in years of participation and 
the level of training over the last two years when only the squash players were 
analysed (data not shown). 
Table 2.7. The distribution of subjects with Achilles tendon injury (ATI) as 
well as the Achilles tendinopathy (TEN) and Achilles tendon rupture (RUP) 
according to the activity of injury. 
ATI TEN RUPActivity (n=107) (n=65) (n=42) 
Running 46.7 (50) 66.2 (43) 16.7 (7) 
Squash 18.6 (20) 4.6 (3) 40.5 (17) 
Tennis 4.7 (5) 1.5 (1) 9.5 (4) 
Rugby 2.8 (3) 3.1 (2) 2.4 (1) 
Touch Rugby 1.9 (2) 0.0 (0) 4.8 (2) 
Hockey 0.9 (1) 0.0 (0) 2.4 (1) 
Soccer Gogging) 0.9 (1) 0.0 (0) 2.4 (1) 
Walking 0.9 (1) 1.5 (1) 0.0 (0) 
Gymnastics 0.9 (1) 0.0 (0) 2.4 (1) 
Unknown 1.9 (2) 3.1 (2) 0.0(0) 
Other# 19.6 (21) 20.0 (13) 19.0 (8) 
Values are expressed as percentage with the number of subjects (n) in parenthesis. 
#Other activities included activities such as house work (1), horse riding (1), running 
upstairs (1), digging in the garden (1), getting off a flight (1), sudden crossing of a road 
(1), descending stairways (1), pushing a car (1), slipping down the road (1) and 
dismantling the antenna (1). 
. University of Cape Town 95 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER TWO CHROMOSOME 9q32-q34 AND ACHILLES TENDON INJURY 
Table 2.8. Participation in physical activity and training of the control (CON) 
and Achilles tendon injury (ATI) groups. 
Running (yrs) 

Running in the past 2 

yrs (h/wk) 

High Impact Sports (yrs) 

High Impact Sports in 

the past 2 yrs (h/wk) 

CON ATI 
(n=127) (n=114) 
7.9 ± 8.1 (127) 8.5 ± 10.6 (114) 
3.3 ± 2.9 (123)a 2.0 ± 2.6 (102)a 
11.5 ± 8.6 (127)a 19.6 ± 13.0 (114)a 
5.1 ± 4.9 (127) 3.9 ± 5.0 (114) 
Values are expressed as mean ± standard deviation. Numbers of subjects are in 
parentheses. 
aeON vs A TI, p<O.OOl 
2.3.4 Blood group distribution 
As shown in Table 2.9, the overall ABO blood group distribution between the 5 
groups was significantly different (Chi Square=32.1, p=O.OOl). Interestingly, the 
ABO blood group frequency distribution between the CON and WC POP groups 
were significantly different (Chi square=9.2, p=0.027). The CON and AT! ABO 
blood group distribution was also significantly different (Chi square=10.6, 
p=0.0l4). However, there were no significant differences in the ABO blood 
group distribution between the CON vs TEN, the CON vs RUP or the TEN vs 
RUP groups. The percentage of individuals with blood group 0 was similarly 
distributed between the CON, ATI, TEN and RUP groups (Chi-square=0.2, 
p=0.983). The A/O ratio of the CON (1.0) ,ATI (1.0), TEN (1.1), and RUP (1.0) 
groups were also similar. The A/O ratio of the WC POP group was however 
lower (0.7). The ABO blood group distribution of the individuals with bilateral 
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injuries were also similar (data not shown) to those of the CON group (Chi 
square=OA, p=0.795) 
Table 2.9. ABO blood group relative frequencies of the control (CON), Achilles 
tendon injury (ATI), Achilles tendinopathy (TEN), Achilles tendon rupture 
(RUP) and the Western Cape Caucasian population (WC POP) subgroups~ 
CON ATI TEN RUP WCPOP 
(n=131) (n=118) (n=75) (n=43) (n=62,216) 
A(%) 39.7 (52) 40.7 (48) 41.3 (31) 39.5 (17) 34.7 (21,564) 
0(%) 41.2 (54) 39.8 (47) 38.7 (29) 41.9 (18) 48.9 (30,448) 
B (%) 18.3 (24) 11.0 (13) 13.3(10) 7.0 (3) 12.6 (7,825) 
AB (%) 0.8 (1) 8.5 (10) 6.7 (5) 11.6 (5) 3.8 (2,379) 
Values are expressed as percentage with the number of subjects (n) in parenthesis. 

CON vs WC POP Chi-square=9.2, p=O.027i CON vs ATI Chi-square=10.6, p=O.014; CON 

vs TEN Chi-square=O.l, p=O.937i CON vs RUP Chi-square=O.O, p=O.996 and TEN vs RUP 

Chi-square=O.l, p=O.942. 

2.3~5 Identification ofgenes on chromosome 9q32-q34 
One thousand and sixty-two genes have been mapped to chromosome 9 were 
initially identified by searching the OMIMTM (Online Mendelian Inheritance In . 
Man) (www.ncbi.nlm.nih.gov/entrenz/) and NCBI Map Viewer 
(www.ncbLnlm.gov/mapview/) databases. Of these, 404 have been mapped to 
the same locus as the ABO gene between 9q32-q34 (Appendix 2.7). Seven genes 
.were identified as pseudogenes and were therefore excluded as candidate genes. 
Twenty-one of the remaining genes were identified as possible candidate genes 
for Achilles tendon injuries (Table 2.10). Four of the 21 genes, COL5Al, TNC, 
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COL27Al and LAMC3 encode for components of the extracellular matrix. Nine 
of the candidate genes, TNFSF15, TRAFl, GSN, DAPK1, PTGES, WDR31, WDR34, 
CARD9 and TRAF2, encode for proteins involved in cell death. Four of the 
genes, PPP2R4, ABL1, PRRX2 and EDG2, encode for proteins involved in cell 
growth, while the remaining 4 genes encode encode for proteins involved in a 
variety of processes ranging from angiogensis (PTGS1), signal transduction 
(RAPGEF1), cell interactions (NOTCH1) and a proteasome component (PSMB7). 
The relative location of these genes within the 9q32-9q34 region is shown in 
figure 2.2. 
Table 2.10. Possible candidate genes for Achilles Tendon Injury, identified in 
the 9q32-34 locus flanking the ABO gene 
Candidate 
Gene No 
Cytogenetic 
Location 
Gene 
Name Short Description 
1 9q34.2-q34.3 COL5Al Encodes for the 01 chain of type V collagen 
2 9q33 TNC Encodes for a matricellular protein found in 
connective tissues, including tendons 
3 9q33.1 COL27Al Encodes for a fibrillar collagen found in a 
number of tissues 
4 9q31-q34 LAMC3 Encodes for the gamma 3 chain of the 
extracellular matrix protein laminin 12 
5 9q32 TNFSF15 
Encodes for a cytokine expressed in 
endothelial cells and is capable of inducing 
apoptosis in endothelial cells 
6 9q33-q34 TRAF1 Encodes for a protein that mediates signal transduction and anti-apoptotic signals 
7 
8 
9q33 
9q34.1 
GSN 
DAPKl 
Encodes for a protein that is involved in 
apoptosis 
Encodes for a kinase which mediates gamma­
interferon induced cell death 
9 9q34.3 PTGES Encodes for a protein involved in apoptosis 
and inflammation 
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Table 2.10. Possible candidate genes for Achilles Tendon Injury, identified in 
the 9q32-34 locus flanking the ABO gene (Continued) 
Candidate 
Gene No. 
Cytogenetic 
Location 
Gene 
Name Short Description 
10 9q32 WDR31 Encodes for protein involved in apoptosis 
and cell signaling 
11 9q34.11 WDR34 Encodes for protein involved in apoptosis 
and cell signaling 
12 9q34.3 CARD9 Encodes for a protein involved in cell 
apoptosis 
13 9q34 IRAF2 Encodes for a protein that mediates signal 
transduction and anti-apoptotic signals. 
14 9q34 PPP2R4 Encodes for a phosphatase involved in cell division and growth 
15 9q34.1 ABLl 
Encodes for a kinase involved in cell 
division, differentiation and adhesion and 
stress response 
16 9q34.1 PRRX2 Encodes for a protein whose expression is localized to proliferating fetal fibroblasts 
17 9q32 EDG2 Encodes for a protein involved in cell prolifera tion and signaling 
18 9q32-q33.3 PIGSl 
Encodes for an enzyme prostaglandin­
endoperoxide synthase, which regulates 
angiogenesis 
19 9q34.3 RAPGEF1 
Encodes for a globular protein that mediates 
signal transduction from cell surface to the 
nucleus 
20 9q34.3 NOICHl Encodes for a transmembrane protein which is thought to playa role in cell interaction 
21 9q34.11-q34.12 PSMB7 Encodes for a core beta subunit in proteasome B-type family 
Candidate genes number 1 to 4 encode for components of the extracellular matrix, while 
the proteins encoded for by candidate genes number 5 to 13 are involved in apoptosis. 
Proteins encoded for candidate genes number 14 to 17 are involved in cell growth. The 
remaining 4 candidate genes encode for proteins involved in a variety of biological 
process including angiogensis (18), signal transduction (19), cell interactions (20) and a 
proteasome component (21). 
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Figure 2.2. Schematic diagram depicting the relative positions of the genes 
within the chromosome 9q32-q34.3 locus (*). The position of the ABO gene is 
shown in blue. The genes which encode for components of the extracellular 
matrix are shown in red, while the remaining genes are shown in black. The 
dashed line represents 20 Mb of DNA not shown. 
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2.4 DISCUSSION 
The ABO blood group was evenly distributed between the asymptomatic control 
subjects and the subjects with clinical symptoms of Achilles tendon injuries. 
There were also similar distributions of the ABO blood group when the Achilles 
tendon injury subjects were divided into the rupture and tendinopathy sub­
groups. The ABO blood group distribution in the control and the Achilles 
tendon injury groups, as well as the Achilles tendon rupture and Achilles 
tendinopathy sub-groups, were however significantly different than the general 
Caucasian population in the greater Cape Town area. The a blood group and the 
A/a ratio were however not over-represented in the Achilles tendon injury 
group or any of the sub-groups when compared to the control group or the 
general population. The reason for differences in the blood group distribution of 
the general population when compared to the recruited subjects is not clear. The 
values for the general population are however similar to published values for 
other Caucasian populations (Maffulli et al., 2000; Garratty et al., 2004). 
Since the ABO antigens are ubiquitous glycoproteins found throughout the body, 
some scientists have speculated that the different transferases encoded for by the 
ABO gene might playa role in tendon extracellular matrix function (Maffulli et 
aI, 2000; Jozsa et aL, 1989). A more plausible explanation for the reported 
association of the ABO blood group and Achilles tendon pathology would be that 
another gene(s) closely linked to the ABO gene encodes for a protein(s) which is 
directly involved in the aetiology of the pathology (Kujala et al., 1992). The ABO 
gene has been mapped to the telomeric end of the long arm of chromosome 9 
(9q34). It could be that another gene(s) in linkage disequilibrium with the ABO 
gene encode for protein(s) either directly or indirectly involved in the synthesis, 
degradation, remodelling and/ or metabolism of the tendon matrix. Nail Patella 
Syndrome (NPS), for example, was initially shown to be linked to the ABO blood 
group (reviewed in McIntosh et aL, 2005). The gene causing NPS, LMX1B, was 
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identified and mapped 40 years later to the same locus as the ABO gene on 
chromosome 9q34 (Riddle et al., 1995; Chen et aL, 1998). This supports the 
hypothesis that the reported association of the ABO blood group with Achilles 
tendon pathology is suggesting that other genes mapped to the long arm of 
chromosome 9q34 are involved in this pathology. 
The novel component of the present study was to identify possible candidate 
genes that have been mapped to the same locus as the ABO gene on the tip of the 
long arm of chromosome 9 which could encode for proteins that theoretically 
could be involved in Achilles tendon pathology. Four hundred and four genes 
were initially identified within the same locus as the ABO gene between 9q32­
q34. This region was calculated to be about 31 Mb or 31 centiMorgans (cM). One 
centimorgan in linkage terms represents about 1 million base pairs and is usually 
equivalent to 1% recombination in the offspring (ghr.nlm.gov / ghr/glossary). 
Twenty one candidate genes were identified from the 404 genes. The 21 
candidate genes were divided into four groups according to the function of the 
proteins they code for, namely (i) structural proteins of connective tissue (4 of 21), 
(ii) proteins involved in cell proliferation (4 of the 21), (iii) proteins involved in 
regulatory processes (4 of the 21) (iv) and finally proteins involved in 
programmed cell death (apoptosis) (9 of the 21). Although four of the identified 
genes encode for structural components of the extracellular matrix, none of the 
genes on the tip of the long arm of chromosome 9 appeared to encode for 
enzymes and regulatory proteins, such as the matrix metalloproteinases (NIMPs), 
tissue inhibitors of metalloproteinases (TIMPs) and AD AMTS (a disintegrin and 
metalloproteinase with thrombospondin-like repeats) enzymes, involved in the 
remodeling of the extracellular matrix. However, these class of proteins would 
also be ideal candidate genes for tendinopathy (reviewed in Riley et al., 2005a). 
Information on the gene function for almost half of the 404 genes found in the 
9q32-q34 locus was either unavailable or scanty. There may, therefore, be 
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additional candidate genes in this region, which will only be identified once their 
function has been elucidated. 
When the ABO blood group was first shown to be associated with Achilles 
tendon injuries Gozsa et al., 1989), researchers speculated that one of the collagen 
genes might be linked to the ABO gene on chromosome 9 (Maffulli et al., 2000; 
Kannus and Natri, 1997). It was reasoned that because the main structural 
component of tendons are collagen fibrils, consisting predominately of type I and 
III collagens, any gene encoding for a collagen a chain which mapped to the 
9q32-q34 locus would be a very strong candidate gene for Achilles tendon injury. 
However, in 1992 it was erroneously stated that none of the collagen genes have 
been mapped to this region of chromosome 9 (cited in Kannus and Natri, 1997). 
Two of the identified candidate genes in this study, namely the COL5Al and 
COL27Al genes, encode for a-chains of type V and XXVII collagens, respectively. 
The COL5Al gene encodes for the a1 chain (pro- a1(V) chain) of the low 
abundance heterotrimeric type V fibrillar collagen (Smith and Simpson, 1989; 
Kujala et al., 1989; Greenspan et al., 1992). The pro- a1(V) chain is found in most 
of the isoforms of type V collagen (reviewed in Ristiniemi and Oikarinen, 1989). 
Type V collagen is found in tissues, including tendons, containing type I collagen 
and appears to regulate the assembly (fibrillogenesis) of heterotypic fibers 
composed of both type I and type V collagen (Birk et al., 1990). It is thought that 
the proportion of type V collagen in tendons may influence the diameter of the 
fibre. Increases in type V collagen content have been reported with age in the 
rabbit patellar tendon and in biopsy samples of degenerative tendons (Dressler et 
al., 2002; Goncalves-Neto et al., 2002). In healing tendons and ligaments of 
rabbits, increases in type V collagen content relative to type I collagen are 
associated with increased proportion of smaller fibril diameters (Dressler et al., 
2002). Recently, it has been demonstrated that type V collagen deficient mice 
could not form collagen fibrils (Wenstrup et al., 2004), emphasizing the role of 
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type V collagen in fibrillogenesis. The authors proposed that no other collagen 
studied so far, including type I, has such major control in fibril initiation as type 
V collagen. It was therefore reasonable that the COL5Al gene was identified as a 
strong candidate gene for this study, even though type V collagen is only a minor 
fibrillar collagen in tendons. The association of polymorphisms with the COL5Al 
gene and Achilles tendon injuries were investigated in this thesis. The results of 
this investigation are presented in the following chapter (Chapter 3). 
The COL27Al gene, on the other hand, encodes for the homotrimeric type XXVII 
collagen, which is the latest fibrillar collagen to be characterized to date (Boot­
Handford et a1., 2003; Pace et aL, 2003). Fibrillar collagens, which also include 
type I, II, III, V and XI collagens, form structural elements in extracellular 
matrices of tendons as well as other tissues. Type XXVII collagen is 
predominantly expressed in cartilage, eye, ear, lung and colon of the mouse and 
its precise function within these tissues is unknown (Pace et al., 2003). Although 
no investigators have to our knowledge reported that the gene is expressed in 
tendons, it is conceivable that it plays a role in tendon connective tissue. Since 
the expression and function, if any, of the COL27Al gene in tendons is currently 
unknown, the association of this gene with Achilles tendon injuries was not 
investigated in this study. 
In addition to the two collagenous genes, two other genes, TNC and LAMC3, 
which encode for non-collagenous components of the ECM, were also mapped to 
the tip of the long arm of chromosome 9. The TNC gene encodes for tenascin Cj 
which is a glycoprotein abundantly found in tissues subjected to high tensile and 
compressive stress such as tendons. In tendons the protein is found 
predominantly in the myotendinous and osteotendinous junctions, as well as in 
tendon substance (Jarvinen, 2000). The protein is believed to regulate cell-matrix 
interactions due to its ability to bind various cell surface receptors, such as 
integrins, and other components of the ECM (reviewed in Jones and Jones, 2000). 
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In addition, it has also been shown that expression of TNC gene is regulated in a 
dose-response manner by mechanical loading in tendons Garvinen et aLI 1999; 
Jarvinen et al., 2003). In addition it has also been suggested that tenascin C might 
play an important role in providing elasticity to musculoskeletal tissues 
Garvinen, 2000). TNC gene expression has been shown to be up-regulated in 
Achilles tendinopathy Garvinen et al., 1999), suggesting the protein involvement 
in tendinopathy. The TNC gene is therefore also a strong candidate gene for 
Achilles tendon injuries due to its chromosomal location, its regulation by 
mechanical loading and its possible association with musculoskeletal elasticity. 
The association of polymorphisms within this gene and Achilles tendon injuries 
are presented in Chapter 4 of this thesis. 
The LAMC3 gene, which encodes for the v-chain of laminin 12, is expressed in 
lung, reproductive tract, brain and retina (Koch et al., 1999, Gerhalmi-Friedman 
et al., 2001). To our knowledge it is not expressed in tendons. The laminins are a 
family of heterotrimeric glycoproteins consisting of an a-, p- and v-chain to form 
a characteristic cruciform structure, which are the major non-collagenous 
constituent of basement membranes (Fuller and Shields, 1998). They have been 
implicated in a wide variety of biological processes including cell adhesion, 
differentiation, migration and signaling (Fuller and Shields, 1998). Although 
some laminin are found in human myotendinous junctions (Pedrosa-Domellof et 
al., 2000), none of the genes that encode for their a-, p- and v-chains have not 
been mapped to the tip of the long arm of chromosome 9. The association of this 
gene with Achilles tendon pathology was therefore not investigated in this thesis. 
The primary focus of this thesis was to identify genes located on the telomeric 
end of chromosome 9q that encode for structural components of the ECM and in 
particular tendons of which four and two were identified respectively. Since 
other biological processes, such as but not limited to apoptosis of tenocytes and 
neovascularization, have been proposed to be involved in tendon overuse 
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injuries, candidate genes encoding for proteins that, at least theoretically, could 
be involved in these biological processes were also identified. There associations 
with Achilles overuse injuries were however not investigated in this thesis. 
As mentioned above, apoptosis (programmed cell death) has received some 
attention as one possible mechanism associated with mechanical loading-induced 
tendinopathy (Murrell, 2002). Nine candidate genes, TNFSF15, TRAF1, TRAF2, 
GSN, DAPK1, PTGES, WDR31, WDR34 and CARD9, mapped to the tip of 
chromosome 9q that encode for proteins believed to be involved in the apoptosis 
pathway were identified in the study. 
The protein encoded for by the TNFSF15 gene is a cytokine, which is abundantly 
expressed in endothelial cells (Zhai et al., 1999). It can activate NF-KB and MAP 
kinases in an autocrine manner to induce apoptosis of endothelial cells (Yue et 
al., 1999). This cytokine is also found to inhibit endothelial cell proliferation, and 
thus may function as an angiogenesis inhibitor (Zhai et al., 1999). It is known 
that formation of new vessels in the tendon is associated with Achilles 
tendinopathy (Ohberg et al., 2001). The proteins encoded for by the TRAFl (TNF 
receptor-associated factor 1) and the TRAF2 genes mediate the anti-apoptotic 
signals from TNF receptors (Tsitsikov et al., 2001). The two proteins form a 
complex, which activates the stress activated protein kinase (c-Jun N-terrriinal 
kinase, JNK) as well as the MAPK8 and NF-KB. TRAF2 also act indirectly to 
inhibit caspase activity, a process vital in apoptosis. 
The GSN gene encodes a protein gels olin, which has been shown to inhibit 
apoptosis via a reduction of caspase-3 activation as well as inhibiting cytochrome 
c release (Kamada et al., 1998). Both caspase activation and cytochrome c release 
are important steps in apoptosis (Kamada et al., 1998). Furthermore, caspase-3 
has been shown to be responsible for cleavage of gels olin (Kamada et aI, 1998). It 
is therefore likely that during chronic tendinopathy there is an imbalance 
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between gels olin cleavage and caspase-3 activity, which might be associated with 
the increased apoptosis during tendinopathy. The death-associated protein 
kinase 1 (DAPK1) gene is a positive mediator of programmed cell death which is 
initiated by either v-interferon, TNF-a, activated Fas or detachment of the cell 
from the extracellular matrix (Cohen et al., 1997; Cohen et al., 1999). The DAPKl 
gene encodes a calcium/calmodulin dependent serine-threonine kinase, which is 
localized to the cytoskeleton (Cohen et al., 1997). 
The protein encoded by the prostaglandin E sythase (PTGES) gene is a 
glutathione-dependent prostaglandin E synthase. The expression of PTGES has 
been shown to be induced by interleukin 1p (IL-1P) and p53 tumour suppressor 
protein (TP53) Gakobsson et al., 1999a; Jakobsson et al., 1999b). It has been 
suggested that prostaglandin synthase E may be involved in TP53 induced 
apoptosis (Polyak et al., 1999). Knockout studies in mice suggest that this gene 
may contribute to the pathogenesis of collagen-induced arthritis and mediate 
acute pain during inflammatory responses (Trebino et al., 2003). 
Both the WDR31 and WDR34 genes encode proteins which may facilitate 
formation of heterotrimeric or multiprotein complexes involved in a variety of 
cellular processes, including cell cycle progression, signal transduction, 
apoptosis, and ge e regulation (reviewed in Lin et al., 2003). It is not clear 
whether these two proteins are found in tendons. 
The CARD9 protein is encoded by the caspase-associated recruitment domain 
(CARD9) gene, which like all CARD family members, is defined by the presence 
of a caspase-associated recruitment domain (CARD) (Bertin et al., 2000). It is 
likely that the caspase-associated recruitment domain participates in the 
activation or suppression of CARD containing members of the caspase family, 
and thus plays an important regulatory role in cell apoptosis, via the activation of 
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NF-KB (Bertin et al., 2000). It is also not clear whether this protein is found in 
tendons. 
It is important to note that although connective tissues, such as tendons, are 
made up predominantly of the ECM, the synthesis, degradation and maintenance 
of the ECM depends on the presence of cells within it. Piez (1997) summed this 
up beautifully by stating that "there can not be any ECM without cells". The cells 
possess membrane surface receptors such as integrins, which are crucial for cell­
matrix interaction in many biological processes, such as signaling and detection 
of external stimuli such as mechanical loading in the case of tenocytes. The cells 
also contain autocrine and paracrine factors that are responsible for cell-cell 
communication (Piez, 1997). Four of the candidate genes, PPP2R4, ABL1, PRRX2 
and EDG2, identified in this study encode for proteins involved in cell growth, 
while the remaining 4 genes encode for proteins involved in a variety of 
processes ranging from angiogensis (PTGS1), signal transduction (RAPGEF1), cell 
interactions (NOTCH1) and a proteasome component (PSMB7). 
The PPP2R4 gene encodes a protein that catalyses the conversion of a known 
inactive Serine/Threonine phosphatase (protein phosphates 2A or PP2A) to an 
active form. PP2A is implicated in the negative control of cell growth and 
division and other cellular processes (reviewed in Janssens et al., 2005; Gallego 
and Virshup, 2005). The ABLl gene is an oncogene that encodes a tyrosine kinase 
that has been implicated in processes of cell differentiation, cell division, cell 
adhesion, and stress response in normal cells (reviewed in Cejkova et al., 2005). 
The PRRX2 gene encodes a protein that is expressed predominantly in 
proliferating foetal fibroblasts and the developing dermal layer (reviewed in 
White et aL, 2003). Protein expression is however down-regulated in the adult 
skin. Increased expression of this gene during foetal but not adult wound 
healing suggest a possible role in mechanisms that control mammalian dermal 
regeneration and prevent formation of scar tissue during foetal growth. Wound 
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healing by scar formation is the most prominent healing response during adult 
tendon repair, whereas foetal tendons heal without scar formation (reviewed in 
White et al., 2003). Interestingly, the tenascin C gene promoter has a PRRX2 
binding site about 20 bp upstream of the TATA box (Norris and Kern, 2001). 
Blood borne lysophospholipids, Sphingosine-1-phophate (S1P) and 
Lysophosphatic acid (LPA) require receptors to mediate their varied functions, 
which include modulation of cell shape, cell migration, cell invasion, stimulation 
of cell growth, prevention of apoptosis, regulation of actin cytoskeleton (Takuwa 
et al., 2002). One of the receptors is encoded by the EDG2 gene, modulates the 
function of LP A and is involved in cell signaling and other diverse biologic 
functions, including proliferation and chemotaxis (Takuwa et al., 2002). EDG2 is 
widely expressed in almost all tissues (Takuwa et al., 2002). 
The PTGSl gene encodes PTGS1 or cyclooxygenase 1, a constitutively active 
enzyme, involved in prostaglandin biosynthesis and regulation of angiogenesis 
in endothelial cells (reviewed in Warner and Mitchell, 2004). PTGS1 is thought to 
be involved in cell-cell signaling and maintaining tissue homeostasis and PTGS1 
protein is regulated by cytokines and growth factors (Warner and Mitchelt 2004). 
It is possible that it is involved in the pain associated with tendinopathy. 
Proteasomes (encoded for by the PSMB7 gene) are proteolytic enzymes 
responsible for the degradation of misfolded and denatured proteins in response 
to different cell stressors as well as mediate other activities such as cell division, 
metabolism, DNA repair and transcription (reviewed in Maupin-Furlow et al., 
2005; Wolf and Hilt, 2004). RAPGEFl gene encodes a human guanine nucleotide 
releaSing protein for Ras protein (reviewed in Shivakrupa et al., 2003). It 
mediates binding events that control the activity and localization of ~ny 
proteins involved in the transmission of signals from the cell surface to the 
nucleus. It is expressed, at least at the mRNA level, widely in most tissues, but it 
is not known whether it is found in tendons. The NOTCHl gene encodes a 
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transmembrane protein, involved in intercellular signaling and also acts as a 
receptor for membrane bound ligands (Conboy et al., 2003). Incidentally, 
NOTCHl signaling is vital for skeletal muscle regeneration and its activity 
decreases with age (Conboy et al., 2003). The authors suggested that this activity 
might be a generalized mechanism associated with reduced regenerative capacity 
of most aged tissues. Because tendinopathy is associated with aging, it is 
possible that NOTCHl signalling plays an important role in the tendon 
regenerative capacity in response to mechanical loading . 
.In addition to the genetic factors, several non-genetic intrinsic factors, such as 
amongst others, age, gender, body weight and a history of previous injury; as 
well as extrinsic factors, such as type of activity and training, have been 
implicated in the aetiology of Achilles tendon overuse injuries Garvinen et al., 
2005). Although the subjects in the Achilles tendon injury groups and sub­
groups were significantly older than the asymptomatic control subjects when 
recruited into the trial, there were similarly matched for age when the age of 
onset of the initial symptoms in the Achilles tendon injury group was used in the 
analysis. The symptomatic subjects in this study were significantly heavier than 
the control subjects and also participated for significantly more years in high­
impact sports. Any possible interaction of weight and/or physical activity 
exposure with their genetic make-up was responsible for the development of 
symptoms of Achilles tendon injuries could not be excluded. This will be 
discussed further in chapter 7 of this thesis. It should be noted however that 
because this was a retrospective study, body weight of the subjects at the onset of 
their initial injury could not be recorded accurately. Anecdotally, many subjects 
reported increases in their body weight after injury as a result of a decrease or in 
worst cases a complete cessation in physical activity. 
In the current study, a significant number of control subjects either smoked or 
were ex-smokers compared to the Achilles tendon injury subjects. Two studies 
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were found in the literature that investigated the possible association between 
smoking and tendon injury. In one study of wrist tendinopathy, the proportion 
of smokers in the injury group was significantly higher than would be expected 
in the general population (Safrin and Graham, 2002). The sample size of the 
injured subjects was however very smalt consisting of only 14 subjects. In the 
second study, no association was found between smoking and risk of tendon 
injury (Harris et al., 1999). 
It has been suggested that the majority of ruptures occur in the non-dominant or 
left leg (assuming that most people are right footed) (reviewed in Maffulli et a1., 
1999). In the current study the vast majority of the subjects were right handed 
(and assumed to be right footed), 91.9% in the CON and RUP groups. There 
were slight less right-handed individuals in the ATI (82.0%) and TEN (78.1 %) 
groups. There was however an even distribution in of injuries in either the left or 
right Achilles tendon in study with just over 30% of the subjects injuring both 
tendons. 
All the control subjects in this study did not have any clinical symptoms of 
Achilles tendinopathy. The Achilles tendons of only 22 (16.8%) of these subjects 
were examined using imaging technique (ultrasonography) (refer to Chapter 6). 
Two of the subjects had some form of abnormality in one of their tendons. This is 
therefore a limitation of this study, since we did not exclude any of the control 
subjects with sub-clinical signs of tendinopathy. These sub-clinical signs are 
known to precede clinical presentation of signs and symptoms of tendinopathy 
(Khan et al., 1998). Furthermore, the number of signs and symptoms associated 
with chronic Achilles tendinopathy may be much lower than would be expected 
because the study was mainly retrospective. 
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In conclusion, twenty-one candidate genes were identified from a possible 404 
genes, which have been mapped to the 9q32-q34.3 locus. Two of the 21 candidate 
genes, namely COL5Al and TNC, encode for structural components of tendons 
and whose expression have previously been shown to be altered during tendon 
pathology. The association of polymorphisms with these two genes with Achilles 
tendon overuse injuries was investigated in this thesis. The distribution of ABO 
blood groups was, however, similar between the control and symptomatic 
subjects. 
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POLYMORPHISMS WITHIN THE COL5Al GENE AND ACHILLES TENDON INJURY 
The data presented in this chapter has been published in the following article:­
Mokone GG, Schwellnus MP, Noakes TD, Collins M (2006) The COLSAl gene and 
Achilles tendon pathology. Scandinavian Journal of Medicine and Science and Sports, 
16 (1): 19-26. 
3.1 INTRODUCTION 
Although there is a high incidence of chronic tendon injuries during sporting or 
exercise activities, the aetiologies of these conditions are not yet fully understood 
(Jarvinen et al., 2005; Jozsa and Kannus, 1997; Kannus and Natri, 1997; Maffulli, 
1999). Some studies have suggested that there is, at least in part, a genetic 
component involved in Achilles tendon (Kannus and Natri, 1997; Maffulli, 1999) 
and, more recently, rotator cuff tendon injuries (Harvie et al., 2004). None of these 
studies, have however, identified or proposed specific genes that might be 
associated with overuse tendon injuries. 
As discussed in chapter 2, several investigators have suggested that a gene(s) on the 
tip of the long arm chromosome 9, closely linked to the ABO blood group gene, is 
associated with Achilles tendon pathology (reviewed in Kannus and Natri, 1997). 
Recently, Ar0en et al (2004) also suggested, based on their findings that individuals 
who had ruptured an Achilles tendon had an increased risk of rupturing their 
contralateral tendon, the possible involvement of genetic elements in the aetiology of 
Achilles tendon pathology. An earlier study found that 41 % of individuals with 
unilateral Achilles tendinopathy developed symptoms of Achilles tendinopathy in 
the contralateral leg during an 8-year follow-up period (Paavola et al., 2000). 
. Although beyond the scope of this thesis, a recent study has also suggested that 
there is a genetic component toward tearing the anterior cruciate ligament (Flynn et 
al.,2005). The above studies all suggest that they may be a genetic predisposition 
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towards connective tissue disorders associated with mechanical overuse, including 
tendon injuries. 
Tendons have a highly ordered hierarchical structure made up of tightly packed 
protein bundles consisting predominantly of type I collagen fibres (reviewed in 
Silver et al., 2003). Trace amounts of other collagens, such as types III and V, form 
heterotypic fibres with the type I collagen found in tendons (Birk, 2001; reviewed in 
Silver et al., 2003). The pro-a1(V) chain is found in most of the isoforms of type V 
collagen and is encoded by the COLSAl genet which has been mapped to the same 
locus as the ABO gene on chromosome 9q34 (Caridi et al.t 1992). This gene was 
therefore identified as one of the ideal candidate genetic markers of Achilles tendon 
injuries in the previous chapter. 
Pro-oc2(V) and pro-oc3(V) chains are also found in some of the type V collagen 
isoforms. Neither of the genes that enc de for these two oc-chains has however been 
mapped to human chromosome 9 and was therefore not investigated as candidate 
genes in this study (reviewed in Myllyharju and Kivirikko, 2001). In addition, 
several mutations within the COL5Al and COL5A2 genes have been shown to cause 
more severe connective tissue disorders such as some of the Ehlers-Danlos 
syndromes (EDS), which have been shown to affect tendons (reviewed in 
Myllyharju and Kivirikko, 2001; Riley, 2004). 
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The COL5Al gene contains a BstUI and a DpnII restriction fragment length 
polymorphisms (RFLPs) within its 3' -untranslated region (UTR) (Greenspan and 
Pasquinelli, 1994). The influence of these polymorphisms on the expression of the 
COLSAl gene and the ultimate function of type V collagen is currently unknown. 
The aim of this chapter of the thesis therefore was to determine whether the BstUI 
and/ or DpnII RFLPs within the 3' -UTR of the. COL5Al gene are associated with 
Achilles tendon injury. 
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3.2 MATERIALS AND METHODS 
3.2.1 Subjects 
The recruitment strategy, inclusion and exclusion criteria for the subjects included in 
Jhe Achilles tendon injury (AT!) and control (CON) groups, as well as the Achilles 
tendinopathy (TEN) and Achilles tendon rupture (RUP) sub-groups have been 
described in detail in Chapter 2 (refer to section 2.2.1). One-hundred and sixteen of 
the 122 Caucasian patients with a current or past clinical history of Achilles tendon 
injury (AT!) were included in this study. The AT! patients included 76 of the 79 
subjects with chronic tendinopathy (TEN) and 40 of the 43 subjects with either a 
complete (37 of 40) or partial (3 of 40) rupture (RUP). All the subjects were 
physically active prior to the development of symptoms. One-hundred and twenty­
nine of the 131 apparently healthy physically active Caucasian asymptomatic control 
(CON) subjects without any history of Achilles tendon injury were also included in 
this study. 
3.2.2 Sample collection and total DNA extraction 
Approximately 4.5 m1 of venous blood was collected from each subject into EDTA 
vacutainer tubes by venipuncture of a forearm vein and stored at 4°C until total 
DNA extraction. Total DNA was extracted from the sample as described by Lahiri 
and Nurnberger (1991), with some modifications. Briefly, the blood samples were 
transferred to 15 rol polypropylene tubes, to which two volumes of TKM1 buffer (10 
mM Tris-HCl pH 7.6, 10 mM KCl, 10 mM MgCh and 2 mM EDTA) containing 2.5 % 
Nonidet P-40 was added to lyse the red blood cells. After a 10 minute incubation at 
room temperature, the white blood cells were pelleted by centrifugation at 1 200 x g 
at room temperature for 10 minutes and washed at least once with one volume of 
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TKM1 buffer. The washed pellets were resuspended in 800 J!l of TKM2 buffer (10 
mM Tris-HCI pH 7.6, 10 mM KCl, 10 mM MgCh, 0.4 M NaCh and 2 mM EDTA) 
containing 50 J!l of 10 % SDS and incubated for at least 10 minutes at 55°C or until 
the pellets had dissolved. One hundred and fifty )11 of 5 M NaCI04 and 500 J!l of 
chloroform was added to each sample, which was then mixed thoroughly by 
vortexing for 15 - 20 seconds. The samples were transferred to 1.5 ml microfuge 
tubes and the protein precipitated by centrifugation at 13 000 rpm (15 000 x g) for 5 
minutes at room temperature. Five hundred J!l of the top aqueous phases were 
transferred to new microfuge tubes containing 1 ml of absolute ethanol, mixed and 
the DNA pelleted by centrifugation at 13 000 rpm (15 000 x g) for 2 minutes at room 
temperature. The precipitated DNA was air dried for 30 minutes, resuspended in at 
least 100 )11 of TE buffer (10 mM Tris-HCI, 1 mM EDTA, pH 8.0) either by incubation 
for one hour at 65°C or over-night at room temperature, and stored at 4°C until PCR 
analysis. 
3.2.3 COL5Al genotyping 
A 667 bp fragment containing the BstUI and DpnII restriction fragment length 
polymorphisms (RFLPs) within the 3' -UTR of the COL5Al gene was PCR amplified 
as described by Greenspan and Pasquinelli (1994) (Figure 3.1). The PCR was carried 
out in a total volume of 60 J!l containing at least 100 ng of DNA, 20 pmol of the 
forward and reverse primers, 20 mM Tris-HCl pH 8.4, 50 mM KCl, 1.5 mM MgC12, 
0.2 mM of each dN1P (dA1P, dTJP, dC1P and dG1P) and 2.5 units of DNA Taq 
polymerase (Invitrogen Life Technologies, Carlsbad, California, USA), using a PCR 
Express Thermal Cycler (Hybaid Limited, Middlesex, UK). The amplification was 
performed with an initial denaturing step at 94°C for 3 min, followed by 35 cycles of 
denaturing at 94°C for 1 min, annealing at 53°C for 1 min, extension at 72°C for 1.5 
min, and a final extension step at 72°C for 8 min. The PCR products were digested 
with BstUI to produce 351 bp and 316 bp fragments for the Al allele or variant (1 
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BstUI site), 316 bp, 271 bp and 80 bp fragments for the A2 allele or variant (2 BstUI 
sites) and a 667 bp fragment for the A3 allele or variant (no BstUI site). Since the 
rare A3 allele did not contain a BstUI restriction site, all the samples with an A3 
allele were digested at least in duplicate to confirm the genotype of the subject. The 
PCR products were also digested with DpnII to produce 418 bp, 194 bp, 40 bp and 15 
bp fragments for the B1 allele (3 DpnII sites) and 612 bp, 40 bp and 15 bp fragments 
for the B2 allele (2 DpnII sites). The resulting fragments were separated, together 
with 100 bp DNA ladder known size markers (Promega Corporation, Madison, 
Wisconsin, USA), on 5% non-denaturing polyacrylamide gels and visualized by 
ethidium bromide staining. The gels were photographed under UV light using a 
Uvitec photodocumentation system (Uvitec Limited, Cambridge, UK) and the sizes 
of the DNA fragments determined (Figure 3.2). 
The BstUI and DpnII RFLPs are probably produced by single nucleotide 
polymorphisms (SNPs) within the 3' -end of the COL5Al gene, which were not 
identified in the original article in which the AI, A2, A3, B1 and B2 alleles were 
initially described (Greenspan and Pasquinelli, 1994). The number and sizes of the 
produced alleles indicate that all three BstUI sites are polymorphic while only the 
middle DpnII site is polymorphic (Figure 3.1). All the published SNPs within exon 
66 of the COL5Al gene, which corresponds to the gene's 3'-end, were therefore 
identified using the NCBI SNP database (www.ncbi.nlm.nih.gov/SNP/) (Figure 
3.1). The Al and A2 alleles of the BstUI RFLP have T and C nucleotides at position 
67579, respectively (SNP ID number rs12722). The A3 allele also has a T nucleotide 
at position 67579. The restriction enzyme BstUI recognised the consensus sequence 
5'-CGCG-3' which is destroyed when a T replaces the C at position 67579. There is 
also a BstUI site at position 67499, which is destroyed to produce the A3 allele. 
Because the A3 allele is rare, the polymorphic site at position 67499 was not present 
in the SNP database. Individuals with a AlAI, A1A3 or A3A3 genotype were IT at 
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nucleotide 67579, while individuals with a A2A2 genotype were Cc. Individuals 
with AIA2 and A3A2 genotype were TC at nucleotide 67579. The Bl and B2 alleles 
of the DpnII RFLP have T and C nucleotides at position 67395, respectively (SNP ID 
number rs13946). The DpnII restriction sites at positions 67198 and 67812 are found 
in both alleles and therefore function as internal digestion sites (Le. they are not 
polymorphic). Individuals with a BIBl, BIB2 and B2B2 genotypes are TT, TC and 
CC at nucleotide 67395, respectively. 
3.2.4 Statistical analyses 
The required sample size for this study was determined using QUANTO Version 0.5 
(http://hydra.usc.edu/ gxe) (Gauderman, 2002). Data were analyzed using the 
STATISTIC A version 7 (StatSoft Inc., Tulsa, OK, USA) and GraphPad InStat version 
3.0 (Graph Pad Software, San Diego, CAl USA) statistical programs. A one-way 
. analysis 	of variance (ANOV A) was used to determine any significant differences 
between the characteristics of the ATI and CON groups, as well as the TEN and RUP 
sub-groups. When the overall F value was significant, a LSD post hoc test was used 
to identify specific differences. Statistical significance was accepted when p<0.05. 
Where applicable, data are presented as means ± standard deviations (SD) with the 
number of subjects in parentheses. Pearson's Chi-square analysis was used to 
analyze differences in the genotype and allele frequencies between the A TI and 
CON groups. The genotype frequencies of the BstUI RFLP of the COL5Al gene 
were analyzed using Monte Carlo simulations (CLUMP version 2.0 program) (Sham 
and Curtis, 1995). The BstUI (AlAI, AIA2, A2A2, AIA3, A2A3 and A3A3) and 
DpnII (BIBl, BIB2 and B2B2) RFLP genotypes were converted into their actual 
nucleotide genotypes (Le. TT, TC and CC) at positions 67579 and 67395. Lewontin's 
standardized disequilibrium coefficient (D') was calculated from the actual 
genotypes using the Linkage Disequilibrium Analyzer 1.0 software (Ding et al., 
2003). 
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67166 67198 
I I 
ACCAAGAAAG GCTACCAGAA GACGGTTCTG GAGATCGACA CCCCCAAAGT GGAGCAGGTG 60 
Forward Primer DpnII 
CCCATCGTGG ACATCATGTT CAATGACTTC GGTGAAGCGT CACAGAAATT TGGATTTGAA 120 
67312 67326 
I I 
GTGGGGCCGG CTTGCTTCAT GGGCTAGGAG CCGCCGAGCC CGGGCTCCCG AGAGCAACCT 180 
stop codon T (rs12553247) 
67395 
I 
CGTGACCTCA GCATGCCATT GCTTCGTGAG TGTCCCGTGC ACGTCCTGAC CCTGGACAGT 240 
T (rs13946) 
DpnII 
GAAGGCTTCT CCCTCCCCTC CCACCTGACT TCATCTACGC CTCGGCACCA CGGGGTGTGG 270 
67499 
I 
GACCCCAGCC CGGAGAGAAC AGAGGGAAGG AGCCGCGCCC CCACCTGGAG CTGAATCACA 360 
BstU! 
67579 
I 
TGACCTAGCT GCACCCCAGC GCCTGGGCCC GCCCCACGCT CTGTCCACAC CCACGCGCCC 420 
T (rs12722) 
BstU! 
67593 
I 
CGGGAGCGGG GCCATGCCTC CAGCCCCCCA GCTCGCCCGA CCCATCCTGT TCGTGAATAG 480 
T (rs1134114) 
GTCTCAGGGG TTGGGGGAGG GACTGCCAGA TTTGGACACT ATATTTTTTT CTAAATTCAA 540 
CTTGAAGATG TGTATTTCCC CTGACCTTCA AAAAATGTTC CAAGGTAAGC CTCGTAAAGG 600 
67812 
I 
TCATCCCACC ATCACCAAAG CCTCCGTTTT TAACAACCTC CAACACGATC CATTTAGAGG 660 
Dpn!! 
GCCTTCCCGA TGGATTAAAG GTGCTTATGT TTTTGTGAGT 720 ~~~~~~~~~~ 
Reverse 
67902 
I 
TTTAAGTAAA TATTTGT 
Figure 3.1 The legend is on the next page. 
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Figure 3.1. Nucleotide sequence of the 3'-end (exon 66) of the COLSAl gene. The sequence 
was obtained from clone RPll-263F14 on chromosome 9 (accession number AL603650). The 
nucleotide numbers within the clone are indicated. The forward and reverse primer 
sequences are underlined. The stop codon is also underlined. The BstUr (CGjCG) and 
DpnII (/GATC) restriction sequence are in bold and double underlined. All three BstUr sites 
are polymorphic, while only the middle (position 67395) DpnII site is polymorphic. Single 
nucleotide polymorphisms (SNPs) within exon 66 of the gene were identified using the 
NCBI SNP database (www.ncbLnlm.nih.govjSNPj). The positions of these SNPs, together 
with there NCBr db SNP 10 number, are also shown. The alternative nucleotide is given 
under the wild type sequence. 
A B 
..... N N N ..... ..... 
<{ <{ m m CD CD 
..... N 'l1li""" ~ ~ ~ 
<{ <{ CD CD CD CD 
612 bp 
80 bp 
1 2 1 2 3 4 
Figure 3.2. Typical 5% non-denaturing polyacrylamide gels showing the common (A) 
Bstur and (B) DpnII RFLP genotypes. The sizes of the various DNA fragments are indicated 
on the left size of each gel. Panel A: Lane 1 is an AlAI genotype, while lane 2 is an A2A2 
genotype for the Bstur RFLP. Panel B: Lanes 1 and 2 are a B1B2 genotype, while lanes 3 and 
4 are a B1B1 genotype of the DpnII RFLP. The 40 bp and 15 bp products produced during 
digestion of the PCR fragments with DpnII are not shown in panel B. 
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3.3 RESULTS 
3.3.1 Subject characteristics 
As shown in Table 3.1, the ATI, TEN, RUP and CON groups were similarly matched 
for age, height and country of birth. The TEN (71 .1 %) and CON (61.7%) groups 
were similarly matched for gender (p=0.224), while the ATI (74.1%, p=0.041) and 
RUP groups (80.0%, p=0.036) contained significantly more male subjects than the 
CON group. In addition, the ATI (80.5 ± 14.9 kg, p<O.OOl), TEN (76.8 ± 13.6 kg, 
p=0.006) and RUP (87.1 ± 15.1 kg, p<O.OOl) groups were significantly heavier with a 
corresponding higher BMI's than the CON (71.1 ± 12.1 kg) group. The RUP sub­
group was also significantly heavier with a corresponding higher BMI than the TEN 
sub-group (p<O.OOl). The weights of the A TI, groups were recorded at the time of 
recruitment into the trial on average 8.0 ± 9.2 years, ranging from 0 to 39 years, after 
the onset of the symptoms. There was however no BstUI or DpnII COLSAl RFLP 
genotype effect on weight (BstUI, p=0.526; DpnII, p=0.735) or BMI (BstUI, p=0.283; 
DpnII, p=0.915) (data not shown). 
3.3.2 COL5A1 genotype and allele frequencies 
There was a significant difference when the distribution of the three COLSAl BstUI 
RFLP alleles or variants (AI, A2 and A3) of the CON group was compared to the 
ATI group (Pearson's Chi-square=10.2, p=0.006) (Table 3.2 and Figure 3.3A). The 
frequencies of the Al and A3 alleles were higher in the ATI group (177 AI, 76.3% 
and 13 A3, 5.6%) than in the CON group (173 AI, 67.1% and 8 A3, 3.1%), while the 
frequency of the A2 allele was higher in the CON subjects (77 A2, 29.8%) than in the 
ATI group (42 ATP, 18.1 %) (odds ratio of 1.9; 95% CI 1.3 - 3.0; p=0.003). 
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Table 3.1. Characteristics of the control (CON) and Achilles tendon injury (ATI) 
groups, as well as the Achilles tendinopathy (TEN) and Achilles rupture (RUP) 
sub-groups. 
CON ATI TEN RUP 
(n=129) (n=116) (n=76) (n=40) 
Age (yrs)1 
Height (cm) 
Weight (kg) 
BMI (kg/cm2) 
Gender (% males) 
Country of Birth 
(% South Africa) 
41.3 ± 11.0 
(122) 
175 ±9 
(121) 
71.1 ± 12.1 
(125)a,c,e 
23.2±2.7 
(121)a,d,e 
61.7 (12B)b,f 
71.0 (124) 
40.1 ± 13.B 
(112) 
176±9 
(112) 
BO.5 ± 14.9 
(112)a 
25.B ±3.9 
(112)a 
74.1 (116)b 
76.6 (111) 
39.B ± 15.2 

(72) 

176 ± 10 

(72) 

76.B ± 13.6 
(72)c,g 
24.6 ± 3.2 
(72)d,g 
71.1 (76) 
74.7 (71) 
40.6 ± 11.2 
(40) 
176±B 
(40) 
B7.1 ± 15.1 
(40)e,g . 
2B.l ±4.0 
(40)e,g 
BO.O (40)f 
BO.O (40) 
Values are expressed as mean ± standard deviation or a frequency (%) where applicable. 
Number of subjects en) is in parentheses. 
lThe age of the ATP group as well as the TEN and RUP sub-groups are the age of onset of 
the symptoms of Achilles tendon pathology. 
a,CON vs ATI (p<O.OOl) 
bCON vs ATI (p=O.041) 
cCON vs TEN (p=O.006) 
dCON vs TEN (p=O.004) 
eCON vs RUP (p<O.OOl) 
fCON vs RUP (p=O.036) 
gTEN vs RUP (p<O.OOl) 
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When the ATI group was sub-divided into more homogeneous pathologies, namely, 
the chronic tendinopathy (TEN) or the rupture (RUP) sub-groups, there was a more 
significant difference in the frequencies of the distribution of the A1, A2 and A3 
alleles when the CON and TEN groups were compared (Pearson's Chi-square=13.3, 
p=O.OOl) (Table 3.2 and Figure 3.3A). The frequencies of the A1 and A3 alleles were 
higher in the TEN group (121 A1, 79.6% and 9 A3, 5.9%) than in the CON group, 
while the frequency of the A2 allele was higher in the CON group than in the TEN 
group (22 A2, 14.5%) (odds ratio of 2.5; 95% CI 1.5 - 4.2; p<O.OOl). Although it 
should be interpreted with caution because of the small sample size (SO alleles), 
there was no significant difference in the distribution of these three alleles between 
the CON and RUP group (56 A1, 70.0%; 20 A2, 25.0% and 4 A3, 5.0 %) (Pearson's 
Chi-square=1.3, p=0.549) (Table 3.2 and Figure 3.3A). 
Table 3.2. Relative frequencies of BstUI RFLP allele of the COL5Al gene within 
the control (CON) and Achilles tendon injury (ATI) groups, as well as the 
Achilles tendinopathy (TEN) and Achilles rupture (RUP) sub-groups. 
Nucleotide CON ATI TEN RUPAlleles 
atpos 67579 (n=25S) (n=232) (n=152) (n=SO) 
Ai (%) T 67.1 (173) 76.3 (177) 79.6 (121) 70.0 (56) 
A2(%) C 29.S (77) lS.l (42) 14.5 (22) 25.0 (20) 
A3 (%) T 3.1 (S) 5.6 (13) 5.9 (9) 5.0 (4) 
The values are expressed as percentage with the number of alleles (n) in parentheses. The 
nucleotide at position 67579 (SNP rs12722) for the three alleles are also shown. 
CON vs ATI, Pearson's Chi-square=10.2, p=O.006 
CON vs TEN, Pearson's Chi-square=13.3, p=O.OOl 
CON vs RUP, Pearson's Chi-square=1.3, p=0.549 
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Figure 3.3. Allele frequencies of the (A) BstUI and (B) DpnII restriction fragment length 
polymorphism within the COL5Al gene of the asymptomatic control subjects (CON, solid 
bars), as well as the symptomatic Achilles tendon injury (ATI, grey bars), chronic Achilles 
tendinopathy (TEN, hatched bars) and Achilles tendon rupture (RUP, clear bars) patients. 
(A) p=O.006 CON vs ATI, p=O.OOl CON vs TEN, p=0.549 CON vs RUP and (B) p=0,453 CON 
vs ATI, p=0,424 CON vs TEN, p=O.837 CON vs RUP. 
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Since the polymorphic nucleotide at position 67579, which produces SNP rs12722, is 
a T in both the A1 and A3 alleles and a C in the A2 allele, the A1 and A3 alleles were 
combined and the data re-analysed to determine whether this specific SNP at 
position 67579 was associated with Achilles tendon over-use injuries (Figure 3.1 and 
Table 3.2). The frequency of the T allele at position 67579 was significantly higher in 
the ATI group (190 T, 81.9% and 42 C, 18.1%) than in the CON group (187 T, 72.5% 
and 77 C, 29.8%) (odds ratio of 1.9; 95% CI 1.2 - 2.9; p=0.004). The frequency of the T 
allele was also significantly higher in the TEN sub-group (130 T, 85.5 % and 22 C, 
14.5%) than in the CON group (odds ratio of 2.4; 95% CI 1.4 - 4.1; p<O.OOl). The 
frequency of the T allele in the RUP sub-group (60 T, 75.0% and 20 C, 25.0%) was 
similar to its frequency within the CON group (odds ratio of 1.2; 95% CI 0.7 - 2.2; 
p=0.571). 
Table 3.3. Relative frequencies of DpnII RFLP allele of the COL5Al gene within 
the control (CON) and Achilles tendon injury (ATI) groups, as well as the 
Achilles tendinopathy (TEN) and Achilles rupture (RUP) sub-groups. 
Nucleotide at CON ATI TEN RUPAlleles pos 67395 (n=258) (n=222) (n=l44) (n=78) 
Bl(%) T 73.6 (190) 77.0 (171) 77.8 (112) 75.6 (59) 

B2(%) C 26.4 (68) 23.0 (51) 22.2 (32) 24A (19) 

The values are expressed as percentage with the number of alleles (n) in parentheses. The 
nucleotide at position 67395 (SNP rs13946) for the two alleles are also shown. 
CON vs A TI, Pearson's Chi-square=O.6, p=0.453 
CON vs TEN, Pearson~s Chi-square=O.6, p=O.424 
CON vs RUP, Pearson's Chi-square=O.04, p=O.837 
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Figure 3.3B and table 3.3 shows that there were no significant differences in the 
distribution pf the two COL5Al DpnII RFLP alleles (B1 and B2) between the CON 
group and either the entire A TI group (Pearson's Chi-square=0.6, p=0.453) or the 
TEN (Pearson's Chi-square=0.6, p=0.424) and RUP (Pearson's Chi-square=0.04, 
p=0.837) sub-groups. 
Table 3.4. Relative frequencies of BstUI RFLP genotype of the COL5Al gene 
within the control (CON) and Achilles tendon injury (ATI) groups, as well as the 
Achilles tendinopathy (TEN) and Achilles rupture (RUP) sub-groups. 
Genotype at CON ATI . TEN RUPGenotype pos 67579 (n=129) (n=116) (n=76) (n=40) 
AIA1(%) IT 62..8 (81) 69.8 (81) 75.0 (57) 60.0 (24) 
AIA2(%) TC 7.0 (9) 7.8 (9) 6.6 (5) 10.0 (4) 
AIA3 (%) IT 1.6 (2) 5.2 (6) 2.6 (2) 10.0 (4) 
A2A2(%) CC 26.4 (34) 13.8 (16) 10.5 (8) 20.0 (8) 
A2A3 (%) TC 0(0) 0.9 (1) 1.3 (1) 0(0) 
A3A3(%) IT 2.3 (3) 2.6 (3) 4.0 (3) 0(0) 
The values are expressed as percentage with the number of subjects (n) in parentheses. The 
genotypes at position 67579 (SNP rs12722) are also shown. 
CON vs ATI, Clump's T4 Chi-square=5.9, p=O.117 
CON vs TEN, Clump's T4 Chi-square=1.2, p=O.911 
.CON vs RUP, Clump's T4 Chi-square=2.5, p=O.712 
There were no significant differences in the distributions of the genotype frequencies 
of the COL5Al BstUI (Table 3.4) and DpnII (Table 3.5) RFLPs between the CON and 
AT! (Clump T4 Chi-square of the BstUI RFLP =5.9, p=0.117 and Pearson's Chi-
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square of the DpnII RFLP =3.7, p=0.160) groups, nor the CON and TEN (Clump T4 
Chi-square of the BstUI RFLP =1.2, p=0.911 and Pearson's Chi-square of the DpnII 
RFLP =2.8, p=0.243) or RUP (Clump T4 Chi-square of the BstUI RfLP =2.5, p=0.712 
and Pearson's Chi-square of the DpnII RFLP =1.6, p=0.460) sub-groups. 
Table 3.5. Relative frequencies of DpnII RFLP genotype of the COL5Al gene 
within the control (CON) and Achilles tendon injury (ATI) grOUPSI as well as the 
Achilles tendinopathy (TEN) and Achilles rupture (RUP) sub-groups. 
Genotype Genotype 
at pos 67395 
CON 
(n=129) 
ATI 
(n=111) 
TEN 
(n=72) 
RUP 
(n=39) 
BIBl(%) TI 58.1 (75) 58.6 (65) 59.7 (43) 56.4 (22) 
BIB2(%) TC 31.0 (40) 36.9 (41) 36.1 (26) 38.5 (15) 
B2B2(%) 
.q.x • 
CC 10.9 (14) 4.5 (5) 4.2 (3) 5.1 (2) 
The values are expressed as percentage with the number of subjects (n) in parentheses. The 
genotypes at position 67395 (SNP rs13946) for the two alleles are also shown. 
CON vs ATI, Pearson's Chi-square=3.7, p=O.160 
CON vs TEN, Pearson's Chi-square=2.8, p=O.243 
CON vs RUP, Pearson's Chi-square=1.6, p=0.460 
Since the Al and A3 alleles both hi:we a T at nucleotide 67579 (refer to figure 3.1), the 
A1Al, A1A3 and A3A3 genotypes are all a TI genotype at position 67579, while the 
A1A2 and A2A3 genotypes are also both a TC genotype at this position. Only the 
A2A2 genotype is a CC genotype at nucleotide 67579. There was a significant 
difference in the genotype distribution ofSNP rs12722 when the CON (86 TI, 66.7%, 
9 TC, 7.0% and 34 CC, 26.4%) group was compared to the TEN (62 TI, 81.6%, 6 Te, 
7.9% and 8 CC, 10.5%; Chi-square=7.4 and p=0.025) group, but not the ATI (90 TI, 
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77.6%,10 TC, 8.6% and 16 CC, 13.8%; Chi-square=6.0 and p=0.051) or RUP (28 TI, 
70.0%, 4 TC, 10.0% and 8 CC, 20.0%; Chi-square=0.9 and p=0.635) groups. 
Individuals with an A2A2 or CC genotype were however under represented in the 
ATI (odds ratio of 2.1i 95% CI 1.1-4.1; p=0.035) and TEN (odds ratio of 2.9; 95% CI 
1.2-6.6; p=0.018).subjects. SNP rs12722 (BstU1 RFLP) and SNP rs13946 (DpnII RFLP) 
of the COLSAl gene were not in linkage disequilibrium (D' for CON=0.476 and D' 
for ATI=0.383). 
The relative frequencies of the BstUI RFLP genotypes of the COL5Al gene in the ATI 
and TEN groups of subjects who had either a single or multiple injuries are shown 
in table 3.6 while the relative frequencies of those who had a unilateral or bilateral 
injuries are shown in Table 3.7. There were no significant differences in the COLSAl 
genotype distribution (A1A1, A1A3 and A3A3 versus A2A2, A1A2 and A2A3 
genotypes) ~between Achilles tendon injury (ATI) patients who had single or 
multiple injuries (Fisher's exact test, p=0.603) as well as between Achilles 
tendinopathy (TEN) patients who had single or multiple injuries (Fisher's exact test, 
p=1.00) (Table 3.6). There were also no significant differences in the COLSAl 
genotype distribution (A1A1, A1A3 and A3A3 versus A2A2, A1A2 and A2A3 
genotypes) between Achilles tendon injury (ATI) patients who had unilateral and 
bilateral injuries (Fisher's exact test, p=1.00). There were also no significant 
differences in the COLSAl genotype distribution between Achilles tendinopathy 
(TEN) patients who had unilateral or bilateral injuries (Fisher's exact test, p=0.757) 
(Table 3.7). 
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Table 3.6. The distribution of single and multiple injuries in the Achilles tendon 
injury (ATI) and Achilles tendinopathy (TEN) subjects. 
BstUIRFLP Single Injury Multiple Injuries Single Injury Multiple Injuries 
COL5Al ATI ATI TEN TEN 
Genotype (n=80) (n=27) (n=54) (n=13) 
AlAI 71.3 (57) 63.0 (17) 72.2 (39) 84.6 (11) 
A1A3 3.8 (3) 11.1 (3) 3.7 (2) 0.0 (0) 
A3A3 3.8 (3) 0.0 (0) 5.6 (3) 0.0 (0) 
At Su b-total 78.8 (63) 74.1 (20) 81.5 (44) 84.6 (11) 
A2A2 15.0 (12) 11.1 (3) 11.1 (6) 7.7 (1) 
A1A2 5.0 (4) 14.8 (4) 5.6 (3) 7.7 (1) 
A2A3 1.3 (1) 0.0 (0) 1.9 (1) 0.0 (0) 
A2 Sub-total 21.3 (17) 25.9 (7) 18.5 (10) 15.4 (2) . 
The values are expressed as percentage with the number of alleles (n) in parentheses. The 
number of subjects without an A2 allele (AlAl, AlA3 and A3A3 genotype) were added 
together to produce the Al sub-total. The number of subjects with an A2 allele (A2A2, 
AlA2 and A2A3 genotype) were added together to produce the A2 sub-total. There were 
no significant differences in A1 and A2 sub-total distributions between Achilles tendon 
injury (ATI) patients who.had single or multiple injuries (Fisher's exact test, p=O.603) as well 
as between Achilles tendinopathy patients who had single or multiple injuries (Fisher's 
exact test, p=l.OO). 
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Table 3.7. The distribution of unilateral and bilateral injuries in the Achilles 
tendon injury (ATI) and Achilles tendinopathy (TEN) subjects. 
Unilateral Bilateral Unilateral BilateralBstUIRFLP injuries Injuries injuries InjuriesCOL5Al ATI ATI TEN TENGenotype (n;;;70) (n;;;34) (n=34) (n=30) 
A1A1 65.7 (46) 73.5 (25) 70.6 (24) 76.7 (23) 
A1A3 8.6 (6) 0.0 (0) 5.9 (2) 0.0 (0) 
A3A3 1.4 (1) 5.9 (2) 2.9 (1) 6.7 (2) 
A1 Sub-total 78.1 (57) 79.4 (27) 79.4 (27) 83.4 (25) 
A2A2 17.1 (12) 8.8 (3) 11.8 (4) 10.0 (3) 
A1A2 7.1 (5) 8.8 (3) 8.8 (3) 3.3 (1) 
A2A3 0.0 (0) 2.9 (1) 0.0 (0) 3.3 (1) 
A2 Sub-total 21.9 (16) 20.6 (7) 20.6 (7) 16.6 (5)' 
The values are expressed as percentage with the number of alleles (n) in parentheses. The 
number of subjects without an A2 allele (A1Al, A1A3 and A3A3 genotype) were added 
together to produce the Al sub-total. The number of subjects with an A2 allele (A2A2, 
A1A2 and A2A3 genotype) were added together to produce the A2 sub-total. There were 
no significant differences in Al and A2 sub-total distributions between Achilles tendon 
injury (ATI) patients who had unilateral and bilateral injuries (Fisher's exact test, p=1.00). 
There were also no significant differences in the COL5Al genotype distribution between 
Achilles tendinopathy (TEN) patients who had unilateral or bilateral injuries (Fisher's exact 
test, p=O.757). 
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3.4 DISCUSSION 
The novel and main finding of this study was that the three alleles (or variants) 
produced by the BstUI restriction fragment length polymorphism (RFLP), or more 
specifically the T / C single nucleotide polymorphism at position 67579, within the 3' ­
UTR of the COLSAI gene were associated with Achilles tendon injury (p=0.006). 
Although a genetic predisposition to Achilles tendon (Kannus and Natri, 1997), 
rotator cuff tendon (Harvie et aL, 2004) and anterior cruciate ligament injuries (Flynn 
et al., 2005) have been suggested, no specific genes have been shown to be associated 
with these connective tissue patholOgies. This is the first study to demonstrate an 
association between a polymorphism within a gene expressed in tendons, namely 
COLSAl, and symptoms or signs of Achilles tendon pathology in physically active 
individuals. There was a Significant higher frequency of the A2 allele (C nucleotide 
at position 67579) of this gene in the asymptomatic control subjects (CON 29.8% vs 
ATI 18.1 %). Individuals with the A2 allele were therefore less likely of developing 
symptoms or signs of Achilles tendon injury (odds ratio = 1.9; 95% CI 1.3-3.0; 
p=0.003). 
The COLSAI gene encodes for the pro-a.1(V) chain, which is found in most of the 
isoforms of type V collagen (reviewed in Ristiniemi and Oikarinen, 1989). The major 
isoform of type V collagen is a heterotrimer consisting of two pro~a.1(V) chains and 
one pro-a.2(V) chain. Trace amounts of type V collagen are found in tendons where 
it forms heterotypic fibres with the major structural collagen, namely type I collagen 
(reviewed in Silver et aL, 2003; Birk, 2001). Although most investigators have 
speculated, based on the function of type V collagen in the cornea, that the protein 
plays an important role in regulating fibrillogenesis and modulating fibril growth in 
tendons, some investigators have suggested that the function of type V collagen in 
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tendons, and other tissues where its content is low, is actually unknown (reviewed 
in Riley, 2004; Birk, 2001). Although there is no consensus 
, 
about the function of type 
V collagen in tendons, Dressler et aL (2002) have reported an age-dependent increase 
in the content of the protein, together with a decrease in fibril diameter and the 
biomechanical properties in the rabbit patellar tendon. In addition, Goncalves-Neto 
et al. (2002) has shown an increase in types III and V collagen together with a 
reduction in the content of type I collagen in biopsy samples of degenerative 
tendons from patients with posterior tibial tendon dysfunction syndrome. Recently, 
Wenstrup et al. (2004) demonstrated that type V collagen deficient mice could not 
form collagen fibrils, emphasizing the role of type V collagen in fibrillogenesis. The 
authors proposed that no other collagen type, including type I, plays such a major 
role in the control of fibril initiation as type V collagen, even though type V collagen 
is only a minor fibrillar collagen of tendon and other connective tissue structures. 
An additional finding of this study was that the alleles of the COL5Al BstUI RFLP 
were strongly associated with chronic Achilles tendinopathy (p=O.OO1), since 
individuals with the A2 allele were less likely to present with symptoms or signs of 
tendinopathy (odds ratio of 2.5; 95% CI 1.5 - 4.2, p=O.OOOS). This RFLP was however 
not associated with Achilles tendon ruptures in this study, suggesting that the 
aetiology of ruptures and tendinopathies may be distinct. These findings must 
however be interpreted with caution since only 80 alleles were analyzed. 
Because of its proximity to the ABO gene on chromosome 9 as well as the presence 
and proposed function of type V collagen in tendons, we propose that the COLSAl 
gene is a better candidate genetic marker than the ABO gene for Achilles tendon 
injury. Although the COL5Al gene is an ideal marker for Achilles tendon pathology 
and more specifically chronic Achilles tendinopathy, the findings of this thesis do 
not prove that type V collagen is involved in the aetiology of tendon pathology. It is 
possible, due to the nature of association studies, that another gene closely linked to 
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the COL5Al and ABO genes on the tip of the long arm of chromosome 9 encodes for 
a protein, which is directly involved in the pathogenesis of Achilles tendon injuries. 
Any possible role of type V collagen in the development of Achilles tendon 
pathology needs to be investigated. The results of the present study nevertheless 
suggest that the COL5Al gene is a marker of Achilles tendon pathology. As 
mentioned in chapter 2, a second gene, namely the TNC gene, which is closely 
linked to the ABO gene and encodes for a component of the tendon extracellular 
matrix, was also identified as an ideal candidate gene. The possible association of 
polymorphisms within the TNC gene and Achilles tendon pathology will be 
discussed in the next chapter (Chapter 4). 
The DpnII RFLP or more specifically the T / C single nucleotide polymorphism at 
position 67395, within exon 66 of the COL5Al was not associated with Achilles 
tendon injury or Achilles tendinopathy. Although this single nucleotide 
polymorphism is only 184 bases upstream from the T / C single nucleotide 
polymorphism at position 67579 responsible for the generation of A2 allele, these 
polymorphisms were not in linkage disequilibrium. The allele distributions of the 
COLSAl DpnII RFLP within the control subjects and the various groups of subjects 
with symptoms of Achilles tendon pathology were similar to those of previously 
repo:rted values. In addition there was no significant difference in the. allele 
distribution of the COL5Al BstUI RFLP when the control subjects where compared 
to previously reported values (p=0.206) (Greenspan and Pasquinelli, 1994). 
When the individuals in the A TI and TEN groups were divided into those subjects 
who experienced unilateral or bilateral injuries, there were no significant differences 
in the BstUI genotype frequency distributions between the groups. Furthermore, 
there were no significant BstUI genotype frequency distribution between the 
subjects who had single or multiple (2 or more) injuries within both the ATI and 
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TEN groups. Therefore, this polymorphism was not associated the severity of 
Achilles tendon injury experienced. 
In addition to the genetic factors identified in this study, several non-genetic 
intrinsic factors, such as, amongst others, age, gender, body weight and a history of 
a previous injury; as well as extrinsic factors, such as type of activity and training, 
have been implicated in the aetiology of Achilles tendon pathology (reviewed in 
Jarvinen et al., 2005; Riley, 2005;). Because the symptomatic subjects in this study 
were significantly heavier than the control subjects and had also participated for a 
significantly more years in high impact sports (refer to chapter 2), we cannot exclude 
the possibility that an interaction of body weight and/or physical activity exposure 
with the COL5Al gene was responsible or at least played a part in the development 
of symptoms and signs of Achilles tendon injury. It should be noted however that 
because this was a retrospective study we could not record body weight of the 
subjects accurately at the time of injury. Anecdotally, many subjects reported 
increases in their body weight after injury as a result of a decrease in physical 
activity. Increased body weight has been documented as a risk factor for lower 
extremity injuries in some studies (Murphy et aL, 2003), and therefore has also been 
suggested as an intrinsic risk factor for Achilles tendon injury (Paavola et al., 2002; 
Riley, 2004). However, to our knowledge no prospective cohort studies have shown 
that increased body weight is an independent risk factor for Achilles tendon injuries. 
It can however be noted that there is a reported interaction of obesity with the 
COL9A3 gene and lumber disc degeneration (Solovieva et aL, 2002). Therefore, the 
possible interaction of non-genetic factors, such as body weight and exposure to 
physical activity, with the COLSAl gene or any other gene needs to be investigated. 
In conclusion, the BsfUI RFLP or the T / C single nucleotide polymorphism at 
position 67579 within the 3'-UTR of the COLSAl gene is associated with Achilles 
tendon injury and more specifically chronic Achilles tendinopathy. This thesis 
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suggests that individuals with the A2 allele, or a C nucleotide at position 67579, of 
the COLSAI gene are less likely of developing symptoms and signs of chronic 
Achilles tendinopathy. 
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The data presented in this chapter has been published in the following article:­
Mokone GG, Gajjar M, September AV, Schwellnus MP, Noakes TD, Collins M 
(2005) The guanine-thymine dinucleotide repeat polymorphism within the Tenascin­
C gene is associated with Achilles tendon injuries. American Journal of Sports 
Medicine. 33 (7): 1016-21. 
4.1 INTRODUCTION 
As shown in Chapter 3, the COLSAl gene is associated with Achilles tendon injuries 
or more specifically Achilles tendinopathy. Individuals with the AllA3 alleles were 
more likely to develop Achilles tendon pathology compared to those with the A2 
allele. However, as already discussed, this finding does not necessarily imply that 
the COL5Al gene is directly involved in the aetiology and pathogenesis of Achilles 
tendon injuries. The BstUl RFLP of the COL5Al gene is only associated with 
Achilles tendon injuries. Due to the nature of association studies it is possible that 
another gene, which is closely linked to the ABO and COL5Al genes may be directly 
involved in the aetiology of Achilles tendon injuries. 
The extracellular matrix glycoprotein, tenascin-C is expressed in a variety of tissues, 
including tendons, (reviewed in Mackie, 1997) and is encoded by the tenascin-C 
(TNq or hexabrachion (HXB) gene, which has been mapped to chromosome 9q33 18 
Mb upstream from the ABO gene (Bennet et al., 1995; Rocchi et al., 1991) (Refer to 
figure 2.2). Tenascin-C binds other components of the extracellular matrix and cell 
receptors and plays an important role in regulating cell-matrix interactions 
(reviewed in Jones and Jones, 2000a). In normal adult tendons, the TNC gene is 
expressed predominantly in regions responsible for transmitting high levels of 
mechanical force such as the myotendinous and oesteotendinous junctions (Chiquet 
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and Fambrough, 1984a; Chiquet and Fambrough, 1984b; Jarvinen et aL, 1999). The 
protein is also expressed around the cells and the collagen fibres of the Achilles 
tendon (Jarvinen et al., 2003). In addition, it has been shown that expression of the 
TNC gene is regulated in a dose-dependent manner by mechanical loading in 
tendons (Jarvinen et aL, 1999; Jarvinen et aL, 2003). 
Isoforms of the protein, with distinct functions, are produced by alternative splicing 
of the primary transcript (reviewed in Bosman and Stamenkovic, 2003; Jones and 
Jones,2000a). Riley et al (1996) have shown that healthy tendons express a small 200 
KDa tenascin-C isoform, while degenerate tendons also express a functionally 
distinct larger 300 KDa isoform. In investigating this finding, Ireland et al (2001), 
but not Alfredson et al (2003), have reported an increase in tenascin-C expression in 
biopsy samples of chronic Achilles tendinopathies using cDNA arrays. 
Since (1) several investigators have suggested that either the ABO gene or a closely 
linked gene(s) on the tip of the long arm of chromosome 9 maybe associated with 
Achilles tendon pathology (Jozsa et a1., 1989a; Jozsa et aI., 1989b; Kujala et aI., 1992), 
(2) the TNC gene has be n mapped to chromosome 9q33 which is in close proximity 
to the ABO gene (Bennet et a1., 1995; Rocchi et al., 1991), (3) the gene encodes for 
tenascin·C which is an important structural component of tendons (Jarvinen et aLI 
1999; Jarvinen et aI., 2003) and (4) its expression is regulated by mechanical stimuli 
(Jarvinen et aL, 1999; Jarvinen et aLI 2003) and altered during tendon pathology 
(Ireland et a1., 2001; Riley at al., 1996); it is, like the COL5Al gene, also an ideal 
candidate genetic marker of tendon injury. The TNC gene contains a guanine­
thymine (GT) dinucleotide repeat polymorphism (a tandem repeat consisting of a 
repeated 2-base pair sequence of varying lengths in different people) within intron 
17. The influence of this polymorphism in the expression of the gene or the 
biolOgical function of tenascin-C is currently unknown. The aim of the study was 
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therefore to investigate the association of the GT dinucleotide repeat polymorphism 
within intron 17 of the TNC gene with Achilles tendon injuries. 
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4.2 MATERIALS AND METHODS 
4.2.1 Subjects 
I
The recruitment strategy, inclusion and exclusion criteria for the subjects included in 
the Achilles tendon injury (ATI) and control (CON) groups, as well as the Achilles 
tendinopathy (TEN) and Achilles tendon rupture (RUP) sub-groups have been 
described in detail in Chapter 2 (refer to section 2.2.1). One-hundred and fourteen of 
the 122 Caucasian patients with a current or past clinical diagnosis of Achilles 
tendon injury (ATI) were included in this study. The ATI patients included 72 of the 
79 subjects with chronic tendinopathy (TEN) and 42 of the 43 subjects with either a 
complete (39 of 42) or partial (3 of 42) rupture (RUP). All the subjects were 
physically active prior to the development of symptoms. One-hundred and twenty­
seven of the 131 apparently healthy physically active Caucasian asymptomatic 
control (CON) subjects without any history of Achilles tendon injury were also 
included in this study. 
4.2.2 Sample collection and total DNA extraction 
Approximately 4.5 ml of venous blood was obtained from each subject by 
venipuncture of a forearm vein and collected into an EDTA vacutainer tube. Blood 
samples were stored at 4°C until total DNA extraction could be undertaken as 
previously described in detail in Chapter 3 (refer to section 3.2.2). 
4.2.3 TNe genotyping 
The GT dinucleotide repeat polymorphism within the TNC gene (Figure 4.1) was 
PCR amplified as described by Ozelius et al (1992) using the following fluorescently 
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labeled (56-FAM) forward primer, 5'-ATA GCC CAA AGA GAG GTG CCC-3', and 
reverse primer, 5' -AGA GCC CTT CTG TCT TCT CC-3', to produce a PCR product 
of approximately 110 bp. The PCR was carried out in a total volume of 25 }II 
containing at least 200 ng DNA, 10 pmol of each primer, 20 mM Tris-HCI pH 8.4, 50 
mM KCt 1.5 mM MgCh, 0.2 mM dATP, 0.2 mM dCTP, 0.2 mM dGTP, 0.2 mM dTTP 
and 0.5 units of DNA Taq polymerase (Invitrogen Life Technologies, Carlsbad, 
California, USA), using a PCR Express Thermal Cycler (Hybaid Limited, Middlesex, 
UK). Amplification was performed with an initial denaturing step at 94°C for 3 min, 
followed by 25 cycles at 94°C for 30 sec, 53°C for 30 sec, 72°C for 40 sec, and a final 
extension step at 72°C for 7 min. The resultant PCR products were resolved on 4% 
polyacrylamide gels using an ABI PRISM 377 DNA sequencer (Applied Biosystems, 
Foster City, California, USA). Each individual sample was run with a size standard. 
The repeat length was calculated by subtracting the forward (21 bp) and reverse (20 
bp) primer lengths and the intervening sequences (16 bp from the end of the 
forward primer to the start of the GT dinucleotide repeat polymorphism and the 25 
bp from the end of the repeat polymorphism until the start of the reverse primer) 
from the resultant PCR product sizes (Figure 4.1). These 82 base pairs are common 
to all the variants. The number of repeats was determined by dividing the repeat 
length by two. 
4.2.4 Statistical analyses 
Data were analysed using the STATISTICA version 7 (StatSoft Inc., Tulsa, OK, USA) 
statistical programme. A one-way analysis of variance, (ANOV A) was used to 
determine any significant differences between the characteristics of the Achilles 
tendon injury (ATI) and control (CON) groups, as well as the Achilles tendinopathy 
(TEN) and Achilles tendon rupture (RUP)· sub-groups. When the overall F value 
was significant, a LSD post hoc test was used to identify specific differences. 
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Pearson's chi-square analysis was used to analyse any gender and country of birth 
differences between the CON and ATI groups and as well as the TEN and RUP sub­
groups. The allele frequencies of the TNC gene were analysed using the Monte 
Carlo test (CLUMP version 2.0 programme) (Sham and Curtis, 1995). The odds 
ratios and the 95% confidence intervals were determined using GraphPad Instat 
version 3 (GraphPad Software, San Diego, CAl USA) statistical programme. Where 
applicable, data were presented as means ± standard deviations (SD) or a frequency 
with the number of subjects in parentheses. Statistical significance was accepted 
when p<0.05. 
142 Department of Human Biology 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER FOUR - THE GUANINE-THYMINE (GT) DINUCLEOTIDE REPEAT 
POLYMORPHISM WITHIN THE TENASCIN-C GENE IS ASSOCIATED WITH 
ACHILLES TENDON INJURY 
atagcccaaa gagaggtgcc catgcgcgtg 
Forward Primer 
gctgcttGTG TGTGTGTGTG TGTGTGTGTG 
TGTGTGTGTG Tctcaactgc ctgtgctcca 
ggaccaggag aagacagaag ggctct 
Reverse Primer 
I 1111 IIII I111I 11*1/ 111111111 

'-y--.J '--y-' '--y---' '-y--J '-v---' TNCgene10 kb 1 2 3-6 7-10 11-15 16 17 18·22 23-27 28 29 
Figure 4.1. (Top Panel) The 116 bp PeR product containing 17 GT dinuleotide repeat 
polymorphism (shown in capital letters) within intron 17 of the TNC gene. The underlined 
sequences denote the forward and reverse primers. The sequence, GenBank accession 
number Z11654, corresponds to part of intron 17 of the TNC gene. (Bottom Panel) A 
schematic diagramm of the TNC gene showing the relative positions and sizes of the 29 
exons (numbered) and the 28 introns. The position of intron 17 is marked with an asterisk. 
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4.3 RESULTS 
4.3.1 Subject characteristics 
The ATI, CON, TEN and RUP subjects were similarly matched for age, height, 
gender and country of birth (Table 4.1). The ATI (80.8 ± 15.3 k~ p<O.OOI), TEN (77.3 
± 14.2 k~ p=0.003) and RUP (86.6 ± 15.3 k~ p<O.OOl) groups were significantly 
heavier with corresponding higher body mass indices (BMIs) than the CON (71.4 ± 
11.9 kg) group. In addition, the RUP group was heavier with a corresponding 
higher BMI than the TEN group (p<O.OOl). The weights of the ATI group were 
recorded at the time of recruitment into the study on average 7.7 ± 8.7 years, ranging 
from 0 to 39 yrs, after the onset of symptoms. 
4.3.2 TNC genotyping 
As shown in table 4.2, 18 different alleles or variants of the GT dinucleotide repeat 
polymorphism within the TNC gene were identified within the ATI (n=14) and CON 
(n=15) groups. The number of GT repeats within the identified alleles ranged from 3 
to 21, with 95.0 % of the alleles containing between 12 and 17 repeats. There was a 
significant difference in the distribution of the alleles between the ATI and CON 
groups (Chi-square=51.0 p=O.OOI), with the alleles containing 12 and 14 GT 
dinucleotide repeats being significantly over represented in the A TI group (Chi­
square=21.6 p<O.OOI) (Figure 4.2). The alleles containing 13 and 17 repeats were on 
the other hand significantly under represented in the subjects diagnosed with 
Achilles tendon injury (Chi-square=42.4 p<O.OOl) (Figure 4.2). When the ATI group 
was divided into the TEN and RUP sub-groups, their allele distributions were 
similar to those of the ATI group (ATI vs TEN, Chi-square=3.1, p=I.000 and ATI vs 
RUP, Chi-square=5.0, p=0.989). The allele distribution of these two groups was 
therefore also significantly different to the CON group (CON vs TEN, Chi­
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square=56.0, p<O.OOl and CON vs RUP, Chi-square=47.2, p<O.OOl). In addition, the 
allele distribution of the TEN and RUP sub-groups were not significantly different 
(Chi-square=11.0 p=0.855) (Table 4.2). 
Table 4.1. Characteristics of the control (CON) and Achilles tendon injury (ATI) 
groups, as well as the Achilles tendinopathy (TEN) and Achilles tendon rupture 
(RUP) sub-groups. 
CON (n=127) ATI (n=114) TEN (n=72) RUP (n=42) 
40.4 ± 10.8 39.8 ± 13.3 39.2 ± 14.5 40.7 ± 11.1 
Age (yrs) 1 
(120) (112) (70) (42) 
Height (cm) 175±9 176±9 176±9 176±8 
(120) (112) (70) (42) 
Weight (kg) 71.4 ± 11.9 80.8 ±15.3 77.3 ± 14.2 86.6 ± 15.3 
(123)a,b,c (112)a, (70)b,d (42)c,d 
BMI (kg/cm2) 23.3 ±2.7 26.0 ±4.0 24.9 ± 3.5 27.9 ±4.0 
(120)a,c,e (112)a (70)d,e (42)c,d 
Gender (% males) 63.5 (126) 72.8 (114) 70.8 (72) 76.2 (42) 
Country of Birth 
(% South Africa) 69.7 (122) 76.6 (111) 73.9 (69) 81.0 (42) 
Values are expressed as mean ± standard deviation or a frequency where applicable. 

Number of subjects (n) is in parentheses. IThe age of the ATI group, as well as the TEN and 

RUP sub-groups, are the ages of onset of the symptoms. 

a CON vs A TI, P < 0.001, b CON vs TEN, P = 0.003, 

c CON vs RUP, P < 0.001, d TEN vs RUP, P < 0.001 

e CON vs TEN, P < 0.001 
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Table 4.2. The distributions of the TNC gene's 18 GT dinucleotide repeat 
polymorphism alleles within the control (CON) and Achilles tendon injury (ATI) 
groups.. as well as the Achilles tendinopathy (TEN) and Achilles rupture (RUP) 
sub-grOUps. 
NumberofGT CON (n=254) ATI (n=228) TEN (n=l44) RUP (n=84)Repeatsl 
3 	 0.4 (1) 0.4 (1) 0.0 (0) 1.2 (1) 
4 	 0.4 (1) 0.0 (0) 0.0 (0) 0.0 (0) 
5 	 0.4 (1) 0.4(1) 0.0 (0) 1.2 (1) 
6 	 0.4 (1) 1.3 (3) 1.4 (2) 1.2 (1) 
7 	 0.0 (0) 0.4 (1) 0.0 (0) 1.2 (1) 
8 	 0.4 (1) 0.0 (0) 0.0 (0) 0.0 (0) 
9 	 0.0 (0) 0.4 (1) 0.7 (1) 0.0 (0) 
"11 	 0.0 (0) 1.3 (3) 2.1 (3) 0.0 (0) 
122 10.2 (26) 18.9 (43) 17.4 (25) 21.4"(18) 
133 24.0 (61) 8.8 (20) 8.3 (12) 9.5 (8) 
142 0.8 (2) 9.2 (21) 8.3 (12) 10.7 (9) 
15 17.3 (44) 21.5 (49) 24.3 (35) 16.7 (14) 
16 22.8 (58) 28.9 (66) 28.5 (41) 29.8 (25) 
173 20.1 (51) 7.5 (17) 7.6 (11) 7.1 (6) 
18 1.2 (3) 0.4 (1) 0.7 (1) 0.0 (0) 
19 0.4 (1) 0.0 (0) 0.0 (0) 0.0 (0) 
20 0.4 (1) 0.4 (1) 0.7 (1) 0.0 (0) 
21 0.8 (2) 0.0 (0) 0.0 (0) 0.0 (0) 
The values are expressed as percentage with the number of alleles (n) in parentheses" lThe 
number of GT repeats was calculated from the size of the PCR products and the published 
sequence, accession no 211654. 2Alleles (12 repeats p=O.010 and 14 repeats p<O.OOl) are 
over-represented within the AT! group when compared to the CON group. 3Alleles (13 
repeats p<O.OOl and 17 repeats p<O.OOl) are significantly lower in the ATI group when 
compared to the CON group. The distribution of the TEN (p=1.000) and RUP (p=O.989) sub­
groups where similar to the AT! group and to each other (p=O.855). 
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Figure 4.2. Allele frequency of the GT dinucleotide repeats polymorphism within the TNC 
gene of the asymptomatic control (CON, white bars) and symptomatic Achilles injury (ATI, 
solid bars) groups. The frequencies of the rare alleles containing less than 11 and greater 
than 18 repeats are not shown. 0 = over represented alleles and U = under represented 
alleles. 
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Figure 4.3. Genotype frequency of the GT dinucleotide repeats polymorphism within the 
TNe gene of the asymptomatic control (CON, white bars) and symptomatic Achilles injury 
(ATI, solid bars) groups. 0 = over represented alleles containing 12 or 14 GT dinucleotide 
repeats. U = under represented alleles containing 13 or 17 repeats. E = evenly distributed 
alleles. 
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Alleles which were significantly over represented (0) in the ATI group (12 repeats, 
p=0.010 and 14 repeats, p<O.OOl), significantly under represented (U) in the ATI 
group (13 repeats, p<O.OO1 and 17 repeats, p<O.OOl) or evenly distributed (E) 
between groups, were grouped (Figure 4.2). Individuals with a UU (32 CON, 25.2% 
vs 9 ATI, 7.9%) or UE (47 CON, 37.0% vs 15 ATI, 13.2%) genotype were under 
represented in the ATI group (odds ratio=6.2, 95% CI 3.5-11.0, p<O.OO1) (Figure 4.3). 
Individuals that were either homozygous (00; 5 CON, 3.9% vs 14 ATI, 12.3%) or 
heterozygous (OE; 17 CON, 13.4% vs 32 ATI, 28.1 % or OU; 1 CON, 0.8% vs 4 ATe 
3.5%) for the 0 alleles were over represented in the ATI subjects. Interestingly, the 
frequency of the EE genotype was higher in the ATI group (n=40, 35.1 %) than in the 
CON group (n=25, 19.7%) (Figure 4.3). 
Although the sample size is small, the distribution of the TNC genotype in the thirty 
subjects who had bilateral injury was not significantly different to the 73 subjects 
with unilateral injuries (Table 4.3) (Clump T4 chi-Square=3.3, p=0,488). In addition, 
there was no significant difference when the over-represented (00, OE, OU and EE) 
genotype were added together and compared to the under-represented (UE and 
UU) genotypes (Fisher's exact test, p=0,416). Individuals with an EE genotype were 
included with those with the over-represented (00, OE and OU) genotypes based 
on the findings presented in figure 4.3. 
Similarly, the distribution of the TNC genotype in the twenty-six subjects who had 
multiple injuries was not significantly different from those subjects (n=81) who had 
only one injury event (Clump T4 chi-square=1,49, p=0.881) (Table 4,4). There was 
also no significant difference when the over-represented (00, OE, OU and EE) 
genotype were added together and compared to the under-represented (UE and 
UU) genotypes (Fisher's exact test, p=0.582). 
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Table 4.3. The distribution of unilateral and bilateral injuries in the Achilles 
tendon injury (ATI) subjects. 
TNC Genotype Unilateral injuries (n=73) 
Bilateral Injuries 
(n=30) 
00 16.4 (12) 6.7 (2) 
OE 27.4 (20) 33.3 (10) 
OU 4.1 (3) 3.3 (1) 
EE 30.1 (22) 43.3 (13) 
"0" Sub-total 78.1 (57) . 86.6 (26) 
UE 13.7 (10) 6.7 (2) 
UU B.2 (6) 6.7 (2) 
"u" Sub-total 21.9 (16) 13.4 (4) 
The values are expressed as percentage with the number of alleles (n) in parentheses. There 
were no significant differences in the 6 possible genotype distributions between Achilles 
tendon injury (ATI) patients who had unilateral and bilateral injuries (Clump T4 Chi 
Square=3.3, p=0.488). The number of subjects with an 00, OE, OU and EE genotypes were 
added together to produce the "0" sub-total. The number of subjects with an UE and UU 
genotypes were added together to produce the "U" sub-total. There were no significant 
differences irt "0" and "U" sub-total distributions between ATI patients who had unilateral 
and bilateral injuries (Fisher's exact test, p=0.461). 
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Table 4.4. The distribution of single and multiple injuries in the Achilles tendon 
injury (ATI) subjects. 
Single Injury Multiple InjuriesTNC Genotype (n=81) (n=26) 
00 13.6 (11) 11.5 (3) 
OE 28.4 (23) 26.9 (7) 
OU 2.5 (2) 7.7 (2) 
EE 33.3 (27) 38.5 (10) 
"0" Sub-total 77.8 (63) 84.6 (22) 
UE 12.4 (10) 11.5 (3) 

UU 9.9 (8) 3.8 (1) 

"U" Sub-total 22.2 (18) 15.4 (4) 
The values are expressed as percentage with the number of alleles (n) in parentheses. There 
were no significant differences in the 6 possible genotype distributions between Achilles 
tendon injury (AT!) patients who had unilateral and bilateral injuries (Clump T4 chi­
square=3.3, p=O.881). The number of subjects with an 00, OE, OU and EE genotypes were 
added together to produce the "0" sub-total. The number of subjects with an UE and UU 
genotypes were added together to produce the "U" sub-total. There were no significant 
differences in "0" and "U" sub-total distributions between AT! patients who had unilateral 
and bilateral injuries (Fisher's exact test, p=O.582). 
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In an attempt to investigate the combined genotype effects of the COL5Al and TNC 
genes on Achilles tendon injuries, the over-represented (IT) and under-represented 
(CC or TC) genotypes of the COLSAl single nucleotide polymorphism (SNP) rs12722 
(refer to Table 3.4) were combined with the over-represented (00, OE and OU) and 
under-represented (UU and UE) genotypes of the TNC dincluceotide repeat 
polymorphism (Figure 4.3). 'Although the E alleles were evenly distributed between 
the groups (Figure 4.2), the EE genotype was over-represented in the ATI subjects 
(Figure 4.3). The genotype of TNC gene was also combined with either the over­
or under-represented COLSAl genotypes. The distribution of the six groups of 
combined COL5Al and TNC genotypes were significantly different between the 
CON and ATI groups (Clump T4 chi-square=36.3, p<O.OOl), as well as between the 
CON and the TEN (Clump T4 chi square=25.9, p<O.OO1) and RUP (Clump T4 chi­
square=22.4, p<O.OO1) sub-groups (Table 4.5). There were similar combined 
genotype distributions between the TEN and RUP sub-groups (Clump T4 chi­
square=3.5, p=0.395). 
Individuals with any of the under-represented TNC genotypes (UU and UE) 
combined with any of the three COLSAl genotypes (IT, TC or CC) were 
significantly less likely of developing symptoms of Achilles tendon injury (CON: 
n=78, 62.9% and ATI: n=24, 23.1%) compared to individuals all the other possible 
genotype combinations (CON: n=46, 37.1 % and ATI: n~80, 77.0%) (Fisher's exact 
test, p<O.OOl,odds ratio=5.6, 95% CI3.2-10.1). Although it appears that the TNC UU 
or UE genotype combined with a C allele (CC or TC genotype) of the COL5Al gene 
is the strongest genetic marker associated with developing symptoms of Achilles 
tendon injuries, the TNC UU or UE genotype combined with a IT genotype of the 
COLSAl gene is also a genetic marker but to a lesser extent. Individuals with any of 
the over-represented TNC genotypes (00, OE and aU) combined with any of the . 
COL5Al genotypes, together with the COL5Al IT genotype combined with the TNC 
------------------------------------------------------------~-
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EE genotype, were significantly more likely of developing symptoms of Achilles 
tendon injury (CON: n=36, 29.0% and ATI: n=71, 68.3%) compared to individuals all 
the other possible genotype combinations (CON: n=88, 71 % and ATI: n=33, 31.8%) 
(Fisher's exact test, p<O.OOl, odds ratio=5.2, 95% CI3.0-9.3). The combined COL5Al 
CC and TNC EE genotypes were however evenly distributed between the CON 
(8.1%) and AT! (8.7%) groups. 
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Table 4.5. The frequency distribution of the combined COL5Al SNP rs12722 and 
TNC dinucleotide repeat genotypes within the control (CON) and Achilles tendon 
injury (ATI) group, as wells as the Achilles tendinopathy (TEN) and Achilles 
tendon rupture (RUP) sub-groups. 
COL5Al TNC Genotype CON ATI TEN RUP 

Genotype (n==124) (n=104) (n=67) (n==37) 

TTl SOO,OEorOU 14.5 (18) 30.8 (32) 29.9 (20) 32.4 (12) 
TTl 4EE 11.3 (14) 27.9 (29) 29.9 (20) 24.3 (9) 
TTl sUU orUE 40.3 (50) 19.2 (20) 23.9 (16) 10.8 (4) 
CCorTC2 sao, OE or au 3.2 (4) 9.6 (10) 7.5 (5) 13.5 (5) 
CCorTC2 4EE 8.1 (10) 8.7 (9) 7.5 (5) 10.8 (4) 
CCorTC2 sUU orUE 22.6 (28) 3.9 (4) 1.5 (1) 8.1 (3) 
The values are expressed as percentage with the number of alleles (n) in parentheses. 

IThe SNP rs 12722 IT genotype of the COL5Al gene produces the A1Al, A1A3 and A3A3 

BstUI RFLPs which are over-represented in the A TI and TEN groups. 

2'fhe SNP rs 12722 TC genotype of the COL5Al gene produces the A1A2 and A2A3 BstUI 

RFLPs, while the CC genotype produces the A2A2 RFLP. These genotypes are under­

represented in the A TI and TEN groups. 

3The TNC 00, OE and au genotypes are over-represented in the ATI group. 

4Althought the E alleles were evenly distributed between the groups, the EE genotype was 

over-represented within the A TI group. 

5The TNC UU and UE genotypes are under-represented in the ATI group. 

CON vs ATI, Clump T4 chi-square=36.3, p<O.OOl 

CON vs TEN, Clump T4 chi-square=25.9, p=<O.OOl 

CON vs RUP, Clump T4 chi-square=22.1, p<O.OO1 

TEN vs RUP, Clump T4 chi-square=3.5, p=O.395 
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4.4 DISCUSSION 
Several studies have previously suggested there is, at least in part, a genetic 
component involved in the development Achilles tendon (Kannus and Natri, 1997; 
Maffulli, 1999; A.men et al,2004), rotator cuff tendon (Harvie et aL, 2004) and 
anterior cruciate ligament injuries (Flynn et al, 2005). However, as mentioned 
(chapter 3, section 3.1) none of these studies have identified specific genes that might 
be associated with overuse tendon injuries. 
The novel finding of this study was that the allele distributions of the GT 
dinucleotide repeat polymorphism within the TNC gene were significantly different· 
between the subjects presenting with signs and symptoms of Achilles tendon injury 
and the asymptomatic control subjects. The frequencies of the alleles containing 12 
and 14 GT repeats were significantly over-represented in the symptomatic subjects, 
while the frequencies of the alleles containing 13 and 17 GT repeats were 
significantly under-represented in these subjects. Further analysis demonstrated 
that individuals who were homozygous or heterozygous for the under represented 
alleles (containing either 13 or 17 GT repeats) were 6.2 times less likely to develop 
symptoms of Achilles tendon injury. The heterozygous individuals did not contain 
an allele with either 12 or 14 repeats. This polymorphism within the TNC gene, 
together with the Bs.tUI RFLP within the COLSAl gene (chapter 3), is associated with 
Achilles tendon over-use injuries. 
Further comparison of the allele distribution of the TEN and RUP sub-groups to the 
CON group yielded similar results obtained for the ATl group. In addition, there 
were no significant differences in the allele distribution between the TEN and RUP 
sub-groups. These results suggest that perhaps both tendinopathy and rupture have 
similar aetiology or the involvement of tenascin-C in both pathologies is via the 
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same mechanism. This finding is in contrast to the COLSAl BstUI allele distribution 
in the Achilles tendon rupture sub-group, which was not different to the CON 
group (see Chapter 3, sections 3.3 and 3.4). The reasons for this are unclear and 
warrant further investigation. 
When the individuals in the ATI group were divided into those subjects who 
experienced unilateral or bilateral injuries, there were no significant differences in 
the TNC genotype frequency distributions between the groups. Furthermore, there 
was no significant TNC genotype frequency distribution between the subjects who 
had single or multiple (2 or more) injuries within the ATI group. Similar to the 
BstUI RLFP of the COL5Al gene, the GT dinucleotide repeat polymorphism of the 
TNC gene was not associated the number of injuri s or side of Achilles tendon injury 
experienced. These findings should however be interpreted with caution and 
considered preliminary since larger sample sizes need to analysed until a more firm 
conclusion can be drawn. 
Individuals with any of the under-represented TNC genotypes (UU and UE) 
combined with any of the three COL5Al genotypes (TT, TC or CC) were less likely 
of developing symptoms of Achilles tendon injury compared to individuals with all 
the other possible genotype combinations, suggesting that the GT dinucleotide 
repeat polymorphism of the TNC gene was more strongly associated with Achilles 
tendon injury. It should be noted however that individuals with both the under­
represented TNC (UU and UE) and COL5Al (CC and TC) genotypes (C allele was 
over-represented in the asymptomatic control subjects) were the least likely of 
developing symptoms of Achilles tendon injuries. The over-represented TNC 
genotypes (00, OE and OU) combined with any of the COL5Al genotypes, the over­
, represented and under-represented, were more likely of developing symptoms of 
Achilles tendon injury. This also suggests that the TNC genotypes are more strongly 
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associated with Achilles tendon injury. Although polymorphisms in both the 
COLSAl (chapter 3) and TNC (this chapter) genes have been associated with Achilles 
tendon pathology in this study, these results suggest that perhaps the GT 
dinucleotide repeat polymorphism within intron 17 of the TNC is a stronger genetic 
marker of Achilles tendon injury compared to the BstUI RFLP within the COLSAl 
gene and that the observed association of the COL5Al gene with Achilles tendon 
injuries is merely due to the close proximity of the COLSAl gene to the TNC gene on 
the tip of the long arm of chromosome 9. Although, only speculative at this stage, 
the combined genotype data did not exclude the possibility that both the COL5Al 
and TNC genes interact with one another to influence the outcome of Achilles 
tendon adaptation to chronic repetitive mechanical loading. Further studies with 
larger sample sizes will have to be done to answering this question. 
Tenascin-C is expressed in numerous tissues and, in particular those subject to high 
tensile stress such as tendons, ligaments and arterial walls (reviewed in Chiquet­
Ehrismann and Chiquet, 2003). The expression of this extracellular matrix protein is 
usually absent or very low in fully differentiated tissues, but is up-regulated during 
embryogenesis, tissue regen ration, wound healing and certain pathologic 
conditions (reviewed in Chiquet-Ehrismann and Chiquet, 2003; Jones and Jones, 
2000a; Jones and Jones, 2000b). Tenascin-C has a characteristic modular structure 
consisting of a tenascin assembly (TA) domain, heptad repeats, epidermal growth 
factor (EGF)-like repeats, fibronectin type III (FN-III) domains and fibrinogen-like 
globular domain (reviewed in Bosman and Stamenkovicl 2003; Jones and Jones, 
2000a). Because of its modular structurel the protein is able to interact with various 
protein, such as fibronectin, and glycosaminoglycan components of the extracelluar 
matrix. The glycosaminoglycan components include the family of chondroitin 
sulphate proteoglycans known as lecticans (aggrecan, versicanl brevican and 
neurocan). Tenascin-C interacts also with numerous cell surface receptors, such as 
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integrins, cell adhesion molecules (CAM), and annexin II. These diverse interactions 
are believed to play an important role in regulating cell-matrix interactions. 
A recent study have found that a coding single nucleotide polymorphism (SNP) in 
exon 17 (44413A/T) of TNC gene's fibronectin type III-D (Fn-III-D) domain was 
associated with adult bronchial asthma in Japanese patients (Matsuda et al., 2005). 
In both Asthma (reviewed in Matsuda et al., 2005) and Achilles tendinopathy (Riley 
et al., 1996), tenascin-C expression, more especially the larger alternatively spliced 
form, is increased. Curiously, the GT-dinucleotide repeat polymorphism associated 
with tendinopathy in the current study is located in intron 17 only 2090 bp 
drownstream of the functional SNP. This raises a possibility of a functional 
relationship between intron 17 and exon 17. Furth r studies need to be conducted to 
determine whether this SNP in exon 17 is associated with Achilles tendon injury. 
Investigators have suggested that apoptosis of tendon cells precedes tendinopathy 
(reviewed in Murrell, 2002). Abnormal mechanical loading is believed to initiate this 
programmed cell death in tendons. Since mechanical signals are able to alter the 
synthesis of tenascin-C (reviewed in Chiquet, 1999; Chiquet and Fambrough, 1984; 
Chiquet et al., 2003), which in turn is able to regulate cell-matrix interactions, it is 
tempting to speculate that this protein may play an important role in the proposed 
apoptotic model of tendinopathy. This theory invites future study. 
The association of the TNC gene or the COLSAl gene (Chapter 3) with symptoms of 
Achilles tendon injury does not prove that the tenascin-C protein or type V collagen 
is involved in a cause-effect relationship of Achilles tendon pathology. It is also 
possible that another gene(s) within this locus, such as any of the other genes 
identified within chapter 2, may be involved. In addition, it is highly unlikely that a 
single gene on chromosome 9q32-q34 is exclusively associated with the development 
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of the symptoms of Achilles tendon injury, since numerous proteins are involved in 
. tendon structure, development and regeneration (reviewed in Birk, 2001; Silver et 
al., 2003). These alternative possibilities need to be further investigated and will be 
discussed further in chapter 7. 
Besides the involvement of genetic factors, investigators have identified a number of 
non-genetic intrinsic factors and extrinsic factors that are implicated in the 
development of Achilles tendon injury. These factors include, amongst others, body 
weight, type of actiyity and type of training (reviewed in Riley, 2004). Since the 
subjects in this study with symptoms of Achilles tendon injury were significantly 
heavier and had participated for significantly more years in high impact sports than 
the asymptomatic control subjects, any possible interactions of weight and load with 
the genetic background in the development of the symptoms of Achilles tendon 
injury cannot be excluded, and needs to be investigated further (refer to Chapters 2 
and 3). Nevertheless, although Achilles tendon injury is typically a chronic 
condition, the first symptoms usually develop within the first few years of 
beginning regular, weight-bearing physical activity (Mazzone and Mc Cue, 2002). 
Since the subjects in the control group had been active for an average of 11.5 years 
and were currently exercising an average of 5 hours per week of high impact sport, 
it seems improbable that their apparent resistance to Achilles tendon injury was due 
purely to a lesser exposure to high impact loading of their Achilles tendons (refer to 
Chapter 2). The possible gene-gene and gene-environment interactions will be 
discussed further in chapter 7. 
In conclusion, the GT dinucleotide repeat polymorphism within intron 17 of the 
TNC gene is associated with the symptoms of chronic Achilles tendon injury. 
Alleles containing 12 and 14 GT repeats were over represented in individuals with 
symptoms of Achilles tendon injury, while the alleles containing 13 and 17 repeats 
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were under represented. There were no differences in the distribution of these 
alleles between the RUP and TEN sub-groups. 
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5.1 INTRODUCTION 
Flexibility can be defined as "the ability to move a joint through its complete 
range of motion" (ROM) (ACSM,2000). Traditionally, a reduced joint ROM is 
postulated to increase the risk of muscle-tendon injuries during both recreational 
and professional sporting activities (Beaulieu, 1981; Renstrom and Kannus, 1991). 
It is therefore a common practise that many professional and recreational athletes 
stretch their muscle-tendon units (MTUs), before, during or after exercise or 
physical activity in order to increase joint ROM (Pope et al., 2000; Smith, 1984). 
This practise of regular and habitual stretching is based on the belief that 
stretching will improve musculotendinous flexibility and therefore, minimize the 
risk of injury (Pope et al., 2000). The relationship between stretching and 
improved joint ROM is well established (reviewed in Smith, 1994; Nelson and 
Bandy, 2004). However, the question as to whether an improved joint ROM 
translates to a decrease in muscle-tendon injury is unclear and is currently being 
investigated (Andrish et a1., 1974; Ekstrand et aL, 1984; Laurenson, 1999; Safran et 
al., 1988; Witvrouv et al., 2001; Worrel and Perrin, 1992; Witvrouw et aL, 2004; 
Pope et al., 2000; van Mechelen et a1., 1993; Gleim and McHugh, 1997; Shrier, 
1999; Thacker et a1., 2004; van Mechelen et al., 2002; Weldon and Hill, 2003; 
Yeung and Yeung, 2003). In a recent prospective study, it was found that pre­
season hip adductor inflexibility was not a risk factor for adductor muscle strains 
in professional ice hockey players (Tyler et al., 2002). In another study of 
children (mean age of 12 years) with ligament sprains and fractures, ankle 
dorsiflesion ROM was found to be significantly lower in the injured compared to 
an age-matched control group (Tabrizi et al., 2000). 
More recently, a prospective study in professional soccer players and athletic 
population, however, found that pre-season decreased range of motion in the 
quadriceps and the hamstring muscle groups were associated with increased risk 
of injury in those muscle groups (Witvrouw et a1., 2001). Another two-year 
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prospective study in an athletic population also demonstrated that lower 
hamstring and quadriceps flexibility measured before the study was predictive of 
patellar /I tendinitis" after 2 years (Witvrouw et a1., 2003). Therefore, it appears 
that regular stretching results in increase muscle-tendon unit flexibility that can 
have positive effect and reduce the risk of muscle-tendon unit injuries. 
There are no specific studies that have investigated the relationship between 
general flexibility and Achilles tendon injuries. In a few studies, investigators 
have studied the relationship between multiple lower extremity injuries, 
including Achilles tendon injuries, and flexibility. In one prospective study, 303 
army male trainees were followed up for 12 weeks Gones et a1., 1993). It was 
shown that the back and hamstring flexibility (as measured indirectly by the sit­
and-reach test) was associated with risk of lower extremity injuries. In this study, 
86 (28.4%) subjects experienced lower extremity overuse injuries, which included 
Achilles tendinopathy,· patellofemoral syndrome and stress fractures. 
Furthermore, individuals with the sit-and-reach test ROM at both extremes (most 
flexible and least flexible) were at more than two times at greater risk of 
developing an injury compared to the individuals with an average flexibility. In 
this study the ROM therefore displayed a V-shaped relationship with injury. It 
was unclear whether this relationship would be observed with the ankle 
dorsiflexion.plantarflexion ROM. In another study of military recruits, the 
control (n=148) and intervention (n=lS0) groups were enrolled for a 13-week 
basic military training. The intervention group however included an additional 
three hamstring stretching sessions conducted in the morning, during lunch and 
evening. Measurements of hamstring flexibility were recorded before and after 
military training. After 13 weeks of training, the intervention group showed 
significantly greater hamstring flexibility compared to the control group. The 
results of the study also showed that the incidence of lower overuse extremity 
injuries, which included Achilles tendinopathy, was significantly lower in the 
intervention group (Hartig and Henderson, 1999) (16.7% injuries, intervension vs 
29.1 % injuries, control group). The main limitation of the above studies was that 
162 Department of Human Biology 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER FIVE - COL5Al AND TNC GENOTYPE EFFECTS ON 
FLEXIBILITY DURING ACHILLES TENDON INJURIES 
the specific relationship between ankle dorsiflexion ROM and Achilles tendon 
injury was not studied. 
Currently, there are few specific investigative studies (Clement et al., 1984; 
Kuafman et al., 1999; Wiesler et al., 1996; Pope et al., 1998; Pope et al., 2000; K vist, 
1994) on the role of musculotendinous flexibility in Achilles tendon injury. Data 
from these studies are mostly in the form of case series and are therefore limited 
because a cause-effect relationship could not be established. Regular stretching is 
often prescribed as part of the conservative treatment for chronic Achilles tendon 
injuries (Clement et al. 1984). In 109 runners, it was found that 41 (38%) 
displayed insufficiency in strength and flexibility of the gastrocnemius/soleus 
musclotendinous unit (Clement et al., 1984). It was suggested that 
musculotendinous flexibility could, be one of the aetiological factors in overuse 
chronic Achilles tendon injury. However, this study included no control group 
of non-injured runners. In a study on dancers, it was shown that abnormalities in 
ankle range of motion were a poor predictor of future injuries in modem and 
ballet dancers and it was instead suggested that"over-stretching can also result 
in increased risk of injury (Wiesler et al., 1996). It has also been observed that 
athletes with symptoms of Achilles tendinopathy frequently have decreased 
ankle range of motion as well as limited subtalar joint mobility (reviewed in 
Kvist, 1994) and that ankle dorsiflexion measured with straight knee was 
decreased in individuals with Achilles tendinopathy (Kaufman et al., 1999). In 
randomised controlled studies of over 1000 army recruits, divided into pre­
exercise stretching and pre-exercise non-stretching groups, it was found 
stretching before performing exercise did not significantly reduce the risk of 
injury to the Achilles tendon (Pope et al., 1998; Pope et a1., 2000). These latter two 
studies used the same subjects, with the 2000 study expanding the subject 
numbers to improve the power. More recently, a prospective cohort study 
suggested that increased ankle dorsiflexion ROM may be associated with 
Achilles tendinopathy (Mahieu et al., 2006). 
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In summary, a direct association between reduced or excessive increased ankle 
ROM and subsequent Achilles tendon injury is still not clear (Jarvinen et a1., 2005; 
Hunter and Spriggs, 2000). Data from most studies do not indicate whether a 
decreased ankle ROM was the cause or result of Achilles tendon injury because 
injured individuals were studied without baseline data. More prospective cohort 
studies will be required to determine this cause-effect relationship. 
In addition to the possibility that a decreased joint ROM may be related to 
Achilles tendon injury, it is also possible that excessive increases in joint ROM 
may be related to Achilles tendon injury. In particular, the relationship between 
joint hypermobility, genetic factors and Achilles tendon injury risk need to be 
explored. Joint hypermobility or laxity is a common unifying feature of the 
heritable disorders of connective tissue (HDCTs) (Hakim and Grahame, 2003). 
These include Marfan syndrome, Ehlers Danlos Syndrome (EDS), Osteogenesis 
imperfecta (01) and benign joint hypermobility syndrome (BJHS). Joint 
hypermobility, which can be defined as an asymptomatic increased range of joint 
or spinal movement, per se is not a disease (Grahame, 1999). Joint hypermobility 
must therefore be distinguished from BJHS, which is often symptomatic, and 
presents with chronic joint pain as the cardinal symptom (Grahame, 1999; Hakim 
and Grahame, 2003). 
Mutations in the COL5Al gene have been shown to cause types I and II forms of 
EDS (Loughlin et al., 1995; De Paepe et al., 1997; reviewed in Myllyharju and 
Kivirikko, 2001; Riley, 2004; Malfait et aLI 2005), while mutations in the tenascin 
X (TNX) gene, on the other hand have been shown to be associated with both 
hypermobility type-Ehlers Danlos Syndrome (HT-EDS) and BJHS (Schalkwilk et 
al., 2001, Zweers et al., 2005). As discussed in Chapter 4, tenascin X is a member 
of the same family of matricellular glycoproteins as Tenascin C. 
Mutations within the TNX gene have also been associated with tenascin X 
deficiency, since reduced serum levels of Tenascin X are present in 5-10% of 
patients diagnosed with BJHS or HT-EDS (Zweers et. al., 2003, Zweers et. aL, 
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2005). In addition, patients with tenascin X haploinsufficiency (which is a 
mutation in one of the TNX alleles resulting in phenotypic alteration, while the 
other allele remains normal) also show generalized joint hypermobility (Zweers 
et al., 2005). Tenascin X is produced predominantly by dermal fibroblasts where 
it has been shown to influence collagen fibre deposition (Chiquet-Ehrismann and 
Tucker, 2004). Furthermore, it has also been shown that tenascin X is secreted by 
fibroblasts in the endow, peri- and epimysium of skeletal muscle (Chiquet­
Ehrismann and Tucker, 2004). Since the detailed functions of the family of 
tenascin proteins are not fully understood, it is possible that tenascin X has other 
similar functions as Tenascin-C in the tendon extracellular matrix, which has not 
been described yet. 
As described ih Chapter 3, the BstUI restriction fragment length polymorphism 
(RFLP) within the COL5Al gene was associated with symptoms of Achilles 
tendon injuries. Individuals with the A1 and A3 alleles were over-represented in 
the Achilles tendon injury (ATI) group, while individuals with the A2 allele were 
under-represented in the ATI group. Furthermore, the GT dinucleotide repeat 
polymorphism within the TNC gene was also associated with symptoms of 
Achilles tendon injuries (Chapter 4). Individuals with 12 or 14 GT repeats were 
over-represented (grouped together and termed the a alleles) in the ATI group, 
while individuals 'with 13 or 17 GT repeats were under-represented (termed the 
U alleles) in the ATI group. There were no significant differences in the 
distribution of the remaining alleles between the two groups (termed the E 
alleles). 
Since mutations within both the COL5Al and TNX genes have been associated 
with joint hypermobility pathologies, such as HT-EDS and BJHS, and Tenascin-C 
belongs to the same,family of glycoproteins as Tenascin X, it is possible that the 
variants of the COL5Al and/or TNC genes, which are either over- or under­
represented within Achilles tendon injury group (Chapters 3 and 4) are 
associated with alterations in musculotendinous flexibility. 
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The alm of this present study therefore was to investigate the possible 
interactions of polymorphisms within the COL5Al and!or TNC genes and 
musculotendinous flexibility in symptomatic subjects with Achilles tendon 
injuries as well as asymptomatic control subjects. A secondary aim was to 
investigate whether the subjects with Achilles tendon injuries would exhibit 
either an asymmetrical limb or decreased flexibility compared to non-injured 
subjects. 
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5.2 MATERIALS AND METHODS 
5.2.1 Subjects 
The recruitment strategy, inclusion and exclusion criteria for the subjects 
included in the Achilles tendon injury (ATI) and control (CON) groups, as well as 
the Achilles tendinopathy (TEN) and Achilles tendon rupture (RUP) sub-groups 
has been previously described in detail in Chapter 2 (refer to section 2.2.1). The 
subjects were also informed and gave written informed consent of the sub-study 
on the measurement of the range of motion to evaluate musculotendinous 
flexibility. During the same visit to the laboratory when the subjects were 
provided with information and explanation on the overall study, completed 
questionnaires and an informed consent form, range of motion (refer to section 
5.2.2) was also measured in a those subjects who agreed to participate in the 
flexibility component of the study. Participation in the flexibility sub-study was 
based on the subject's willingness to spend extra-time (about 45min) on the trial 
so that the range of motion could be measured. Therefore, a sub-group of 71 
subjects (62% of the ATI group) with a current or past clinical history of Achilles 
tendon injury (ATI-F) and a sub-group of 37 (29% of the CON group) apparently 
healthy asymptomatic control (CON-F) subjects were recruited for the flexibility 
component of the study as well. The ATI-F group consisted of 38 (53% of the 
TEN group) subjects diagnosed with chronic Achilles tendinopathy (TEN-F) and 
33 (79% of the RUP group), all with a complete rupture of the Achilles tendon 
(RUP-F). 
5.2.2 Subjects grouping according to the BstUI alleles of the COL5A1 gene 
The A1 and A3 alleles of the BstUI restriction fragment length polymorphisms 
(RFLPs) within the COL5Al gene were significantly over-represented in the ATI 
than in the CON group, while the A2 allele was under-represented in the ATI 
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subjects (Chapter 3). The CON-F and ATI-F groups were therefore divided into 
those individuals who were heterozygous or homozygous for the A2 allele, 
namely the CON-F-A2 and ATI-F-A2 sub-groups and the remaining subjects who 
did not have an A2 allele, namely the CON-F-A1/ A3 and ATI-F-A1/A3 sub­
groups. 
5.2.3 Subjects grouping according to the GT repeat alleles of the mcgene 
As shown in Chapter 4, the 12 and 14 repeats of the GT dinucleotide repeat 
polymorphism (the 0 alleles) within the TNC gene were significantly over­
represented in ATI than in the CON group, while the 13 and 17 repeats (the U 
alleles) were under-represented in the ATI group. The remaining GT repeats 
were evenly distributed (the E alleles) between CON and ATI groups. Therefore, 
the CON-F and ATI-F subjects were also divided into those individuals who were 
heterozygous or homozygous for the 0 alleles (00 and OE) (sub-groups CON-F­
o and ATI-F-O), individuals homozygous for the evenly distributed alleles (EE) 
(sub-groups CON-F-E and ATI-F-E) and individuals who had either a UU or UE 
TNC genotype (sub-groups CON-F-U and ATI-F-U). 
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5.2.4 Flexibility measurements 
The following flexibility measurements were conducted and recorded in all the 
. subjects: (i) sit and reach test (SR), (ii) passive straight leg raise (SLR), (iii) passive 
ankle dorsiflexion (ADF), (iv) passive shoulder external (Sho ER) and internal 
rotation (Sho IR), (v) passive hip external (Hip ER) and internal rotation (Hip IR) 
and (vi) active elbow extension (Elb Ext) and flexion (Elb FIe). Subjects were 
requested not to exercise in excess of their normal training habits in the 2 days 
before being tested in an effort to exclude the effects of delayed onset muscle 
soreness on flexibility (Cleak and Eston, 1992; reviewed in Marginson et aLI 
2005). Subjects were not allowed to warm up before taking flexibility 
measurements and no prior stretching between tests was permitted. The time of 
the day of the test and instructions given to the subjects was also kept as similar 
as possible. Except for the sit and reach test, all other measurements were 
assessed twice and the average score later calculated. The same researcher (GM) 
tested all the subjects. 
In the test-retest pilot study the 17 of the 19 subjects recruited and tested were 
right handed, while two were left handed. Fifteen of the 17 (88%) right-handed 
subjects were also right footed. Of the 2 remaining left-handed subjects, 1 was 
left footed. Therefore, the reported dominant hand in the questionnaire was 
used to assign the corresponding dominant hand. In comparing the injured 
versus non-injured limbs, individuals who had experienced bilateral injuries 
were not included in that particular analysis. 
5.2.4.1 The sit and reach test 
The standard floor sit-and-reach test was used to assess lower back and hip joint 
flexibility (ACSM, 2000) as well as an indirect technique to measure hamstring 
muscle flexibility (Hui et al., 1999). Participants were instructed on how to 
perform test using the sit-and-reach box in which the zero point is set at 23 cm 
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(ACSM, 2000). The best of the four test trials were recorded and used for 
analysis. The furthest distance c.overed during one of the four trials by the 
subject was the best sit and reach test score recorded. 
5.2.4.2 The straight leg raise test 
The straight leg raise was performed with the subject lying supine on a plinth, 
with the head resting on the plinth, arms placed on the chest, and both knees 
fully extended and their ankles resting slightly over the end of the plinth (Norkin 
and White, 2003). An L-shaped ankle splint, constructed from moulded 
polyurethane and lined with foam cushioning (constructed by Mr. John Rex, an 
Othortist at Claremont Medical Centre, Cape Town), was attached to the leg that 
was being tested using three Velcro straps. The ankle joint was held in a neutral 
position at 90°. One of the straps was fastened across the foot, while the 
remaining two straps were fastened across the subject's anterior tibia (Hughes, 
1996; Cobbing, 1999). 
An inclinometer, which was used to measure the range of motion, was secured to 
the lateral side of the splint using two Velcro straps. The inclinometer was 
constructed from a 30 cm goniometer. The original swinging arm of the 
protractor was replaced with a free swinging 2cm wide and 10cm long 
rectangular Perspex arm to which a small weight was attached. Readings were 
taken from the inclinometer where the free-swinging Perspex arm bisected the 
periphery of a standard protractor. Prior to each test the inclinometer was 
calibrated to a starting point of 99°, with the leg fully extended on the plinth. The 
subject was instructed to relax the muscles in the leg throughout the testing 
procedure. The researcher then slowly lifted the subject's experimental leg with 
one hand placed over the subject's knee and the other over the subject's heel, 
ensuring that full knee extension was maintained during the test. The researcher 
stopped raising the leg once the subject indicated a feeling of discomfort. The leg 
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was then returned to the starting position and the procedure repeated for the 
second measurement after about 30 seconds of rest. 
5.2.4.3 Passive Ankle dorsiflexion test 
Ankle dorsiflexion was performed with the subject lying supine on the plinth 
with the knees fully extended and the ankles relaxed (Clarkson and Gilewich, 
1989; Evans, 1994). The start position of ankle was therefore not standardized to 
a neutral position. For this test, a goniometer was used, where the short arm of 
the inclinometer was replaced with the original swinging long arm of the 
instrument. The fulcrum of the goniometer was placed over the lateral malleolus 
so that the stationary arm was aligned with the lateral midline of the fibula, using 
the fibular head as a reference point. The swinging arm was aligned with the 
lateral aspect of the fifth metatarsaL 
During this test the ankle of the subject was progressively dorsiflexed while 
keeping the knee fully extended until discomfort was felt or the ankle could not 
be moved further into dorsiflexion. The final reading of the moving arm on the 
goniometer was substracted from the reference reading taken at the start. 
5.2.4.4 Passive shoulder internal and external rotation test 
Passive internal and external shoulder rotation was performed with the subject 
lying supine on a plinth (Herrington, 1998; Norkin and White, 2003). The arm 
that was tested was abducted to 90° and the elbow, which was positioned just off 
the edge of the plinth, was flexed to 90°. The forearm was therefore upright and 
perpendicular to the ground with the palm of the hand facing forwards. The· 
fulcrum of the inclinometer was placed over the olecranon between the medial 
and lateral epicondyles of the humerus. The long stationary arm of the 
inclinometer was placed perpendicular to the ground, pointing upward and was 
secured by two Velcro straps to the lower arm, one near the wrist and the other 
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near the elbow joint. The short free-swinging arm of the inclinometer was 
hanging facing downwards creating a reference point. To measure passive 
external rotation, the subject's experimental forearm was rotated backward from 
the upright to a position where the subject indicated discoinfort and this was 
used as the end point for rotation. Similarly, to measure passive internal 
rotation, the forearm was gently rotated to a position of maximal forward 
rotation from vertical position. Throughout the tests, the shoulder of the arm 
being tested was held firmly against the plinth to limit rotation of the scapula. 
5.2.4.5 Passive hip internal and external rotation test 
Passive hip internal and external rotation measurements were performed with 
the subject seated upright on the edge of the plinth (Norkin and White, 2003). 
The hips were flexed at 90° flexion and kept in 0° abduction/adduction. The 
lower .legs were hanging over the edge of the plinth with their knees at 90° 
flexion. The fulcrum of the inclinometer was placed over the centre of the 
anterior surface of the patella. Both the long and short arms of the inclinometer 
were aligned perpendicular to the floor, facing downwards, and the reference 
point of the short arm was at an angle of 0°. Passive hip external rotation was 
recorded as the maximal rotation of the lower leg to a position in which it was 
rolled outward by moving the foot medially. Passive hip internal rotation was 
measured as the maximal rotation of the lower leg by moving the foot laterally. 
The subject was asked to keep their hands behind their back on the plinth to 
stabilize themselves and their pelvis was not allowed to rotate up off the plinth. 
The subject Was instructed by the researcher to remain upright and relaxed 
during all passive movements of the hip. 
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5.2.4.6 Active elbow flexion and extension test 
Elbow flexion/ extension was performed with the subject kneeling on both legs 
on a mat, with the upper arm placed horizontally on the plinth and the elbow 
flexed 90° (Norkin and White, 2003). The elbow joint was placed just off the 
corner and edge of the plinth, to allow for any possible elbow extension beyond 
90°. The fulcrum of the inclinometer was placed over the medial epicondyle of 
the humerus. The long stationary arm of the inclinometer was aligned with 
medial surface of the ulna, using the ulna styloid process as a reference point. 
Elbow flexion was recorded as the maximal movement of the forearm toward the 
humerus, and extension as the maximal movement of the fulcrum away from the 
humerus to a fully extended position. 
5.2.5 Test-retest reliability of the flexibility tests 
Before actively testing all the subjects for flexibility measurements, the tester 
performed a test-retest repeatability study on asymptomatic subjects after 
written informed consent had been obtained. The reliability study was 
performed for two main reasons; (i) to establish if the inexperienced examiner 
was consistent with flexibility measurements and (ii) to establish the consistency 
of the modified goniometer used. Each of the subjects was tested on two 
different days so that the second visit was separated from the first visit by 
between 2 to 6 days (mean ± SD: 2.7± 1.0 days). All subjects performed the range 
of flexibility measures as described above. Most of the nineteen (7 males and 12 
females) asymptomatic physically active Caucasian volunteers were recruited 
from the Sports Science Institute of South Africa. One subject was excluded from 
the study on account of age, (a 52 year old female) which was outside the narrow 
age range. A second subject (a 30 year old female) was also excluded for only 
completing the first set of tests. The subjects were included in this test-retest 
. study if they participated in some form of regular physical activity and free of 
musculoskeletal injury and had never been treated for Achilles tendon injury. 
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The subject'S mean age, weight and height were 25.5 ± 3.3 yrs (range 21-34), 68.7 
± 11.5 kg (range 51-87) and 173.1 ± 10.6 cm (range 153-186), respectively. The 
test-retest reliabilities (Rs) for the 17 range of motion (ROM) measurements 
ranged from 0.736 to 0.995 (Table 5.1). Six (35%) of the seventeen measurements 
showed a moderate (Rs between 0.80 and 0.89) and eight (47%) of the 
measurements showed high (Rs > 0.90) consistency between test 1 and test 2. 
Only three measurements (non-dominant elbow extension, dominant and non­
dominant elbow flexion, ICC < 0.8) were less reliable, but acceptable. In addition, 
except for the dominant hip internal rotation (p=0.024) and dominant ankle 
dorsiflexion (p=0.023), all other measurements were repeatable, when the test 1 
and test 2 were analysed using the paired t-test. 
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Table 5.1 Intra-observer reliability of the lower and upper limb flexibility (0) 

and sit and reach (cm) measurements of the subject'S (n=l7). 

Test 1 Test 2 ICC (R) Pvaluea 
D-Sho ER 95.3 ± 10.0 93.6 ± 12.3 0.863 0.366 
D-Sho IR 59.0 ± 9.4 59.1 ± 7.4 0.918 0.901 
ND-Sho ER 88.6 ± 10.1 89.7 ± 12.0 0.893 0.509 
ND-Sho IR 73.4 ± 7.8 72.4 ± 7.1 0.890 0.396 
D-Elb Ext 92.1 ± 6.5 92.3 ± 5.9 0.840 0.880 
D-Elb FIe 54.5 ± 5.7 54.1 ± 5.6 0.738b 0.786 
ND-Elb Ext 94.5 ± 5.4 92.7 ± 5.6 0.799b 0.100 
ND-Elb FIe 55.1 ± 4.7 57.0 ± 6.0 0.736b 0.128 
D-Hip ER 69.2± 11.9 68.9± 12.3 0.976 0.686 
D-Hip IR 55.6 ± 7.8 58.9 ± 9.6 0.865 0.024 
ND-Hip ER 68.9 ± 12.3 69.6 ± 13.0 0.939 0.673 
ND-Hip IR 56.3 ± 8.5 57.7 ± 8.7 0.901 0.274 
D-SLR 97.2 ± 21.1 94.4 ± 19.1 0.970 0.097 
ND-SLR 93.7 ± 19.8 93.0 ± 18.8 0.971 0.651 
D-ADF 63.4 ± 7.7 60.3 ± 7.7 0.848 0.023 
ND-ADF 67.4 ± 11.9 68.7 ± 12.8 0.933 0.394 
SR (em) 28.2 ± 9.4 28.3 ± 9.4 0.995 0.715 
Values are expressed as mean ± standard deviation. 

D, Dominant; ND, Non-Dominant; Sho ER, Shoulder External Rotation, Sho IR, 

Shoulder Internal Rotation; Elb Ext, Elbow Extension, ElbFle, Elbow Flexion, Hip ER, 

Hip External Rotation; Hip IR, Hip Internal Rotation; SLRI Straight Leg Raise; ADF, 

Ankle Dorsiflexion, SRI Sit and Reach. aThe P values of the repeated measures ANOV A 

and the paired t-test are identical. bThe lee values which were less than O.S. 
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5.2.6 Statistical analysis 
Data were analyzed using Statistic a for Windows (Version 7, Statsoft Inc., Tulsa, 
OK, USA). A one-way analysis of variance (ANOV A) was used to determine any 
significant differences between the characteristics of the CON, TEN and RUP 
groups. When the overall F value was significant, a Tukey's HSD post hoc test 
was used to identify specific differences. Unless otherwise specified, statistical 
significance was accepted when p<0.05. Where applicable, data are presented as 
means ± standard deviations (SD) with the number of subjects in parentheses. 
Pearson's Chi-square or Fisher's exact test analyses were used to analyze 
differences in the percentage of males between the CON, TEN and RUP groups. 
Differences in the right versus left, dominant versus non-dominant or right 
versus dominant or left versus non-dominant sides in the CON group were 
tested using a two-tailed dependent t-test (Stefanyshyn and Engsberg, 1994; 
Ekstrand et al., 1982) with a Bonferroni adjustment as four multiple t-tests of 
interest were conducted (Vincent, 1999). Therefore, the significance level was 
adjusted to 0.0125 (calculated from the alpha level of 0.05 divided by 4 
comparisons). For the differences between the injured and non-injured lower 
limb in the TEN-F and RUP-F groups a paired t-test was used without a 
Bonferroni adjustment as only 1 comparison was made within each group (alpha 
level was set at p<0.05). When both legs were injured, the data were not included 
in the comparison of injured versus non-injured. An intra-class reliability (R) or 
intra-class correlation coefficient (ICC) was calculated using values obtained from 
a repeated measures analysis of variance (refer to Appendix 5) for test-retest 
reliability between tests 1 and 2 measurements. In addition, paired t-test was 
performed to determine the consistency between tests 1 and 2 measurements. 
Flexibility measurements were compared between the CON-F, TEN-F and RUP-F 
groups using a one-way analysis of variance (ANOV A). 
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5.3 RESULTS 
5.3.1 Subject characteristics of the CON-F, TEN-F and RUP-F groups 
The CON-F, TEN-F and RUP-F groups were similarly matched for height and 
gender (Table 5.2). The CON-F group was however significantly younger than 
the TEN-F and RUP-F groups. The CON-F group was also significantly lighter, 
with a corresponding lower BMI, than the RUP-F group. There were no 
significant differences in the weight and BMI of the CON-F and TEN-F groups. 
The range of motion within the TEN-F and RUP-F groups were tested 9.8 ± 10.3 
(range 0-33) and 8.1 ± 9.2 (range 0-40) years after the age of onset for the Achilles 
tendon injury, respectively. 
Table 5.2 Characteristics of the control (CON-F), Achilles tendinopathy (TEN­
F) and Achilles Rupture (RUP-F) groups. 
CON-F TEN-F RUP-F 

Age (yrs) 33.3 ± 11.0 (37)a,b 47.3 ± 12.7 (38)a 48.7 ± 11.5 (33)b 
-Height (cm) 173 ± 10 (35) 176 ± 9 (37) 175 ± 9 (33) 
Weight (kg) 69.5 ± 13.0 (37)b 76.2 ± 14.8 (37) 85.1 ± 15.3 (33)b 
BMI (kg/m2) 22.8 ± 2.7 (35)b 24.7 ± 3.6 (36) 27.9 ± 4.2 (33)b 
Gender (% males) 62.2 (37) 63.2 (38) 69.7 (33) 
Values are expressed as mean ± standard deviation or a frequency (%) where applicable. 

Number of subjects (n) is in parentheses. BMI, Body Mass Index. 

aeON vs TEN (p<O.OOl), "CON vs RUP (p<O.OOl). 
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5.3.2 Achilles tendon injury and flexibility of the CON, TEN and RUPgroups 
When co-varied for age and body weight at the time of measurement there were 
significant group differences in only the active dominant elbow flexion (D-Elb 
FIe, p=0.049) and the non-dominant active elbow extension (ND-Elb Ext, p=0.038) 
(Table 5.3). No significant differences were observed between the CON-F, TEN-F 
and RUP-F groups in the remaining upper (Table 5.3) and all lower (Table 504) 
limb flexibility measurements. 
Table 5.3 Upper limb flexibility (0) measurements of the control (CON-F), 
Achilles tendinopathy (TEN-F) and Achilles rupture (RUP-F) groups. 
CON-F TEN-F RUP-F 

D-Sho ER 95.0 ±11.8 (36) 86.3 ± 11.2 (27) 88.3 ±14.8 (11) 
D-Sho III 70.9 ±12.7 (36) 71.3 ± 9.8 (27) 82.1 ±14.6 (11) 
ND-ShoER 85.7 ±11.8 (36) 81.0 ±12.6 (27) 84.7 ± lOA (11) 
ND-ShoIR 80.4 ±1404 (36) 78.9 ± 13.1 (27) 84.8 ±11.9 (11) 
D-Elb Flea 54.5 ±8.1 (26) 56.3 ±13.8 (16) 57.9 ±5.2 (9) 
D-Elb Ext 96.2 ±11.2 (26) 87.5 ±17.4 (16) 92.8 ±11.6 (9) 
ND-Elb FIe 55.9 ±8.9 (26) 52.8 ±12.8 (16) 59.3 ± 7.1 (9) 
ND-Elb Exta 95.6 ±9.9 (26) 91.3 ±11.6 (16) 94.6 ±12.6 (9) 
Values are expressed as mean ± standard deviation, with the number of subjects (n) in 

parentheses. 

D, Dominant; ND, Non-dominant; Sho ER, Shoulder External Rotation; Sho IR, 

Shoulder Internal Rotation; Elb FIe, Elbow Flexion; Elb Ext, Elbow Extension 

ap<O.05 (after covarying for age and weight at the time of measurement) 
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Table 5.4 Lower limb flexibility (0) and sit and reach (cm) measurements of the 
control (CON-F), Achilles tendinopathy (TEN-F) and Achilles rupture (RUP-F) 
groups. 
CON-F TEN-F RUP-F 
D-Hip ER 70.2 ±12.8 (31) 68.1 ± 12.0 (19) 59.8 ±8.6 (11) 
D-Hip IR 59.3 ± 9.7 (32) 59.4 ± 8.5 (19) 65.6 ± 5.1 (11) 
ND-HipER 72.7 ± 13.6 (31) 71.1 ± 13.5 (18) 64.5 ± 8.6 (11) 
ND-Hip IR 63.2 ±11.2 (32) 61.0 ± 9.5 (18) 67.8 ± 8.5 (11) 
D-SLR 88.0 ± 20.1 (37) 81.6 ± 15.0 (38) 86.0 ± 18.7 (28) 
ND-SLR 88.6 ±19.3 (37) 80.8 ±14.2 (38) 85.9 ± 17.7 (28) 
D-ADF 58.1 ± 7.9 (37) 56.8 ± 9.6 (37) 53.5 ± 7.9 (29) 
ND-ADF 60.0 ± 9.3 (37) 59.8 ±10.3 (37) 58.2 ± 8.8 (27) 
SR (em) 27.9 ±10.8 (35) 21.3 ±11.6 (38) 21.9 ± 12.1 (33) 
Values are expressed as mean ± standard deviation, with the number of subjects (n) in 
parentheses. 
D, dominant; ND, non-dominant; I, injured; NI, non-injured; ER, External Rotation; IR, 
Internal Rotation; SLR, straight leg raise; ADF, ankle dorsiflexion; SR, Sit and Reach. 
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5.3.3 Lower and upper limb dominance and flexibility in the control group 
Most of the control subjects were right handed (33 of 37) and none of the subjects 
indicated that they were ambidextrous. None of the ROM measurements, 
therefore, showed any differences between the right limb versus the dominant 
limb or the left limb versus the non~dominant limb (data not shown). Therefore, 
only the dominant and non-dominant ROM measurements are reported. 
Table 5.5 The comparison of the dominant and non-dominant flexibility (0) 
measurements of the control subjects in the upper and lower limbs. 
Dominant Non-dominant Pvalue 
Sho-ER 95.0 ± 11.8 (36) 85.7 ± 11.8 (36) <0.001 

Sho-IR 70.9 ± 12.7 (36) 80.4 ± 14.4 (36) <0.001 

Elb-Ext 96.2 f 11.2 (26) 95.6 ± 9.9 (26) 0.685 

Elb-Fle 54.5 ± 8.1 (26) 55.9 ± 8.9 (26) 0.205 

Hip-ER 70.2 ± 12.8 (31) 72.7 ± 13.6 (31) 0.100 

Hip-IR 59.3 ± 9.7 (32) 63.2 ± 11.2 (32) 0.007 

SLR 88.0 ± 20.1 (37) 88.6 ± 19.3 (37) 0.390 

ADF 58.1 ± 7.9 (37) 60.0 ± 9.3 (37) 0.048 

Values are expressed as mean ± standard deviation, with the number of subjects (n) in 
parentheses. 
Sho ER, Shoulder external rotatio; Sho IR, Shoulder internal rotation; Elb Ext, Elbow 
extension; Elb FIe, Elbow flexion; Hip ER, Hip external rotation; Hip IR, Hip internal 
rotaion; SLR Straight leg raise; ADF, Ankle dorsiflexion. 
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As shown in table 5.5, there were no significant differences between the 
dominant versus non-dominant limb measurements of the active elbow flexion 
and extension, straight leg raise as well as the passive hip external rotation ROM. 
The dominant shoulder external rotation (95.0 ± 11.6°) was significantly larger 
(p<0.001) than the non-dominant shoulder external rotation (85.7 ± 11.7°). The 
dominant shoulder internal rotation (70.9 ± 12.7°) was significantly lower 
(p<0.001) than the non-dominant shoulder internal rotation (80.4 ± 14.4°). The 
dominant hip external rotation (70.2 ± 12.8°) was not significantly lower (p=0.100) 
than the non-dominant hip external rotation (72.7 ± 13.6°). The dominant hip 
internal rotation (59.3 ± 9.7°) was significantly lower (p=O.OO7) than the non­
dominant hip internal rotation (63.2 ± 11.2°). Finally, the dominant ankle 
dorsiflexion (58.1 ± 7.9°) was significantly lower than the non-dominant ankle 
dorsiflexion (60.0 ± 9.3°) (p=0.048). 
5.3.2 Lower limb flexibility and Achilles tendon injury 
Table 5.6 shows a summary of the results of injured and non-injured ROM 
measured in the hip and lower leg for the TEN-F and RUP-F groups. In the TEN­
F group none of the ROM measurements (Hip ER, Hip IR, SLR and ADF) showed 
significant differences between the injured versus non-injured limbs. However, 
the ROM of the injured hip external rotation (65.4 ±9.4°) was significantly higher 
(p=0.021) than the non-injured hip internal rotation (58.9 ± 7.0°) in the RUP-F 
group. In addition, the ROM of the injured hip internal rotation (69.1 ± 6.7°) was 
significantly higher (p=0.045) than the non-injured hip internal rotation (64.4 ± 
6.5°) in the RUP-F group. The ROM of the SLR and ADF were however not 
significantly different between the injured and non-injured limbs in the RUP-F 
group. 
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Table 5.6 The differences in injured and non-injured limb flexibility (0) of the 
Achilles tendinopathy (TEN-F) and Achilles tendon rupture (RUP-F) subjects. 
TEN-F RUP-F 

Injured Non-injured Injured Non-injured 
66.5 ±11.2 66.6 ±10.6 65.4 ±9.4 58.9 ±7.0 
Hip-ER 
(11) (10) (ll)a (ll)a 
59.4 ±6.2 60.1 ±8.5 69.1 ±6.7 64.4 ±6.5 
Hip-IR 
(11) (10) (ll)b (ll)b 
76.8 ±13.6 78.6 ±14.8 87.7 ±16.7 87.5 ±15.7 
SLR 
(19) (19) (26) (26) 
55.9 ± 9.2 55.9 ±9.8 54.7 ±10.3 57.1 ±7.4 
ADF 
(19) (19) (24) (26) 
Values are expressed as mean ± standard deviation, with the number of subjects (n) in 

parentheses. 

Hip ER, Hip external rotation; Hip IR, Hip internal rotation; SLR, Straight leg raise; 

ADF, Ankle dorsiflexion 

aRUP-F (Injured) vs RUP-F (Non-injured), p=O.021 

bRUP-F (Injured) vs RUP-F (Non-injured), p=O.045. 
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5.5.3 The COL5Al allelic grouping and flexibility in the CON-F and ATI-F 
groups 
Tables 5.7 and 5.8 show the characteristics of the CON-F and ATI-F subjects when 
divided into their COL5Al gene A2 and Al/A3 allelic groupings, respectively. 
The control subjects with an A2 allele (CON-F-A2) and those with either an Al or 
A3 allele (CON-F-A1/ A3) were similarly matched for age, height, weight and 
BMI and gender (Table 5.7). Similarly, the Achilles tendon injury subjects with 
an A2 allele (ATI-F-A2), were matched for age, height, weight and gender when 
compared to the Achilles tendon injury subjects with either an Al or A3 (ATI-F­
A1/A3) (Table 5.8). The ATI-F-A2 sub-group however had a significantly higher 
BMI than the ATI-F-A1/ A3 sub-group. The two control COL5Al allelic sub­
groups were however both younger and lighter with a corresponding lower 
BMIs than the two Achilles tendon injury COLSA1 allelic sub-groups (data not 
shown). 
Table 5.7 Characteristics of the control subjects with an A2 (CON-F-A2) and 
either an A1 or A3 (CON-F-Al/A3) alleles of the COL5Al gene.· 
CON-F-Al/A3 CON-F-A2 Pvalue 
Age (yrs) 35.7 ± 11.2 (23) 29.4 ± 9.6 (14) 0.095 
Height (em) 173 ± 10 (22) 173 ± 10 (13) 0.920 
Weight (kg) 69.8 ± 14.6 (23) 69.1 ± 10.3 (14) 0.874 
BMI (kg/m2) 23.0 ± 3.0 (22) 22.4 ± 2.3 (13) 0.577 
Gender (% males) 60.9 (23) 64.3 (14) 1.00 
Values are expressed as mean ± standard deviation, with the number of subjects (n) in 
parentheses. 
BMI, Body Mass Index 
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Table 5.8 Characteristics of the Achilles tendon injury subjects with an A2 
(ATI-F-A2) and either an Al or A3 (ATI-F-Al/A3) alleles of the COL5Al gene. 
ATI-F-Al/A3 ATI-F-A2 Pvalue 
Age (yrs) 
Height (cm) 
Weight (kg)· 
BMI (kg/m2) 
Gender (% males) 
47.1 ± 12.7 (49) 
17S± 10 (48) 
78.4 ± 14.4 (48) 
25.4 ± 3.7 (48) 
65.3 (49) 
51.1 ± 10.6 (17) 
175 ± 7 (17) 
85.2 ± 17.1 (17) 
27.9 ± 4.8 (17) 
70.6 (17) 
0.257 
0.837 
0.113 
0.040 
0.773 
Values are expressed as mean ± standard deviation, with the number of subjects (n) in 

parentheses. Sighificant differences are highlighted in bold. 

BMI, Body Mass Index. 

There were no differences found in the lower limb flexibility measurements 
between the CON-F-A2 and CON-F-Al/A3 groups (Table 5.9). Except for the 
non-dominant ankle dorsiflexion (ND-ADF), which was significantly larger in the 
ATI-F subjects with either an Al or an A3 allele than in the subjects with an A2, 
there were no other differences found in the lower limb flexibility measurements 
between the ATI-F-A2 and ATI-F-Al/ A3 sub-groups (Table 5.10). 
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Table 5.9 Lower limb flexibility (0) and sit and reach (cm) measurements of the 
control subjects with an A2 (CON-F-A2) and either an Al or A3 (CON-F-Al/A3) 
alleles of the COL5Al gene. 
CON-F-Al/A3 CON-F-A2 Pvalue 
D-SLR 86.9 ± 22.9 (23) 89.8 ± 14.9 (14) 0.681 
ND-SLR 87.4 ± 21.8 (23) 90.5 ± 15.1 (14) 0.655 
D-ADF 57.0 ± 8.6 (23) 59.9 ± 6.7 (14) 0.298 
ND-ADF 59.5 ± 9.0 (23) 60.8 ± 10.0 (14) 0.685 
SR (em) 26.3 ± 12.0 (21) 30.3 ± 8.5 (14) 0.290 
Values are expressed as mean ± standard deviation, with the number of subjects (n) in 

parentheses. 

0, dominant; NO, non-dominant; SLR, Straight leg raise; AOF, Ankle dorsiflexion; SR, 

sit and reach. 
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Table 5.10 Lower limb flexibility (0) and sit and reach (cm) measurements of 
the Achilles tendon injury subjects with an A2 (ATI-F-A2) and either an Al or 
A3 (ATI-F-A1/A3) alleles of the COL5Al gene. 
ATI-F-A1/A3 ATI-F-A2 Pvalue 
0.088 
ND-SLR 85.4 ± 14.2 (46) 79.4 ± 17.9 (15) 0.191 
I-SLR 86.9 ± 15.2 (29) 77.8 ±14.5 (11) 0.094 
NI-SLR 86.7 ±14.6 (29) 80.5 ±15.8 (11) 0.247 
D-ADF 56.7 ± 8.9 (45) 53.7 ± 9.1 (16) 0.256 
ND-ADF 60.7 ± 9.3 (45) 55.0 ±8.9 (15) 0.046 
I-ADF 55.9 ±8.9 (29) 53.4 ± 10.7 (10) 0.477 
NI-ADF 57.7 ± 8.2 (29) 56.2 ± 9.0 (11) 0.607 
SR (cm) 22.9 ±10.6 (49) 18.9 ±13.9 (17) 0.227 
D-SLR 86.3 ±15.2 (46) 78.1 ±18.5 (15) 
Values are expressed as mean ± standard deviation, with the number of subjects (n) in 

parentheses. 

D, Dominant; ND, Non-dominant; I, Injured; NI, Non-Injured SLR, Straight Leg Raise; 

ADF, Ankle Dorsiflexion, SR, Sit-and-Reach. 

5.5.4 The TNe allelic grouping and flexibility in the CON-F and ATI-F groups 
The control subjects with the genotypes UU and UE (CON-F-UUjUE), EE (CON­
F-EE) and 00 and OE (CON-F-OOjOE) were similarly matched for gender, 
height, weight and BMI (Table 5.11). The CON-F-EE sub-group was significantly 
younger than the CON-F-OOjOE sub-group (p=O.019), but not the CON-F­
UUJUE sub-group. There was also no significant difference in age between the 
CON-F-OOjOE and CON-F-UUjUE sub-groups. The Achilles tendon injury 
su~jects with genotypes UU and UE (ATI-F-UUjUE), EE (ATI-F-EE) and 00 and 
OE (ATI-F-OOjOE) were similarly matched for age, height, weight and BMI and 
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gender (Table 5.12). The three TNC genotype CON-F sub-groups were however 
both younger and lighter with a corresponding lower BMIs than the three TNC 
genotype ATI-F sub-groups (data not shown). 
Table 5.11 Characteristics of the control subjects with UU or UE (CON-F.. 
UU/UE), EE (CON-F-EE) and 00 or OE (CON-F-OO/OE) genotypes of the 'INC 
gene. 
CON-F-UU/UE CON-F-EE CON-F-OO/OE Pvalue . 
~ Age (yrs) 31.8 ±10.2 (13) 27.4 ±4.6 (9)a 39.9 ±11.3 (11)a 0.019 
Height (cm) 171 ±9 (12) 174 ±11 (9) 176 ±10 (11) 0.380 
Weight (kg) 67.7 ±13.2 (13) 69.3 ±9.4 (9) 73.8 ±15.4 (11) 0.517 
8MI (kg/m2) 22.5 ±3.0 (12) 22.9 ±2.4 (9) 23.5 ±2.8 (11) 0.695 
Gender (% males) 61.5 (13 ) 66.7 (9 ) 72.7 (11 ) NS 
Values are expressed as mean ± standard deviation, with the number of subjects (n) in 
parentheses. 
BMt Body Mass Index. 
aCON-F-EE vs CON-F-OOjOE, P=O.024 
NS, not significant, where CON-F-UU/UE vs CON-EE, p=I.00; CON-F-EE vs 
CON-F-OO/EE, p=I.00, CON-F-UU/UE vs CON-F-OO/OE, p=0.679 
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Table 5.12 Characteristics of the Achilles tendon injury subjects with UU or 
UE (CON·F·UUjUE), EE (CON-F-EE)' and 00 or OE (CON-F-OO/OE) 
genotypes of the TNe gene. 
ATI-F-UUjUE ATI-F-EE ATI-F-OO/OE Pvalue 
Age (yrs) 46.1 ± 12.6 (15) 48.6 ± 10.0 (24) 47.5 ± 13.0 (28) 0.815 
Height (cm) 174 ± 11 (14) 176 ± 8 (24) 173 ± 9 (28) 0.505 
Weight (kg) 75.2 ± 12.3 (14) 80.3 ± 15.3 (24) 82.1 ± 17.8 (28) 0.413 
BMI (kg/m2) 24.8 ± 3.2 (14) 26.0 ± 4.7 (24) 27.1 ± 4.3 (27) 0.267 
Gender (% males) 46.7 (15) 75.0 (24) 64.3 (28) NS 
Values are exptessed as mean ± standard deviation, with the number of subjects (n) in 
parentheses. 
BMI, Body Mass Index 
NS, not significant, where ATI-F-UU/UE vs ATI-EE, p=O.0953; ATI-F-EE vs ATI-F­
OO/EE, p=O.549, ATI-F-UU/UE vs ATI-F-OO/OE, p=O.338 
There were no Significant differences in the lower limb flexibility measurements 
between the CON-F-UU/UE, CON-F-EE and CON-F-OO/OE sub-groups (Table 
5.13). The dominant ankle dorsiflexion (D-ADF) of the ATI-F-UUjUE was 
significantly greater than in the ATI-F-OO/OE sub-group (p=0.046), but not in 
the ATI-F-EE sub-group (Table 5.14). The dominant ankle dorsiflexion (D-ADF) 
of the ATI-F-OO/OE sub-group was similar to the ATI-F-EE sub-group. All the 
other flexibility and the sit and reach measurements were similar between the 
TNC genotype ATI-F sub-groups. 
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Table 5.13 Lower limb flexibility (0) and sit and reach (cm) measurements of 
the control subjects with UU or UE (CON-F-UUjUE), EE (CON-F-EE) and 00 
or OE (CON-F-OOjOE) genotypes of the TNC gene. 
CON-F-UUjUE CON-F-EE CON-F-OOjOE P value· 
D-SLR 86.5 ±17.2 (13) 97.2 ± 28.1 (9) 82.2 ±17.3 (11) 0.271 
ND-SLR 86.7 ±17.4 (13) 97.6 ± 25.4 (9) 83.5 ± 17.7 (11) 0.277 
D-ADF 56.2 ± 9.4 (13) 62.1 ±4.8 (9) 57.7 ± 6.0 (11) 0.186 
ND-ADF 59.5 ± 11.8 (13) 61.2 ± 6.0 (9) 60.4 ± 6.8 (11) 0.906 
SR(cm) 27.3 ± 10.1 (12) 30.2 ± 11.5 (9) 26.5 ± 12.5 (10) 0.752 
Values are expressed as mean ± standard deviation, with the number of subjects (n) in 

parentheses. 

D, Dominant; ND, Non-dominant; I, Injured; NI, Non-Injured SLR, Straight Leg Raise; 

ADF, Ankle Dorsiflexion, SR, Sit-and-Reach. 
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Table 5.14 Lower limb flexibility e) and sit and reach (cm) measurements of 
the Achilles tendon injury subjects with UU or UE (ATI-F-UUfUE), EE (ATI-F­
EE) and 00 or OE (ATI-F-OOjOE) genotypes of the TNC gene. 
ATI-F-UUfUE ATI-F-EE ATI-F-OOjOE Pvalue 
D-SLR 86.8 ±13.9 (14) 80.8 ±16.9 (23) 83.1 ±18.7 (25) 0.593 
ND-SLR 86.9 ±12.9 (14) 81.7 ± 18.2 (23) 81.9 ±16.2 (25) 0.589 
I-SLR 90.4 ±11.3 (9) 81.3 ±15.0 (15) 80.4 ±19.1 (19) 0.301 
NI-SLR 92.0 ±13.1 (9) 82.2 ±16.1 (15) 80.9 ±16.8 (19) 0.218 
D-ADF 60.5 ± 7.7 (14) 54.1 ±6.8 (22) 53.5 ± 10.7 (26) 0.047 
ND-ADF 60.2 ± 9.9 (13) 59.3 ± 9.3 (22) 58.5 ±10.6 (25) 0.878 
I-ADF 57,4 ± 7.7 (8) 53.5 ±7.7 (15) 54.9 ±12.1 (18) 0.670 
NI-ADF 57.5 ± 6.1 (9) 56.5 ± 8.0 (15) 55.7 ±10.2 (19) 0.877 
SR (em) 26.3 ±10.8 (15) 22.7 ±11.2 (24) 18.6 ±12.4 (28) 0.118 
, 	 Values are expressed as mean ± standard deviation, with the number of subjects (n) in 
parentheses. 
D, Dominant; NO, Non-dominant; I, Injured; NI, Non-Injured SLR, Straight Leg Raise; 
ADF, Ankle Dorsiflexion, SR, Sit-and-Reach. 
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5.4 DISCUSSION 
The study investigated whether the BstUI RFLP within the COL5Al gene and/or 
the GT dinucleotide repeat polymorphism within the TNC gene were associated 
with the ROM in symptomatic patients with Achilles tendon injuries and 
asymptomatic controls. The study investigated whether there was a genotype 
effect on muscle-tendon flexibility as represented by the measurement of ROM. 
Because few studies (Clement et aL, 1984) have inv~stigated the specific role of 
flexibility on Achilles tendon injuries, a further secondary aim was to test 
whether flexibility was associated with the risk of developing Achilles tendon 
injuries. 
The main finding of the study was that the different polymorphisms of both 
COL5Al and TNC genes were not associated with measurements of ROM of all 
joints tested in the study. The results suggest that both COL5Al and TNC genes 
do not influence the ROM measured and therefore have no effect on the 
corresponding muscle-tendon flexibility in the joints measured. 
Most treatment programs for chronic Achilles tendinopathy include stretching 
because of the notion that "inflexibility is a major cause of the injury" (El Hawary 
et. aL, 1997). However, there is conflicting evidence with regard to the role of 
flexibility in tendon injury (reviewed in Shrier, 1999; Witvrouv et. aL, 2003; 
Weldon and Hill, 2003; Yeung and Yeung, 2001). It has been shown that both 
decreased and increased flexibility could be related to an increased risk of tendon 
injury Gones et. al., 1993). It has also been suggested that the relationship 
between flexibility and injury risk is U-shaped, with the number of injuries 
increasing at both extreme ranges of motion (Taimela et. a1., 1990; Jones et. a1., 
1993). 
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In support of this, there is a group of heritable disorders of connective tissue 
(HDCTs) with a unifying characteristic of joint hypermobility. As well as having 
joint ROM in the extreme, these conditions are all characterized by increased 
musculo~skeletal fragility. These conditions in various forms of expressions or 
severity may represent the one of the spectrum in V-shape relationship between 
injury risk and joint ROM. Two of these HDCTs, namely Ehlers Danlos 
syndrome (EDS) and Benign Joint Hypermobility syndromes (BJHS) have been 
associated with mutations in the COL5Al and TN-X genes. Because (i) TNC 
belongs to the same family of proteins as TNX and possibly share some 
functional roles in the extracellualar matrix, (ii) both COL5Al and TNC genes 
have been associated with Achilles tendinopathy (chapter 3 and 4) and (iii) both 
COL5Al and TNX genes have been associated with pathologies associated with 
hyperflexible joints, it is probable that these genes and their protein products 
playa role i~ the quality of connective tissue including those of tendons. 
However, the passive properties of the muscle-tendon unit have recently been 
shown to be similar between female patients with BJHS and an age and gender 
matched control group, and the authors interpreted these findings to suggest that 
connective tissue of the muscle-tendon unit is unaffected in BJHS (Magnusson et 
al.,2001). This notion argues against the belief that the increased musculoskeletal 
flexibility associated with BJHS is a result of altered mechanical properties of the 
connective tissue (Bilkey et al., 1981). Subjects with BJHS tolerated stretch 
loading as shown by their greater peak moment compared to the controls. 
However, the structures and mechanisms that allow BJHS subjects to tolerate 
more stretch loading are not known (Magnusson et al., 2001). 
Although it makes intuitive sense that a more flexible and less stiff tendon should 
be at lower risk for tendon injury, it is also understood that Achilles tendon 
injury is a manifestation of many factors (Riley, 2004; Jarvinen et al., 2005). These 
factors include amongst others, the magnitude, rate and type of mechanical load 
and other environmental factors such training surfaces as well as other 
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physiological (such as age, gender, ankle dorsiflexion and hamstring ROM), 
psychological and other random factors (Gleim and Mc Hugh, 1997; Riley, 2004). 
It is therefore very difficult to isolate and quantify the contribution of all these 
factors and control their effects in order to study the effects of a single factor such 
as flexibility. 
The second finding of this study was that there were no significant differences 
between joint range of motion measurements between the control (CON-F), 
Achilles tendinopathy (TEN-F) and Achilles tendon rupture (RUP-F) groups. 
These results suggest that flexibility is perhaps not associated with Achilles 
tendon injury. Although the CON-F, TEN-F and RUP-F groups were matched 
for gender and height, the symptomatic groups were consistently heavier and 
older. Because there were generally no differences in the ROM measurements of 
most joints (except for the elbow measurements, Table 5.3) between the TEN-F 
and RUP-F groups, these two sub-groups were combined for the genotype 
studies to help increase the sample size. Interestingly, both the dominant elbow 
flexion (D-Elb FIe) and non-dominant elbow flexion (ND-Elb FIe) produced the· 
lowest repeatability scores (ICC of 0.738 and 0.745 respectively). Furthermore, it 
is highly unlikely that elbow ROM has any effect on Achilles tendon function. 
Although, there is unequivocal evidence that stretching improves the ROM 
around most joints and therefore improves muscle-tendon joint flexibility 
(Witvrouw et al., 2004), scientific evidence relating decreased ROM to increased 
risk of muscle-tendon injury is at best controversial (Yeung and Yeung, 2001; 
Gleim and McHugh, 1997; Witvrouw et al., 2004; Thacker et al., 2004; Weldon 
and Hill, 2003; Shrier, 1999). To illustrate the importance of muscle-tendon 
flexibility, guidelines from the America College of Sports Medicine and the 
World Health Organization include flexibility as one of the tenets of health and 
wellness (ACSM, 2000). Furthermore, stretching to increase flexibility is 
routinely prescribed as part of training programs for both recreational and 
professional athletes (Witvrouw et al., 2004). It is therefore not surprising that 
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flexibility has become part of most athlete's fitness training and testing programs. 
In a recent review, it was concluded that due to improper study design and small 
sample sizes, only one study so far has fulfilled the two criteria in trying to 
understand risk factors, which included the role of muscle-tendon flexibility, 
associated with lower extremity injuries (Bahr and Holme., 2003). 
The lower limb ROM measurements were of interest in this study, in particular 
the ankle dorsiflexion ROM, as a decreased ankle dorsiflexion ROM has been 
associated with an increased risk of Achilles tendon injury (Clement et. al.,1984). 
These investigators retrospectively examined runners with Achilles tendinopathy 
and found that they had insufficient strength and flexibility in the triceps surae 
muscle complex (Clement et al., 1984). However, the study could not distinguish 
cause and effect and did not have an age- and physical activity matched control. 
Our study was also a retrospective study, but it included a control group, which 
due to an age-at-onset matching attempt for the larger study, could not be 
precisely matched for present age-at-testing of subjects. Nonetheless, no 
differences were found in the flexibility measurements between the CON-F, TEN­
F and RUP-F groups, in particular, the ankle dorsiflexion ROM, even after 
controlling for differences in age and body weight between groups. 
Because of the nature of their design, case-control studies are unable to 
distinguish between risk factors and consequence of injury (Bahr and Holme, 
2003). Therefore, lack of baseline flexibility data before Achilles tendon injury 
occurrence would make it difficult to determine if reduced or increased flexibility 
was ~s a result of the injury or a risk factor for the injury. However, such 
information points towards conducting a prospective cohort study or 
randomised controlled triaL At least one study (Hartig and Henderson, 1999), 
has shown reduction of muscle-tendon injuries as a result of increased flexibility. 
Compared to other movements around joints, the range of ankle dorsiflexion is 
largely fixed, probably due to bony factors, rather than connective tissue stretch 
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(Bennell et. al., 2001). For instance, a six-week static stretching failed to elicit a 
change in active ankle dorsiflexion range of motion (Youdas et. al., 2003). 
However, other studies have found an increased ankle dorsiflexion ROM after 
immediate intense stretching session or after 10 weeks of static stretching 
exercises and weights (Swank et al., 2003; Wiktorsson-Moller et al., 1983). 
Although shown to be reliable and valid, goniometric measurements are static, 
therefore it is difficult to extrapolate the values to dynamic, continous and 
functional range of motion that occurs during human body movement. These 
measurements are also performed in a non-weight bearing position, however 
body movement often occur with some weight bearing activity. This makes it 
difficult to interpret these measurements in the context of range of motion during 
activity. Hunter and Spriggs (2000) have suggested there are differences in the 
functional correlates of passive and active ROM around joint. Therefore, it could 
mean that measurement of active ROM would result in possibly different results 
compared to the current results, as all of our measurements were passive ROM, 
except for the elbow flexion and extension ROM and sit-and-reach test. 
Because flexibility is highly specific to joints (ACSM, 2000), upper body flexibility 
me,asurements were recorded in this study in order to correlate some lower body 
versus upper body range of motion. No specific relationships or trend could be 
observed between lower and upper body limb ROM, perhaps supporting the 
notion that one joint ROM such as the sit-and reach test, does not represent the 
individual's general flexibility (Boyle et al., 2004; ACSM, 2000). 
The role of limb dominance in flexibility was investigated in the control, but not 
in symptomatic subjects, as they were uninjured. The dominant shoulder 
external rotation was significantly greater than the non-dominant shoulder 
external rotation. Interestingly in the opposite movement, the dominant 
shoulder internal rotation was significantly lower than the non-dominant 
shoulder internal rotation. When the two movements in each limb were added to 
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give total shoulder rotation, there were no significant differences in the total 
shoulder ROM (data not presented). The dominant hip internal rotation and 
ankle dorsiflexion were lower than in the non-dominant sides, although the 
differences (3.90 Hip IR and 1.90 Ankle dorsiflexion) were probably not of clinical 
importance. Whether these limb ROM differences may predispose individuals to 
an injury is not known, as there was no baseline data before injury for the 
symptomatic subjects to compare with CON subjects. Nonetheless, it has been 
suggested that asymmetrical limb flexibility could predispose a joint or soft tissue 
to injury (Ash and Werlinger, 1997). 
In the TEN-F group, there were no signifi~ant differences between the injured 
and non-injured hip external rotation (Hip ER), hip internal rotation (Hip IR), 
straight leg raise (SLR) and ankle dorsiflexion (ADF). he result of comparisons 
of injured versus non-injured limbs in the TEN-F group are interesting especially 
for the ankle dorsiflexion as no differences were found in passive ROM. The 
result could suggest that either the measurement of passive ADF is unable to 
detect the differences in changes in connective tissue of the muscle-tendon or that 
passive ADF is not associated with tendinopathy. It is possible that active ADF 
range of motion will yield different results. 
However, both the Hip ER and Hip IR, of the injured limb had a significantly 
greater ROM than that of the non-injured limb in the RUP-F group. It is not clear 
why both the Hip ER and Hip IR are larger in the injured limb compared the 
non-injured sides. However, it is possible that during the period leading up to 
Achilles tendon rupture and during recovery, the ipsilateral hip to the injured 
Achilles tendon probably has to adapt in some way to increase both its internal 
and external ROM. However, it is difficult to make that conclusion as no baseline 
data before injury were obtained in these subjects. The SLR and ADF range of 
motions were similar for the injured and non-injured limb in the RUP-F group. 
These latter results suggest that either the Achilles tendon passive properties are 
unaffected by rupture and surgery, or alternatively surgery is effective in the 
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healing of Achilles tendon rupture to restore the passive property of the Achilles 
tendon. Over ninety percent (30 of 33) of the subjects in the RUP-F group had 
undergone surgical operation of their Achilles tendons. None of the subjects in 
TEN-F group were surgically repaired. 
An additional finding was that the measurements of flexibility were found to 
have in the majority a moderate to high reliability as determined by the intra­
class coefficient (ICC) (Vincent, 1999; Thomas and Nelson, 1996). The reliability 
and validity of hand held goniometers have been shown to be fairly good 
(Gajdosik and Bohannon, 1987). The results show that data obtained from 
flexibility measurements were reliable. Hartig and Henderson, 1999 found a test­
re-test reliability coefficient of 0.98 (n=20) for passive hamstring ROM, when the 
same researcher performed the tests, which is similar to some of our results. 
Significant statistical difference (p<O.OO1) of 4° was found between the 
experimental (n=148, 41.7±8.3°) and the control (n=150, 45.9 ± 6.5°) groups at the 
beginning of the intervention. This difference was significant (p<0.001) again 
after 13 weeks (experimental, 34.7° vs control, 42.9°) of the training intervention. 
In this case, the lower values indicate a more flexible hamstring muscle-tendon 
unit. Murphy et al. (2003) attributed the lack of consistent findings in most injury 
studies·to improper study design and small sample sizes. This study serves to 
demonstrate the value of larger sample sizes in determining small to moderate 
differences in ROM measurements. 
In the current study, the same researcher conducted the testing as it is well 
documented that intra-observer error is less than inter-observer error in 
goniometric measurements (Low, 1976). It has been shown that taking more than 
one measurement recording further enhances measurement reliability (Low, 
1976). Therefore, in this study, an average of two recordings were measured for 
each joint range of motion, except for the sit and reach test, where the best and 
furthest of 4 measurements was recorded. Furthermore, all subjects were not 
allowed warm-up before the measurements in order to standardize the testing 
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procedure as it has been shown that warm-up may improve range of motion 
around joints (Low, 1976). 
Furthermore, it has been shown that certain joint range of motion measurements 
were associated with less variation compared with others (Low, 1976). In our 
study, certain joint measurements were more reproducible than others. It has 
also been suggested that it was easier to measure certain joints more accurately 
than others (Low, 1976). Other factors affecting the measurements could be the 
difficulty as'sociated with aligning the goniometer arms with bony marks, as well 
as the development ~f tissue tension from day to day which might influence the 
result of test-retest measurements. 
One of the limitations of the present study is that plantar-flexion ROM was not 
assessed. The reason for not including this measurement was a poor 
reproducibility of this measurement during the pilot testing. It could be that the 
total available ROM, e.g. the sum of ankle plantar- and flexion, at any joint is 
more importaht than a single isolated unidirectional movement in joint function, 
although that remains speculation. It was also impossible to control for age of 
individual's flexibility testing as matching was conducted for the larger studies 
(chapters 3 and 4). 
It was also not possible to test range of motion measurements in each subject, as 
only individuals Who were prepared to give an extra hour of testing enrolled for 
the range of motion measurement testing. This may have introduced a selection 
bias in subject recruitment for, this component of the study. Those subjects who 
were likely to benefit from the flexibility information feedback were more likely 
to participate. Thus the majority of the symptomatic subjects volunteered for this 
component of the study compared to the control subjects. Furthermore, some 
subjects were visited at their clubs for a collection of blood sample for DNA 
extraction and therefore their flexibility could not be tested. 
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The study's sample size was small (Murphy et al., 2003) and the data collection 
was largely retrospective. There was also large inter-subject variability in the 
value obtained for most range of motion in the CON-F and ATI-F groups. 
However, Hartig and Henderson (1999) study showed that the intervention 
group had reduced number of injuries as a result of the stretching intervention, 
suggesting that perhaps a 7°degree change in ROM in the hamstring may be 
clinically important. In our study, some ROM measurement differences between 
groups were much higher than 7°, but due to the small sample sizes and in most 
cases large variations between individuals (SDs), the study probably lacked 
enough power to detect differences. 
The present study was unable to show a relationship between the range of 
motion measurements and polymorphisms with both the COL5Al and TNC 
genes. The range of motion of the CON-F-A1/ A3 and CON-F-A2 groups 
measured was similar as well as ~hose of ATI-F-A1/ A3 versus ATI-F-A2 group. 
The results were similar for the TNC genotypes. This suggested a lack of 
genotype interaction between these studied polymorphisms of the COLSAl and 
TNC genes with the ROM or flexibility in the development of Achilles tendon 
injuries. There were also no significant differences between the CON-F, TEN-F 
and RUP-F groups in the range of motion measured, without regard for the 
genotype, suggesting that the range of motion in the joint measured is not 
associated with Achilles tendon injuries. However, the results need to be 
interpreted cautiously as the sample sizes were small. (Murphy et aL, 2003; Bahr 
and Holme, 2003). 
Further research is needed in larger sample size randomised controlled trials or 
prospective cohort studies to define the precise role of flexibility or ROM on 
Achilles tendon injury. Furthermore, the exact role of genetic factors in tendon 
connective tissues need to be further investigated. Although, goniometric 
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measurement of ROM has been found to be reliable and valid, the role of passive 
versus active in muscle-tendon function needs to be investigated. 
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6.1 INTRODUCTION 
In chapters 3 and 4, it was shown that polymorphisms within both the COL5Al 
and TNC genes, located on chromosome 9q32-q34, are associated with Achilles 
tendinopathy. Further support for the products of these genes being involved in 
Achilles tendon injury could be gained by investigating any associations of these 
polymorphisms with Achilles tendon morphology using non-invasive imaging 
techniques. 
Several imaging methods such as soft tissue radiography, computerized 
tomography (CT), ultrasonography (US) and magnetic resonance imaging (MRI) 
have been used to assist clinicians in the diagnosis of Achilles tendon injuries 
(Astrom et al., 1996). MRI and US are currently considered superior to 
radiography and CT and are therefore the methods of choice in imaging the 
Achilles tendon (Astrom et al., 1996). Although MRI has been shown to provide 
marginally better images, it is more expensive and less available than US. In 
addition, US device are also portable and dynamic. US can also be used to show 
real time pictures and offers a sessment of versatile functions such as blood flow 
measurements. I t is therefore often the preferred method to assess tendon 
morphology (Astrom et al., 1996). Assessment of the paratenon, however, using 
both MRI and US techniques has been shown to be less reliable than the 
measurements within the tendon substance itself (A strom et al., 1996). 
The shape, sagittal diameter, contour, intratendinous structure and signal 
intensity of the Achilles tendon can be determined using either MRI or US 
(Neuhold et al., 1992;Nehrer et al., 1997; Astrom et al., 1996; Gibbon et al., 2000; 
Schweitzer and Karasick, 2000). The normal Achilles tendon is oval in shape, 
approximately 6 nUn in diameter, with a well-defined contour, and a sagittal scan 
shows the antero-posterior (AP) margins to be parallel to one another. The 
intratendinous structure appears homogenous and the signal intensity 
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hypointense (Le. appears black) using MRI while the intratendinous structure 
appears honeycomb and whiter using US. 
In contrast, a pathological Achilles tendon is rounder in shape, greater than 6 mm 
in diameter (generally 10-18 mm. thick), with an ill-defined contour. Sagittal 
scans show that the AP margins are no longer parallel to one another and the 
intratendinous structure is seen with increased signal intensity (Le. appears 
whiter) using MRI while it appears hypoechoic (i.e. black) using US. The 
increased signal intensity by MRI and hypo echoic intra tendinous scans by US are 
believed to indicate tendon degeneration. These changes in the signal intensity 
have been shown to correlate well with the histopathology of Achilles 
tendinopathy (Astrom et aL, 1996; Maffulli et aL, 2000; Jozsa and Kannus, 1991). 
As shown in Chapter 3 the alpha 1 type V collagen (COL5Al) gene, which 
encodes for a minor structural component of tendons, is associated with chronic 
Achilles tendinopathy. The A2 variant (AIA2, A2A2 and A2A3 genotypes) of 
this gene was under-represented in individuals with symptoms of chronic 
Achilles tendinopathy compared to asymptomatic control subjects. Individuals 
who are homozygous (AlAI or A3A3) or heterozygous (AIA3) for the Al or A3 
variants were however over-represented in individuals with symptoms of 
Achilles tendinopathy compared to asymptomatic control subjects. Type V 
collagen forms hetrotypic fibers with type I collagen, which are the mpjor 
structural units of tendons, where it is believed to regulate the formation and 
growth of the fibres (Birk, 2001). Wenstrup et aL (2004) have recently shown that 
initiation of fibril assembly in col5al-deficient mice is completely dependent on 
type V collagen. 
It was also shown (Chapter 4), that the GT dinucleotide repeat polymorphism 
within the TNC gene was associated with chronic Achilles tendinopathy. 
Individuals with the 12 and 14 GT repeats (0 alleles) were over-represented, 
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whereas the 13 and 17 GT repeats (U alleles) were under-represented in the 
Achilles tendinopathy group compared to the control subjects. The TNC gene 
encodes for a protein which is also an important component of tendons and 
whose expression is regulated by mechanical stress (Jarvinen et al., 1999; Jarvinen 
et al., 2003). 
Since both type V collagen and tenascin C are structural components of tendon 
and expression of both their genes are altered during tendon pathology (Dressler 
et al., 2002; Ireland et al., 2001; Riley et al., 1996), it is possible that individuals 
who are at a greater genetic risk for developing symptoms of Achilles 
tendinopathy would display greater tendon morphological abnormalities. These 
tendon morphological abnormalities may be assessed using imaging techniques 
such soft tissue diagnostic ultrasonography. 
Therefore, the aim of this chapter of the thesis was to investigate the association 
between Achilles tendon morphology and the COL5Al and/ or TNC genotype, 
using soft tissue diagnostic ultrasonography (US). 
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6.2 MATERIALS AND METHODS 
6.2.1 Subjects 
The recruitment strategy, inclusion and exclusion criteria for the subjects 
included in the Achilles tendon injury (AT!) and control (CON) groups, as well as 
the Achilles tendinopathy (TEN) and Achilles tendon rupture (RUP) sub-groups 
has been previously described in detail in Chapter 2 (refer to section 2.2.1). 
During the same visit to the laboratory when the subjects were provided with 
information and explanation on the overall study, they were also informed and 
gave written informed consent of the US component of the study on the 
measurement of the morphological characteristics of the Achilles tendon using 
ultrasonography (US). Similar to the flexibility study (Chapter 5), participation in 
the US component of the study was based on the subject's known COL5Al and 
TNC genotype and availability at the time of the ultrasonography. A sub-group 
of 36 male subjects (45.6% of the Achilles tendinopathy (TEN) group) with a 
current or past clinical history of Achilles tendinopathy (TEN-M) and a sub­
group of 22 (16.8% of the CON group) apparently healthy asymptomatic male 
control (CON-M) subjects were recruited for the US component of the study. 
Only male subjects were included in this study as it was anticipated that few 
subjects would be enrolled and therefore a homogeneous sub-group was 
required. Subjects who had an Achilles tendon rupture were not included in the 
study as most of them were no longer experiencing symptoms associated with 
injury. For the purpose of this thesis it was assumed that the dominant leg of 
each subject was the same as their self-reported dominant hand on the completed 
questionnaire. 
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6.2.2 Subjects grouping according to the AI, A2 and A3 alleles of the COL5AI 
gene 
The Al and A3 alleles of the BstUI restriction fragment length polymorphism 
(RFLP) within the COL5Al gene were significantly over-represented in the AIl 
than in the CON group, while the A2 allele was under-represented in the ATI 
subjects (Chapter 3). The CON-M and TEN-M groups were therefore divided 
into those individuals who were heterozygous (A1A2 or A3A2) or homozygous' 
(A2A2) for the A2 allele, namely the CON-M-A2 and TEN-M-A2 sub-groups, 
respectively. The remaining subjects who did not have an A2 allele (i.e. those 
with an A1Al, A1A3 or A3A3 genotype) were divided into the CON-M-Al/A3 
and TEN-M-Al/A3 sub-groups. 
6.2.3 Subjects grouping according to the GT repeat alleles of the TNC gene 
As shown in Chapter 4, the 12 and 14 repeats of the GT dinucleotide repeat 
polymorphism (the 0 alleles) within the TNC gene were significantly over­
represented in TEN than in the CON group, while the 13 and 17 repeats (the U 
alleles) were under-represented in the TEN group. The remaining GT repeats 
were evenly distributed (the E alleles) between CON and ATI groups. Therefore, 
the CON-M and TEN-M subjects were also divided into those individualswho 
were heterozygous or homozygous for the 0 alleles (i.e. an 00, OE or OU 
genotype) to produce the CON-M-O and TEN-M-O sub-groups, respectively. The 
remaining individuals within the CON-M and TEN-M groups who had either a 
UU, UE or EE TNC genotype were divided into the CON-M-U and TEN-M-U 
sub-groups, respectively. 
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6.2.4 Testing Procedure 
Three experienced musculoskeletal radiologists, who were blinded to the subject 
group, conducted the soft tissue diagnostic ultrasound investigation. The 
majority of the subjects were examined by the same radiologist (RdV, n=46), and 
in a few cases a different radiologist was involved (CG, n=6 and BM, n=6). The 
method of analysing the Achilles tendon using soft tissue diagnostic US has 
previously been described (Gibbon et al., 2000). A Toshiba Nemio scanner 
(Nemio 20, Toshiba Diagnostic Ultrasound Systems, Tochigi-Ken, Japan) and a 
12-MHz linear-array transducer were used. During each examination, the subject 
was in a prone position with the feet overhanging the examination couch. The 
ankles were in their naturally relaxed position with the Achilles tendon fairly 
taut. For each subject, both Achilles tendons were examined from the 
musculotendinous junction to the calcaneal insertion in both the transverse and 
longitudinal axes. The sonographic probe was placed parallel to the Achilles 
tendon for transverse scans to avoid anisotrophy artifacts (Fornage, 1987). 
Tendon degeneration was defined as an area of decreased echogenecity, 
heterogeneous echogenecity, or both within a tendon, with or without associated 
thickening (Gihhon et al., 2000). Para tendinitis was diagnosed if the paratenon 
was abnormally thickened or contained fluid (Gibbon et al., 2000). Bursitis was 
defined by an area of increased fluid distention, adjacent oedema, or both in the 
region of the tetrocalcaneal or superficial precalcaneal bursa (Gibbon et aI., 2000). 
Colour Doppler was used to detect an increased blood flow in both the tendon 
substance and the para tenon. Additionally, tendon sagittal and transverse 
diameters in the antero-posterior positions were measured (mm) at the thickest 
point of Achilles tendon (Astrom et al., 1996). 
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Tendon shape, sagittal diameter, and echogenecity were classified as either 
normal (score of 0) or abnormal (score of 1) (Table 6.1). Blood flow was assessed 
in both the tendon substance (maximum score of 1 for each leg) and the 
paratenon (maximum score of 1 for each leg), therefore the maximum score for 
blood flow was 2. For the tendon dimensions measured, only the sagittal 
diameter was used and the mean diameter ± 2SD of the CON-M group was used 
to define the normal range (score of 0) (Schimdt et al., 2004). The normal mean 
sagittal diameter was 5.1 mm ± 2SD, therefore any sagittal diameter less than 3.9 
mm or greater than 6.3 mm was considered abnormal and assigned a score of1 . 
. A pathology score (ranging from 0 to 10) was calculated as the sum of the 
dominant and non-dominant scores of the (i) tendon shape (maximum score of 1 
for each leg), (ii) sagittal diameter (maximum score of 1 for each leg), (iii) tendon 
and paratendon blood flow (maximum score of 2 for each leg) and (iv) 
echogenecity (maximum score of 1 for each leg). Therefore, the worst pathology 
score (10 points) for an individual would be as follows: abnormal tendon shape (2 
points), increased sagittal diameter (2 points), increased blood flow (4 points), 
decreased echogenecity (2 points). Other characteristics such as the sizes of the 
retrocalcaneal bursa, Kager's fat pad, structure of calcaneal bone and the 
myotendinous junction (MTJ) were also recorded (Appendix 6.1) to exclude other 
conditions, such as inflammation of the retrocalcaneal bursa (bursitis), formation 
of bone spurs and tricep surae muscle injuries associated with the MTJ, as the 
cause of the subject's pain and discomfort. 
Both Achilles tendons were examined and investigated in all the subjects. 
Morphological characteristics of the dominant (D) and non-dominant (ND) leg 
were compared. Within the pathology group, morphological characteristics of 
injured (I) versus non-injured (NI) leg were also compared. 
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Table 6.1. Ultrasonography morphological pathology score determination in 
the dominant and non-dominant Achilles tendons. 
Variable Achilles Tendon Pathology 
\ 
Dominant Hand Left D Right D Both D 
Injured Achilles Tendon Left D Right D Both D 
Normal Left D Left DTendon Shape Fusiform (1)(0) Right D Right 0 
Left .RightAP sagittal diameter (mm) 
, 
Left DIncreased vascularity 
of the tendon (1) Right DNormal Left DBlood Flow (0) Right D Left DIncreased vascularity 
of the paratenon (1) Right D 
Left DNormal Left D Hypoechogenic (1)Echogenecity (0) Right DRight D 
(min 0 and max 10)Pathology Scorea 
... 
AP, anteroposterior 
aPathology score is the· sum. scores of both the left and right Achilles tendon 
measurements of the (i) tendon shape, (ii) sagittal diameter, (iii) blood flow and (iv) 
echogenecity. The Pathology score has a minimum value of zero and a maximum value 
of 10 for each individual. 
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6.2.3 Statistical analysis 
Data were analyzed using Statistica for Windows (Version 7 Statsoft, Tulsa, OK, 
USA) software. The differences between group subject's characteristics were 
performed using a one-way analysis of variance. Differences between the 
frequency counts of the injured (I) versus non-injured (NI) sides were tested 
using a Fisher's Exact test, while the differences in the sagittal diameters were 
analysed using the paired t-test. Differences between all subjects in the control 
(CON-M) and tendinopathy (TEN-M) groups were analysed using the Fisher's 
Exact test to compare the frequencies of abnormal morphological changes. 
Ultrasonography scores were compared between the CON-M-Al/A3, CON-M­
A2, TEN-M-Al/A3, TEN-M-A2 or the CON-M-U, CON-M-O, TEN-M-U and 
TEN-M-O groups using the Fisher's Exact test. When the contingency table was 
larger than 2x2, the results were collapsed into a 2x2 table and the Fisher's exact 
test performed using Graphpad Instat (version 3) software. The differences in the 
pathology scores between groups were analyzed using the non-parametric 
Kruskal-Wallis ANOV A and the median test. Values were reported as 
percentages of individual with abnormal morphological changes for a particular 
variable. Where appropriate, group values were reported as mean and standard 
deviation (SD). Significance for all analyses was set at p<O.05. 
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6.3 RESULTS 
6.3.1 Subject characteristics of the CON-M and TEN-M groups 
The characteristics of all the subjects included in CON-M and TEN-M groups ar~ 
shown in Table 6.2. The CON-M and TEN-M groups were similarly matched for 
body height and weight. However, the TEN-M group was older (p<O.OOl) and 
had a higher BMI (p=0.035) than the CON-M group (Table 6.2). The sonographic 
measurements of individuals in the TEN-M group were recorded on average 7.7 
± 7.7 years, ranging from 0 to 30 years, after the age of onset of the symptoms for 
Achilles tendinopathy. 
Because age and BMI were significantly different between the CON-M and TEN­
M groups, a correlation analysis of age, weight and BMI with the pathology 
scores of the TEN-M only group was conducted. There was a significant positive 
correlation between weight and pathology score (r=0.39, p=0.019). However, the 
correlations between age and pathology score (r=0.32, p=0.059) as well as BMI 
and pathology score (r=0.30, p= 0.112) were not significant. 
Table 6.2. Characteristics of all the subjects included in the control (CON-M) 
and Achilles tendinopathy (TEN-M) grOUps. 
CON-M TEN-M Pvalue(n=22) (n=36) 
Agel (yrs) 39.2 ± 12.1 (22) 51.9 ± 10.7 (36) < 0.001 
Height (cm) 179 ± 7 (22) 180 ± 6 (35) 0.520 
Weight (kg) 78.1 ± 10.0 (22) 84.0 ± 12.6 (35) 0.071 
BMI (kgjm2) 24.4 ± 2.4 (22) 26.2 ± 3.5 (30) 0.035 
Values are expressed as mean ± standard deviation with the number of subjects (n) in 
parentheses. lAge=the age at which the ultrasound recordings were performed. 
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6.3.2 Achilles tendinopathy and morphological characteristics of the CON-M 
and TEN-M groups 
Five (22.7%) of the 22 asymptomatic control subjects (CON-M) had only one 
ultrasonographic sign of Achilles tendon pathology. Three of the five subjects 
had increased blood flow in only one of their Achilles tendons, while the fourth 
subject had increased bilateral sagittal diameters (left, 6.7 mm and right, 6.6 mm). 
The fifth subject had a slight decreased echogenecity of the left (non-dominant) 
Achilles tendon. All the other measured features within these five subjects were 
normal (refer to Table 6.7). The tendon shape, sagittal and transverse diameters, 
blood flow as well as the echogenecity of the remaining 17 subjects were normal 
in both tendons. The retrocalcaneal bursa, Kager's fat pad, calcaneal bone and the 
myotendinous junction were normal in all the subjects within the CON-M group. 
Thirty four (94.5%) of the 36 TEN-M subjects diagnosed with clinical symptoms 
of Achilles tendinopathy had ultrasonographic signs of tendinopathy. Based on 
their clinical symptoms, 18 (50%) of the 36 subjects were diagnosed with bilateral 
Achilles tendinopathy. However, 25 (69.4%) of the TEN-M subjects were shown 
ultrasonographically to have bilateral tendinopathy. The sagittal diameter was 
abnormal in both tendons in 19 (52.7%) of these subjects. Abnormal tendon 
shape, decreased echogenecity and increased blood flow were observed in both 
Achilles tendons of 21 (58.3%), 21 (58.3%) and 9 (25%) subjects, respectively. In 
addition to the abnormal findings in the tendon, 8 of the subjects also had 
abnormalities in either the retrocalcaneal bursa, Kager's fat pad, calcaneal bone 
and/or the myotendinous junction. One subject had bilateral calcaneal bone 
spurs, bilateral retrocalcaneal bursitis and a unilateral abnormal Kager's fat pad. 
A second subject had a unilateral abnormal MTJ, unilateral retrocalcaneal bursitis 
and a bilateral swollen Kager's fat pad. A third subject had unilateral abnormal 
Kager's fat pads, while an additional 5 and 3 subjects subjects had unilateral and 
bilateral swollen Kager's fat pads, respectively. 
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The two subjects whose diagnoses were not confirmed by US were clinically 
diagnosed with bilateral Achilles tendinopathy. Both subjects reported gradual 
progressive pain, swelling and stiffness in the Achilles tendon area during the 
time of the injury. Once recruited into the study, the clinical diagnosis was 
confirmed (MS) in one of the subjects. During the examination there was 
tenderness to palpation, palpable nodular thickening and movement of the 
painful area in the Achilles tendon with plantar-dorsiflexion (positive shift test). 
The second subject saw a doctor who initially diagnosed him as having a partial 
rupture of the right Achilles tendon 10 years ago and was treated by a 
physiotherapist. 
There were no significant differences in the number of musculotendinous 
junction, Kager's fat pad, retrocalcaneal bursa and the ca1caneous abnormalities 
within the dominant and non-dominant Achilles tendons of the CON-M group 
when compared to the TEN-M group (data not shown) (refer to Appendix 6). 
Table 6.3. Ultrasonography measurements of the Achilles tendon diameters of 
the subjects in the control (CON-M) and Achilles tendinopathy (TEN-M) 
groups. 
CON-M TEN-M Pvalue(n=22) (n=36) 
D-AP Sagittal Diameter (mm) 5.1 ± 0.6 (22) 7.8 ± 2.4 (36) <0.001 
ND-AP Sagittal Diameter (mm) 5.1 ± 0.6 (22) 7.8 ± 2.5 (36) <0.001 
D-AP Transverse Diameter (mm) 5.1 ± 0.5 (22) 7.6 ± 2.8 (36) <0.001 
ND-AP Transverse Diameter (mm) 5.0 ± 0.5 (22) 7.2 ± 2.5 (36) <0.001 
Values are expressed as mean ± standard deviation with the number of subjects (n) in 
parentheses. D, Dominant; ND, Non-dominant; AP, anteroposterior. 
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The mean anteroposterior sagittal diameter of the CON-M group's dominant (5.1 
± 0.6 mm) and non-dominant (5.1 ± 0.6 mm) Achilles tendon were both 
significantly smaller (dominant and non-dominant comparisons were both 
p<O.OOl) than that of the TEN-M group (dominant 7.8 ± 2.5 mm and non­
dominant 7.8 ± 2.5 mm). The transverse diameters of the dominant and the non­
dominant Achilles tendons were also significantly different when the average 
measurements of the CON-M and TEN-M groups were compared (Table 6.3). 
The mean sagittal diameter ± 2 standard deviation of the CON-M group was 
used to define the normal size range (score=O) (Schidmt et al., 2004). Tendon 
sagittal diameters of less than 3.9 mm or greater than 6.3 mm were therefore 
classified as abnormal and obtained a score of 1. As expected the relative 
sonographic score for anteroposterior sagittal diameter of the dominant and non­
dominant Achill~s tendons were significantly different when the CON-M group 
(dominant 4.6 % and non-dominant 4.6%) was compared to the TEN-M group 
(dominant 65.7 %, p<0.001 and non-dominant 68.6 %, p<0.001) (Table 6.4). Since 
the mean transverse diameters were similar to the mean sagittal diameters, only 
the sagittal diameter was included in the subsequent analyses of 
ultrasonographic scores. 
The average ultrasonographic scores of all the other measurements in the CON­
M and TEN-M subjects are shown in Table 6.4. There were significant differences 
in the tendon shapes when the dominant (0.0% CON-M vs 72.2% TEN-M, 
p<0.001) and non-dominant (0.0% CON-M vs 69.4% TEN-M, p<0.001) CON-M 
group was compared to the TEN-M group. There were also significant 
differences in the blood flow when the dominant (9.1 % CON-M vs 41.7% TEN-M, 
p=0.009) and non-dominant (4.6% CON-M vs 36.1 % TEN-M, p=0.010), as well as 
in the echogenicity of the dominant (0.0% CON-M vs 66.7% TEN-M, p<O.OOl) and 
non-dominant (4.6% CON-M vs 69.4% TEN-M, p<0.001) CON-M and TEN-M 
groups were compared. 
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Table 6.4. Percentage of subjects in the control (CON-M) and Achilles 
tendinopathy (TEN-M) groups with abnormal findings in the dominant and 
non-dominant legs. 
CON-M TEN-M Pvalue(n=22) (n=36) 
D-Tendon Shape 0.0 (0) 72.2 (26) <0.001 
ND-Tendon Shape 0.0 (0) 69.4 (25) <0.001 
D.:.AP Sagittal Diameter 4.6 (1) 65.7 (23) <0.001 
ND-AP Sagittal Diameter 4.6 (1) 68.6 (24) <0.001 
D-Blood flow 9.1 (2) 41.7 (15) 0.009 
ND-Blood flow· 4.6 (1) 36.1 (13) 0.010 
D-Echogenidty 0.0 (0) 66.7 (24) <0.001 
ND-Echogenedty 4.6 (1) 69.4 (25) <0.001 
Pathology Scotea 0.27 ± 0.55 (0-2) 5.16 ± 2.9 (0-9) <0.001 
Pathology Scoteb O-~O--O 3--5.5--8.0 <0.001 
Values are expressed as percentages and the number of subjects with abnormal 

morphology in parentheses. . 

aValues are expressed as means ± SD (range). 

bValues are expressed as first quartile--median--third quartile. 

D, Dominant; ND, Non-dominant; AP, anteroposterior. 
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6.3.3 	 The sonographic morphological characteristics of the injured and non­
injured Achilles tendons. 
For those subjects who sustained a unilateral Achilles tendinopathy (n=18), the 
mean anteroposterior sagittal diameter of the injured tendon (8.3 ± 2.7 mm) was 
significantly larger than the non-injured tendon (6.2 ± 1.9 mm) (p=O.OO7). Except 
for the percentage abnormal score for the sagittal diameter (p=0.032), the tendon 
shape, blood flow and echogenicity were not significantly different between the 
injured and non-injured tendon (Table 6.5). 
Table 6.5. The comparison of percentage of abnormal morphological 
characteristics in the injured and non-injured leg of the Achilles tendinopathy 
(TEN-M) subjects who sustained a unilateral injury, n=18a 
Injured limb Non-InjuredCON-M (n=22)c 	 Pvalueb (n=18) limb (n=18) 
Tendon 0.0 (0/22) 77.7 (14/18) 50.0 (9/18) 0.164Shape 
AP Sagittal 4.6 (1/22) 76.5 (14/17) 41.7 (7/17) 0.032Diameter 
Blood Flow 9.1 (2/22) 44.4 (8/18) 27.8 (5/18) 0.489 
Echogenidty 4.6 (1/22) 72.2 (13/18) 44.4 (8/18) 0.176 
Values are expressed as percentages with the number of subjects (n) in parentheses. 

aSubjects who sustained .a bilateral injury were not included in this analysis. AP, 

anteroposterior . 

b Non-injured versus injured only 

cColumn added to illustrate the differences between CON-M and non-injured subjects 
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6.3.4 	 The COL5Al allelic effects on the sonographic morphological 
characteristics of the CON-M and TEN-M groups. 
Tables 6.6 and 6.7 show the characteristics of the CON-M and TEN-M subjects 
when divided into their COL5Al gene A2 and Alj A3 allelic groupings, 
respectively. The control subjects with an A2 allele (CON-M-A2; 2 AIA2, 5 
A2A2, 0 A2A3) and those with either an Al or A3 allele (CON-M-Alj A3; 13 
AIA1, 1 AIA3, 1 A3A3) were similarly matched for age, height, weight and BMI 
(Table 6.6). Similarly, the Achilles tendon injury subjects with an A2 allele (ATI­
M-A2; 4 AIA2, 4 A2A2, 0 A2A3) were matched for age, height, weight and BMI 
when compared to the Achilles tendon injury subjects with either an Al or A3 
(TEN-M-AljA3; 21 AIA1, 1 AIA3, 2 A3A3) (Table 6.7). The two control 
COLSAl allelic sub-groups were however both younger and lighter with a 
corresponding lower BMIs than the two Achilles tendinopathy COL5Al allelic 
sub-groups (data not shown). 
There were no differences found in the percentages of abnormal sonographic 
morphological characteristics between the CON-M-A2 and CON-M-Alj A3 
groups (Table 6.8). Similarly, there were no differences found in the sonographic 
morphological characteristics between the TEN-M-A2 and TEN-M-AljA3 sub­
groups (Table 6.9). However, the percentages of abnormal sonographic 
characteristics were higher in the two TEN-M groups compared to the two COM­
M groups. Although very few, some abnormal changes were found in 
asymptomatic subjects (Table 6.8). However, all of the five subjects with a sub­
clinical abnormalities detected via US were in the CON-M-AljA3 group only 
and therefore did not have the A2 allele. 
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Table 6.6. Characteristics of the control (CON-M) subjects with A2 and A1/A3 
\
alleles. 
A1/A3 (n=lS) A2(n=7) Pvalue 
Age (yrs) 40.7 ± 10.9 (15) 36.1 ± 14.9 (7) 0.428 
Height (cm) 1.'79 ± 9 (15) 180 ± 4 (7) 0.642 
Weight (kg) 78.2 ± 11.3 (15) 78.0 ± 7.3 (7) 0.972 

BMI (kg/m2) " 24.5 ± 2.5 (15) 24.0 ± 2.2 (7) 0.693 

Values are expressed as mean ± standard deviation. Number of subjects (n) is in" 
parentheses. 
Table 6.7. Characteristics of the Achilles tendinopathy (TEN-M) subjects with 
A2 and A1/ A3 alleles. 
TEN-M-A1/A3 TEN-M-A2 Pvalue 
Age (yrs) 53.3 ± 11.7 (23) 51.8 ± 7.7 (6) 0.781 
Height (cm) 181± 6 (23) 180 ± 9 (7) 0.839 
Weight (kg) 84.0 ± 11.5 (23) 87.1 ± 10.9 (7) 0.534 
BMI(kg/m2) 25.7 ± 3.1 (23) 26.7 ± 2.5 (6) 0.477 
Values are expressed as mean ± standard deviation. Number of subjects (n) is in 
parentheses. 
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Table 6.S. Percentages of abnormal ultrasonography recordings of the control 
(CON-M) subjects with A1/A3 and A2 alleles. 
CON-M-A1/A3 CON-M-A2 Pvalue{n=15} {n=7) 
D-Tendon Shape 0(0/15) 0(0/7) NS 
ND-Tendon Shape 0(0/15) 0(0/7) NS 
D-Ap Sagittal Diameter 6.7 (1/15) 0.0 (0/7) 1.00 
ND-AP Sagittal Diameter 6.7 (1/15) 0.0 (0/7) 1.00 
D-Blood Flow 13.3 (2/15) 0.0 (0/7) 1.00 
ND-Blood Flow 6.7 (1/15) 0.0 (0/7) 1.00 
D-Echogenicity 0.0 (0/15) 0.0 (0/7) NS 
ND-Echogenicity 6.7 (1/15) 0.0 (0/7) 1.00 
Pathology Scorea 0.4 ± 0.6 (0-2) 0.0 ± 0.0 (0-0) 0.091 
Pathology Scoret; 0-0--1 0-0--0 0.082 
ND-Sag Diameter (mm) S.0±0.6 S.2±0.S 0.608 

D-Sag Diameter (mm) S.2±0.6 S.0±0.6 0.461 

Values are expressed as percentages with number of subjects (n) in parentheses. 

D, Dominant; NO, Non-dominant 

aValues are expressed as means ±SD (range). 

bValues are expressed as first quartile--median--third quartile. 
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Table 6.9. The percentages of abnormal ultrasonography recordings. of the 
Achilles tendinopathy (TEN-M) subjects with Al/A3 and A2 alleles. 
TEN-M-Al/A3 TEN-M-A2 Pvalue{n=23} (n=!) 
D-Tendon Shape 73.9 (17/23) 85.7 (6/7) 1.00 
ND-Tendon Shape 69.6 (16/23) 71.4 (5/7) 1.00 
D-AP Sagittal Diameter 73.9 (17/23) 71.4 (5/7) 1.00 
ND-AP Sagittal Diameter 69.6 (16/23) 71.4 (5/7) 1.00 
D-Blood Flow 43.5 (10/23) 28.6 (2/5) 0.669 
ND-Blood Flow 30.4 (7/23) 57.2 (4/7) 0.372 
D-Echogenicity 69.6 (16/23) 71.4 (5/7) 1.00 
ND-Echogenicity 69.6 (16/23) 71.4 (5/7) 1.00 
Pathology Scorea 5.4 ± 2.9 (0-9) 5.6 ± 2.6 (3-9) 0.941 
Pathology Scoreb 3--6-8 3--4-8 0.666 
ND-Sag Diameter (mm) 7.2± 2.0 7.5 ± 2.3 0.064 

D-Sag Diameter (mm) 8.1 ± 2.3 7.8 ± 2.8 0.134 

Values are expressed as percentages with number of subjects (n) in parentheses. 

D, Dominant; ND, Non-dominant 

aValues are expressed as means ± SD (range). 

bValues are expressed as first quartile--median--third quartile. 
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6.3.5 	 The TNC allelic effects on the sonographic morphological characteristics of 
the CON-M and TEN-M groups 
The control subjects with the genotypes UU, UE and EE (CON-M-U; 6 UU, 5 UE, 
4 EE) and 00 and OE (CON-M-O; 1 00 and 4 OE) were similarly matched for 
age, height, weight and BMI (Table 6.10). Similarly, the Achilles tendinopathy 
subjects with genotypes UU, UE and EE (TEN-M-U; 1 UU, 3 UE, 16 EE ) and 00 
and OE (TEN-M-O; 1 00 and 9 OE) were similarly matched for age, height, 
weight and BMI (Table 6.11). The two TNC genotypes of CON-M sub-groups 
were however both younger and lighter with a corresponding lower BMls than 
the two TNC genotypes of the TEN-M sub-groups (data not shown). However, 
this differences. However, these differences do not affect the results as the 
comparisons were made between either the two CON-M groups or the two TEN­
M, which were matched for age, weight and BMI. 
The percentages of abnormal sonographic morphological characteristics for the 
tendon shape, diameter, blood flow, echogenecity and pathology score were all 
higher in the two TEN groups compared with the two CON-M groups. There 
were no significant differences in the percentages of sonographic morphological 
characteristics between the two CON-M groups or between the two TEN-M 
groups (Table 6.12 and 6.13). However, percentages of individuals with 
increased blood flow and/or sagittal diameter in the TEN-M-U group were 
significantly higher than in the TEN-M-O group in the non-dominant Achilles 
tendons (Table 6.13). 
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Table 6.10. Characteristics of the control (CON-M) subjects with UU, UE, EE, 
00 or OE genotypes. 
CON-M-U (n=15) CON-M-O (n=5) Pvalue 
Age (yrs) 39.7 ± 13.3 (15) 39.6 ± 11.1 (5) 0.984 
Height (em) 179 ± 6 (15) 181 ± 12 (5) 0.554 
Weight (kg) 75.7 ± 8.0 (15) 84.8 ± 14.8 (5) 0.092 
BMI (kgjm2) 23.8 ± 2.4 (15) 25.7 ± 1.7 (5) 0.112 
Values are expressed as mean ± standard deviation. Number of subjects (n) is in 
parentheses. 
Table 6.11. Characteristics of the Achilles tendinopathy (TEN-M) subjects with 
UU, UE, EE, 00 or OE genotypes. 
TEN-M-U (n=20) TEN-M-O (n=11) Pvalue 
Age (yrs) 50.8 ± 8.8 (20) 53.5 ± 12.1 (10) 0.481 
Height (em) 180 ± 7 (20) 179 ± 4 (11) 0.675 
Weight (kg) 84.5 ± 13.0 (20) 85.6 ± 12.4 (11) 0.809 
BMI (kgjm2) 26.3 ± 3.4 (18) 26.1 ± 4.0 (11) 0.676 
Values are expressed as mean ± standard deviation. Number of subjects (n) is in 
, parentheses. 
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Table 6.12. Ultrasonography measurements of the control (CON-M) subjects 
with UU, UE, EE, 00 or OE genotypes. 
CON-M-U (n=15) CON-M-O (n=5) Pvalue 
D-Tendon Shape 
ND-Tendon Shape 
D-AP Sagittal Diameter 
ND-AP Sagittal Diameter 
D-Blood Flow 
ND-Blood Flow 
D-Echogenidty 
ND-Echogenidty . 
Pathology Scorea 
Pathology Scoreb 
0.0 (0/15) 

0.0 (0/15) 

0.0 (0/15) 

0.0 (0/15) 

13.3 (2/15) 

6.67 (1/15) 

0.0 (0/15) 

0.0 (0/15) 

0.2 ± 0.4 (0-1) 

0--0--0 

0.0 (0/5) 

0.0 (0/5) 

20.0 (1/5) 

20.0 (1/5) 

0.0 (0/5) 

0.0 (0/5) 

0.0 (0/5) 

20.0 (1/5) 

0.6 ± 0.9 (0-2) 

0-0--0.5 

1.00· 
1.00 
0.250 
0.250 
1.00 
1.00 
1.00 
0.250 
0.299 
0.371 
.... ,,) 
ND-Sag Diameter (mm) 5.1 ± 0.4 5.0± 0.9 0.713 
D-Sag Diameter (mm) 5.2± 0.6 5.4 ± 0.8 0.497 
Values are expressed as percentages with number of subjects (n) in parentheses. 

0, Dominanti ND, Non-dominant 

aValues are expressed as means ±SD (range). 

bValues are expressed as first quartile--median--third quartile. 
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Table 6.13. Ultrasonography measurements of the Achilles tendinopathy (TEN­
M) subjects with UU, UE, EE, 00 or OE genotypes. 
TEN-M-U 
{n=1S} 
TEN-M-O 
{n=11} Pvalue 
D-Tendon Shape 75.0 (15/20) 72.7 (8/11) 1.00 
ND-Tendon Shape 70.0 (14/20) 54.6 (6/11) 0.452 
D-AP Sagittal Diameter 65.0 (13/20) 63.6 (7/11) 1.00 
ND-AP Sagittal Diameter 80.0 (16/20) 36.4 (4/11) 0.023 
D-Blood Flow 35.0 (7/20) 36.4 (4/11) 1.00 
ND-Blood Flow 55.0 (11/20) 9.1 (1/11) 0.020 
D-Echogenicity 65.0 (13/20) 72.7 (8/11) 1.00 
ND-Echogenicity 70.0 (14/20) 54.6 (6/11) 0.452 
Pathology Score a 5.6 ± 3.0 (1-9) 4.2 ± 2.7 (0-8) 0.220 
Pathology Scoreb 3.0-5.5-8.5 2.0-5.0-6.0 0.465 
ND-Sag Diameter (mm) 
D-Sag Diameter (mm) 
7.6 ±2.1 
7.6±2.2 
7.2 ±3.3 
7.4 ± 1.8 
0.671 
0.869 
Values are expressed as percentages with number of subjects (n) in parentheses. 

D, Dominant; ND, Non-dominant 

aValues are expressed as means ± SD (range). 

bValues are expressed as first quartile--median--third quartile. 
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6.4 DISCUSSION 
The aim of this chapter of the thesis was to investigate whether the morphology of 
the Achilles tendon displayed greater abnormality in individuals of the A1/A3 
variant of the COL5Al gene or 12 and 14 GT repeats (00 and OE) within the TNC 
gene, when compared to individuals with the A2 variant of the COLSAI gene or the 
13 and 17 GT repeats (UU, UE and EE) within the TNC gene, respectively, 
irrespective of the underlying pathology. The rationale was that because subjects 
with the A2 allele of the COL5A1 gene or the 13 and 17 GT repeats within the TNC 
gene would be at lower risk for developing Achilles tendon injury, and should 
therefore display less morphological changes associated with tendon abnormality. 
There were two main findings of this chapter of the thesis. Firstly, as expected, the 
TEN-M group clearly had significantly more abnormal features within their Achilles 
tendon substance than the CON-M group. The abnormal features included a 
fusiform shape, a larger sagittal or transverse tendon diameter, increased blood flow 
in the tendon but rarely in the paratenon and a non-homogenous and/or 
hypoechogenic areas. However, individuals in the TEN-M group were older and 
had a higher EMI compared to the individuals in the CON-M group. The age 
difference was due the fact that subjects were matched for age-at-onset of Achilles 
tendinopathy for the studies described in Chapters 3 and 4. Therefore the age-at­
sonography measurements did not always coincide with age-at-onset of injury as 
the US study was largely retrospective. However, the differences in the age, weight 
and BMI were eliminated during the genotype analysis by comparing either the two 
sub-groups of the CON-M (e.g. CON-M-A2 versus CON-M-A1/ A3) or the TEN-M 
(eg. TEN-M-A2 versus TEN-M-A1/ A3) groups as genetic differences sought were 
theoretically independent of the injury to the Achilles tendon. 
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The use of non-invasive techniques such as ultrasonography adds another 
dimension to the understanding of the tendon pathology. It provides an 
opportunity to measure live tissue and its response to mechanical loading such as 
blood flow rather than biopsy tendon samples obtained from cadavers that are 
usually used in histopathological studies of Achilles tendinopathy. However, such 
non-invasive techniques need to be reliable and valid so as to reflect the extent of 
pathology in the tendon that is true. Currently, the validity of sonography as 
measure of pathology in the tendon is complicated by a lack of a universally 
acceptable quantitative pathology score. 
The second finding was that polymorphisms within both COL5Al and TNC genes 
were not associated with the Achilles tendon morphological characteristics found in 
individuals with tendinopathy. However, for the TNC gene, the percentages of 
individuals with increased and therefore abnormal blood flow and sagittal diameter 
of the TEN-M-U group were significantly higher in the TEN-M-O group in the non­
dominant Achilles tendons. The reason for these differences is not clear. For the 
COL5A1 gene, it is interesting to note that although the sample size is small and that 
these are preliminary results, abnormal changes in the control group only occurred 
in the CON-M-A1/ A3 group, with none occurring in the CON-M-A2 group. There 
are currently no other studies with which to compare these findings, as there have 
been no studies on the association of gene polymorphisms and Achilles 
tendinopathy. 
In a study describing the standard reference values for musculoskeletal 
ultrasonography of 102 healthy but non-sporting individuals (mean age 38 yrs; 
range=20-60; 54 women), there were no statistical differences in US morphology 
between the dominant and non-dominant sides (Schmidt et aL, 2004). There were 
University of Cape Town 225 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
CHAPTER SIX - THE COL5Al AND TENASCIN C GENOTYPE EFFECTS ON THE 
MORPHOLOGY OF THE ACHILLES TENDON: A Preliminary Analysis Using 
Ultrasonography 
also no US morphological differences between subjects of age <40 years and age >40 
years and between subjects engaging in low and high physical activity at work 
(Schmidt et al., 2004). Although the study sample size in our study was relatively 
smaller, the CON-M group (n=22, mean age=40.5 yrs, range=24-69; mean 
weight=78kg, range=64-110) had a similar mean age, weight distribution compared 
to the Schimdt et al., 2004 male group (n=48), with mean age of 39 yrs (range, 20-60), 
mean weight of 80kg (range=62-103). 
In our study, the Achilles tendon mean sagittal diameter was 5.1mm, 95%CI 3.9-6.3 
(range=4.2-6.7mm), which was similar to the 5.3mm and 5.2mm reported for 
Spanish men (Civiera et al., 1988) and Chinese subjects (Ying et al., 2003), 
respectively. However, the CON-M mean sagittal diameter was larger compared· to 
that of 4.6mm obtained by Schmidt et al. (2004), but it was smaller than the 6.2mm 
(range=4-9) reported by Mathieson et al., (1988). 
In the Schimdt et al (2004) study, all diameter measurements were carried out at the 
same defined location (2cm proximal to the calcaneus). In a sample of healthy 
individuals, it is reasonable to assume that the tendon diameter should not vary 
greatly along its length. However, in symptomatic tendons, the location of 
hypoechogenic regions or focal degenerations for instance could occur anywhere 
along the length of the Achilles tendon. These might be the reason for discrepancies. 
in the reported results in the mean sagittal diameter. For example, we chose to take 
dimension measurements at a position of greatest diameter, which might not 
necessarily relate to the position of increased blood flow. To report increased blood 
flow, the greatest area of abnormality along the tendon independent of the tendon 
thickness was chosen. Therefore for every parameter, measurements were recorded 
at location of greatest abnormality for that parameter. 
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An additional finding in our study was that a larger percentage of the injured 
Achilles tendons displayed features of abnormality compared to the uninjured 
Achilles tendon within TEN-M group. Furthermore, the frequency of abnormal US 
morphological features found in the uninjured legs of the tendinopathy subjects 
(50% altered tendon shape, 41.7% increased sagittal diameter, 27.8% increased blood 
flow and 44.4 % hypoechoic) were higher than would be expected in normal tendons. 
The corresponding mean values in the normal tendons were 0% altered tendon 
shape, 4.6% increased sagittal diameter, 9.1% increased blood flow and 4.6% 
hypoechoic tendon substance (Tables 6.4 and 6.5). These results suggest that a 
unilateral Achilles tendinopathy is a good predictor of sub-clinical pathology in the 
other leg of the same individual. 
There were some limitations to this study. Firstly, there were few individuals with 
the A2 allele in the Achilles tendinopathy group as a whole (Chapter 3), and this 
therefore meant it was difficult to obtain large enough sample size (about 10-15 
subjects as desired) in both CON-M-A2 and TEN-M-A2 groups. The same argument 
applies equally to the 0 allele, which was overrepresented in the Achilles 
tendinopathy (TEN) group (chapter 4). Secondly, although we used information on 
the dominant leg, this was based on the known dominant hand obtained via the 
questionnaire. However, the correlation between dominant leg and hand is high 
and therefore this method would not have significantly altered the results. Thirdly, 
we only obtained access to the ultrasound equipment and the radiologist 3 years 
into the study. However, only 12 (33.3%) ·of the 36 injured subjects included in this 
component of the study were examined via sonography an average of 1.5 years after 
the initial date of testing (ie blood samples, questionnaire and others). Fourthly, 
subjects enrolled into the study an average of 7.7 years after first date of injury. 
Although the tendons of the TEN-M group clearly exhibited more abnormal features 
than those of the CON-M group, we may not have determined the true 
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representation of their abnormality. Fifthly, there is no universally acceptable 
Achilles tendon pathology score determined from US measurements that could be 
used to compare results of different studies. 
Finally, in case-control genetic association studies, the asymptomatic subjects must 
be matched to cases on an age-at-diagnosis or age-at-onset, which may not 
necessarily coincide. In addition, age-at-onset (a self reported measure) can be 
difficult to accurately establish especially with chronic Achilles tendinopathy, for 
example, compared to an acute complete Achilles tendon rupture. For this present 
chapter, the age at which measurements were made was considered more 
important, but as shown the Achilles tendinopathy (TEN-M) group was significantly 
older than the control group (CON-M). 
In conclusion, this pilot investigation did not show that polymorphisms within the 
COLSAl and TNC genes were associated with the morphology of the Achilles 
tendon. However, the investigation showed that there was significant pathology in 
the TEN-M group compared with the CON-M group. Therefore, the results of this 
chapter of the' thesis support the findings of other studies that have shown 
sonography as a valid technique that could be used to confirm the clinical diagnosis 
of Achilles tendinopathy. Another interesting observation of this investigation was 
the increased number of abnormal US morphological features in the uninjured 
tendons of subjects who had sustained a unilateral injury (TEN-M) when compared 
to the asymptomatic subjects (CON-M). In this study, the ultrasonographic features 
such as the tendon shape, diameter, blood flow and echogenecity were identified as 
important in diagnosing Achilles tendinopathy, while features such as the 
musculotendinous junction, calcaneus, bursars, Kager's fat pad may be less 
important. However, a reliable quantitative ultrasound Achilles tendinopathy score, 
which provides information on extent of abnormality, is currently unavailable. 
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Finally, it is recommended that a larger prospective study need to be conducted to 
investigate the changes in tendon morphology and the association with genetic 
factors in Achilles tendinopathy. Also, because US is widely used in the diagnosis of 
Achilles tendinopathy, it is important that a reliable and valid ultrasonography 
pathology score be developed that can be used universally in other research studies. 
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The aetiology of Achilles tendon injuries is believed to be multifactorial. A number 
of extrinsic and intrinsic risk factors for Achilles tendon injuries have been 
proposed. It has also been suggested for several years that genetic factors, at least in 
part, playa role in the development of tendon injuries (Kannus and Jozsa, 1997). 
More recently, investigators have suggested that there is a possible genetic 
component to rotator cuff tendon and anterior cruciate ligament injuries (Flynn et 
al, 2005; Harvie et al., 2004). To date, none of the studies have proposed or shown 
that specific genes are associated with these injuries. However, since previous 
studies have suggested that the ABO blood group is associated with Achilles tendon 
injuries, it has been proposed that specific genes in the proximity of the ABO gene 
on chromosome 9q34 might be associated with tendon injury (Kannus and Natri, 
1997; Kujala et aL, 1992; Maffulli et aL, 2002). 
The purpose of this thesis therefore was to explore the possible intrinsic risk factors 
for Achilles tendon injuries. More specifically the aim was to identify specific genes 
on chromosome 9 in close proximity to the ABO gene that might be associated with 
Achilles tendon injuries and to investigate whether these genes were associated with 
Achilles tendon injuries in physically active South African Caucasian subjects. The 
specific objectives and results were: 
1. 	 To identify any candidate gene(s) that are located on the tip of the long arm of 
chromosome 9 (more specifically the 9q32-q34 locus) closely linked to the ABO 
gene which could theoretically be associated with Achilles tendon overuse 
injuries. In addition, the association of ABO blood group system with Achilles 
tendon rupture or chronic tendinopathy in a South African Caucasian population 
was investigated. 
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Twenty-one candidate genes were identified from a possible 404 genes and 
pseudogenes, which have been mapped to the 9q32~q34.3 locus. Two of the 21 
candidate genes, namely COL5Al and TNC encode for structural components of 
tendons. Another two genes, the COL27Al and LAMC3, encode for components of 
the extracellular matrix, namely the alpha chain of type XXVII collagen and gamma 
chain of laminin 12, respectively (Pace et al., 2003; Koch et al., 1999). Neither type 
XXVII Collagen nor laminin 12 have been shown to be structural components of 
tendons. It must however be pointed out that due to the limited amount of work 
done on the recently identified type XXVII collagen, it is theoretically possible that 
the protein plays a role in tendons. Although none of the other 17 proposed 
candidate genes are known to encode structural components of Achilles tendons, it 
was theoretically possible based on the proposed functions of the proteins that they 
could be involved in the aetiology of Achilles tendon pathology. Further studies 
need to be done to determine whether any of these other genes are associated with 
tendon injuries. In addition, it is possible that there are other genes located on the 
tip of the long arm of chromosome 9, which have not been accurately mapped or 
whose function is currently poorly understood, that might be associated with these 
injuries. However, both the identified COLSAl and TNC gene expression had 
previously been shown to be altered during tendon pathology. Thus, the 
associations of polymorphisms within these two genes with Achilles tendon injuries 
were chosen to be investigated in this thesis. 
In addition, the distribution of ABO blood groups was compared between the 
asymptomatic and symptomatic subjects. It was found that the ABO blood group 0 
distribution and the A/O ratio were similar between the control and symptomatic 
subjects. Blood group 0 and the A/O ratio have previously been shown to be over­
represented in some, but not all populations, with Achilles tendon injuries (Aroen et 
aI., 2004; Jozsa et al., 1989; Kujala et al., 1992; Leppilahti et al., 1996; Maffulli et aL 
2000; Mahrlein et al., 1995). 
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2. 	 To determine whether the BstUI RFLP within the 3' -UTR of the COL5Al gene, 
which encodes a tendon protein, is associated with the symptoms of Achilles 
tendon injury (ATI). 
It was found that the frequency of the A2 allele (or C allele) of the COLSAl gene was 
significantly under-represented in the ATI group when compared to the CON 
group. The frequency of the Al and A3 alleles (or T allele) of the COLSAl gene on 
the other hand, was over-represented when the A TI group was compared to the 
CON group. Therefore, individuals containing the A2 allele of the COL5Al gene are 
less likely of developing Achilles tendon injury (P=O.004, odds ratio of 1.9; 95%CI 
1.3-3.0). This association was even stronger when the CON group was compared to 
a sub-group of ATI subjects diagnosed with chronic Achilles tendinopathy (TEN) 
(P=0.0005, odds ratio of 2.6; 95%Cll.5-4.5). Although it should be interpreted with 
caution because of the small sample size, the BstUI RFLP within the COLSAl gene 
was not associated with a sub-group of subjects diagnosed with Achilles tendon 
ruptures (RUP). 
The COL5Al gene codes for the pro-a.l(V) chain, which is found in most of the 
isoforms of type V collagen (Caridi et aL 1992). The major isoform of type V 
collagen is a heterotrimer consisting of two pro-a.l(V) chains and one pro-a.2(V) 
chain (Caridi et al., 1992). Trace amounts of type V collagen are found in tendons 
where it forms heterotypic fibres with the major structural type I collagen (reviewed 
in Birk, 2001). Type V collagen is believed to play an important role in regulating 
fibrillogenesis and modulating fibril growth in tendons (Birk et al., 1990). An age­
dependent increase in the content of the protein, together with a decrease in fibril 
diameter and the biomechanical properties in the rabbit patellar tendon has been 
reported (Dressler et al., 2002; Goncalves-Neto et aL 2002). In addition, some 
investigators have shown an increase in types III and V collagen, together with a 
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reduction in the content of type I collagen in biopsy samples of degenerative 

tendons from patients with posterior tibial tendon dysfunction syndrome 

(Goncalves-Neto et aLI 2002). Recently, it was demonstrated that type V collagen 

, deficient mice could not form collagen fibrils, emphasizing the role of type V 

collagen in fibrillogenesis (Wenstrup et al., 2004). 
3. 	 To investigate whether the GT dinucleotide repeat polymorphism within intron 
17 of the TNC gene, which also encodes a tendon protein, is also associated with 
Achilles tendon injury. 
Altogether, this thesis established 18 different alleles of the GT dinucleotide repeat 
polymorphism within the TNC gene, ranging from 3 to 21 GT repeats. The 
frequencies of the alleles containing the 12 and 14 repeats were significantly over­
represented in the ATI group, while the frequencies of the alleles containing the 13 
and 17 repeats were significantly under-represented in the ATI group. The rest of 
the GT repeats were evenly distributed when the CON and ATI groups were 
compared. Further analysis showed that individuals containing alleles with the 13 
and 17 repeats and did not contain the 12 and 14 repeats have a lower risk of 
developing Achilles tendon injuries (P<O.OOl, odds ratio of 6.2, 95%CI 3.5-11.0). 
When the ATI group was divided into the TEN and RUP sub-groups, their allele 
distribution were similar to each other and to those of the ATI group. Therefore, 
unlike the polymorphism within the COLSAl gene which appeared to be specifically 
associated with Achilles tendinopathies, the GT dinucleotide repeat polymorphism 
within the TNC gene was associated with both Achilles tendinopathy and ruptures. 
The tenascin-C (TNC), or hexabrachion (HXB) gene as it was originally called, encodes 
for the extracellular matrix glycoprotein; tenascin-C, and is located 18 Mb upstream 
from the ABO gene on locus 9q33 (Rocchi et al, 1991). Tenascin-C is expressed in a 
variety of tissues, including tendons, where it binds to other components of the 
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extracellular matrix and cell receptors and plays an important role in regulating cell­
matrix interactions (Mackie, 1997; Jones and Jones, 2000a). In normal adult tendons, 
the TNC gene is expressed predominantly in regions responsible for transmitting 
high levels of mechanical force such as· the myotendinous and osteotendinous 
junctions (Chiquet and Fambrough, 1984a, Chiquet and Fambrough, 1984b; Jarvinen 
et aL, 1999). The protein is also expressed around the cells and the collagen fibres of 
the Achilles tendon. In addition, it has been shown that expression of the TNC gene 
is regulated in a dose-dependent manner by mechanical loading in tendons 
Garvin en et aL, 1999; Jarvinen et aL, 2003). 
Isoforms of the protein, with distinct functions, are produced by alternative splicing 
of the primary transcript. It has been shown that healthy tendons express a small 
200 KDa tenascin-C isoform, while degenerate tendons also express a functionally 
distinct larger 300 KDa isoform (Riley et al., 1996). One study, but not a second, has 
so far reported an increase in tenascin-C expression in biopsy samples of chronic 
Achilles tendinopathy human subjects using cDNA arrays (Ireland et aL, 2001). 
Although there has been research on the expression of various genes coding for 
proteins found within the tendon in normal versus tendinopathic tendons, this is to 
our knowledge, the first study to identify specific genes shown to be associated with 
Achilles tendon injuries. However, because this thesis was a case-control 
association design, causality cannot be established. It is possible that other genes on 
chromosome 9 closely linked to both the COL5Al and TNC genes might be directly 
involved in aetiology and pathogenesis of tendon injuries. As previously 
mentioned, although the COL27Al gene was not analysed in this thesis because 
there is to date no evidence that the gene is expressed in tendons, its expression in 
tendons has not been excluded. It is theoretically possible that due to the presence 
of type XXVII collagen in cartilage, eye, ear, lung and colon, that the protein is 
expressed in tendon. 
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In addition, the results of this thesis need to be replicated in an independent 
Caucasian population. Whether these polymorphisms are also associated with 
Achilles tendinopathy in other ethnic groups also needs to be investigated. Other 
alternative methods to confirm these associations would involve studies of siblings 
and family members of the affected subjects (linkage studies). 
If the TNC and/or COLSAl genes are directly involved in the aetiology of Achilles 
tendinopathy, the functional polymorphisms within these genes need to be 
identified. Recently, Matsuda et al. (2005) have identified a single nucleotide 
polymorphism (SNP) located in exon 17 of TNC gene, which interestingly is adjacent 
to the GT repeat dinucleotide polymorphism within intron 17 of this gene, which 
creates an amino acid substitution (Leu1677Ile) believed to change structural 
stability of the fibronectin III domain contained in the tenascin C protein. The 
association of this SNP with Achilles tendon injury needs to be investigated. 
It is known that other proteins, besides type V collagen and tenascin C are involved 
in the structure and/ or function of tendons and therefore the possible association of 
polymorphisms (eg. single nucleotide polymorphisms (SNPs), restriction fragment 
length polymorphisms (RFLPs), microsatellites) in the multiple genes located on 
other chromosomes, which encode for these proteins (see Table 7.1), with Achilles 
tendinopathy also need to be investigated. It is unlikely that a single gene is 
associated with this complex condition and that Achilles tendinopathies are rather 
polygenic in nature. 
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Table 7.1. The genes encoding for tendon extracellular matrix (ECM) proteins. 
CoiIagen Structure/fype Gene(s) and Location (s) 
I 
II 
III 
IV 
V 
VI 
IX 
X 
XI 
XII 
XIV 
Fibril-forming 
Fibril-forming 
Fibril-forming 
Forms meshwork 
Fibril-forming 
Forms beaded filaments 
FACI'fb 
Forms meshwork 
Fibril-forming 
FACITb 
FACI'fb 
COL1Al (17q21.3-q22.1); COLlA2 (7q22.1) 
COL2Al (12q13.11 M q13.2)a 
COL3Al (2q31) 
COL4Al & COL4A2 (13q34); COL4A3 & 
COL4A4 (2q36-q37); COL4A5 & COL4A6 
(Xq22.3) 
COLSAl (9q34.2-q34.3); COLSA2 (2q31); 
COLSA3 (19q13.2) 
COL6Al & COL6A2 (21q22.3); COL6A3 
(20q13.3) 
COL9Al (6q13); COL9A2 (lp33-32.2); 
COL9A3 (20q13.3) 
COLlDAl (6q21-q22.3) 
COL11Al (lp21); COLllA2 (6p21.3); 
COL2Al (12q13.11-q13.2)a 
COL12Al (6q12-q13) 
COLl4Al (8q23) 
nCOL2Al = COLllA3 
bFACIT, Fibril-associated collagens with interrupted triple helix 
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Table 7.1 (Continued) The genes encoding for tendon extracellular matrix (ECM) 
proteins. 
Protein StructurtifType Gene (s) and Locations 
Decorin SLRPC DCN (12q21.33) 
Biglycan SLRPC BGN (Xq28) 
c:: 
!U 
!;"I 
;:.." Fibromodullin SRLPC FMOD (7q22.1)
"6h Q 
'Q.I
.... Q Lumican SLRPc LUM (12q21.3-q22) 
~ 
Aggrecan Hyalectan AGCl (15q26.1) 
Versican Hyalectan CSPG2 (5q14.3) 
Elastin Branched network ELN (7qll.23) 
Fibrillin Linear arrays FBNl (15q21.1); FBN2 (5q23.-q31) 
Tenascin-C Branched molecule TNC (9q33) 
COMpd Branched molecule ,COMP (19p13.1) 
c::
.... 
Q.I
.... Q Fibronectin Mod ular protein . FNl (2q34)
Iof 
c.. Q 
~
-
Laminine Modular protein 
"" Thrombospondin Modular protein THBSl (15q15); THBS2 (6q27); THBS3 (lq21); THBS4 (5q13) 
Link protein Globular protein CTRl (5q13-q14) 
Tenotnodulin Transmembrane TNMD (Xq21.33-q23) 
protein 
cSLRP, small leucine-rich repeat proteoglycan; dCOMP, cartilage oligomeric matrix 

protein; eMultiple genes, coding for multiple proteins. 

(Adapted from Riley, 2005b). 
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For instance, both type XII and XIV collagens respond to mechanical loading and are 
involved in fibrillogenesis, processes that both COLSAl and TNC are involved in as 
well (Fluck et al., 2000)~ In a rat model of rotator cuff tendinopathy, it has been 
shown that type XII collagen is up-regulated during tendon healing (Thomopoulos 
et al., 2002). Therefore it would be interesting investigate the association of genes 
coding for some of the other collagen and non-collagenous proteins found in 
tendons. 
Further studies also need to investigate the possible role of the interaction of the 
COLSA1, TNC and any other genes (gene-gene interactions) that might be identified 
in the further studies in tendon pathology. As already mentioned in thesis, it is 
generally well-established that the aetiology of Achilles tendon injuries is multiw 
factorial. Therefore, future studies also need to investigate the extent of the 
interaction, if any, of the different intrinsic and extrinsic risk factors with genetic risk 
factors, the gene-environment interactions, in tendon pathology. The interaction of 
other intrinsic factors such as age and body weight, as well as extrinsic factors such 
as the type and amount of physical activity and training, with either the COL5Al 
and!or TNC genes could not be excluded in this thesis. In support of this, an 
interaction of increased body weight and the COL9A3 gene has been reported in 
lumbar disc degeneration (Solovieva et al., 2002). Therefore, the possible interaction 
of non-genetic factors, such as body weight and physical activity with the COL5Al, 
. ,J 
TNC and!or any other genes needs to be investigated. 
As previously mentioned, investigators have shown that there is a genetic 
component to rotator cuff tendon and anterior cruciate ligament injuries. Further 
research also needs to be conducted to establish whether the TNC and COL5Al 
genes are also associated with other tendon as well as ligament injuries. 
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4. 	 To investigate whether there was any COLSAl or TNC genotype effect on the 
muscle-tendon unit range of motion (ROM). 
The thesis established that both COL5Al and TNC genotypes did not influence the 
individual's muscle-tendon unit ROM in the joints examined. Comparison of 
individuals who had sustained a chronic Achilles tendinopathy and control subjects, 
irrespective of their genotype also showed similar measurements of ROM. This is in 
contrast to a recent finding that showed that an increased ankle dorsiflexion was a 
risk factor for the development of Achilles tendinopathy. However, our study had 
limitations as the measurements of ROM were conducted in individuals who had 
already been injured (either chronic Achilles tendinopathy or rupture), therefore we 
did not have .baseline ROM data on all our A TI subjects. We also studied injuries 
from various sports. It may be ideal to study a cohort of individual beginners of a 
single sport such as running, which is known to be highly associated with Achilles 
tendinopathy and obtain baseline and periodic measurements on the cohort. 
Since mutations in COL5Al and TNX genes have been associated with both 
hypermobility type-Ehlers Danlos Syndrome (HT-EDS) and benign joint 
hypermobilty syndrome (BJHS) and tenascin C belongs to the same family as 
tenascin X, therefore it will be interesting to investigate further the function of 
tenascin X in tendons. 
5. 	 To investigate whether there was any COLSAl or TNC genotype effect on the 
morphological changes associated with Achilles tendon injury by using grey 
scale and colour Doppler ultrasonography. 
There was no genotype effect of both the COL5Al and TNC genes on the 
morphological changes of the Achilles tendon as determined via grey scale and 
colour Doppler ultrasonography. In this thesis, 34 of the 36 sub-group of 
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individuals who had been clinically diagnosed with Achilles tendinopathy were 
confirmed via ultrasonographic examination to have Achilles tendinopathy as they 
satisfied the majority of the four conditions associated with tendinopathy. The 
current thesis suggests that four main characteristics, which were found to be 
informative, include increased tendon diameter, increased tendon flow, decreased 
echogenecity and an alteration in tendon shape. These four characteristics support 
previous histopathological findings which indicates that in chronic tendinopathy a 
tendon becomes thicker hence the increased diameter and change in shape. The 
tendon also has increased ground substance, which is hydrophilic and therefore 
attracts water into the extracellular matrix. This increased water content causes 
tendon swelling and the decrease in tendon echogenecity with ultrasonography. It 
is proposed that a number of intratendinous changes need to be present, not just 
one, to predict future development of symptoms of tendon injury. 
Although the sample size was too small, and the results are therefore only 
preliminary, it was observed that none of the 7 control (CON-M) subjects with the 
A2 allele of the COL5Al gene had tendon abnormalities. Six of the 15 (40%) subjects 
with the A1Al allele genotype had at least one tendon abnormality as determined 
by a pathology score of lor more (range of scores= 1-4). 
Because of (i) the sample size for the ultrasonography component of the thesis and 
(li) there was an interesting result concerning control subjects containing the A2 
allele of the COL5Al gene, further research is warranted to increase the sample size 
and perhaps replicate the results in a prospective cohort study. The majority of 
studies in the literature investigating possible risk factors for tendon injuries have 
been retrospective and therefore, future research need to design and conduct 
prospective cohort studies to identify risk factors for Achilles tendon injuries. In one 
prospective cohort study, asymptomatic soccer players with preseason US 
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abnormality had increased risk for developing tendinopathy during the season 
(Fredberg and Bolvig, 2002). 
In conclusion, polymorphisms within the COL5Al and TNC genes, which are both 
located on the long arm of chromosome 9 in close proximity with the ABO gene 
have been shown in this thesis to be associated with Achilles tendon injury in a 
physically active South African Caucasian population. This thesis has shown that 
although many extrinsic and intrinsic factors have been implicated in Achilles 
tendon injury, the level of evidence for the majority (21 of 29 (72%)) of these factors 
have a level of evidence of weak. So far the level of evidence for genetic factors as 
independent risk factors for Achilles tendon injuries has been weak (Chapter 1, 
Table 1.8). However, this thesis has strengthened the level of evidence for genetic 
factors from weak to limited (Table 7.2). There was no COLSAI or TNC genotype 
effects on the muscle tendon unit range of motion or flexibility, at least in the 
measured joints, as well as in the Achilles tendon morphology as measured via 
ultrasonography. 
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Table 7.2 Intrinsic risk factors associated with acute and overuse Achilles tendon 
injuries 
i 

, Intrinsic risk factor Level of evidence Key references 
I 

1. Age 
2. Gender 
3. Body mass and size 
4. Previous injury 
5. Tendon blood supply 
6. Tendon temperature 
7. Biomechanical factors: 
• Flexibility 
• Leg length inequality 
• Leg dominance 
• Foot morphology 
• Muscle strength 
• Associated Plantaris 
8. Genetic factors 
• ABO blood group 

.HLA 

• Ethnic group 
• COL5A1 gene 
• TNCgene 
9. Systemic diseases 
• Hyperlipidemia 
Weak 
Limited 
Weak 
Strong 
Weak 
Weak 
Limited 
Weak 
Weak 
Weak 
Limited 
Weak 
Weak 
Weak 
Weak 
Limited 
Limited 
Weak 
Limited 
Leppilahti et aL, 1996 

Jozsa et al., 1989 

Kannus and Natri, 1997 

Fredberg and Bolvi~ 2002 

Knobloch et aLI 2006 

Wilson and Goodship, 1994 

Mahieu et al., 2006 

Leppilahti et al., 1998 

Levi,1997 

Kvist, 1994; Leppilahti et al" 1998 

Mahieu et al., 2005; Kvist,1994 

Daseler and Anson, 1943 

Jozsa et al., 1989 

Olivieri et al., 1987 

Davis et al., 1999 

Mokone et al., 2006 

Mokone.et al., 2005 

J ozsa et al., 1989 

Ozgurtas et at, 2003 
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Appendix 1.1 Levels of evidence for primary research question 
Prognostic studies 
Strong evidence Level I 	 e High quality prospective study (all patients 
were enrolled at the same point in their disease 
with 2: 80% follow-up of enrolled patients 
eSystematic review of level-I Studies 
Limited evidence Level II 
Level III 
e Retrospective study 
e Untreated controls from a randomized 
controlled trial 
eLesser quality prospective study (e.g., patients 
enrolled at different time points in their disease 
or ~ 80% follow-up 
eSystematic review of level-II Studies 
eCase-control study 
Weak evidence Level IV eCase Series 
Level V eExpert opinion 
Notes: 

Adapted from the level-of-evidence rating system used by JBJS-A (Reprinted from: Instructions 

to Authors, The Journal of Bone and Joint Surgery (American), December 2005.) 

Detailed explanations ofthe studies are provided by IBIS-A. 
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APPENDIX21 

RECRUITMENT LkTTER 

Clinician's Name 
Clinician's Address 
Date 
Dear 
RE: STUDY ON THE GENETIC BASIS OF CHRONIC iENDON PATHOLOGY 
The UCT/MRC Research Unit for Exercise Science and ~Sports Medicine within the Department of 
Human Biology and the Division of Human Genetics within the Department of Clinical Laboratory 
Sciences at the University of Cape Town recently apprdached me about a research study on the 
genetic basis of chronic tendon pathology they are currbntly undertaking. The researchers have 
asked me to inform you about this study and to invite yo~ to participate in their research. 
, 
If you would like to participate in this study, you will be rrqUired to donate five millilitres of venous 
blood or a mouthwash sample containing some of the roose cells which lined the inside of your 
cheeks. After receiving written consent, the blood orlmouthwash sample will be used for the 
extraction and analysis of genetic material (DNA). You will also be required to complete personal 
particulars, sporting participation, medical history, stretching and warm up questionnaires. All the 
I 
information collected during the study will be treated with the strictest confidentiality and will only 
be used for scientific research purposes. Your name an~ personal particulars will not be released 
under any circumstances and all the data obtained will be analysed anonymously. There will also 
be other additional tests that we will ask you to do if you [agree to participate in this study. 
If you would like to participate in the study and/or obtain lany additional information, please contact 
one of the following:­ : 
I 
I 
Mr. George Mokone, BSc (Hons) Dr. rylalcolm Collins, PhD 
(021) 650-4569 (021) 650-4574 
g mokone@sports.uct.ac.za mC11IinS@sports.uct.ac.za 
Yours faithfully , 
! 
Clinician's Name and Qualifications 
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APPENDIX 2.2 
ETHICS APPROVAL LETTER 
-
UNIVERSITY OF CAPE TOWN 
Research Ethics Committee 
Faculty of Medicine 
Anzi'J Road, Observatory, 7925 
Queries: Martha .Jacobs 
Tel: (021) 406-6492 Fax: (021) 406-6390 
E-mail: Martha@medicine.uct.ac.za 
17 April 2000 
REC REF: 321199 
Mr G Mokone 
BERV 
Dear Mr Mokone 
GENETIC BASIS OF ACHILLES TENDON RUPTURES AND CHRONIC 
ACHILLES TENDINOPATHY 
Thank you for your application submitted to the Research Ethics Committee on 
14 December 1999. 
I have pleasure in informing you that the Research Ethics Committee has fonnally 
approved the above study on 24 January 2000. 
You may proceed with the trial once the tinancial agreement/contract and protocol 
have been processed through the department of Research Development and duly 
signed by the authorised University of Cape Town signatories. 
Included is a list of Research Ethics Committee Members who have lormally approved 
your protocol 
Please quote the above Reference number in all correspondence. 
YO"!i::;Y 
PROFESSOR DM DENT 
ACTlNG-CHAlRPERSON 
Queries: 'Martha Jacobs 
Research Ethics Committee 
Room 212 Werner and Beit 
vcr Medical School 
Anzio Road, Observatory, 7925 
Tel : (021) 406-6492 Fax: (021) 406-6390 
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APPENDIX 

INFORMED CONSENT 

I, the have been fully about the Research Unit for Exercise 

Science and Sports Medicine within the Department of Human and the Division of 

Human Genetics within the of Clinical Laboratory Sciences at the University of 
Town's on the genetic basis of exercise induced chronic tendinopathy. I have to 
donate five millilitres of venous blood or a Buccal mouthwash which will be used for the 
extraction and analysis of ge11eriC material (DNA). I have also to complete 
sporting participation, medical history, stretching and warm up questionnaires and 
understand that all the information that is collected during the will be treated with the 
strictest confidentiality and will only be used for scientific research purposes. I also 
that my name and personal will be not released under any circumstances and that all 
data will be analysed anonymously. I have agreed that my blood can also be used to 
(1"tCP,.''Y1lT'P my ABO blood group I have also to allow my flexibility and 
ankle dorsiflexion to be determined. 
for a second visit in an 
fasted state to donate another 5 ml blood sample for a total blood cholesterol test 
If reqlue:sted, I am also prepared to visit SSISA eady in the 
delete this sentence if not applicable). If requested, I am also prepared to visit a doctor 
delete this sentence if(radiologist) at a later stage for a tendon scan at no cost to 
If requested, I am also to visit the SSISA for measurements to determinenot 
musculo-tendinous stiffness. 
I to in the study and I have been informed that I will be free to withdraw from 
the at any time if I so wish. I understand that my DNA will be on 
completion of the study on the of tendon pathology. I understand that I will be 
free to that my DNA sample be before the completion of the 
FULL OF SUBJECT: 
SIGNATURE: 
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APPENDIX 2.4 

GENETIC BASIS OF EXERCISE-INDUCED TENDON INJURY 

QUESTIONNAIRE 

A. PERSONAL PARTICULARS 
Surname 
First Name 
Postal Address 
Code 
E-mail address Phone (day Time) 
Date of birth Y Y YY /MM/DD Cell 
Height (cm) Gender male D female D 
Weight (kg) 
Ethnic group Black/African D White D Indian D (Only Required 
and Used for Mixed Ancestry (Coloured) D Asian D Other D Research 
Purposes) 
Ancestry: Tribal 
Dor national Father Unknown background 
(eg Xhosa, 
Dutch, Zulu, Mother Unknown 
DGerman Italian) 
Nationality Dominant LeftD Ri9htDHandedness 
Country of Birth 
Yes (Current) D I Yes (Ex smoker) D I No, never D 
Smoker If yes, Number of years Ilf stopped, when 
If yes, number per day 
Do you know your Yes 0 AO BO ABO 00 
blood group? No 0 Rh Pos 0 RhNeg 0 
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(If you participate or have participated in more than 6 sports, please complete additional 
Sporting Details Questionnaires, Part B) 
B. SPORTING DETAILS 
Type of sport(s) you have 
participated in 
Sport 1 Sport 2 Sport 3 
Current or past participation CurrenO pastD CurrenD PasO CurrenD PastD 
Year started participation 
Years involved in the sport 
Years in competitive sport 
Professional or amateur 
Hours of training per week 
(last 3 months) 
Hours of training per week 
(3-12 months) 
Hours of training per week 
(12-24 months) 
Type of sport(s) you have 
participated in 
Sport 4 Sport 5 Sport 6 
Current or past participation CurrentD PastD CurrenD PastD CurrenDPastD 
Year started participation 
Years involved in the sport 
Years in competitive sport 
Professional or amateur 
Hours of training per week 
(last 3 months) 
Hours of training per week 
(3-12 months) 
Hours of training per week 
(12-24 months) 
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C. MEDICAL DETAILS {GENERAL TENDON INJURX} 
How many times have Event Date Acute or Sudden or Gradual" Chronic Injury Onsetyou had tendon injuries? 1 
1Sudden onset is within a 2few seconds or minutes 
2Gradual onset is over 3 
days or weeks 4 
5 
Please comQlete a seQarate form. Part C onJ~. for each Tendon Ini!J,O:: ~ou have had 
Event Number (l1213141or S} 
Rotator cuff tendon > Patellar tendon ...J....... 
• Supraspinatus ...J Wrist extensor tendons ...J Which tendon did you injure? 
• Infraspinatus ...J Achilles tendon ...J 
• teres minor ...J D pain only after exercise 
D pain during exercise, but did not cause you to alter training. 
Grade of injury at the time of D pain during exercise, which causes you to alter training 
injury D pain which causes you to stop training 
D none of the above 
D not sure Bpain only after exercise 
pain during exercise, but did not cause you to alter training . 
Grade of injury currently D pain during exercise, which causes you to alter training r= 
pain which causes you to stop training 
-­ none of the above 
-
not sure 
How were you injured? 
(e.g. sport, walking) 
Pain (less than 1 week) D Stiffness D 
Which of the following 
Pain (1-4 weeks) D Swelling Dsymptoms were present before 
the injury 
Pain (> 4 weeks) D None D 
Diagnosis ~ 
I 
Which type of Tendon Disease were you 
diagnosed with e.g. Rupture, Tendinitis, etc. 
Please indicate the name and contact number of the clinician who 
diagnosed you . 
.J Doctor 
Diagnosed by .J Physiotherapist 
.J Biokineticist 
.J Podiatrist 
.J Other 
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To what extent was your Tendon 
ruptured? complete 0 partial 0 none 0 
If applicable, what diagnostic 
imaging was performed? ultrasound 0 MRI 0 Other 
If applicable, who did the 
imaging? Clinician I Phone 
Specifics 
Which side was injured? left 0 right 0 both 0 
Which region of your tendon was 
injured? Please indicate on a 
diagram. (Only if applicable) 
Upper 1/30 Middle 1/3 0 Lower 1/3 0 
Genera/Information 
Have you ever used oral 
corticosteroids (cortisone 
tablets)? yes 0 no 0 
If Yes, How long Ago 
o 3months 0 6 months 012 months 0 24 or more months 
Have you ever been given an 
injection with corticosteroids? 
yes 0 no 0 o 3months 0 6 months 012 months 0 24 or more months 
Have you ever been given an 
injection of corticosteroids in or 
around the injured tendon? 
yes 0 no 0 Once 0 Twice 0 
0 03times >3 times 
Have you ever used anabolic 
steroids? yes 0 no 0 
o 3months 0 6 months 
012 months 0 24 or more months 
Do you suffer from any 
Connective Tissue Disorders? yes 0 0no If Yes, please state the condition 
Have any other members of your 
family suffered from any tendon 
pathology? 
yes 0 no D If Yes, please specify the family member 
and type of injury (eg Mother
l
, Sin) 
Acute Injury 
Chronic Pain and Swell ing D 
Other D 
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Do you suffer from elevated blood cholesterol? Yes D No D 
Do any other members of your family suffer from Yes D No Delevated blood cholesterol? 
If you had a tendon rupture. How was it treated? Surgically D Non-surgically D 
If you have or had chronic tendon pain, what 
seems to alleviate the pain? 
D. STRETCHING AND WARM UP 
I usually stretch each week as follows: 
(Please tick ALL the appropriate boxes) 
f--­
f--­
r-­
r-­
f--­
f--­
Never 
Occasionally 
Before sport 
After sport 
Once daily 
Twice daily 
More than twice daily 
Which of these muscle 
groups do you stretch? 
Lower Back 
Buttock 
Hip Flexors 
Quads 
Hamstrings 
Calf Muscles 
-
-
-
t--­
f--­
Always 
Always 
Always 
Always 
Always 
Always 
-
-
-
-
-
Occasionally 
Occasionally 
Occasionally 
Occasionally 
Occasionally 
Occasionally 
How many times do you stretch per week? 
f--­
f--­
r-­
I-­
f--­
f--­
I-­
Never 
< 5 min 
5 min 
10 min 
15 min 
20 min 
25 min 
> 30 min 
Do you warm up before exercise? Yes D No D 
If yes, for how many minutes and how? 
Do you cool down after exercise? Yes D No D 
If yes, for how many minutes and how? 
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List of Common Connective Tissue Disorders 
1. heumatoid Arthiritis 
2. Ankylosing Spondylitis 
3. Systemic Lupus Erythematosus 
4. Vasulatis 
5. Polyarteritis Nodosa 
6. Temporal Arteritis 
7. Wegener's Granulomatosis 
8. Crohn's Disease 
9. Discoid Lupus Erythromatosus 
10. Relapsing Polychrondritis 
11. Systemic Sclerosis 
12. Eosinophilic Fascitis 
13. Polymyositis & n .. 'Tn",t"""'.....iti... 
14. Polymyalgia Rheumatics 
15. Sjogren's Syndrome 
16. Behcet's Syndrome 
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APPENDIX 2.5 

CLINICAL DIAGNOSIS OF ACHILLES TENDINOPATHY 

SUBJECT NUMBER/CODE: 
Clinical criteria 1; 2 Present 
Gradual progressive pain over the posterior lower leg - Achilles 
tendon area (> 6 weeks) 
Earl y morning pain 
Earl y morning stiffness 
History of swelling over the Achilles tendon area 
Tenderness to palpation over the Achilles tendon 
Palpable nodular thickening over the affected Achilles 
Positive "shift" test (movement of the nodular area with plantar­
/ dorsi-flexion) 
Date: 	 ___ / ___ / 2003 
Investigator: 	 Prof M Schwellnus 
Signature: 
References: 
1. 	 Schepsis AA, Jones H, Haas AL. Achilles tendon disorders in athletes. Am.] 
Sports Med 2002;30:287-305. 
2. 	 Kader D, Saxena A, Movin T, Maffulli N. Achilles tendinopathy: some aspects 
of basic science and clinical management. Br.] Sports Med 2002;36:239-49. 
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APPENDIX 2.6 

CLINICAL DIAGNOSIS OF ACHILLES TENDON RUPTURES 

Clinical criteria 1 Present 
- Achilles area 
Positive 
Palpable .................... , 
Date: 
---I I 
Investigator: Prof Schwellnus 
Signature: 
References: 
tendon athletes.1. AA, Jones H, AL. 
<";rlrl"TC Med 2002;30:287-305. 
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APPENDIX 2.7 

LIST OF ALL THE GENES MAPPED TO CHROMOSOME 9q32 - 9q34.3 
I N I Cytogenetic 
• 0 Location 
Start 
(Mb) Gene Name Short Description 
I 9q32 105 FLJl3385 Hypothetical protein FLJl3385 
2 9q32 105 ZNF462 Zinc finger protein 462 
3 9q32 105 LOC389782 LOC389782 
!4 9q31.2 105 RAD23B RAD23 homolog B (S. cerevisiae) 
5 9q31 106 KLF4 Kruppel-like factor 4 (gut) 
6 9q32 106 LOC392380 Similar to peptidylprolyl isomerase A(cyclophilin A) 
i7 9q32 106 LOC39238I Similar to large subunit ribosomal protein L36a 
8 9q32 106 LOC392382 Similar to ribosomal protein L31 
9 9q32 107 LOC347292 Similar to ribosomal protein L36; 60S ribosomal protein L36 
ilO 9q31 107 ACTL7B Actin-like 7B 
!11 9q31 107 ACTL7A Actin-like 7 A 
12 9q31 107 IIKBKAP inhibitor ofkappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein 
in 9q32 107 FLJ20457 hypothetical protein FLJ20457 
14 9q31.2 107 CTNNALl Catenin (cadherin-associated protein), alpha-like I 
15 9q31 107 C90rf5 chromosome 9 open reading frame 5 
16 9q31 107 IC90rf4 Ichromosome 9 open reading frame 4 
!17 19q31 I IL4B lerythrocyte membrane protein band 4.1 like 4B 
18 19q32 107 FLJ21596 hypothetical protein FLJ21596 
19 9q31 108 PTPN3 Iprotein tyrosine phosphatase, non-receptor type 3 
~ 9q32 108 LOC402375 similar to DNA-binding protein B 9q32 108 LOC389783 ~OC389~83 
22 9q31-q33 108 AKAP2 PRKA) anchor protein 2 
23 9q31-q33 108 in 2 
24 9q32 108 LOC401546 RlKEN cDNA D630039A03 gene 
~ 9q31 108 TXN thioredoxin i9q32 108 LOC255220 similar to RlKEN cDNA 4930429J24 9q31.3-q32 109 MUSK muscle, skeletal, receptor tyrosine kinase 
28 9q32 109 EDG2 endothelial differentiation, lysophosphatidic acid G-protein­
coupled receptor, 2 
i29 9q32 109 OR2K2 olfactory receptor, family 2, subfamily K, member 2 
!30 3 109 OR2ARIP olfactory receptor, family 2, subfamily AR, member 1 Ipseudogene 
31 9q32 110 KIAA0368 KIAA0368 I 
i32 9q32 110 ZNF483 zinc fmger protein 483 
33 9q32 110 LTB4DH leukotriene B4 12-hydroxydehydrogenase 
34 9q32 110 LOC401547 similar to KIAA0563 gene product 
35 9q32 110 GNGIO Iguanine nucleotide binding protein (G protein), gamma 10 
36 9q32 no C90rf84 I. me 9 open reading frame 84 
37 9q31 110 UGCG UDP-glucose ceramide glucosyltransferase 
38 9 -" 1 " 33.1 110 SUSDI sushi domain containing I 
39 9q33.1 110 ROD I RODI regulator ofdifferentiation I (S. pombe) 
40 9q33.1 110 EPF5 EPF5 pseudo gene 
41 9q33.1 111 LOC392384 similar to 60S ribosomal protein L32 
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No Cytogenetic Start Gene Name Short DescriptionLocation (Mb) 
42 9q33.l III MGC10940 hypothetical protein MGC 10940 
43 9q33.l III L...OC389784 LOC389784 
44 9q33.1 111 KIAAl958 KIAAl958 
45 9q32 III C90rf80 chromosome 9 open reading frame 80 
46 9q33.l 111 LOC389785 similar to RIKEN cDNA 4732481H14 
!47 9q33.l 111 LOC401548 imilar to RIKEN cDNA 473248lHI4 
48 9q32 III TSCOT mic stromal co-transporter 
!49 9q33.l 111 LOCI69834 othetical protein LOC 169834 
50 9q32 III ZFP37 !zinc fmger protein 37 homolog (mouse) 
51 9q33.1 III LOC401549 hypothetical gene supported by BX647840 
52 9q33.l III LOC286333 hypothetical protein LOC286333 
53 9q31-q32 III SLC31A2 solute carrier family 31 (copper transporters), member 2 
54 9q33.l III A0674 KIAA0674 protein 
55 9q31-q32 III SLC31AI solute carrier family 31 (copper transporters), member I 
56 9q32 111 CDC26 cell division cycle 26 
57 9q31-q33 III PRPF4 PRP4 pre-mRNA processing factor 4 homolog (yeast) I 
58 9q33.1 111 MGC4734 hypothetical protein MGC4734 
59 9q33.l III WDR31 WD repeat domain 31 
60 9q33.l III BSPRY B-box and SPRY domain containing 
61 9q33.1 ,112 MGC I 2904 hypothetical protein MGCI2904 
62 9q34 1112 ALAD aminolevulinate, delta-, dehydratase 
63 9q33 112 polymerase (DNA directed), epsilon 3 (p17 subunit) 
64 9q33.l 112 iC9orf43 chromosome 9 open reading frame 43 
!65 9q32 112 RGS3 regulator of G-protein signalling 3 
66 9q33.1 112 FLJ31713 hypothetical protein FLJ31713 
67 9q33.l 112 LOC392385 similar to programmed cell death 2 isoform 1; zinc finger protein Rp-8; programmed cell death 2/Rp8 homolog 
68 9q33.l 112 KIAAI952 KIAAI952 protein 
~ 112 AMBP alpha-I-microglobulinlbikunin precursor 70 q33.l 112 KIF12 kinesin family member 12 
71 9q33.1 112 COL27Al Collagen, type XXVII, alpha 1 
72 9q31-q32 112 ORMI orosomucoid I 
73 9q32 112 ORM2 orosomucoid 2 
74 19q32 112 AKNA AT-hook transcription factor AKNA 
!75 19q33.l 113 CIP98 CASK-interacting protein CIP98 
1 
76 9q33.1 113 ATP6VIGI ATPase, H+ transporting, lysosomal13kDa, VI subunit G isoform I 
77 9q33.l 113 DKFZp547P234 DKFZp547P234 protein 
78 9q33.1 113 LOC389786 LOC389786 
79 9q32 113 TNFSF15 tumor necrosis factor (ligand) superfamily, member 15 1 
80 9q33.l 113 LOC402376 similar to KIAA0536 protein 
81 9q33 113 TNFSF8 tumor necrosis factor (ligand) superfamily, member 8 
82 9q33 113 TNC Tenascin C (hexabrachion) 
83 9q32 113 38322 deleted in esophageal cancer 1 
84 9q31.3 114 C90rf27 chromosome 9 open reading frame 27 
85 9q33.2 114 PAPPA pregnancy-associated plasma protein A 
86 9q33.2 115 ASTN2 astrotactin 2 
187 9q33.2 115 TRIM32 tripartite motif-containing 32 
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No Cytogenetic Start I Gene Name Short Description ILocation (Mb) 
88 9q32-q33 116 TLR4 ItolI-like receptor 4 
89 9q33.2 116 LOC340477 hypothetical LOC340477 
90 9q33.2 116 LOC389787 similar to Translationally controlled tumor protein (TCTP) (023) (Histamine-releasing factor) (HRF) 
91 19q33.3 117 LOC347 I 65 similar to beta-tubulin 4Q 
192 9q32-q33 117 DBCI deleted in bladder cancer I 
93 9q33.3 119 CDK5RAP2 CDK5 regulatory subunit associated protein 2 
94 9q32-q33.3 119 EGFL5 EGF-like-domain, multiple 5 
95 9q34.11 119 LOC392387 similar to Ahcy protein 
.96 9q34 119 !FBXW2 F-box and WD-40 domain protein 2 
97 9q34.l1 119 LOC402377 similar to beta-I ,3-N-acetylglucosaminyltransferase 5 
98 9q34.11 119 !PSMD5 proteasome (prosome, macropain) 26S subunit, non-ATPase, 5 
99 9q34.l1 119 PHFI9 PHD finger protein 19 
100 9q33-q34 119 TRAFI TNF receptor-associated factor I 
101 9q33-q34 119 C5 complement component 5 
il02 9q33-q34 119 CEPI centrosomal protein I 
il03 9q32-q34.l1 119 RAB14 RABI4, member RAS oncogene family 
104 9q34.ll 119 LOC392388 similar to ATPase, H+ transporting, lysosomal 56158kD, VI 
subunit B, isoform 2 
105 9q33 119 GSN Igelsolin (amyloidosis, Finnish type) 
!106 9q34.11 119 OST2 MOST2 protein 
1107 9q34.l 119 M stomatin 
108 9q34.l1 120 a1l3GTP alpha-I,3-galactosyltransferase pseudo gene 
!109 9q33.I-q33.3 120 DAB2IP DAB2 interacting protein 
110 9q34.l1 120 LOC158135 similar to H23L24.3.p 
III 9q34.l1 120 LOC401550 hypothetical gene supported by BC039180 
112 9q33.2-q34.l1 120 NDUFA8 NADH dehydrogenase (ubiquinone) I alpha subcomplex, 8, 19kDa 
113 9q34.11 120 FLJ46909 FLJ46909 protein 
,114 9q34.11 120 LHX6 LIM homeobox 6 
115 j9q34.11 120 RBM18 RNA binding motif protein 18 
116 j9q34.l1 120 MRRF mitochondrial ribosome recycling factor 
9q32-q33.3 121 PTGSI prostaglandin-endoperoxide synthase 1 (prostaglandin GIRl117 
synthase and cyclooxygenase) 
118 9q34.l1 121 ORlJ5 olfactory receptor, family I, subfamily J, member 5 
119 9q34.ll 121 LOC347168 similar to Olfactory receptor 111 
120 9q34.ll 121 ORIJ4 olfactory receptor, family I, subfamily J, member 4 
il21 9q34.l1 1121 LOC138883 similar to Olfactory receptor IN3 
i122 9q34.11 121 LOC138882 similar to Olfactory receptor IN2 
123 9q34.11 121 LOC138881 similar to Olfactory receptor I L8 
il24 9q34.11 121 LOC392389 similar to G protein-coupled receptor homolog clone H8 
il25 9q34.II 121 LOC158131 similar to Olfactory receptor 1 QI (Olfactory receptor TPCRI06) (Olfactory receptor 9-A) (OR9-A) (OST226) 
126 9q34.l1 121 LOC347169 similar to Olfactory receptor IBI (Olfactory receptor 9-B) (OR9-B) 
127 9q34.11 121 LOCI58130 similar to tousled-like kinase 1; serine threonine protein kinase 
128 9q34.ll 121 LOC254973 similar to Olfactory receptor IL4 (Olfactory receptor 9-E) (OR9-E) (OST046) 
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Cytogenetic Gene Name Short Description iLocation (Mb). I 
129 9q34.l1 121 LOC392390 similar to Olfactory receetor 1L6 
130 9q34.l1 121 LOC389789 LOC389789 simila~ to Olfactory receptor 5C1 (Olfactory receptor 9-F) 
131 9q34.1l 121 LOC392391 (OR9-F) 
1132 9q34.l1 121 LOC392392 similar to Olfacto~rece~tor lKI 
i133 9qI2-q13 121 PDCL phosducin-like 
134 9q34.1l 121 LOC402378 
similar to Keratin, type I cytoskeletal 18 (Cytokeratin 18) 
(KI8) (CK 18) 
9q34 121 MNAB membrane-associated nucleic acid binding protein 
136 9q34.11 121 ZNF482 zinc fmger protein 482 
137 9q34.11 121 ZNF481 zinc finger protein 481 
138 9q34.11 121 RABGAP1 RAB GTPase activating protein 1 
139 9q33 121 GPR21 G protein-coupled rec~tor 21 
140 9q34.11 121 C90rf45 chromosome 9 ~en reading frame 45 
141 9q33.3 121 STRBP ~£ermatid perinuclear RNA binding--'I>fotein i 
142 9q34.11 122 FLJ38464 hypothetical protein FLJ38464 
143 9q34.11 122 KIAA1608 KIAA1608 
144 9q33-q34.1 122 ~~ LIM homeobox 2 I 145 9q33.3-q34.l1 122 [NlMA (never in mitosis Jiene '!krelated kinase 6 i 
146 9q34.l1-q34.12 122 PSMB7 Iproteasome (prosome, macropain) subunit, beta type, 7 
147 9q34.l1 123 GPR144 G protein-coupled rec~tor 144 I 
148 9q33 123 NR5Al nuclear receptor subfamily 5, group A, member 1 
149 9q33-q34.1 123 NR6Al nuclear receptor subfamily 6, group A, member 1 
150 9q34.l1 123 LOC169611 hypothetical protein LOC 169611 I 
151 9q34.11 123 LOC401551 similar to hypothetical protein FLJ25955 
152 9q34.l 123 RPL35 ribosomal protein L35 
153 9q34.11 123 ARPC5L actin relatedj)rotein 2/3 com~lex, subunit 5-Jike 
154 9q34.11 123 GOLGAI Igoigi autoantigen, golgin subfamily a, 1 i 
155 9q34.11 123 FLJ36664 hypothetical protein FLJ36664 
156 9q34.11 123 PPP6C Iprotein phosphatase 6, catalytic subunit 
157 9q32-q34.1 123 NDUFB3P2 NADH dehydrogenase (ubiquinone) 1 beta sub complex, 3, 12kDa pseudogene 2 
158 9q34.11 123 RAB9P40 Rab9 effector p40 
159 9q33-q34.l 123 HSPA5 heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) 
~q34.11 123 DKFZP434C212 DKFZP434C212 j)rotein 
16 q34.12 124 MAPKAPI mitogen-activated protein kinase associated J'l'otein 1 
162 9q34.l2 124 LOC51145 erythrocyte transmembrane jlfotein 
163 9q33-q34 124 PBX3 Ipre-B-cell leukemia transcription factor 3 
i-­
[2i34.l2164 124 C90rf28 chromosome 9 open readin.Ji frame 28 I-­
165 9q34 125 LMXlB LIM homeobox transcription factor 1, beta 
1166 9p24.l-q22.33 125 ZNF297B zinc fmger protein 297B 
167 9q34 125 ANGPTL2 angi~oietin-like 2 i 
168 9q34.13 125 DKFZp76lJ1523 hypothetical protein DKFZp761J 1523 
169 9q34.l3 126 SLC2A8 solute carrier family 2, (facilitated glucose transporter) 
member 8 
170 9q34 126 ZNF79 zinc finger protein 79(PT7) 
171 9q34 126 RPLl2 ribosomal protein Ll2 
172 9q34.l3 126 LRSAMI leucine rich r~eat and sterile al£ha motif containing I 
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173 9q34.13 126 C90rf88 chromosome 9 open reading frame 88 
174 9q34.1 126 STXBPI syntaxin bindin,g protein I 
175 9q34.l3 126 LOC286207 hypothetical protein LOC286207 
176 9q34.13 ~138428 hypothetical protein LOC138428 
177 9q34.13 Cl6 tetratricopeptide repeat domain 16 
1178 9q34.l1 OR2A torsin family 2, member A 
179 9q34.l3 6 SH2D3C SH2 domain containing 3C 
!180 9q34.l 126 ICDK9 cyclin-dependent kinase 9 (CDC2-related kinase) 
181 9cen-q34 126 ~GS folylpolygiutamate synthase 
182 9q33-q34.1 126 ENG endoglin (Osler-Rendu-Weber syndrome U 
183 9q34.1 126 AKI adenylate kinase 1 
184 9q34.13 126 ST6GALNAC6 CMP-NeuAC:(beta)-N-acetylgalactosaminide (alpha)2,6­
sialvltransferase member VI 
1 
185 
sialyltransferase 7D «alpha-N-acetylneuraminyl-2,3-beta­
9q34 126 SIAT7D galactosyl-l,3)-N-acetyl galactosaminide alpha-2,6­
isialy ltransferase ) 
186 9q34.13 126 PIP5KLl Iphosphatidylinositol-4-phosphate 5-kinase-like 1 
1187 9q34.l3 126 FLJ10232 hypothetical protein FLJ 1 0232 
188 9q34.13 126 LOC389790 similar to phosphatidylinositol pho~hate kinase-like protein 
I dolichyl-phosphate mannosyltransferase polypeptide 2, 189 9q34.13 126 DPM2 
regulatory subunit 
190 9q34.13 126 C90rf90 omosome 9 open reading frame 90 
191 9q34.13 126 MCSC ochondrial Ca2+-dependent solute carrier 
~34.l3 126 LOC401552 Ihypothetical gene supported by AKI24723; AL833509 
1193 34.13 126 PTGES2 Iprostaglandin E synthase 2 
194 9q34.l3 126 LOC38979I LOC389791 
195 9q34 [126 LCN2 lipocalin 2 (oncogene 24p3) 
1196 9q34.1 126 C90rf16 chromosome 9 open reading frame 16 
197 9q34.1 126 CIZI NIA interacting zinc finger protein 1 
~q34 126 DNMI dynamin 1 
.199 q34.13 126 GOLGA2 Igolgi autoantigen, golgin subfamily a, 2 
200 9q34.13 126 LOC375757 hypothetical protein LOC375757 
201 9q34.13 126 FLJ21673 hypothetical protein FLJ21673 
202 9q34.l3 126 TRUB2 TruB pseudouridine (psi) synthase homolog 2 (E. coli) 
1203 9q34.13 126 COQ4 coenzyme Q4 homolog (yeast) 
204 9q34.13 126 SLC27A4 solute carrier family 27 (fatty acid transporter), member 4 
205 9q34.13 126 TMSL4 thymosin-like 4 
206 9q34.13 127 C90rf74 chromosome 9 open reading frame 74 
!207 i9q34.13 127 CEECAMI cerebral endothelial cell adhesion molecule I 
1208 9q34.l3 127 LOC392394 similar to hypothetical protein 
209 9q34.11 127 ODF2 outer dense fiber of sperm tails 2 
210 9q34.13 127 GLEIL GLEI RNA export mediator-like (yeastl 
211 9q33-q34 127 SPTAN1 spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) 
~413 127 WDR34 WD repeat domain 34 9q34 127 SET ISET translocation (myeloid leukemia-associated) 
4.13 127 pknbeta Iprotein kinase PKNbeta 
215 q34.13 127 ZDHHCI2 zinc finger, DHHC domain containing 12 
216 9q34.13 127 C90rf60 chromosome 9 open reading frame 60 
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217 9q34.l3 127 TBClDI3 TBCl domain famil~ member 13 
218 9q34.l 127 ENDOG endonuclease G 
1219 9q34.13 127 HSPC109 hypothetical protein HSPC 109 
~I3 127 CCBU 
cysteine conjugate-beta lyase; cytoplasmic (glutamine 
transaminase K, kyneurenine aminotransferas~ 
221 q34.l3 127 LRRC8 leucine rich repeat containing 8 
222 9q34.13 127 PHYHDl phytanoyl-CoA dioxygenase domain containing 1 
223 9q34.13 127 TMEM15 transmembrane protein 15 
224 9q34 127 SH3GLB2 SH3-domain GRB2-like end()£hilin B2 
225 9q34.13 127 C90rf54 chromosome 9 open reading frame 54 
226 9q34.l 127 DOLPPI dolichyl pyrophosphate phosphatase 1 
227 9q34.1 127 CRAT carnitine acetyltransferase 
228 9q34 127 PPP2R4 ~roteinj)hosphatase 2A, regulat()I')' subunit B' (PR 53) 
229 9q34.13 127 LOC389792 similar to RIKEN cDNA 2610524G09 i 
230 9q34.l3 127 LOC389793 iLOC389793 i 
231 9q34.2 128 LOC389794 ILOC389794 
232 9q34.2 128 LOC401553 hypothetical gene supported by BC019073; BC036842; i~C044229 
233 9q34.2 128 LOC375759 hypothetical protein LOC375759 I 
234 i9q34.2 128 AD-003 AD-003 protein i 
235 19q34.13 128 ASB6 ankyrin repeat and SOCS box-containing 6 
236 9q34.1 128 PRRX2 Ipaired related homeobox 2 
237 9q34.3 128 PTGES Iprosta~landin E ~nthase 
238 9q34 128 TORlB Itorsin family 1, member B (torsin B) 1 
239 9q34.2 128 C90rf78 chromosome 9 open reading frame 78 
240 9q34 128 DYTl dystonia 1, torsioniautosomal dominant; torsin A) 
241 9q34.2 128 USP20 ubiquitin specific protease 20 
242 9q34 128 FNBPI iformin binding protein 1 
243 19q34.2 128 GPRI07 G protein-coupled receptor 107 
244 9q34.2 128 LOC401554 hypothetical gene s1!QPorted by AK128673 
245 9q34 128 FREQ frequenin homolog (Drosophila) 
246 9q34.2 128 LOC392395 similar to hemicentin 
247 9q34.2 128 DKFZp434P0216 hemicentin-2 
.248 9q34.2 129 LOC389796 similar to CDNA se...9.uence BC034076 
249 9q34.2 129 LOC389797 similar to cDNA sequence BC034076 
250 9q34.l 129 ASS argininosuccinate ~nthetase 
251 9q34.2 129 FUBP3 far upstream element (FUSE) binding protein 3 
252 9q34.2 129 LOC402379 similar to hypotheticalprotein 
253 9q33-q34 129 PRDM12 PR domain containing 12 
254 9q34 129 RRP4 homolog of Yeast RRP4 (ribosomal RNA processing 4),3'-5'-! 
exoribonuclease 
• 
255 9q34.1 129 ABU v-abl Abelson murine leukemia viral onco..£ene homolog 1 
256 '9q34.2 129 P518 P 518 precursor protein ! 
257 9q34.2 129 FIBCDl fibrinogen C domain containing 1 I 
258 9q31-q34 129 LAMC3 laminin, gamma 3 I 
259 9q34.13-q34.3 129 C90rf58 chromosome 9 open reading frame 58 
260 9q34.l 129 NUP214 nucleoporin 214kDa 
261 9q34 129 C90rf59 chromosome 9 oEen reading frame 59 i 
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262 i9q34.2-q34.3 129 C90rf67 chromosome 9 open reading frame 67 
~I 1130 POMTl protein-O-manno~transferase 1 264 .3 130 UCKI kinase 1 
265 9q34.3 130 GRF2 Iguanine nucleotide-releasing factor 2 (specific for crk proto­
oncogenel 
266 9q34.I-q34.3 130 CRSP8 I~~~~or required for Sp 1 transcriptional activation, subunit 8, 
267 9q34 130 NTNG2 netrin G2 
268 9q34.3 130 KIAA0625 senataxin 
269 9q34.3 131 TTFI transcription termination factor, RNA polymerase I 
270 9q34.3 131 LOC389799 LOC389799 
271 9q34 131 BARHLl BarH-like 1 (Drosophila) 
272 9q34.3 131 DDX31 DEAD (Asp-Glu-Ala-Asp) box polype£tide 31 
273 9q34.3 131 GTF3C4 Igeneral transcrij)tion factor IIIC,J?o~tide 4, 90kDa 
274 9q34.3 131 FLJ32704 ~othetical~otein FLJ32704 
275 9q34 131 C90rf9 chromosome 9 open reading frame 9 
276 19q34 131 TSCI ~ous sclerosis 1 
277 9q34.l3 131 GFIlB growth factor independent IB (potential regulator of CDKNIA, translocated in CML) 
278 9q34 131 LOCI 58078 eukaryotic translation elon..£ation factor 1 a~ha 1 pseudogene 
279 9q34.3 131 LOC389801 LOC389801 
280 9q34 131 GTF3C5 Igeneral transcription factor mc, polypeptide 5, 63kDa 
281 9q34.3 131 CEL carboxyl ester lij)asel.bile salt-stimillated Il£as~ 
!282 9q34.3 131 CELP carboxyl ester lipase pseudogene 
1283 9q34.3 131 RALGDS ral guanine nucleotide dissociation stimulator 
• 
284 9q34.13-q34.3 131 FS Forssman glycoljj)id ~nthetase 
285 9q34 131 OBP2B odorant binding protein 2B 
286 9q34.3 131 LOC286310 similar to Von Ebners gland protein precursor (VEG protein) (Tear prealbumin) (TP)JTear ljj)ocalin) (Ljj)ocalin 1) 
ABO blood group (transferase A, alpha 1-3-N­
287 9q34.I-q34.2 .131 ABO acetylgalactosaminyltransferase; transferase B, alpha 1-3­
IgaIactosyltransferasel 
288 9q34.3 iif3% similar to Von Ebners gland protein precursor (VEG protein) (Tear prealbumin) (TP) (Tear li~ocalin)iLh>ocalin 1) 
289 9q34.2 1 6 surfeit 6 
290 9q34.2 5 surfeit 5 
291 9q34 131 RPL7A ribosomal protein L 7a 
292 9q34.2 131 SURF 1 surfeit 1 
293 9q34.2 131 SURF2 surfeit 2 
294 9q34.2 132 SURF4 surfeit 4 
295 9q34.3 132 MGC43306 hypothetical protein MGC43306 
296 9q34 132 ADAMTS13 a disintegrin-like and metalloprotease (reprolysin type) with 
thrombospondin type 1 motif, 13 
297 9q34 132 C90rf7 chromosome 9 open reading frame 7 
298 i9q34 LC2A6 solute carrier family 2 (facilitated glucose transporter), 
299 BH ~,e (dopamine beta-monooxy.en",e) 
-
300 SARDH 
r--­
301 9q34.1 VAV2 vav 2 oncogene 
302 9q34.3 132 LOC389803 similar to bA 74PI4.21.novel...Qroteil!) 
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1303 9q34 132 FLJ35348 FLJ35348 
304 19q34 132 BRD3 bromodomain containing 3 
1305 19q34 132 ARF4P ADP-ribosylation factor 4 pseudo~ene 
306 i9q34.3 133 LOC158226 hypothetical LOC158226 
307 9q34.3 133 RXRA retinoid X receptor, alpha 
308 9q34.3 133 LOC157943 hypothetical LOC157943 
309 9q34.2-q34.3 133 COUAI collagen, type V, alpha I 
310 9q34.3 133 LOC389804 LOC389804 
311 9q34.3 133 LOC392397 similar to hypotheticaljJTotein 
312 9q34 133 FCN2 I~~::~~ (collagen/fibrinogen domain containing lectin) 2 lin) 
313 9q34 133 FCNI fico lin (collagen/fibrinogen domain containing) 1 
~4.3 133 OLFMl olfactomedin 1 
4.3 134 LOC401557 hypothetical gene sl.lflQorted ~AK127261 
316 9q34.3 134 LOC402380 similar to ligand-independent activating molecule for estrogen I 
receptor 
f.~ 9q34.3 134 C90rf62 chromosome 9 open readil'!& frame 62 9q34.3 134 KIAA0649 KIAA0649 ! 
319 9q34.3 134 IMGC29761 ~otheticai protein MGC29761 
320 9q34 134 IMRP82 ~ ..al ribosomaljJTotein 82 
321 9q34 134 LCNI lipocalin 1 (tear pre albumin) 
322 9q34 134 OBP2A odor nt binding protein 2A ! 
progestagen-associated endometrial protein (placental protein 
323 9q34 134 PAEP 114, pregnancy-associated endometrial alpha-2-globulin, alpha 
uterine protein) 
324 9q34.3 134 LOC401558 hypothetical gene supported by AK094119 
325 9q34.3 134 LOC138159 beta-Iactoglobulinpseudogene 
326 9q34.3 134 GLTDCl Igalactosyltransferase family 6 domain containing I 
327 9q34.3 134 LOC392399 similar to Putative MUP-Iike lipocalin precursor 
328 9q34.3 134 LOC402381 similar to LOC286220 protein 
329 9q34.3 134 KCNTl Ipotassium channel, subfamily T, member 1 
330 9q34.3 134 CAMSAPI calmodulin r~ulated ~ectrin-associatedjJTotein 1 
331 9q34.3 134 UBADCl ubiquitin associated domain containing 1 
i332 9q34.3 134 LOC401559 hypothetical~ene sl.lflQorted by BC029166 
333 9q34.3 134 BTBD14A BTB (POZ) domain containing 14A 
334 19q34.3 134 LOC402382 similar to F4N2.10 ! 
335 19q34.3 134 LOC389806 LOC389806 
336 9q34.3 134 LOC90120 hypothetical gene sU..QPorted by AK023162 
337 9q34.3 135 LHX3 LIM homeobox 3 
338 9q34.3 135 Q8CN6L1 Iquiescin Q6-like 1 
339 9q34.3 135 GP8Ml Gj>fotein signalling modulator 1 (AGS3-like, C. elegans) 
340 9q34.3 135 LOC389810 LOC389810 
341 19q34.3 135 LOC401560 similar to DNL zinc fin...&er (3D41) 
342 135 CARD9 caspase recruitment domain family, member 9 
135 SNAPC4 small nuclear RNA activating complex, polypeptide 4, 190kDa 
34.3 135 SDCCAG3 serologically defined colon cancer antigen 3 
345 135 PMPCA Ipeptidase (mitochondrial processing) alpha 
346 9q34.3 135 INPP5E inositol polyphosphate-5:J>.hosphatase, 72 kDa 
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q34.3 135 KIAA0310 KIAA0310 
348 9q34.3 135 FLJ36779 hypothetical protein FLJ36779 
349 9q34.3 135 NOTCH 1 Notch homolog 1, translocation-associated (Drosophila) 
350 9q34.3 135 LOC401561 I!YPothetical gene sup~orted by AY129027 ffi 9q34.3 135 LOC3898 I I similar to HSPC324 9q34.3 135 EGFL7 EGF-Iike-domain, multiple 7 
! 
1
9q34
.3 
l-acylglycerol-3-phosphate O-acyltransferase 2 353 135 AGPAT2 l(lysophosphatidic acid acyltransferase, beta) 
354 19q34.3 135 MGC20262 hypothetical protein MGC20262 
355 9q34.3 135 MGCI6037 hy'~otheticai protein MGC 16037 
~q343 135 LCN6 lipocalin 6 
q34.3 135 LCN8 li~ocalin 8 
'358 q34.3 135 UNQ2541 MSFL2541 
359 9q34.3 135 LOC392401 similar to vacuolar H( +)-ATPase subunit; V -ATPase subunit; MI6 
360 9q34.3 135 MGC14141 hypothetical protein MGC 14141 
361 9q34.3 135 KIAAI984 KIAA1984 
362 9q34.3 135 C90rf86 I£hromosome 9 <>Qen reading frame 86 
363 9q34.3 135 LOC389813 imilar to CG 15216-PA 
364 9q34.3 135 PHP14 hohistidine pho~hatase 
365 9q34.3 135 AEGP ~ical early endosomal glycoprotein precursor 
366 9q34.3 135 EDFI endothelial differentiation-related factor I 
j367 9q34 135 TRAF2 TNF rec(!ptor-associated factor 2 
368 9q34.3 135 FBXW5 F-box and WD-40 domain protein 5 
369 9q34.3 1135 C8G complement component 8,--.&.amma---.p.0~tide I 
370 9q34.3 135 MGC48935 ~otheticall)rotein MGC48935 
j371 9q34.3 135 LOC203235 hypothetical LOC203235 
372 9q34.2-q34.3 135 PTGDS Iprostaglandin D2 ~nthase 21 kDaJbrain) 
1373 9q34.3 135 LOC40l562 hypothetical gene supported by AKI27160 
374 9q34.3 135 LOC286257 hypothetical protein LOC286257 
375 9q34.3 135 CLIC3 chloride intracellular channel 3 
376 9q34 135 ABCA2 A TP-binding cassette, sub-fami!y' A (ABC I), member 2 
377 9q34.3 135 FUT7 fucos:yltransferase 7 -.la~hail,3) fuco~transferase) 
378 9q34.3 135 LOC401563 hypothetical gene supported by AK093587; AK124899 
379 9q34.3 135 LOC389814 similar to LP AL643 8 
380 9q34.3 135 INPDCI neural proliferation, differentiation and control, 1 
1381 9q34 135 ENTPD2 ectonucleoside tri~hosphate dipho~hohydrolase 2 
1382 9q34.3 135 LOC89958 hypothetical protein LOC89958 
1383 19q34.3 135~L1 UDP-N-acteylglucosamine pyrophospho!i1ase I-like I 
1384 19q34 135 1Bl mannosidase, alpha, class IB, member 1 
385 9q34.3 135 DPP7 dip(!£ti<!Ylpeptidase 7 
386 9q34.3 135 LOC389815 LOC389815 
mJf3 135 GRIN 1 Iglutamate receptor, ionotropic, N-methyl D-aspartate 1 3 34.3 135 LOC389816 similar to CDNA s~uence BC004853 3 q34.3 135 LOC389817 LOC389817 
390 9q34.3 135 ANAPC2 anaphase promoting complex subunit 2 
391 9q34.3 135 SSNAI Sjogren's syndrome nuclear autoantigen 1 
392 9q34.3 135 C90rf75 chromosome 9 open reading frame 75 
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393 9q34.3 135 MGC14327 hypothetical protein MGC14327 
394 9q34.3 136 NELF 
nasal embryonic luteinizing hormone-releasing hormone 
factor 
395 9q34.3 136 FLJ43 070 FLJ43070 protein 
396 9q34.3 136 MRPL41 mitochondrial ribosomal protein L41 
397 9q34.3 136 LOC92715 hypothetical protein BCO 17335 
398 9q34.3 136 ZMYND19 zinc finger, MYND domain containing 19 
399 9q34.3 136 ARRDCl arrestin domain containing 1 
400 9q34.3 136 C90rf37 chromosome 9 open reading frame 37 
401 9q34.3 136 LOC392402 similar to protein phosphatase 2A inhibitor-2 1-2PP2A 
402 9q34.3 136 Eu-HMTasel euchromatic histone methyltransferase 1 
403 9q34 136 CACNAlB calcium channel, voltage-dependent, L type, alpha IB subunit 
404 9q34.3 136 LOC286222 similar to beta-tubulin 40 
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Purpose: There is an increase in the incidence of Achilles 
tendon injuries as a result of the participation in physical 
activity. It has been suggested that some individuals have a 
genetic predisposition to Achilles tendon pathology (ATP). 
The aim of this study was to determine whether the (X 1 type 
V collagen (COL5Al) gene, which encodes for a tendon 
protein, is associated with the symptoms of ATP. Method­
s: One-hundred and eleven Caucasian subjects diagnosed 
with ATP and 129 Caucasian control (CON) subjects were 
genotyped for the BstUI and DpidI restriction fragment 
length polymorphisms (RFLPs) within the COL5Al gene. 
Results: There was a significant difference in the allele 
frequencies of the COL5Al BstUI RFLP between the ATP 
and CON subjects (P 0.0(6). The frequency ofthe A2 aDele 
was significantly higher in the CON group (29.8%) than in the 
ATP group (18.0%) (odds ratio of 1.9; 95% confidence 
interval (CI) 1.3-3.0; p:= 0'(J04). This aDele had a stronger 
protective role when only the 72 patients diagnosed with 
chronic Achilles tendinopathy were analyzed (odds ratio of 
2.6; 95% CI 1.5--4.5). Conclllsion.~: The COL5Al BstUI 
RFLP is associated with ATP and more specificaDy, chronic 
Achilles tendinopathy. Individuals \lith an A2 aUele of this 
gene are less likely of developing symptoms of chronic 
Achilles tendinopathy. 
There is a reported increase in the incidence of 
injuries of the Achilles tendon in those who part ci­
pate in competitive and recreational physical activity 
(Jozsa et aI., 1989b). Although the causes of Achilles 
tendon injuries are poorly understood, both intrinsic 
and extrinsic factors have been implicated in its 
etiology. The relationship of these factors to Achilles 
tendon pathology (ATP) has recently been reviewed 
(Paavola et ai., 2002; Riley, 2004). Specific intrinsic 
factors that have been identified include age, gender, 
body weight, vascular perfusion, nutrition, anatomi­
cal variants, joint laxity, muscular weakness or im­
balance, the use of certain drugs, systemic disease 
and a history of a previous injury. Extrinsic factors 
include the type of activity, occupation, training, 
physical load, shoes and environmental conditions. 
It has been proposed that, in addition to these 
non-genetic factors, certain genetic clements might, 
in part, be associated with an individual's suscept­
ibility to Achilles tendon injuries. More specifically, 
several investigators have suggested that a gene(s) on 
the tip of chromosome 9q, closely linked to the ABO 
blood group gene, is associated with A TP (reviewed 
in Kannus & Natri, 1997), Jozsa et al. (l989a), Jozsa 
et a1. (l989b), Kujala et aI., (1992) and Kannus and 
Natri (1997) have shown that blood group 0, and by 
implication the ABO gene, is associated with tendon 
injuries in a group of Hungarian or Finnish patients. 
But other studies have not shown an association 
between the ABO blood group with tendon pathology 
(Leppilahti et aI., 1996; Maffulli et aI., 2000). Recently, 
Amen et a1. also suggested, based on their findings 
that individuals who had ruptured an Achilles tendon 
had an increased risk of rupturing their contralateral 
tendon, the possible involvement of genetic elements 
in the etiology of A TP (i\men et aI., 2004). 
Tendons have a highly ordered hierarchical struc­
ture made up of tightly packed protein bundles 
consisting predominantly of type I collagen fibers 
(reviewed in Silver et aI., 2003). Trace amounts of 
other collagens, such as types III and V, form 
heterotypic fibers with the type I collagen found in 
tendons (reviewed in Birk, 2001; Silver et ai., 2003). 
Increases in type V collagen content have been 
reported with age in the rabbit patellar tendon and 
in biopsy samples of degenerative tendons (Dressler 
et aI., 2002; Goncalves-Neto et a1., 2002). 
The pro-cd (V) chain is found in most of the 
isoforms of type V collagen and is encoded by the 
r:t. I type V collagen (COL5Al) gene, which has been 
mapped to the same locus as the ABO gene on 
chromosome 9q34 (Caridi et aI., 1992). The gene 
was therefore identified as an ideal candidate genetic 
marker of ATP. Pro-r:t.2(V) and pro-r:t.3(V) chains are 
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also found in some of the type V collagen isoforms. 
Neither of the genes that encode these two ex-chains 
have, however, been mapped to human chromosome 
9 and were therefore not investigated as candidate 
genes in this study (reviewed in Myllyharju & Kivir­
ikko, 2001). In addition, several mutations within the 
COL5AI and COL5A2 genes have been shown to 
cause more severe connective tissue disorders such as 
some of the Ehlers-Danlos syndromes (EDS), which 
have been shown to affect tendons (reviewed in 
Myllyharju & Kivirikko, 2001; Riley, 2004). 
The COL5Al gene contains a BstUI and a DpnlI 
restriction fragment length polymorphisms (RFLPs) 
within its 3'-untranslated region (UTR) (Greenspan 
& Pasquinelli, 1994). To our knowledge, the influ­
ence of these polymorphisms on the expression of the 
COL5Al gene and the ultimate function of type V 
collagen is unknown. The aim of the study therefore 
was to determine whether the BstUI and/or DpnII 
RFLPs within the 3'-UTR of the COL5Al gene are 
associated with ATP. 
Material and methods 
Subjects 
One-hundred and eleven Caucasian patients with a current or 
past clinical history of A TP were recruited from the Medical 
Practice at the Sports Science Institute of South Africa and 
other Clinical Practices within the Cape Town area in South 
Africa. The A TP patients included 72 with chronic tendino­
pathies (TEN) and 39 with either a complete (36 of 39) or 
partial (three of 39) rupture (RUP). They were all physically 
active prior to the development of symptoms. The clinical 
practices invited their eligible patients to participate in the 
study, by sending them a letter informing them about the 
study. Subjects were requested to contact the investigators if 
they were interested in volunteering for the study. An experi­
enced clinician initially made the diagnosis of chronic Achilles 
tendinopathy (69 of 72) using clinical criteria. The diagnostic 
criteria for every subject were reviewed and confirmed by one 
of the investigators (M. S.). The clinical diagnostic criteria for 
chronic Achilles tendinopathy were gradual progressive pain 
over the posterior lower limb in the Achilles tendon area for 
greater than 6 months, together with at least one out of the 
following six criteria: (1) early morning pain over the Achilles 
tendon area, (2) early morning stiffness over the Achilles 
tendon area, (3) a history of swelling over the Aehilles tendon 
area, (4) tenderness to palpation over the Achilles tendon, (5) 
palpable nodular thickening over the affected Achilles, or (6) 
movement of the painful area in the Achilles tendon with 
plantar-dorsi~flexion (positive "shift" test) (Kader et aI., 2002; 
Paavola et aI., 2002; Schepsis et aI., 2002). ]n addition to these 
clinical diagnostic criteria, soft-tissue ultrasound examination 
was performed in a sub-group (22 of 72) ofsubjects to confirm 
the diagllosis of the affected Achilles tendoil. 
The diagnosis of Aehilles tendon rupture was made clini­
cally using standard validated criteria (Leppilahti & Ora va, 
1998; Schepsis et aI., 2002; Maffulli et aI., 2003) and confirmed 
in all cases by examination at the time of surgery (34 of 39) 
and/or by ultrasound imaging (five of 39), magnetic resonance 
imaging (MR]) (two of 39) or computerized tomography (CT) 
scan (one of 39). 
One-hundred and twenty-nine apparently healthy physi­
cally active Caucasian control (CON) subjects without any 
history of ATP were also recruited for this study from various 
recreational sporting clubs. The subjects were matched for 
age and gender. To avoid any possible effects of population 
stratification. the ATP and CON groups were also similarly 
matched for 'their country of birth. 
Approval for this study was obtained from the Research 
Ethics Committee of the Faculty of Health Sciences within the 
University of Cape Town. Once recruited, both the ATP and 
CON subjects were required to complete an informed consent 
form and personal particulars, physical activity and medical 
history questionnaires prior to participation. Subjects who 
had a history of current or past fluoroquinolone antibiotic use 
or previous local corticosteroids injection in the Achilles 
tendon or the area surrounding the Achilles tendon prior 
to the onset of symptoms were excluded from the study. This 
was necessary because of the known association between fluo­
roquinolone antibiotic (van der Linden et aI., 200 I) or possibly 
corticosteroids use, and an increased risk of Achilles tendon 
rupture (Leppilahti & Orava, 1998). Furthermore, ATP and 
CON subjects who had been diagnosed with any connective 
tissue disorders or any other systemic diseases believed to be 
associated with ATP, such as, but not limited to, EDS, benign 
hypermobility joint syndrome, rheumatoid arthritis, systemie 
lupus erythematosus, hyperparathyroidism, renal insuffi­
ciency, diabetes mellitus and familial hypercholesterolemia 
were also excluded from the study (Leppilahti & Orava, 1998). 
Sample collection, total DNA extraction and 
blood grouping analysis 
Approximately 4.5 mL of venous blood was collected from 
each subjeet into cthylenediaminetetraacetic acid (EDTA) 
vacutainer tubes by venipuncture of 1I forearm vein and stored 
at 4 °C until total DNA extraction. Total DNA was extracted 
from the sample as described by Lahiri and Nurnberger (1991) 
with some modifications. Briefly, the blood samples were 
transferred to 15 mL polypropylene tubes, to which two 
volumes of TKMI buffer (lOmM Tris-HCl pH 7.6, 10mM 
KCl, IOmM MgCI2 and 2mM EDTA) containing 2.5% 
Nonidet P-40 (Sigma, St. Louis, MO, USA) was added to 
lyse the red blood cells. After a 10min incubation at room 
temperature, the white blood cells were pelleted byeentrifuga­
tion at 1200 x g at room temperature for 10min and washed 
at least once with one volume of TKM 1 buffer. The washed 
pellets were resuspended in 800 ilL of TKM2 buffer (10 mM 
Tris-HCl pH 7.6, 10mM KCI, lOmM MgCI2, O.4M NaCI2 
and 2mM EDTA) containing 50 ilL of 10% sodium dodecyl 
sulfate by incubation for at least 10 min at 55 "C or until the 
pellets had dissolved. One hundred and fifty microlitres of 5 M 
NaCl04 and 500 ilL of chloroform was added to each sample, 
which was then mixed thoroughly by vortexing for I 5-20 s. 
The samples were transferred to 1.5 mL microfuge tubes and 
the protein precipitated by centrifugation at 13 000 Lp.m. 
(15 000 x g) for 5 min at room temperature. Five hundred 
microlitres of the top aqueous phases were tmnsferred to new 
microfuge tubes contai11ing 1 ml of absolute ethanol, mixed 
and the DNA pelleted by centrifugation at 13 000 r.p.m. 
(J 5 000 x g) for 2 min at room temperature. The precipitated 
DNA was air dried for 30 min, resuspended in at least 100 III of 
TE buffer (I0mM Tris~HCl, 1 mM EDTA, pH 8.0) either by 
incubation for 1 h at 65°C or over-night at room temperature, 
and stored at 4 °C until polymerase chain reaction (PCR) 
analysis. 
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COL5A 1genotyping 
A 667 bp fragment containing the Bs/VI and DpnII RFLPs 
within the 31-UTR of the COL5A1 gene was PCR amplified as 
described by Greenspan and Pasquinelli (1994). The PCR was 
carried out in a total volume of 60 J.lL containing at least 
lOOng DNA, 20pmol of the forward and reverse primers, 
20mM Tris-HCI pH 8.4, 50mM KCI, I.5mM MgCI2, 0.2mM 
of each dNTP (dATP, dTTP, dCTP and dGTP) and 2.5 U of 
DNA Taq polymerase (Invitrogen Life Technologies, Carls­
bad, California, USA), using a PCR Express Thermal Cycler 
(Hybaid Limited, Middlesex, UK). The amplification was 
performed with an initial denaturing step at 94°C for 3 min, 
followed by 35 cycles of denaturing at 94 DC for 1 min, 
annealing at 53 °C for I min, extension at 72 DC for 1.5 min, 
and a final extension step at 72 DC for 8 min. The PCR 
products werc digested with Bs/UI to produce 351 and 
316bp fragments for the Al allele, 316, 271 and 80bp 
fragments for the A2 allele and a 667 bp fragment for the 
A3 allele. The PCR products were also digested with DpnII to 
produce 418, 194,40 and 15 bp fragments for the Bl allele and 
612, 40 and J5 bp fragments for the B2 allele. The resulting 
fragments were separated, together with 100 bp DNA ladder 
known size markers (Promega Corporation, Madison, Wis­
consin, USA), on 5% non-denaturing polyacrylamide gels and 
visualized by ethidium bromide staining. The gels were photo­
graphed under UV light using a Uvitee photodocumentation 
system (Uvitec Limited, Cambridge, UK) and the sizes of the 
DNA fragments determined (Fig. I). 
Statistical analyses 
The required sample size for this study was determined using 
QUANTO Version 0.5 (http://hydra.usc.edu/gxe) (Gauder­
man, 2002). Data were analyzed using the STATISTICA 
version 6.1 (StatSoft Inc., Tulsa, Oklahoma, USA) and 
GraphPad InStat version 2.05a (GraphPad Software, San 
Diego, California, USA) statistical programs. A one-way 
analysis of variance (ANOVA) was used to determine any 
significant differences between the characteristies of the ATP 
and CON groups, as well as the TEN and RUP sub-groups. 
.. N N N ... ...(a) c( c( (b) IX! IX! IX! IX!
.. N .. .. .. 
c( c( Iii IX! IX! IX! 
351 bp 612 bp 

316bp 

271 bp 
 418 bp 
80bp 194 bp 
2 1 2 3 4 
Fig. 1. Typical 5% non-denaturing polyacrylamide gels 
showing the common (a) BstUI and (b) DpnII restriction 
fragment length polymorphism (RFLP) genotypes. The sizes 
of the various DNA fragments are indicated on the left size 
of each gel. The 40 and [5 bp products produced during 
digestion of the polymerase chain reaction fragments with 
DpllII are not shown in panel (b). (Panel a) Lane I is an 
A I A 1 genotype, while lane 2 is an A2A2 genotype for the 
BsIUI RFLP. (Panel b) Lanes I and 2 are a B1B2 genotype, 
while lanes 3 and 4 are a B 1B [ genotype of the DpllIl RFLP. 
COL5Al gene and tendon pathology 
When the overall F value was significant, a least significant 
difference post-hoc test was used to identify specific differ­
ences. Statistical significance was accepted when P<0.05. 
Where applicable, data are presented as means ± standard 
deviations (SD) with the number of subjects in parentheses. 
Pearson's chi-square analysis was used to analyze differences 
in the genotype and allele frequencies between the ATP 
and CON groups. The genotype frequencies of the BstUI 
RFLP of the COL5Al gene were analyzed using Monte Carlo 
simulations (CLUMP version 2.0 program) (Sham & Curtis, 
1995). 
Results 
Subject characteristics 
As shown in Table I, the ATP, TEN, RUP and CON 
groups were similarly matched for age, height and 
country of birth. The ATP, TEN and CON groups 
were similarly matched for gender, while the RUP 
group (79.5%) contained significantly more male 
subjects than the CON group (61.7%, P 0.040). 
In addition, the ATP, TEN and RUP groups were 
significantly heavier with corresponding higher body 
mass indexes than the CON group. 
In the TEN group, the additional documented 
clinical criteria to confirm the diagnosis were tender­
ness to palpation (59 of 72), early morning stiffness 
(39 of 72), a history of swelling (24 of 72), early 
morning pain (15 of 72), palpable thickening (14 of 
72) and a positive "shift" test (nine of 72). In 22 of 
the 72 subjects, the diagnosis was confirmed by soft­
tissue ultrasound examination of the affected 
Achilles tendon. There were 29 of the 72 subjects 
with confirmed bilateral Achilles tendinopathy. 
In the RUP group, 38 of 39 subjects experienced 
acute severe pain in the posterior lower leg as the 
main presenting symptom. The diagnosis was con­
firmed in all these subjects by either direct examina­
tion at the time of surgery (34 of 39) or by imaging 
(eight of 39) (soft-tissue ultrasound, MRI or CT). 
Four of the 39 subjects had confirmed bilateral 
ruptures of the Achilles tendon, and 16 of 39 subjects 
had a history of tendinopathy prior to rupture. 
Range of motion and flexibility were assessed in 36 
of the 129 CON and 65 of the III ATP subjects (data 
not shown). None of the subjects tested were hyper­
mobile. In addition, none of the subjects included in 
this study had symptoms or signs (skin hyperexten­
sibility, bruising, recurrent joint effusions, subluxa­
tions or dislocations, ocular manifestations or 
cardiovascular manifestations) of EDS or benign 
hypennobility joint syndrome when their medical 
examinations were reviewed by the investigating 
clinician (M. S.). 
The activity resulting in injury in the majority of 
the ATP subjects was running (47 of III, 42.3%) or 
playing squash (17 of Ill, 15.3%), while the remain­
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Table 1. Characteristics of the control (CON) and Achilles tendon pathology (ATP) groups, as well as the Achilles tendinopathy (TEN) and Achilles rupture 
CON 
Age (years)' 
Height (cm) 
Weight (kg) 
Body mass index (kg/cm2) 
Gender (% males) 
Country of birth (% South Africa) 
40.3 ± 11.0 (122) 
175 ± 9 (121) 
71.1 ± 12.1 (125)a.c.c 
23.2 ± 2.7 (121 )b.d.f 
61.7 (128)9 
71.0 (124) 
40.1 ± 14.0 (108) 
176 ± 9 (108) 
80.8 ± 15.1 (108)a 
25.9 ± 3.9 (108)b 
73.0 (111) 
75.7 (107) 
39.7 ± 15.3 (69) 
176 ± 10 (69) 
77.1 ± 13.7 (69th 
24.7 ± 3.3 (69) .1 
69.4 (72) 
73.5 (68) 
40.8 ± 11.3 (39) 
176 ± 8 (39) 
87.3 ± 15.3 (39t 
28.1 ± 4.1 (39) .1 
79.5 (3W 
79.5 (39) 
Values are expressed as mean ± standard deviation or a frequency (%) where applicable. Number of subjects (n) is in parentheses. 

a.beON vs ATP (P<O.001): c.deON vs RUP (P<O.001): eCON vs TEN 0.006); 'CON vs TEN (P"" 0.004); geoN vs RUP (P= 0.040); h.ITEN vs RUP 

(P<0.001). 

'The age of the ATP group as well as the TEN and RUP sub·groups are the age of onset of the symptoms of Achilles tendon pathology. 

Table 2. Participation in physical activity and training of the control (CON) and Achilles tendon pathology (ATP) groups, as well as the Achilles 

tendinopathy (TEN) and Achilles rupture (RUP) sub-groups 

CON ATP TEN RUP 
Running (years) 7.9 ± 8.1 (129) 8.6 ± 10.6 (111) 9.4 ± 10.4 (72) 7.0 ± 10.9 (39) 

Running in the last 2 years (h/week) 3.3 ± 2.9 (126)a.b 2.1 ± 2.6 (98)a 2.6 ± 2.8 (63) 1.2 ± 1.9 (35)b 

High-impact sports (years) 11.5 ± 8.5 (129)c.d.e 20.2 ± 13.7 (111)" 18.5 ± 14.1 (72)d 23.5 ± 12.4 (39)C 

High-impact sports in the last 2 years (h/week) 5.0 ± 4.7 (129) 4.1 ± 5.1 (111) 4.5 ± 5.2 (72) 3.2 ± 5.0 (39) 

Values are expressed as mean ± standard deviation. Number of subjects (n) is in parentheses. 

'CON vs ATP (P= 0.002); b'·CON vs RUP (P<O.OOl): "CON vs ATP (P<O.OOl); dCON vs TEN (p<0.001). 

ing injuries occurred as a result of participating in a 
variety of sports and activities. 
As shown in Table 2, all the subject groups and 
sub-groups were matched for the number of years 
participated in running. Of the CON, A TP, TEN and 
RUP subjects, 74%, 56%, 61 % and 46%, respec­
tively, participated in running. Over the last 2 years, 
both the ATP and RUP groups, but not the TEN 
group, trained significantly less than the CON group. 
The three symptomatic Achilles pathology groups, 
however, participated for significantly more years in 
high-impact sports than the CON group. There were 
no significant differences in the hours of training in 
high-impact sports over the last 2 years between the 
groups. There were also no significant differences in 
years of participation and the level of training over 
the last 2 years when only the squash players were 
analyzed (data not shown). 
COL5A 1 genotype and allele frequencies 
There was a significant difference when the three 
COL5Al BstUI RFLP alleles (AI, A2 and A3) of the 
CON subjects were compared with the ATP group 
(Pearson's X2 = 10.3, P = 0.006) [Fig. 2(a)]. The fre­
quencies of the A I and A3 alleles were higher in the 
ATP group (169 AI, 76.1 % and 13 A3, 5.9%) than in 
the CON group (173 AI, 67.1 'Yo and eight A3, 3.1 %), 
while the frequency of the A2 allele was higher in the 
CON subjects (77 A2, 29.8%) than in the ATP group 
(40 ATP, 18.0%) (odds ratio of 1.9; 95% confidence 
interval (CI) 1.3-3.0; P 0.004). 
When the ATP group was sub-divided into more 
homogeneous pathologies, namely, chronic TEN or 
RUP sub-groups, there was a stronger significant 
difference in the frequencies of the distribution of 
the AI, A2 and A3 alleles when the CON and TEN 
groups were compared (Pearson's X2 = 14.0, 
P 0.0009) [Fig. 2(a)]. The frequencies of the Al 
and A3 alleles were higher in the TEN group (J 15 
AI, 79.9% and nine A3, 6.2°/c) than in the CON 
group. The frequency of the A2 allele was higher in 
the CON group than in the TEN group (20 A2, 
13.9%) (odds ratio of 2.6; 95% CI 1.5-4.5; 
P 0.0005). Although it should be interpreted with 
caution because of the small sample size (78 alleles), 
there was no significant difference in the distribution 
of these three alleles between the CON and RUP 
group (54 AI, 69.2%; 20 A2, 25.7% and four A3, 
5.1 %) (Pearson's X2 = 1.1, P =0.578) [Fig. 2(a»). 
Figure 2(b) shows that there were rio significant 
differences in the distribution of the two COL5Al 
DpnII RFLP alleles (B I and B2) between the CON 
group and either the entire A TP group (Pearson's 
X2 = 0.6, P 0.453) or the TEN (Pearson's X2 = 0.6, 
P 0.424) and RUP (Pearson's X2 0.04, P = 0.837) 
sub-groups. 
There were no significant differences in the geno­
type frequencies of the COL5AI BstUI (Table 3) and 
DpnII (Table 4) RFLPs between the CON and ATP 
(Pearson's X2 of the BstUI RFLP 5.2, P = 0.169 
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Fig. 2. Allele frequencies of the (a) BscUl and (b) Dpnll 
restriction fragment length polymorphism (RFLP) within 
the r:J. 1 type V collagen (COWAl) gene of the asymptomatic 
control subjects (CON, solid bars), as well as the sympto­
matic Achilles tendon pathology (ATP, gray bars), chronic 
Achilles tendinopathy (TEN, hatched bars) and Achilles 
tendon rupture (RUP, clear bars) patients. (a) P = 0.006, 
CON vs ATP; P 0.0009, CON vs TEN; P 0.578, CON vs 
RUP and (b) P = 0.453, CON vs ATP; P = 0.424, CON vs 
TEN; P 0.837, CON vs RUP. 
X2and Pearson's of the DpnII RFLP = 3.7, 
P = 0.160) groups, nor the CON and TEN (Pearson's 
X2 of the BstUI RFLP = 7.7, P = 0.057 and Pearson's 
X2 of the DpnII RFLP = 2.8, P = 0.243) or RUP 
(pearson's X2 of the BsrUI RFLP =6.6, P 0.089 
and Pearson's X2 of the DpnII RFLP 1.6, 
P = 0.460) sub-groups. Individuals with an A2A2 
genotype were under-represented in the ATP (odds 
ratio of 2.1; 95% CI 1.1--4.1; P= 0.035) and TEN 
(odds ratio of 2.9; 95% CI 1.2-6.6; P = 0.018) 
subjects. 
Discussion 
The main finding of this study was that the three 
alleles produced by the BstUI RFLP within the 3'­
UTR of the COL5Al gene were associated with ATP 
COL5Al gene and tendon pathology 
Table 3. Relative frequencies of BstUl restriction fragment length poly­
morphism genotype of the COL5A1 gene within the control (CON) and 
Achilles tendon pathology (ATP) groups, as well as the Achilles tendino­
pathy (TEN) and Achilles rupture (RUP) sub-groups 
Genotype CON ATP TEN RUP 
(n= 129) (n= 111) (n= 72) (n= 39) 
AlA1 (%) 62.8 (81) 70.3 (78) 76.4 (55) 59.0 (23) 
A1A2 (%) 7.0 (9) 6.3 (7) 4.2 (3) 10.3 (4) 
A1A3 (%) 1.6 (2) 5.4 (6) 2.8 (2) 10.3 (4) 
A2A2 (%) 26.4 (34) 14.4 (16) 11.1 (8) 20.5 (8) 
A2A3 (%) 0(0) 0.9 (1) 1.4 (1) 0(0) 
A3A3 (%) 2.3 (3) 2.7 (3) 4.2 (3) 0(0) 
The values are expressed as percentage with the number of subjects (n) 
in parentheses. 
Table 4, Relative frequencies of Opnll restriction fragment length poly­
morphism genotype of the COL5A 1 gene within the control (CON) and 
Achilles tendon pathology (ATP) groups, as well as the Achilles tendino· 
pathy (TEN) and Achilles rupture (RUP) sub-groups 
Genotype COn ATP TEN RUP 
(n=129) (n= 111) (n = 72) (n 39) 
Bl Bl (%) 58.1 (75) 58.6 (65) 59.7 (43) 56.4 (22) 
B182 (%) 31.0 (40) 36.9(41) 36.1 (26) 38.5 (15) 
8282 (%) 10.9 (14) 4.5 (5) 4.2 (3) 5.1 (2) 
The values are expressed as percentage with the number of subjects (n) 
in parentheses. 
(P = 0.006). There was a significant higher frequency 
of the A2 allele of this gene in the asymptomatic 
control subjects (CON 29.8% vs ATP 18.0%). In­
dividuals with the A2 allele were therefore less likely 
of developing symptoms of tendon pathology (odds 
ratio = 1.9; 95% CI l.3~3.0; P 0.004). 
It has previously been suggested that a gene(s) on 
the tip of the long arm of chromosome 9, closely 
linked to the ABO blood group gene, is associated 
with A TP (reviewed in KanllUS & Natri, 1997). Since 
the ABO gene on chromosome 9q34 encodes for 
distinct transferases, some investigators have specu­
lated that these enzymes, not only determine the 
structure of the glycoprotein antigens on red blood 
cells, but also the structure of some proteins making 
up the ground substance of tendons (Jozsa et at, 
1989a; Bennett et a!., 1995). It is however more likely 
that genes, such as COL5Al, which have also been 
mapped to chromosome 9q34 (Caridi et aI., 1992), 
and known to encode for proteins involved in tendon 
structure, development and regeneration, are better 
candidate genes for A TP than the ABO gene. 
The COL5A 1 gene encodes for the prO-ell (V) chain 
which is found in most of the isoforms of type V 
collagen (reviewed in Ristiniemi & Oikarinen, 1989). 
The major isoform of type V collagen is a hetero­
trimer consisting of two prO-eli (V) chains and one 
pro-el2(V) chain. Trace amounts of type V collagen 
are found in tendons where it forms heterotypic 
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fibers with the major structural collagen, namely type 
I collagen (reviewed in Birk, 200 I; Silver et aI., 2003). 
Although most investigators have speculated, based 
on the function of type V collagen in the cornea, that 
the protein plays an important role in regulating 
fibrillogenesis and modulating fibril growth in ten­
dons, some investigators have suggested that the 
function of type V collagen in tendons, and other 
tissues where its content is low, is actually unknown 
(reviewed in Birk, 2001; Riley, 2004). Although there 
is no consensus about the function of type V collagen 
in tendons, Dressler ct al. (2002) have reported an 
age-dependent increase in the content of the protein, 
together with a decrease in fibril diameter and the 
biomechanical properties in the rabbit patellar ten­
don. In addition, Goncalves-Neto et al. (2002) have 
shown an increase in types III and V collagen 
together with a reduction in the content of type I 
collagen in biopsy samples of degenerative tendons 
from patients with posterior tibial tendon dysfunc­
tion syndrome. Because of (i) its proximity to the 
ABO gene on chromosome 9 and (ii) the presence 
and proposed function of type V collagen in tendons, 
we propose that the COL5Al gene is a better 
candidate genetic marker than the ABO gene for 
ATP. 
The allele distributions of the COL5Al DpnII 
RFLP within the control subjects and the various 
groups of subjects with symptoms of ATP were 
similar to those of previously reported values. In 
addition there was no significant difference in the 
allele distribution of the COL5Al BstUI RFLP when 
the control subjects were compared with previously 
reported values (P = 0.206) (Greenspan & Pasqui­
nelli, 1994). 
An additional finding of this study was that the 
alleles of the COL5Al BstUI RFLP were strongly 
associated with chronic Achilles tendinopathy 
(P = 0.0009), since individuals with the A2 allele 
were less likely to present with symptoms of tendino­
pathy (odds ratio of 2.6; 95% CI 1.5-4.5, P = 
0.0005). This RFLP was however 110t associated 
with Achilles tendon ruptures in this study, suggest­
ing that the etiology of ruptures and tendinopathies 
are distinct. These findings must however be in­
terpreted with caution since only 78 alleles were 
analyzed. 
Although the COL5Al gene is an ideal marker for 
ATP and more specifically chronic Achilles tendino­
pathy, the findings of this study do not prove that 
type V collagen is involved in the etiology of tendon 
pathology. It is possible that another gene closely 
linked to the COL5Al and ABO genes on the tip of 
the long arm of chromosome 9 encodes for a protein, 
which is directly involved in the pathogenesis of 
Achilles tendon injuries. One such gene, the ten as­
cin-C (TNC) or hexabrachion (HXB) gene is ex­
pressed in tendons (Chiquet & Fambrough, 1984; 
Jarvinen et al., 1999). Since tenascin-C is able to bind 
to various components of the extracellular matrix 
and to cell receptors, it is believed to play an 
important role in regulating cell-matrix interactions 
(reviewed in Jones & Jones, 2000). In normal adult 
tendons, tenascin-C is localized predominantly in 
regions responsible for transmitting high levels of 
mechanical force such as the myotendinous and 
osteotendinous junctions (Chiquet & Fambrough, 
1984; Jarvinen et aL, 1999). The protein is also 
localized around the cells and the collagen fibers 
(Jarvinen et aL, 2003). In addition, Jarvinen et al. 
(1999,2003) have shown that expression of the TNC 
gene is regulated in a dose-dependent manner by 
mechanical loading in tendons. Mokone et al. (in 
press) have recently shown that the GT dinucleotide 
repeat polymorphism within intron 17 of the TNC 
gene is also associated with ATP. The possible role(s) 
of type V collagen and/or tenascin-C in the develop­
ment of ATP needs to be investigated. Our results 
nevertheless suggest that both the COL5Al and TNC 
genes are markers of ATP. 
Finally, it is highly unlikely that a single gene or 
genes in the vicinity of chromosome 9q34 are exclu­
sively associated with the development of the symp­
toms of ATP. It is perhaps more probable that this 
condition is polygenic in nature and that other genes 
which encode for important structural components 
of tendons are also associated with A TP. 
In addition to the genetic factors identified in 
this study and others that may be identified in the fu­
ture, several non-genetic intrinsic factors, such as, 
amongst others, age, gender, body weight and a 
history of a previous injury; as well as extrinsic 
factors, such as type of activity and training, have 
been implicated in the etiology of ATP (reviewed in 
Riley, 2004). Because the symptomatic subjects in 
this study were significantly heavier than the control 
subjects and had also participated for a significantly 
more years in high-impact sports, we cannot exclude 
the possibility that an interaction of weight and/or 
physical activity exposure with the COL5Al gene 
was responsible for the development of symptoms of 
ATP. It should be noted however that because this 
was a retrospective study we could not record body 
weight of the subjects accurately at the time of injury. 
Anecdotally, many subjects reported increases in 
their body weight after injury as a result of a decrease 
in physical activity. Increased body weight has been 
documented as a risk factor for lower extremity 
injuries in some studies (Murphy et al., 2003), and 
therefore has also been suggested as an intrinsic risk 
factor for ATP (Paavola et aI., 2002; Riley, 2004). 
However, to our knowledge no studies have shown 
that increased body weight is a specific risk factor for 
Achilles tendon injuries. It can however be noted that 
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there is a reported interaction of obesity with the 
COL9A3 gene and lumber disc degeneration (8010­
vieva et al., 2002). Therefore, the possible interaction 
of non-genetic factors, such as body weight and 
exposure to physical activity, with the COL5AI 
gene or any other gene needs to be investigated. 
In conclusion, the BstUJ' RFLP within the 
COL5AI gene is associated with ATP and more 
specifically chronic Achilles tendinopathy and that 
the A2 allele of this gene appears to protect indivi­
duals from developing symptoms. 
Perspectives 
Although a genetic predisposition to A TP has been 
suggested, no specific genes have been shown to be 
associated with this pathology. This is the first study 
to demonstrate an association between a polymorph­
ism within a gene expressed in tendons, namely 
COL5Al, and symptoms of A TP in physically active 
individuals. The novel finding of this study is that the 
BstUI RFLP within the 3'-UTR of the COL5AI gene 
is associated with ATP and more specifically chro­
nic Achilles tendinopathy. The association of the 
COL5Al gene with Achilles tendon injuries however 
does not prove that type V collagen, an important 
component of tendons, is directly involved in the 
development of this pathology. Perhaps other closely 
linked genes are involved. Besides the involvement 
of genetic factors, various non-genetic intrinsic and 
COL5Al gene and tendon pathology 
extrinsic factors have been implicated in the etiology 
of ATP. The interaction of these factors with an 
individual's genetic background in the development 
of A TP needs to be investigated. In conclusion, this 
study suggests that individuals with the A2 allele of 
the COL5AI gene are less likely of developing 
symptoms of chronic Achilles tendinopathy. 
Key words: genetics, polymorphism, type V collagen, 
tendinopathy, rupture. 
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The Guanine-Thymine Dinucleotide Repeat 
Polymorphism Within the Tenascin-C Gene 
Is Associated With Achilles Tendon Injuries 
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Background: Although there is a high incidence of tendon injury as a result of participation in physical activity, the mechanisms 
responsible for such injuries are poorly understood. Investigators have suggested that some people may have a genetiC pre­
disposition to develop tendon injuries; in particular, genes on the tip of the long arm of chromosome 9 might, at least in part, be 
associated with this condition. The tenascin-C gene, which has been mapped to chromosome 9q32-q34, encodes for a struc­
tural component of tendons. 
Hypothesis: The tenascin-C gene is associated with Achilles tendon injury. 
Study Design: Case control study; Level of evidence, 3. 
Methods: A total of 114 physically active white subjects with symptoms of Achilles tendon injury and 127 asymptomatic, phys­
ically active white control subjects were genotyped for the guanine-thymine dinucleotide repeat polymorphism within the 
tenascin-C gene. 
Results: A significant difference in the allele frequencies of this polymorphism existed between the 2 groups of subjects ('l = 
51.0, P .001). The frequencies of the alleles containing 12 repeats (symptomatic group, 18.9% vs control group, 10.2%) and 
14 repeats (symptomatic group, 9.2% vs control group, 0.8%) were significantly higher in the symptomatic group, while the fre­
quencies of the alleles containing 13 repeats (symptomatic group, 8.8% vs control group, 24.0%) and 17 repeats (symptomatic 
group, 7.5% vs control group, 20.1 %) were significantly lower in this same group. Subjects who were homozygous or het­
erozygous for the underrepresented alleles (13 and 17 repeats) but who did not possess an overrepresented allele (12 and 14 
repeats) may have a lower risk of developing Achilles tendon injuries (odds ratio, 6.2; 95% confidence interval, 3.5-11.0; P < .001). 
Conclusions: The guanine-thymine dinUCleotide repeat polymorphism within the tenascin-C gene is associated with Achilles 
tendon injury. Alleles containing 12 and 14 guanine-thymine repeats were overrepresented in subjects with tendon injuries, while 
the alleles containing 13 and 17 repeats were underrepresented. 
Clinical Relevance: Persons who have variants of the tenascin-C gene with 12 and 14 guanine-thymine repeats appear to have 
a 6-fold risk of developing Achilles tendon injuries. 
Keywords: genetics; tendinopathy; rupture; risk factor 
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Many Achilles tendon injuries, ranging from chronic 
tendinopathy to rupture, are associated with participation 
in either recreational or competitive sportS.17 To date, 
research on Achilles tendon injury has focused primarily 
on its management rather than on causal mechanisms. 
Both intrinsic and extrinsic factors have nevertheless been 
implicated in the causes of this condition.21,29 Intrinsic fac­
tors believed to be associated with the condition include 
previous injury, increased age, reduced blood supply to the 
tendon, poor nutrition, lower limb malalignment, reduced 
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flexibility, male gender, systemic disease, and corticosteroids 
and quinoline antibiotics. Extrinsic factors include occupa­
tion, physical activity, training errors, cold weather, run­
ning surface, and shoes and other equipment. 
It has also been suggested that certain genetic elements 
are associated with a person's susceptibility to Achilles 
tendon injury. This idea has recently been highlighted by 
the finding of a significantly higher involvement of bilat­
eral Achilles tendon ruptures in subjects with a previous 
unilateral rupture.2 In addition, some investigators have 
shown that persons with blood group 0 are more suscepti­
ble to tendon injuries.16,17,19,20 These findings suggest that 
either the ABO gene or a closely linked gene(s) may be 
associated with tendon injury. 
The extracellular matrix glycoprotein tenascin-C is 
expressed in a variety of tissues, including tendons,24 and 
is encoded by the tenascin-C (TNC) or hexabrachion 
(HXB) gene, which is closely linked to the ABO gene on 
chromosome 9q32_q34.3,31 Tenascin-C binds other compo­
nents of the extracellular matrix and cell receptors, and it 
plays an important role in regulating cell-matrix interac­
tions. l4 In normal adult tendons, it is expressed predomi­
nately in regions responsible for transmitting high levels 
of mechanical force, such as the myotendinous and osteo­
tendinous junctions.7,8,12 The protein is also expressed 
around the cells and collagen fibers of the Achilles tendon. I3 
In addition, Jarvinen et al I2,13 have shown that expression 
ofthe TNC gene is regulated in a dose-dependent manner 
by mechanical loading in tendons. 
Isoforms of the protein, with distinct functions, are pro­
duced by alternative splicing of the primary transcript.5,I4 
Riley et al30 have shown that healthy tendons express a 
small, 200-kd tenascin-C isoform, while degenerate ten­
dons also express a functionally distinct, larger 300-kd iso­
form. In investigating this finding, Ireland et al,11 but not 
Alfredson et aI, I have reported an increase in tenascin-C 
expression in biopsy samples of chronic Achilles 
tendinopathies using cDNA arrays. 
Tenascin-C is an ideal candidate genetic marker of ten­
don injury for the following reasons: (1) Several investiga­
tors have suggested that either the ABO gene or a closely 
linked gene(s) on the tip of the long arm of chromosome 9 
may be associated with Achilles tendon injuries16,17,20; (2) 
the TNC gene has been mapped to chromosome 9q32-q34, 
which is in close proximity to the ABO gene3,3\ (3) the gene 
encodes for tenascin-C, which is an important structural 
component oftendons12,I3; and (4) tenascin-C expression is 
regulated by mechanical stimuli12,13 and altered during 
tendon injury.ll,30 The TNC gene contains a guanine­
thymine (GT) dinucleotide repeat polymorphism (a tan­
dem repeat consisting of a repeated 2-base pair sequence 
ofvarying lengths in different people) within intron 17 (an 
intervening DNA sequence within a gene which does not 
encode for a protein). The influence of this polymorphism 
in the expression of the gene or the biological function of 
tenascin-C is, to our knowledge, unknown. The aim ofthis 
study was therefore to investigate the association of the 
GT dinucleotide repeat polymorphism within intron 17 of 
the TNC gene with Achilles tendon injuries. 
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MATERIALS AND METHODS 
Subjects 
The Medical Practice at the Sports Science Institute of 
South Africa and other clinical practices within the greater 
Cape Town area of South Africa invited patients with a 
current or past Achilles tendon injury (ATI) to participate 
in the study. Eligible patients were sent a letter informing 
them about the study and requesting those interested in 
volunteering to contact one of the investigators (G.G.M.). 
As a result, 114 physically active white patients with 
symptomatic Achilles tendon injuries (72 chronic Achilles 
tendinopathies and 42 acute Achilles tendon ruptures) 
were recruited for this study. 
The diagnostic criteria for every subject were reviewed 
by one of the investigators (M.P.S'). The clinical diagnostic 
criterion for the subjects with chronic Achilles tendinopa­
thy was gradual, progressive pain in the posterior lower 
limb, localized to the Achilles tendon by manual examina­
tion, for longer than 6 months. In addition, one of the fol­
lowing criteria had to be fulfilled for inclusion in the study: 
(1) early-morning pain in the Achilles tendon area, (2) 
early-morning stiffness in the Achilles tendon area, (3) his­
tory of swelling in the Achilles tendon area, (4) tenderness 
to palpation in the Achilles tendon, (5) palpable nodular 
thickening in the affected Achilles tendon, or (6) move­
ment of the painful area in the Achilles tendon with plan­
tar-dorsiflexion (positive shift test).18,28,32 The diagnosis 
was confirmed by soft tissue ultrasound examination of 
the affected Achilles tendon in 22 subjects with tendinopathy. 
For the subjects with Achilles tendon rupture, the diag­
nosis was made clinically using standard criteria.23,25,32 In 
all cases of rupture, the diagnosis was confirmed by either 
examination at the time of surgery, ultrasound imaging, 
MRI, or CT scan. 
In addition, 127 apparently healthy physically active 
white subjects without any history of symptomatic 
Achilles tendon injuries were recruited as a control (CON) 
group for this study. The ATI and CON groups were simi­
larly matched for age, gender, and, to avoid any possible 
effects of population stratification, country of birth. 
Approval of this study was obtained from the Research 
Ethics Committee of the Faculty of Health Sciences within 
the University of Cape Town (Reference Number 
170/2002). Once recruited, the subjects were required to 
sign an informed consent form, as well as to provide per­
sonal information and to complete physical activity and 
medical history questionnaires before participation. 
Sample Collection, Total DNA Extraction, 
and Blood Grouping Analysis 
Approximately 4.5 mL of venous blood was obtained from 
each subject by venipuncture of a forearm vein and col­
lected into an ethylenediaminetetraacetic acid (EDTA) 
vacutainer tube. Blood samples were stored at 4°C until 
total DNA extraction, as described by Lahiri and 
Nurnberger,22 could be undertaken, 
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TABLE 1 

Characteristics of the Control (CON) and 

Achilles Tendon Injury (AT!) Groupsc 

CON (n =127) ATI (n =114) 
Age,y 40.4 ± 10.8 (120) 39.8 ± 13.3b (112) 
Height, cm 175 ± 9 (120) 176 ± 9 (112) 
Weight, kg 71.4 ± 11.9 (123) 80.8 ± 15.3 (112r 
Body mass index, 
kg/cm2 23.3 ± 2.7 (120) 26.0 ± 4.0 (112)" 
Gender, % males 63.5 (126) 72.8 (114) 
Country of birth, 
% South Africa 69.7 (122) 76.6 (111) 
4Values are expressed as means ± standard deviations or per­
centages where applicable. Numbers of subjects are in parenthe­
ses. 
bAge at onset of symptoms. 
cp < .001. 
TNC Genotyping 
The GT dinucleotide repeat polymorphism within the TNC 
gene was polymerase chain reaction (PCR)-amplified as 
described by Ozelius et a1.27 The resultant PCR products 
were resolved with 4% polyacrylamide gels using an ABI 
PRISM 377 DNA sequencer (Applied Biosystems, Foster 
City, Calif). 
Statistical Analyses 
Data were analyzed using the STATISTICA version 6.1 
program (StatSoft Inc, Tulsa, Okla). A I-way analysis of 
variance was used to determine any significant differences 
between the characteristics of the ATI and CON groups. A 
Pearson 'l test was used to analyze any differences in gen­
der and country of birth between the experimental groups. 
The allele frequencies of the TNC gene were analyzed 
using the Monte Carlo test (CLUMP program, version 
2.0).33 The odds ratios and 95% confidence intervals were 
determined using GraphPad InStat version 2.05a 
(GraphPad Software, San Diego, Calif). Where applicable, 
data were presented as means ± standard deviations or as 
frequencies with numbers of subjects in parentheses. 
Statistical significance was accepted when P < .05. 
RESULTS 
Subject Characteristics 
The ATI and CON subjects were similarly matched for age, 
height, gender, and country of birth (Table 1). The ATI 
group, however, was significantly heavier, with a corre­
sponding higher body mass index than that of the CON 
group. 
In the ATI group, 72 subjects were diagnosed with 
chronic Achilles tendinopathy and 42 with either a partial 
(n = 3) or complete (n = 39) rupture of the Achilles tendon. 
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TABLE 2 

Participation in Physical Activity and Training of the 

Control (CON) and Achilles Tendon Injury (AT!) Groupsc 

CON (n = 127) AT! (n =114) 
Running, y 7.9 ± 8.1 (127) 8.5 ± 10.6 (114) 
Running in the 
past 2 years, 
hlwk 3.3 ± 2.9 (123) 2.0 ± 2.6 (102)6 
High-impact 
sports, y 11.5 ± 8.6 (127) 19.6 ± 13.0 (114)b 
High-impact sports 
in the past 2 years, 
hlwk 5.1 ± 4.9 (127) 3.9 ± 5.0 (114) 
"Values are expressed as means ±standard deviations. Numbers 
of subjects are in parentheses. 
bp < .001. 
Seventeen patients had a history of tendinopathy before 
the rupture. In addition, 41 subjects diagnosed with 
Achilles tendon rupture experienced acute pain in the pos­
terior lower leg. The diagnosis in the group with acute rup­
tures was confirmed at the time of surgery (37 patients), 
with soft tissue diagnostic ultrasound (5 patients), MRI (2 
patients), or CT scan (1 patient). Diagnosis was confirmed 
by surgery as well as by one of the imaging techniques in 
3 patients. In the subjects diagnosed with tendinopathy, 70 
patients experienced gradual progressive pain, 59 were 
tender to palpation, while 16,39, and 23 patients reported 
early-morning pain, early-morning stiffness, and a history 
of swelling, respectively. Palpable thickening was docu­
mented in 13 patients, and a positive shift test was docu­
mented in 8 patients. Twenty-two of the tendinopathy 
diagnoses were confirmed by ultrasound. Thirty subjects 
in the ATI group had bilateral Achilles tendon injuries 
(tendinopathy or rupture). 
The majority of subjects injured the Achilles tendon 
while running (n 49, 43.0%) or playing squash (n = 19, 
16.7%). Because 65% of the subjects participated in dis­
tance running, the ATI and CON groups were matched for 
the number ofyears they participated in running activities 
(P =.651) (Table 2). During the past 2 years, the ATI sub­
jects trained for running significantly less than did the 
CON group (P < .001). The ATI group, however, participated 
for significantly more years in high-impact sports than did 
the CON group (P < .001). There was no significant differ­
ence in the hours of training in high-impact sports during 
the past 2 years between the 2 groups (P = .07). 
TNC Genotyping 
As shown in Table 3, 18 different alleles (alternative forms 
of a specific gene) of the GT dinucleotide repeat polymor­
phism within the TNC gene were identified within the 2 
groups (ATI, 14 alleles; CON, 15 alleles). The number of 
GT repeats within the identified alleles ranged from 3 to 
21, with 95.0% of the alleles containing between 12 and 17 
repeats. There was a significant difference in the distribu­
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Figure 1. Allele frequencies of the guanine-thymine (GT) din­
ucleotide repeat polymorphism within the tenasin-C gene of 
the asymptomatic control (CON) and symptomatic Achilles 
injury (ATI) groups. The frequencies of the rare alleles contain­
ing less than 11 and greater than 18 repeats are not shown. 
0, overrepresented alleles; U, underrepresented alleles. 
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Figure 2. Genotype frequencies of the guanine-thymine (GT) 
dinucleotide repeat polymorphism within the tenasin-C gene 
of the asymptomatic control (CON) and symptomatic Achilles 
injury (ATI) groups. 0, overrepresented alleles containing 12 
or 14 GT dinucleotide repeats; U. underrepresented alleles 
containing 13 or 17 repeats; E, evenly distributed alleles. 
tion of the alleles between the ATI and CON groups (X2 = 
51.0, P = .001), with the alleles containing 12 and 14 GT 
dinucleotide repeats being significantly overrepresented 
in the ATI group (X2 =21.6, P < .001) (Table 3 and Figure 
1). The alleles containing 13 and 17 repeats were, on the 
other hand, significantly underrepresented in the ATI sub­
jects (X2 = 42.4, P < .001) (Table 3 and Figure 1). Alleles 
were grouped according to those significantly overrepre­
sented, containing 12 or 14 GT dinucleotide repeats (0), 
those significantly underrepresented, containing 13 or 17 
repeats (U), or alleles evenly distributed (E), and were 
then paired by genotype (genetic constitution) (Figure 2). 
Subjects with a genotype ofUU (32 CON, 25.2% vs 9 ATI, 
7.9%) or UE (47 CON, 37.0% vs 15 AT!, 13.2%) were sig­
nificantly underrepresented in the AT! group (odds ratio, 
6.2; 95% confidence interval, 3.5-11.0; P < .001). With 
respect to the 0 alleles, subjects who were either homozy-
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TABLE 3 

The Distributions of the TNC Gene's 18 Guanine­

Thymine (GT) Dinucleotide Repeat Polymorphism 

Alleles Within the Control (CON) and 

Achilles Tendon Injury (AT!) GroupsG 

Number of 

GT Repeati CON (n =254) AT! (n =228) 

3 	 0.4 (1) 0.4 (1) 
4 	 0.4 (1) 0.0 (0) 
5 	 0.4 (1) 0.4 (1) 
6 	 0.4 (1) 1.3 (3) 

•
7 	 0.0 (0) 0.4 (1) 
8 	 0.4 (1) 0.0 (0) 
9 	 0.0 (0) 0.4 (1) 
11 0.0 (0) 1.3 (3) 
12< 10.2 (26) 18.9 (43) 
13d 24.0 (61) 8.8 (20) 
14' 0.8 (2) 9.2 (21) 
15 17.3 (44) 21.5 (49) 
16 22.8 (58) 28.9 (66) 
17d 20.1 (51) 7.5 (17) 
18 	 1.2 (3) 0.4 (1) 
19 	 0.4 (1) 0.0 (0) 
20 	 0.4 (1) 0.4 (1) 
21 	 0.8 (2) 0.0 (0) 
aValues are expressed as percentages (numbers of alleles). 
"The number of GT repeats was calculated from the size of the 
polymerase chain reaction products and the published sequence, 
accession no. Z11654. 
<Alleles significantly overrepresented within the AT! group (12 
repeats, P .010 and 14 repeats, P < .001). 
dAlleles significantly underrepresented in the ATI group (13 
repeats, P < .001 and 17 repeats, P < .001). 
gous (containing 2 identical alleles; 00) or heterozygous 
(containing 2 different alleles; OE or OU) were overrepre­
sented in the AT! subjects (00 = 5 CON, 3.9% vs 14 AT!, 
12.3%; OE = 17 CON, 13.4% vs 32 ATI, 28.1%; OU = 1 
CON, 0.8% va 4 AT!, 3.5%). Interestingly, the frequency of 
the EE genotype was higher in the ATI group (n = 40, 
35.1%) than in the CON group (n = 25, 19.7%) (Figure 2). 
DISCUSSION 
The novel finding of this study was that the allele distri­
butions ofthe GT dinucleotide repeat polymorphism within 
the TNC gene were significantly different between the 
subjects presenting with symptoms of Achilles tendon 
injuries and the asymptomatic subjects. The frequency of 
the alleles containing 12 and 14 GT repeats was signifi­
cantly higher in the symptomatic subjects, whereas the 
frequency of the alleles containing 13 and 17 GT repeats 
was significantly higher in the asymptomatic control sub­
jects. Further analysis demonstrated that those subjects 
who were homozygous or heterozygous for the underrepre­
sented alleles (containing either 13 or 17 GT repeats) were 
6.2 times less likely to develop injuries of the Achilles ten­
don. The heterozygous subjects did not contain an allele 
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with either 12 or 14 repeats. Interestingly, Ar0en et al2 
have recently suggested, based on their findings, that 
there was an increased risk for a rupture of the contralat­
eral Achilles tendon in patients who had previously rup­
tured the other side, that a genetic predisposition for 
Achilles tendon ruptures is likely. 
Tenascin-C is expressed in numerous tissues and, in 
particular, areas subject to high tensile stress such as ten­
dons, ligaments, and arterial walls. lo The expression of 
this extracellular matrix protein is usually absent or very 
low in fully differentiated tissues but is upregulated dur­
ing embryogenesis, tissue regeneration, wound healing, 
and certain pathologic conditions.1O.14.15 Tenascin-C has a 
characteristic modular structure consisting of a tenascin 
assembly (TA) domain, heptad repeats, epidermal growth 
factor (EGF)-like repeats, fibronectin type III (FN-UD 
domains, and fibrinogen-like globular domain.5•14 Because 
of its modular structure, the protein is able to interact 
with various other proteins such as fibronectin and with 
glycosaminoglycan components of the extracellular 
matrix. The glycosaminoglycan components include the 
family of chondroitin sulphate proteoglycans known as lec­
ticans (aggrecan, versican, brevican, and neurocan). 
Tenascin-C also interacts with numerous cell surface 
receptors, such as integrins, cell adhesion molecules 
(CAM), and annexin II. These diverse interactions are 
believed to play an important role in regulating cell­
matrix interactions. 
Investigators have suggested that apoptosis of tendon 
cells precedes tendinopathy.26 Abnormal mechanical load­
ing is believed to initiate this programmed cell death in 
tendons. Because mechanical signals are able to alter the 
synthesis of tenascin-C,6.7.9 which in turn is able to regu­
late cell-matrix interactions, it is tempting to speculate 
that this protein may play an important role in the pro­
posed apoptotic model of tendinopathy. This theory invites 
future study. 
The association of the TNC gene with symptoms of 
Achilles tendon injury does not prove that the tenascin-C 
protein is involved in a cause-effect relationship. It is also 
possible that another gene(s) within this locus may be 
involved. In addition, it is highly unlikely that a single 
gene on chromosome 9q32-q34 is exclusively associated 
with the development of Achilles tendon injuries, since 
numerous proteins are involved in tendon structure, 
development, and regeneration.4•34 These alternative pos­
sibilities need to be further investigated. 
Besides the involvement of genetic factors, investigators 
have identified a number of nongenetic intrinsic and 
extrinsic factors that are implicated in the development of 
Achilles tendon injuries. These factors include body 
weight, type of activity, and type oftraining.29 Because the 
subjects in this study with symptoms of Achilles tendon 
injury were significantly heavier and had participated for 
significantly more years in high-impact sports than the 
asymptomatic control subjects, any possible interactions of 
weight and load with genetic background in the develop­
ment of Achilles tendon injury cannot be excluded and 
needs to be further investigated. Nevertheless, although 
Achilles tendon injuries are typically chronic, the first 
The American Journal ofSports Medicine 
symptoms usually develop within the first few years of 
beginning regular weightbearing physical activity. 
Because the subjects in the control group had been active 
for an average of 11.5 years and were currently partici­
pating in high-impact sports for an average of 5 hours per 
week, it seems improbable that their apparent resistance 
to Achilles tendon injuries was due purely to a lesser expo­
sure to high-impact loading of their Achilles tendons. 
In conclusion, the GT dinucleotide repeat polymorphism 
within intron 17 of the TNC gene is associated with the 
symptoms of chronic Achilles tendon injury. Alleles con­
taining 12 and 14 GT repeats were overrepresented in sub­
jects with Achilles tendon injuries, while the alleles con­
taining 13 and 17 repeats were underrepresented. 
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Appendix 5.1 Calculation of Intra-Class Coefficient (ICC) or R 

Example: Using the dominant passive straight leg raise (D-SLR) 

Step 1. Perform a repeated measures analysis ofvariance and obtain the following 

results; 

Effect 	 SS df MS F P 
Subjects 12686.4 16 792.9 
D-SLR (trials) 65.0 1 65.0 3.0982 0.097480 
D-SLR X Subjects (residuals) 335.5 16 21.0 
Key: SS, sum of squares; df, degrees of freedom; MS, mean square; F, calculated F 

value; P, significant level. 

Step 2. Calculate MS error using the following equation: 

MS error (SS trials + SS residuals) / (dftrials + dfresiduals) 

(65.0 + 335.5) / (1 + 16) 

= 400.5/17 

23.55882353 
Step 3. Calculation ofR (or ICC) 
R = (MS subjects MS error) / MS subjects 
(792.9 23.55882353) / 792.9 

769.3411765 / 792.9 

0.970287774 

0.970 
References: 
1. 	 Thomas JR and Nelson JK. (1996). Research methods in physical activity. 3rd Ed. 
Human Kinetics, Champaign, IL; 220-224. 
2. 	 Vincent WJ. (1999). Statistics in Kinesiology. 2nd Ed. Human Kinetics, 

Champaign,IL; 182-185. 
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Appendix 5.1 continued 

Raw data from an excel spreadsheet showing the calculations for ICC (R) 

! 
iF trials ip trialsVariable SStrials SSresidu DFtrials DFresidu MS error MSsubj R 
D-SLR 65 335.5 1 16 23.55882 792.9 0.970288 3.09821 0.09748 
ND-SLR 4.6 346.3 1 16 20.64118 723.8 0.971482 0.2123 0.65114 
D-Sho ER 26.5 489.8 I 16 30.37059 220.9 0.862514 0.865 0.3662361 
D-Sho IR 0.2 182.7 I 16 10.75882 131.3 0.918059 0.0161 0.9006141 
ND-Sho ER 11.2 391.7 I 16 23.7 222.4 0.893435 0.457 0.508756 
ND-ShoIR 8.5 179 1 16 11.02941 99.9 0.889595 0.76 0.39629 
D-HipER 1.2 117.1 1 16 6.958824 286.8 0.975736 0.1697 0.685808 
D-Hip IR 89 230.8 1 16 18.81176 .9 0.864566 6.1684 0.0244641 
ND-Hip ER 3.6 307.4 1 16 18.29412 300.2 0.93906 0.1852 0.672674i 
IND-Hip IR 16.9 211.1 I 16 13.41176 134.9 0.90058 1.2843 0.273801 
D-ADF 78 195.9 1 16 16.11176 106 0.848002 6.372 0.022542 
ND-ADF 14.2 296.3 1 16 18.26471 272.7 0.933023 0.7688 0.3935671 
D-ElbExt 0.3 180.7 1 16 10.64706 66.6 0.840134 0.023 0.880249 
D-Elb Fie 1.1 221.4 1 16 13.08824 50 0.738235 0.077 0.785633 
1 
ND-Elb Ext 28.3 148 I 16 10.37059 51.5 0.798629 3.056 0.0996! 
ND-Elb Fie 29.2 18104 I 16 12.38824 47 0.736421 2.574 0.128221 
SR 0.12 13.63 1 16 0.808824 176.02 0.995405 0.1381 0.715072 
Legend: D, Dominant; ND, Non-Dominant; Sho ER, Shoulder External Rotation, Sho JR, Shoulder 
Internal Rotation; Elb Ext, Elbow Extension, li:lb Fie, Elbow Flexion, Hip ER, Hip External Rotation; Hip 
IR, Hip Internal Rotation; SLR, Straight Leg Raise; ADF, Ankle Dorsiflexion; SR, Sit and Reach 
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Appendix 6.1 Radiological data sheet used in the Achilles tendon injury study 
Subject Name & Age: Date: 
CODE 
Variable Right Leg Left Leg 
I.Musculotendinous Normal 0 Normal 0 
i Junction Abnormal 1 Abnormal 1 
2.Shape Normal 0 Normal 0 
Fusiform 1 Fusiform 1 
3.Ap sagittal 
diameter (cm) 
4.Ap transverse 
diameter (cm) 
5.Colour Doppler Normal 0 tvasc(tendon) 1 Normal 0 tvasc(tendon) 1 
tvasc(paraten) 1 tvasc(paraten) 1 
6.Kager's Fat Pad Normal 0 tEchogenecity 1 Normal 0 tEchogenecity 1 
7.Retrocalcaneal Retrocalcaneal: Normal 0 Retrocalcaneal: Normal 0 
Bursar 
Abnormal 1 Abnormal 1 
8.Echogenecity Normal Hypoechogenic Normal Hypoechogenic 
0 1 0 1 
9.Calcaneous Normal Abnormal Normal Abnormal 
0 1 0 1 
10.Miscellaneous Normal Abnormal Normal Abnormal 
0 1 0 1 
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